Sabra Health Care REIT (SBRA) 10-K 25 Feb 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2018	Feb. 20, 2019	Jun. 30, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	Sabra Health Care REIT, Inc.
Entity Central Index Key	1,492,298
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		178,323,071
Entity Well-known Seasoned Issuer	Yes
Entity Shell Company	false
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 3.8

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Assets
Real estate investments, net of accumulated depreciation of $402,338 and $340,423 as of December 31, 2018 and 2017, respectively	$ 5,853,545	$ 5,994,432
Loans receivable and other investments, net	113,722	114,390
Investment in unconsolidated joint venture	340,120	0
Cash and cash equivalents	50,230	518,632
Restricted cash	9,428	68,817
Lease intangible assets, net	131,097	167,119
Accounts receivable, prepaid expenses and other assets, net	167,161	168,887
Total assets	6,665,303	7,032,277
Liabilities
Secured debt, net	115,679	256,430
Revolving credit facility	624,000	641,000
Term loans, net	1,184,930	1,190,774
Senior unsecured notes, net	1,307,394	1,306,286
Accounts payable and accrued liabilities	94,827	102,523
Lease intangible liabilities, net	83,726	98,015
Total liabilities	3,410,556	3,595,028
Commitments and contingencies (Note 17)
Equity
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of December 31, 2017	0	58
Common stock, $.01 par value; 250,000,000 shares authorized, 178,306,528 and 178,255,843 shares issued and outstanding as of December 31, 2018 and 2017, respectively	1,783	1,783
Additional paid-in capital	3,507,925	3,636,913
Cumulative distributions in excess of net income	(271,595)	(217,236)
Accumulated other comprehensive income	12,301	11,289
Total Sabra Health Care REIT, Inc. stockholders’ equity	3,250,414	3,432,807
Noncontrolling interests	4,333	4,442
Total equity	3,254,747	3,437,249
Total liabilities and equity	$ 6,665,303	$ 7,032,277

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Assets
Accumulated depreciation	$ 402,338	$ 340,423
Equity
Preferred stock, par value (in dollars per share)		$ 0.01
Preferred stock, shares authorized		10,000,000
Preferred stock, shares issued		5,750,000
Preferred stock, shares outstanding		5,750,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	178,306,528	178,255,843
Common stock, shares outstanding	178,306,528	178,255,843

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenues:
Rental income	$ 536,605	$ 364,191	$ 225,275
Interest and other income	16,667	15,026	27,463
Resident fees and services	70,137	26,430	7,788
Total revenues	623,409	405,647	260,526
Expenses:
Depreciation and amortization	191,379	113,882	68,472
Interest	147,106	88,440	64,873
Operating expenses	49,546	17,860	5,703
General and administrative	36,458	32,401	17,672
Merger and acquisition costs	636	30,255	1,197
Provision for doubtful accounts, straight-line rental income and loan losses	39,075	17,113	5,543
Impairment of real estate	1,413	1,326	29,811
Total expenses	465,613	301,277	193,271
Other income:
Loss on extinguishment of debt	(2,917)	(553)	(556)
Other income	4,480	3,170	10,677
Net gain (loss) on sales of real estate	128,198	52,029	(6,122)
Total other income	129,761	54,646	3,999
Income before loss from unconsolidated joint venture and income tax expense	287,557	159,016	71,254
Loss from unconsolidated joint venture	(5,431)	0	0
Income tax expense	(3,011)	(651)	(1,049)
Net income	279,115	158,365	70,205
Net (income) loss attributable to noncontrolling interests	(33)	18	71
Net income attributable to Sabra Health Care REIT, Inc.	279,082	158,383	70,276
Preferred stock dividends	(9,768)	(10,242)	(10,242)
Net income attributable to common stockholders	$ 269,314	$ 148,141	$ 60,034
Net income attributable to common stockholders, per:
Basic common share (in dollars per share)	$ 1.51	$ 1.40	$ 0.92
Diluted common share (in dollars per share)	$ 1.51	$ 1.40	$ 0.92
Weighted-average number of common shares outstanding, basic (in shares)	178,305,738	105,621,242	65,284,251
Weighted-average number of common shares outstanding, diluted (in shares)	178,721,744	105,842,434	65,520,672

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement of Comprehensive Income [Abstract]
Net income		$ 279,115	$ 158,365	$ 70,205
Unrealized gain (loss), net of tax:
Foreign currency translation gain (loss)		720	154	(1,634)
Unrealized gain on cash flow hedges	[1]	292
Unrealized gain on cash flow hedges	[1]		12,933	7,169
Total other comprehensive income		1,012	13,087	5,535
Comprehensive income		280,127	171,452	75,740
Comprehensive (income) loss attributable to noncontrolling interest		(33)	18	71
Comprehensive income attributable to Sabra Health Care REIT, Inc.		$ 280,094	$ 171,470	$ 75,811
[1]	Amounts are net of income tax benefit of $48,000 and expense of $0.1 million for the years ended December 31, 2018 and 2017, respectively, and none for the year ended December 31, 2016.

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement of Comprehensive Income [Abstract]
Income tax expense (benefit) on unrealized gains on cash flow hedges	$ (48,000)
Income tax expense (benefit) on unrealized gains on cash flow hedges		$ 100,000	$ 0

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Total Stockholders’ Equity	Preferred Stock	Common Stock	Additional Paid-in Capital	Cumulative Distributions in Excess of Net Income	Accumulated Other Comprehensive (Loss) Income	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2015			5,750,000	65,182,335
Beginning balance at Dec. 31, 2015	$ 1,053,876	$ 1,053,770	$ 58	$ 652	$ 1,202,541	$ (142,148)	$ (7,333)	$ 106
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	70,205	70,276				70,276		(71)
Other comprehensive income	5,535	5,535					5,535
Amortization of stock-based compensation	8,559	8,559			8,559
Common stock issuance, net (in shares)				134,509
Common stock issuance, net	(1,512)	(1,512)		$ 1	(1,513)
Repurchase of common stock (in shares)				(31,230)
Repurchase of common stock	(725)	(725)			(725)
Preferred dividends	(10,242)	(10,242)				(10,242)
Common dividends	(110,087)	(110,087)				(110,087)
Ending balance (in shares) at Dec. 31, 2016			5,750,000	65,285,614
Ending balance at Dec. 31, 2016	1,015,609	1,015,574	$ 58	$ 653	1,208,862	(192,201)	(1,798)	35
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	158,365	158,383				158,383		(18)
Other comprehensive income	13,087	13,087					13,087
Change in noncontrolling interests	4,455							4,455
Distributions to noncontrolling interests	(30)							(30)
Amortization of stock-based compensation	9,244	9,244			9,244
Common stock issuance, net (in shares)				112,970,229
Common stock issuance, net	2,419,937	2,419,937		$ 1,130	2,418,807
Preferred dividends	(10,242)	(10,242)				(10,242)
Common dividends	(173,176)	(173,176)				(173,176)
Ending balance (in shares) at Dec. 31, 2017			5,750,000	178,255,843
Ending balance at Dec. 31, 2017	3,437,249	3,432,807	$ 58	$ 1,783	3,636,913	(217,236)	11,289	4,442
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of ASU 2017-12 adoption						(795)	795
Net income (loss)	279,115	279,082				279,082		33
Other comprehensive income	217	217					217
Distributions to noncontrolling interests	(142)							(142)
Amortization of stock-based compensation	9,574	9,574			9,574
Preferred stock redemption (in shares)			(5,750,000)
Preferred stock redemption	(143,750)	(143,750)	$ (58)		(138,191)	(5,501)
Common stock issuance, net (in shares)				50,685
Common stock issuance, net	(371)	(371)		$ 0	(371)
Preferred dividends	(4,267)	(4,267)				(4,267)
Common dividends	(322,878)	(322,878)				(322,878)
Ending balance (in shares) at Dec. 31, 2018			0	178,306,528
Ending balance at Dec. 31, 2018	$ 3,254,747	$ 3,250,414	$ 0	$ 1,783	$ 3,507,925	$ (271,595)	$ 12,301	$ 4,333

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement of Stockholders' Equity [Abstract]
Common dividends (in dollars per share)	$ 1.80	$ 1.73	$ 1.67

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net income	$ 279,115	$ 158,365	$ 70,205
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	191,379	113,882	68,472
Amortization of above and below market lease intangibles, net	7,701	(912)	0
Non-cash interest income adjustments	(2,300)	(769)	582
Non-cash interest expense	10,137	7,776	5,678
Stock-based compensation expense	7,648	8,359	7,496
Loss on extinguishment of debt	874	553	556
Straight-line rental income adjustments	(44,144)	(29,440)	(21,984)
Provision for doubtful accounts, straight-line rental income and loan losses	39,075	17,113	5,543
Change in fair value of contingent consideration	0	(426)	(1,526)
Net (gain) loss on sales of real estate	(128,198)	(52,029)	6,122
Impairment of real estate	1,413	1,326	29,811
Loss from unconsolidated joint venture	5,431	0	0
Distributions of earnings from unconsolidated joint venture	8,910	0	0
Changes in operating assets and liabilities:
Accounts receivable, prepaid expenses and other assets, net	(6,753)	(16,811)	(2,339)
Accounts payable and accrued liabilities	(11,745)	(71,198)	7,312
Net cash provided by operating activities	358,543	135,789	175,928
Cash flows from investing activities:
Acquisition of real estate	(261,511)	(419,905)	(153,579)
Cash received in CCP Merger	0	77,859	0
Origination and fundings of loans receivable	(50,731)	(17,239)	(9,675)
Origination and fundings of preferred equity investments	(5,313)	(2,749)	(7,348)
Additions to real estate	(27,697)	(6,954)	(1,003)
Repayments of loans receivable	51,789	32,430	215,962
Repayments of preferred equity investments	6,870	3,755	0
Investment in unconsolidated joint venture	(354,461)	0	0
Net proceeds from sales of real estate	382,560	150,243	98,006
Net cash (used in) provided by investing activities	(258,494)	(182,560)	142,363
Cash flows from financing activities:
Net repayments of revolving credit facility	(17,000)		(229,000)
Net borrowings from revolving credit facility		253,000
Proceeds from term loans	0	181,000	69,360
Principal payments on secured debt	(140,338)	(4,145)	(14,768)
Payments of deferred financing costs	(352)	(15,337)	(5,937)
Payment of contingent consideration	0	(382)	0
Distributions to noncontrolling interests	(142)	(30)	0
Preferred stock redemption	(143,750)	0	0
Issuance of common stock, net	(499)	366,800	(1,289)
Dividends paid on common and preferred stock	(325,220)	(182,089)	(119,264)
Net cash (used in) provided by financing activities	(627,301)	598,817	(300,898)
Net (decrease) increase in cash, cash equivalents and restricted cash	(527,252)	552,046	17,393
Effect of foreign currency translation on cash, cash equivalents and restricted cash	(539)	738	25
Cash, cash equivalents and restricted cash, beginning of period	587,449	34,665	17,247
Cash, cash equivalents and restricted cash, end of period	59,658	587,449	34,665
Supplemental disclosure of cash flow information:
Interest paid	137,668	69,686	59,234
Income taxes paid	1,800	714	854
Supplemental disclosure of non-cash investing and financing activities:
Acquisition of business in CCP Merger (see Note 3)	0	3,726,092	0
Assumption of indebtedness in CCP Merger	0	(1,751,373)	0
Stock exchanged in CCP Merger	0	(2,052,578)	0
Real estate acquired through loan receivable foreclosure	0	19,096	10,100
Decrease in loans receivable and other investments due to acquisition of real estate	$ 0	$ (6,913)	$ 0

BUSINESS

BUSINESS	12 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BUSINESS	BUSINESS Overview Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) was incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group, Inc. (“Sun”) and commenced operations on November 15, 2010 following Sabra’s separation from Sun (the “Separation Date”). Sabra elected to be treated as a real estate investment trust (“REIT”) with the filing of its United States (“U.S.”) federal income tax return for the taxable year beginning January 1, 2011. Sabra believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. Sabra’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. Sabra primarily generates revenues by leasing properties to tenants and operators throughout the United States and Canada. Sabra owns substantially all of its assets and properties and conducts its operations through Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), of which Sabra is the sole general partner and a wholly owned subsidiary of Sabra is currently the only limited partner, or by subsidiaries of the Operating Partnership. The Company’s investment portfolio is primarily comprised of skilled nursing/transitional care facilities, senior housing communities and specialty hospitals and other facilities, in each case leased to third-party operators; senior housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing - Managed”); investments in loans receivable; preferred equity investments; and an investment in an unconsolidated joint venture. On May 7, 2017, the Company, the Operating Partnership, PR Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“Merger Sub”), Care Capital Properties, Inc., a Delaware corporation (“CCP”), and Care Capital Properties, L.P. (“CCPLP”), a Delaware limited partnership and wholly owned subsidiary of CCP, entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which, on August 17, 2017, CCP merged with and into Merger Sub, with Merger Sub continuing as the surviving corporation (the “CCP Merger”), following which Merger Sub merged with and into the Company, with the Company continuing as the surviving entity (the “Subsequent Merger”), and, simultaneous with the Subsequent Merger, CCPLP merged with and into the Operating Partnership, with the Operating Partnership continuing as the surviving entity. Pursuant to the Merger Agreement, as of the effective time of the CCP Merger, each share of CCP common stock, par value $0.01 per share, issued and outstanding immediately prior to the effective time of the CCP Merger (other than shares of CCP common stock owned directly by CCP, the Company or their respective subsidiaries, in each case not held on behalf of third parties) was converted into the right to receive 1.123 newly issued shares of Company common stock, par value $0.01 per share, plus cash in lieu of any fractional shares. See Note 3, “CCP Merger and Recent Real Estate Acquisitions,” for additional information regarding the CCP Merger. The acquisition of CCP has been reflected in the Company’s consolidated financial statements since the effective date of the CCP Merger.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation and Basis of Presentation The accompanying consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries as of December 31, 2018 and 2017 and for the years ended December 31, 2018 , 2017 and 2016 . All significant intercompany transactions and balances have been eliminated in consolidation. The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). GAAP requires the Company to identify entities for which control is achieved through voting rights or other means and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity’s activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity’s activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity’s activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary. The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis. As of December 31, 2018 , the Company determined that it was the primary beneficiary of one VIE—a joint venture variable interest entity owning one skilled nursing/transitional care facility—and has consolidated the operations of this entity in the accompanying consolidated financial statements. As of December 31, 2018 , the Company determined that the operations of this entity were not material to the Company’s results of operations, financial condition or cash flows. As it relates to investments in loans, in addition to the Company’s assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine whether the loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower’s expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At December 31, 2018 and 2017 , none of the Company’s investments in loans were accounted for as real estate joint ventures. As it relates to investments in joint ventures, the Company assesses any limited partners’ rights and their impact on the presumption of control of the limited partnership by any single partner. The Company also applies this guidance to managing member interests in limited liability companies. The Company reassesses its determination of which entity controls the joint venture if: there is a change to the terms or in the exercisability of the rights of any partners or members, the sole general partner or managing member increases or decreases its ownership interests, or there is an increase or decrease in the number of outstanding ownership interests. As of December 31, 2018 , the Company’s determination of which entity controls its investments in joint ventures has not changed as a result of any reassessment. Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. Reclassifications Certain amounts in the Company’s consolidated statements of cash flows for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods. Real Estate Investments and Rental Revenue Recognition Real Estate Acquisition Valuation All assets acquired and liabilities assumed in an acquisition of real estate accounted for as a business combination are measured at their acquisition date fair values. For acquisitions of real estate accounted for as an asset acquisition, the fair value of consideration transferred by the Company (including transaction costs) is allocated to all assets acquired and liabilities assumed on a relative fair value basis. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of above market lease, tenant origination and absorption costs and tenant relationship intangible assets is included in lease intangible assets, net on the accompanying consolidated balance sheets. The acquisition value of below market lease intangible liabilities is included in lease intangible liabilities, net on the accompanying consolidated balance sheets. Acquisition costs associated with real estate acquisitions deemed asset acquisitions are capitalized, and costs associated with real estate acquisitions deemed business combinations are expensed as incurred. The Company capitalized $0.7 million and $1.0 million of acquisition costs during the years ended December 31, 2018 and 2017 , respectively. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the years ended December 31, 2018 , 2017 and 2016 , the Company expensed $0.6 million , $30.3 million and $1.2 million , respectively, of merger and acquisition costs. Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the Company’s evaluation of the specific characteristics of each tenant’s lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income. Depreciation and Amortization Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of tenant origination and absorption costs and tenant relationship lease intangibles are included in depreciation and amortization on the accompanying consolidated statements of income. Amortization of above and below market lease intangibles is included in rental income on the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, five to 20 years; buildings and building improvements, seven to 40 years; and furniture and equipment, three to 20 years. Intangibles are generally amortized over the remaining noncancellable lease terms, with tenant relationship intangible amortization periods including extension periods of up to 10 years . Impairment of Real Estate Investments The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through the undiscounted future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential future cash flows. In these instances, the undiscounted future cash flows used to assess recoverability are probability-weighted based on the Company’s best estimates as of the date of evaluation. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments. Revenue Recognition The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when collectability is reasonably assured. Certain of the Company’s leases provide for contingent rents equal to a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the applicable base amount or other threshold. The Company makes estimates of the collectability of its tenant receivables related to base rents, straight-line rent and other revenues. When the Company analyzes accounts receivable and evaluates the adequacy of the allowance for doubtful accounts, it considers such things as historical bad debts, tenant creditworthiness, current economic trends, facility operating performance, lease structure, credit enhancements (including guarantees), current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. Specifically for straight-line rent receivables, the Company’s assessment includes an estimation of a tenant’s ability to fulfill its rental obligations over the remaining lease term. In addition, with respect to tenants in bankruptcy, management makes estimates of the expected recovery of pre-petition and post-petition claims in assessing the estimated collectability of the related receivable. When a tenant is in bankruptcy, the Company records a provision for doubtful accounts for management’s estimate of the tenant’s receivable balance that is uncollectible and generally will not recognize subsequent rental revenue until cash is received or until the tenant is no longer in bankruptcy and has the ability to make rental payments. The Company’s collectability estimates for straight-line rent receivables include an assessment at the individual or master lease level as well as at an overall portfolio level. Revenue from resident fees and services is recorded monthly as services are provided and includes resident room and care charges and other resident charges. Assets Held for Sale, Dispositions and Discontinued Operations The Company generally considers real estate to be “held for sale” when the following criteria are met: (i) management commits to a plan to sell the property, (ii) the property is available for sale immediately, (iii) the property is actively being marketed for sale at a price that is reasonable in relation to its current fair value, (iv) the sale of the property within one year is considered probable and (v) significant changes to the plan to sell are not expected. Real estate that is held for sale and its related assets are classified as assets held for sale and are included in accounts receivable, prepaid expenses and other assets, net on the accompanying consolidated balance sheets. Secured indebtedness and other liabilities related to real estate held for sale are classified as liabilities related to assets held for sale and are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. Real estate classified as held for sale is no longer depreciated and is reported at the lower of its carrying value or its estimated fair value less estimated costs to sell. As of December 31, 2018 and 2017 , the Company did no t have any assets held for sale. For sales of real estate where the Company has collected the consideration to which it is entitled in exchange for transferring the real estate, the related assets and liabilities are removed from the balance sheet and the resultant gain or loss is recorded in the period in which the transaction closes. Any post-sale involvement is accounted for as separate performance obligations, and when the separate performance obligations are satisfied, the portion of the sales price allocated to each such obligation is recognized. Additionally, the Company records the operating results related to real estate that has been disposed of or classified as held for sale as discontinued operations for all periods presented if it represents a strategic shift that has or will have a major effect on the Company’s operations and financial results. Investment in Unconsolidated Joint Venture The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting. Under this method of accounting, the Company’s share of the investee’s earnings or losses is included in the Company’s consolidated statements of income. The initial carrying value of the investment is based on the amount paid to purchase the joint venture interest. Differences between the Company’s cost basis and the basis reflected at the joint venture level are generally amortized over the lives of the related assets and liabilities, and such amortization is included in the Company’s share of earnings of the joint venture. The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its equity method investments may not be recoverable or realized. When indicators of potential impairment are identified, the Company evaluates its equity method investments for impairment based on a comparison of the fair value of the investment to its carrying value. The fair value is estimated based on discounted cash flows that include all estimated cash inflows and outflows over a specified holding period and any estimated debt premiums or discounts. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its equity method investment, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its equity method investment. On January 2, 2018 , the Company completed its transaction with affiliates of Enlivant and TPG Real Estate, the real estate platform of TPG, and contributed $352.7 million , before closing costs, to acquire a 49% equity interest in an entity that owns 172 senior housing communities managed by Enlivant (the “Enlivant Joint Venture”). At closing, the Enlivant Joint Venture had outstanding indebtedness of $791.3 million and net working capital of $22.9 million . The joint venture agreement includes an option for the Company to acquire the remainder of the outstanding equity interests in the Enlivant Joint Venture by January 2, 2021 and grants the Company the right of first offer if the Company’s partner in the Enlivant Joint Venture desires to transfer its equity interest (which it may do commencing on January 2, 2020). Sabra also has the right to designate three directors on the seven member board of directors of the Enlivant Joint Venture and has other customary minority rights. As of December 31, 2018 , the book value of the Company’s investment in the Enlivant Joint Venture was $340.1 million . Net Investment in Direct Financing Lease As of December 31, 2018 , the Company had a $23.4 million net investment in one skilled nursing/transitional care facility leased to an operator under a direct financing lease, as the tenant is obligated to purchase the property at the end of the lease term. The net investment in direct financing lease is recorded in accounts receivable, prepaid expenses and other assets, net on the accompanying consolidated balance sheets and represents the total undiscounted rental payments of $5.6 million , plus the estimated unguaranteed residual value of $24.7 million , less the unearned lease income of $6.9 million as of December 31, 2018 . Unearned lease income represents the excess of the minimum lease payments and residual value over the cost of the investment. Unearned lease income is deferred and amortized to income over the lease term to provide a constant yield when collectability of the lease payments is reasonably assured. Income from the Company’s net investment in direct financing lease was $2.6 million and $1.0 million for the years ended December 31, 2018 and 2017 , respectively, and is reflected in interest and other income on the accompanying consolidated statements of income. Future minimum lease payments contractually due under the direct financing lease at December 31, 2018 , were as follows: $2.2 million for 2019; $2.3 million for 2020; and $2.1 million for 2021. Loans Receivable and Interest Income Loans Receivable The Company’s loans receivable are reflected at amortized cost on the accompanying consolidated balance sheets. The amortized cost of a loan receivable is the outstanding unpaid principal balance, net of unamortized discounts, costs and fees directly associated with the origination of the loan. Loans acquired in connection with a business combination are recorded at their acquisition date fair value. The Company determines the fair value of loans receivable based on estimates of expected discounted cash flows, collateral, credit risk and other factors. The Company does not establish a valuation allowance at the acquisition date, as the amount of estimated future cash flows reflects its judgment regarding their uncertainty. The Company recognizes the difference between the acquisition date fair value and the total expected cash flows as interest income using the effective interest method over the life of the applicable loan. The Company immediately recognizes in income any unamortized balances if the loan is repaid before its contractual maturity. On a quarterly basis, the Company evaluates the collectability of its loan portfolio, including related interest income receivable, and establishes a reserve for loan losses. The Company’s evaluation includes reviewing credit quality indicators such as payment status, changes affecting the underlying real estate collateral (for collateral dependent loans), changes affecting the operations of the facilities securing the loans, and national and regional economic factors. The reserve for loan losses is a valuation allowance that reflects management’s estimate of loan losses inherent in the loan portfolio as of the balance sheet date. The reserve is adjusted through provision for doubtful accounts, straight-line rental income and loan losses on the Company’s consolidated statements of income and is decreased by charge-offs to specific loans when losses are confirmed. The reserve for loan losses includes an asset-specific component and a portfolio-based component. An asset-specific reserve relates to reserves for losses on loans considered impaired and interest income receivable that is deemed uncollectible. The Company considers a loan to be impaired when, based upon current information and events, management believes that it is probable that the Company will be unable to collect all amounts due under the contractual terms of the loan agreement resulting from the borrower’s failure to repay contractual amounts due, the granting of a concession by the Company or the expectation that the Company will receive assets with fair values less than the carrying value of the loan in satisfaction of the loan. If a loan is considered to be impaired, a reserve is established when the carrying value of that loan is greater than the present value of payments expected to be received, the observable market prices for similar instruments, the estimated fair value of the collateral (for loans that are dependent on the collateral for repayment) or other amounts expected to be received in satisfaction of the loan. A portfolio-based reserve covers the pool of loans that do not have asset-specific reserves. A provision for loan losses is recorded when available information as of each balance sheet date indicates that it is probable that a loss occurred in the pool of loans and the amount of the loss can be reasonably estimated, but the Company does not know which specific loans within the pool will ultimately result in losses. The required reserve balances for this pool of loans is derived based on estimated probabilities of default and estimated loss severities assuming a default occurs. Interest Income Interest income on the Company’s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status, and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan or through the receipts of assets in satisfaction of contractual amounts due is probable, the Company will resume the accrual of interest. In instances where borrowers are in default under the terms of their loans, the Company may continue recognizing interest income provided that all amounts owed under the contractual terms of the loan, including accrued and unpaid interest, do not exceed the estimated fair value of the collateral, less costs to sell. Preferred Equity Investments and Preferred Return Preferred equity investments are accounted for at unreturned capital contributions, plus accrued and unpaid preferred returns. The Company recognizes preferred return income on a monthly basis based on the outstanding investment including any previously accrued and unpaid return. As a preferred member of the preferred equity joint ventures in which the Company participates, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to currently pay the accrued preferred return. Cash and Cash Equivalents The Company considers all short-term (with an original maturity of three months or less), highly-liquid investments utilized as part of the Company’s cash-management activities to be cash equivalents. Cash equivalents may include cash and short-term investments. Short-term investments are stated at cost, which approximates fair value. The Company’s cash and cash equivalents balance exceeded federally insurable limits as of December 31, 2018 . To date, the Company has experienced no loss or lack of access to cash in its operating accounts. The Company has a corporate banking relationship with Bank of America, N.A. in which it deposits the majority of its cash. Restricted Cash Restricted cash primarily consists of amounts held by an exchange accommodation titleholder or by secured debt lenders to provide for future real estate tax expenditures, tenant improvements and capital expenditures. Pursuant to the terms of the Company’s leases with certain tenants, the Company has assigned its interests in certain of these restricted cash accounts with secured debt lenders to the tenants, and this amount is included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets. As of December 31, 2018 and 2017 , restricted cash totaled $9.4 million and $68.8 million , respectively, and restricted cash obligations totaled $5.5 million and $6.5 million , respectively. Restricted cash as of December 31, 2017 included $57.5 million held by exchange accommodation titleholders. Stock-Based Compensation Stock-based compensation expense for stock-based awards granted to Sabra’s employees and its non-employee directors is recognized in the statements of income based on the estimated grant date fair value, as adjusted. Compensation expense for awards with graded vesting schedules is generally recognized ratably over the period from the grant date to the date when the award is no longer contingent on the employee providing additional services. Compensation expense for awards with performance-based vesting conditions is recognized based on the Company’s estimate of the ultimate value of such award after considering the Company’s expectations of future performance. Forfeitures of stock-based awards are recognized as they occur. Deferred Financing Costs Deferred financing costs representing fees paid to third parties are amortized over the terms of the respective financing agreements using the interest method. Deferred financing costs related to secured debt, term loans and senior unsecured notes are recorded as a reduction of the related debt liability, and deferred financing costs related to the revolving credit facility are recorded in accounts receivable, prepaid expenses and other assets, net. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financings that do not close are expensed in the period in which it is determined that the financing will not close. Income Taxes The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. The Company believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of the Company’s annual REIT taxable income to stockholders (which is computed without regard to the dividends-paid deduction or net capital gains and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax on income that it distributes as dividends to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to U.S. federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Such an event could materially and adversely affect the Company’s net income and net cash available for distribution to stockholders. However, the Company believes that it is organized and operates in such a manner as to qualify for treatment as a REIT. As a result of certain investments, the Company now records income tax expense or benefit with respect to certain of its entities that are taxed as taxable REIT subsidiaries under provisions similar to those applicable to regular corporations and not under the REIT provisions. The Company accounts for deferred income taxes using the asset and liability method and recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the Company’s financial statements or tax returns. Under this method, the Company determines deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes a change in the Company’s judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carryforwards. A valuation allowance is provided if the Company believes it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes a change in the Company’s judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur. The Company evaluates its tax positions using a two step approach: step one (recognition) occurs when the Company concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination, and step two (measurement) is only addressed if step one has been satisfied (i.e., the position is more likely than not to be sustained). Under step two, the tax benefit is measured as the largest amount of benefit (determined on a cumulative probability basis) that is more likely than not to be realized upon ultimate settlement. The Company will recognize tax penalties relating to unrecognized tax benefits as additional tax expense. Foreign Currency Certain of the Company’s subsidiaries’ functional currencies are the local currencies of their respective foreign jurisdictions. The Company translates the results of operations of its foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period presented, and it translates balance sheet accounts using exchange rates in effect at the end of the period presented. The Company records resulting currency translation adjustments in accumulated other comprehensive income (loss), a component of stockholders’ equity, on its consolidated balance sheets, and it records foreign currency transaction gains and losses as a component of interest and other income on its consolidated statements of income. Derivative Instruments The Company uses certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception, the Company must make an assessment that the transaction that the Company intends to hedge is probable of occurring, and this assessment must be updated each reporting period. The Company recognizes all derivative instruments as assets or liabilities on the consolidated balance sheets at their fair value. For derivatives designated and qualifie

CCP MERGER AND RECENT REAL ESTA

CCP MERGER AND RECENT REAL ESTATE ACQUISITIONS	12 Months Ended
	Dec. 31, 2018
Business Combinations [Abstract]
CCP MERGER AND RECENT REAL ESTATE ACQUISITIONS	CCP MERGER AND RECENT REAL ESTATE ACQUISITIONS CCP Merger On August 17, 2017, the Company completed the CCP Merger. Under the terms of the Merger Agreement, each share of CCP common stock issued and outstanding immediately prior to the effective time of the CCP Merger (other than any shares owned directly by CCP, the Company or their respective subsidiaries, in each case not held on behalf of third parties) was converted into the right to receive 1.123 newly issued shares of Company common stock, resulting in the issuance of approximately 94.0 million shares of Company common stock at the effective time of the CCP Merger. As a result of the CCP Merger, the Company acquired 330 properties (consisting of 296 skilled nursing/transitional care facilities, 13 senior housing communities and 21 specialty hospitals and other facilities), one skilled nursing/transitional care facility leased to an operator under a direct financing lease (see Note 2, “Summary of Significant Accounting Policies—Net Investment in Direct Financing Lease”), 18 investments in loans receivable (see Note 7, “Loans Receivable and Other Investments”) and one specialty valuation firm that the Company subsequently sold in March 2018. Sabra also assumed certain outstanding equity awards and other debt and liabilities of CCP (see Note 8, “Debt”). Based on the closing price of Sabra’s common stock on August 16, 2017, the Company estimates the fair value of the consideration exchanged or assumed to be approximately $2.1 billion . The following table summarizes the purchase price allocation for the CCP Merger based on the Company’s valuation, including estimates and assumptions of the acquisition date fair value of the tangible and intangible assets acquired and liabilities assumed on August 17, 2017 (in thousands): Real estate investments $ 3,727,310 Loans receivable and other investments 58,244 Cash and cash equivalents 77,859 Restricted cash 779 Lease intangible assets, net 145,786 Accounts receivable, prepaid expenses and other assets, net 35,873 Secured debt, net (98,500 ) Revolving credit facility (362,000 ) Unsecured term loans (674,000 ) Senior unsecured notes, net (616,873 ) Accounts payable and accrued liabilities (134,802 ) Lease intangible liabilities, net (102,643 ) Noncontrolling interests (4,455 ) Total consideration $ 2,052,578 The lease intangible assets and lease intangible liabilities acquired in connection with the CCP Merger have weighted-average amortization periods as of the closing date of the CCP Merger of 10 years . For the year ended December 31, 2017, the Company recognized $135.4 million of total revenues and $87.0 million of net income attributable to common stockholders, excluding merger and acquisition costs, from the CCP Merger investments. Merger and acquisition costs associated with the CCP Merger were $30.2 million during the year ended December 31, 2017. Recent Real Estate Acquisitions During the year ended December 31, 2018 , the Company acquired 11 Senior Housing - Managed communities, eight senior housing communities and two skilled nursing/transitional care facilities. During the year ended December 31, 2017 , in addition to the properties acquired as a result of the CCP Merger, the Company acquired 22 skilled nursing/transitional care facilities and two senior housing communities. The consideration was allocated as follows (in thousands): Year Ended December 31, 2018 2017 Land $ 29,712 $ 58,771 Building and improvements 232,893 359,310 Tenant origination and absorption costs intangible assets 2,046 6,684 Tenant relationship intangible assets 677 2,053 Total consideration $ 265,328 $ 426,818 The tenant origination and absorption costs intangible assets and tenant relationship intangible assets acquired in connection with these acquisitions have weighted-average amortization periods as of the respective dates of acquisition of 13 years and 22 years, respectively, for acquisitions completed during the year ended December 31, 2018 , and 13 years and 23 years, respectively, for acquisitions completed during the year ended December 31, 2017 . For the year ended December 31, 2018 , the Company recognized $44.0 million and $14.0 million of total revenues and net income attributable to common stockholders, respectively, from the properties acquired during the year ended December 31, 2018 . For the year ended December 31, 2017 , the Company recognized $10.6 million and $7.7 million of total revenues and net income attributable to common stockholders, respectively, from the properties acquired during the year ended December 31, 2017 (excluding the properties acquired as a result of the CCP Merger).

REAL ESTATE PROPERTIES HELD FOR

REAL ESTATE PROPERTIES HELD FOR INVESTMENT	12 Months Ended
	Dec. 31, 2018
Real Estate Investments, Net [Abstract]
REAL ESTATE PROPERTIES HELD FOR INVESTMENT	REAL ESTATE PROPERTIES HELD FOR INVESTMENT The Company’s real estate properties held for investment consisted of the following (dollars in thousands): As of December 31, 2018 Property Type Number of Properties Number of Beds/Units Total Real Estate at Cost Accumulated Depreciation Total Real Estate Investments, Net Skilled Nursing/Transitional Care 335 37,628 $ 4,094,484 $ (224,942 ) $ 3,869,542 Senior Housing - Leased 90 7,332 1,237,790 (125,902 ) 1,111,888 Senior Housing - Managed 23 1,603 301,739 (19,537 ) 282,202 Specialty Hospitals and Other 22 1,085 621,236 (31,640 ) 589,596 470 47,648 6,255,249 (402,021 ) 5,853,228 Corporate Level 634 (317 ) 317 $ 6,255,883 $ (402,338 ) $ 5,853,545 As of December 31, 2017 Property Type Number of Properties Number of Beds/Units Total Real Estate at Cost Accumulated Depreciation Total Real Estate Investments, Net Skilled Nursing/Transitional Care 384 43,223 $ 4,364,387 $ (209,039 ) $ 4,155,348 Senior Housing - Leased 88 8,137 1,166,687 (102,370 ) 1,064,317 Senior Housing - Managed 13 1,113 189,120 (12,125 ) 176,995 Specialty Hospitals and Other 22 1,085 614,068 (16,620 ) 597,448 507 53,558 6,334,262 (340,154 ) 5,994,108 Corporate Level 593 (269 ) 324 $ 6,334,855 $ (340,423 ) $ 5,994,432 December 31, 2018 December 31, 2017 Building and improvements $ 5,388,102 $ 5,449,415 Furniture and equipment 237,145 232,889 Land improvements 1,254 3,456 Land 629,382 649,095 6,255,883 6,334,855 Accumulated depreciation (402,338 ) (340,423 ) $ 5,853,545 $ 5,994,432 Operating Leases As of December 31, 2018 , the substantial majority of the Company’s real estate properties (excluding 23 Senior Housing - Managed communities) were leased under triple-net operating leases with expirations ranging from one to 15 years. As of December 31, 2018 , the leases had a weighted-average remaining term of nine years. The leases generally include provisions to extend the lease terms and other negotiated terms and conditions. The Company, through its subsidiaries, retains substantially all of the risks and benefits of ownership of the real estate assets leased to the tenants. The Company may receive additional security under these operating leases in the form of letters of credit and security deposits from the lessee or guarantees from the parent of the lessee. Security deposits received in cash related to tenant leases are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets and totaled $12.4 million and $20.3 million as of December 31, 2018 and 2017 , respectively, and letters of credit deposited with the Company totaled approximately $98 million and $96 million as of December 31, 2018 and 2017 , respectively. In addition, the Company’s tenants have deposited with the Company $17.5 million and $28.3 million as of December 31, 2018 and 2017 , respectively, for future real estate taxes, insurance expenditures and tenant improvements related to our properties and their operations. As of December 31, 2018 , the Company had a $1.3 million reserve for unpaid cash rental income and a $35.8 million reserve associated with accumulated straight-line rental income. As of December 31, 2017 , the Company had a $3.2 million reserve for unpaid cash rental income and a $12.4 million reserve associated with accumulated straight-line rental income. In 2017, the Company entered into memoranda of understanding with Genesis Healthcare, Inc. (“Genesis”) to market for sale up to all of its remaining Genesis facilities and to restructure its lease agreements with Genesis to increase the marketability of these facilities to potential buyers. Effective January 1, 2018, the annual base rent payable under the Genesis leases was reduced by $19.0 million pursuant to a lease restructuring agreement. During the year ended December 31, 2018 , the Company completed the sale of 43 facilities leased to Genesis. The Company has entered into agreements to sell three of its remaining 11 Genesis facilities and expects to retain eight facilities. The three facilities are being sold subject to HUD-insured debt, and the sales are expected to close upon approval by HUD. In addition, on December 5, 2018, the Company entered into a purchase and sale agreement to sell the 36 skilled nursing/transitional care facilities and two senior housing communities currently operated by Senior Care Centers. In January 2019, the agreement was amended to reduce the number of facilities being sold to 26 skilled nursing/transitional care facilities and two senior housing communities (together, the “Senior Care Centers Sale Facilities”) for an aggregate sales price of $282.5 million , all of which is payable in cash by the purchaser at closing. The Company plans to retain the remaining 10 facilities (the “Retained Facilities”) and re-lease those facilities to one or more new operators. The Company expects to complete the sale of the Senior Care Centers Sale Facilities and transition of the Retained Facilities on April 1, 2019, subject to customary closing conditions including approval of operations transfer and related agreements by the bankruptcy court overseeing a petition for relief under Chapter 11 of the United States Bankruptcy Code filed by Senior Care Centers. There can be no assurances that the sale of the Senior Care Centers Sale Facilities or the transition of the Retained Facilities will be consummated, on the foregoing terms or timing or at all. If the closing of the sale occurs, the Company expects to record an impairment equal to the excess of the carrying value of the Senior Care Centers Sale Facilities over the net sales proceeds received at closing. In addition, depending on the terms at which the Company can re-lease the Retained Facilities, the Company may be required to record an impairment related to the Retained Facilities. Accordingly, the Company expects to record an impairment charge of between $60.1 million to $76.0 million during the first quarter of 2019 related to the facilities currently operated by Senior Care Centers. During the third quarter of 2018, the Company issued to Senior Care Centers notices of default and lease termination due to Senior Care Centers’ non-payment of rent under the terms of the master leases. As a result, Senior Care Centers is currently operating the facilities on a month-to-month basis. Deposits were fully exhausted to pay contractual rents and cash rents were recorded through a portion of September 2018. The net shortfall in cash rents from Senior Care Centers through December 31, 2018 was $16.5 million . No straight-line rents have been recorded since May 2018, and during the year ended December 31, 2018, the Company reserved the $5.3 million straight-line rent receivable balance related to the Senior Care Centers master leases. There can be no assurances that the Company will receive any additional rent payments from Senior Care Centers during the pendency of the sale process. Prior to termination of the master leases, the annual lease rate was $58.5 million . On December 4, 2018, Senior Care Centers filed a petition for relief under Chapter 11 of the United States Bankruptcy Code in the Northern District of Texas. Although the sale of the Senior Care Centers Sale Facilities and transition of the Retained Facilities is subject to approval by the bankruptcy court, the Company does not expect Senior Care Centers’ bankruptcy filing to have a substantive impact on the Company’s disposition and transition of the facilities operated by Senior Care Centers. On February 15, 2019, the Company entered into a settlement agreement with Senior Care Centers pursuant to which the Company has agreed to discharge its claims against Senior Care Centers in exchange for certain settlement payments, a portion of which would be applied to pay post-petition rent totaling $5.7 million . The effectiveness of this settlement agreement is subject to bankruptcy court approval. On December 19, 2018, the Company entered into a non-binding letter of intent to terminate its triple-net master lease with Holiday Retirement (“Holiday”) with respect to all 21 senior housing communities subject to the master lease (the “Holiday Communities”) and concurrently enter into one or more management agreements pursuant to which Holiday will manage the Holiday Communities. In exchange, the Company would receive $57.2 million of total consideration, including $15.1 million of retained security deposits and a $42.1 million termination fee to be paid in cash. During the year ended December 31, 2018, the Company reserved the $28.9 million straight-line rent receivable balance related to the Holiday master lease. The Company expects to terminate the Holiday master lease and enter into the Holiday management agreements in early 2019, though there can be no assurances that the transactions will be completed on the foregoing terms or timing or at all. The Company monitors the creditworthiness of its tenants by reviewing credit ratings (if available) and evaluating the ability of the tenants to meet their lease obligations to the Company based on the tenants’ financial performance, including the evaluation of any parent guarantees (or the guarantees of other related parties) of tenant lease obligations. As formal credit ratings may not be available for most of the Company’s tenants, the primary basis for the Company’s evaluation of the credit quality of its tenants (and more specifically the tenant’s ability to pay their rent obligations to the Company) is the tenant’s lease coverage ratio or the parent’s fixed charge coverage ratio for those entities with a parent guarantee. These coverage ratios include earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) to rent and earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) to rent at the lease level and consolidated EBITDAR to total fixed charges at the parent guarantor level when such a guarantee exists. The Company obtains various financial and operational information from its tenants each month and reviews this information in conjunction with the above-described coverage metrics to identify financial and operational trends, evaluate the impact of the industry’s operational and financial environment (including the impact of government reimbursement), and evaluate the management of the tenant’s operations. These metrics help the Company identify potential areas of concern relative to its tenants’ credit quality and ultimately the tenant’s ability to generate sufficient liquidity to meet its obligations, including its obligation to continue to pay the rent due to the Company. For the year ended December 31, 2018 , no tenant relationship represented 10% or more of the Company’s total revenues. As of December 31, 2018 , the future minimum rental payments from the Company’s properties held for investment under non-cancelable operating leases were as follows (in thousands): 2019 $ 465,766 2020 456,207 2021 452,346 2022 454,216 2023 437,277 Thereafter 2,407,064 $ 4,672,876

IMPAIRMENT OF REAL ESTATE AND D

IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS	12 Months Ended
	Dec. 31, 2018
Discontinued Operations and Disposal Groups [Abstract]
IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS	IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS 2018 During the year ended December 31, 2018 , the Company recognized a $1.4 million real estate impairment, of which $0.9 million related to one skilled nursing/transitional care facility and $0.5 million related to one senior housing community sold during the year. During the year ended December 31, 2018 , the Company completed the sale of 51 skilled nursing/transitional care facilities, six senior housing communities and one Senior Housing - Managed community for aggregate consideration, net of closing costs, of $382.6 million . The net carrying value of the assets and liabilities of these facilities was $254.4 million , which resulted in an aggregate $128.2 million net gain on sale. Excluding the net gain on sale and the real estate impairment related to one senior housing community sold during the year, the Company recognized $23.6 million , $47.1 million and $39.4 million of net income during the years ended December 31, 2018 , 2017 and 2016 , respectively, from these facilities. The sale of these facilities does not represent a strategic shift that has or will have a major effect on the Company’s operations and financial results, and therefore the results of operations attributable to these facilities have remained in continuing operations. 2017 During the year ended December 31, 2017 , the Company recognized a $1.3 million real estate impairment related to one skilled nursing/transitional care facility. During the year ended December 31, 2017 , the Company completed the sale of 31 skilled nursing/transitional care facilities and one senior housing community for aggregate consideration, net of closing costs, of $150.2 million . The net carrying value of the assets and liabilities of these facilities was $98.2 million , resulting in an aggregate $52.0 million net gain on sale. Excluding the net gain on sale, the Company recognized $12.6 million and $15.2 million of net income during the years ended December 31, 2017 and 2016 , respectively, from these facilities. The sale of these facilities does not represent a strategic shift that has or will have a major effect on the Company’s operations and financial results, and therefore the results of operations attributable to these facilities have remained in continuing operations. 2016 During the year ended December 31, 2016 , the Company recognized a $29.8 million real estate impairment related to one acute care hospital sold during the year. During the year ended December 31, 2016 , the Company completed the sale of four skilled nursing/transitional care facilities, one acute care hospital and one parcel of land for aggregate consideration, net of closing costs, of $98.0 million . The net carrying value of the assets and liabilities of these facilities was $104.1 million , resulting in an aggregate $6.1 million net loss on sale. Excluding the net loss on sale and the real estate impairment related to one acute care hospital sold during the year, the Company recognized $0.7 million of net income during the year ended December 31, 2016 from these facilities. The sale of these facilities does not represent a strategic shift that has or will have a major effect on the Company’s operations and financial results, and therefore the results of operations attributable to these facilities have remained in continuing operations.

INTANGIBLE ASSETS AND LIABILITI

INTANGIBLE ASSETS AND LIABILITIES	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS AND LIABILITIES	INTANGIBLE ASSETS AND LIABILITIES The following table summarizes the Company’s intangible assets and liabilities as of December 31, 2018 and 2017 (in thousands): December 31, 2018 2017 Lease Intangible Assets: Above market leases $ 61,572 $ 76,443 Tenant origination and absorption costs 73,323 76,336 Tenant relationship 26,936 27,436 Gross lease intangible assets 161,831 180,215 Accumulated amortization (30,734 ) (13,096 ) Lease intangible assets, net $ 131,097 $ 167,119 Lease Intangible Liabilities: Below market leases $ 102,098 $ 102,643 Accumulated amortization (18,372 ) (4,628 ) Lease intangible liabilities, net $ 83,726 $ 98,015 The following is a summary of real estate intangible amortization income (expense) for the years ended December 31, 2018 , 2017 and 2016 (in thousands): Year Ended December 31, 2018 2017 2016 (Decrease) increase to rental income related to above/below market leases, net $ (7,701 ) $ 912 $ — Depreciation and amortization related to tenant origination and absorption costs and tenant relationship (16,118 ) (11,822 ) (3,182 ) The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2018 will be amortized for the years ending December 31 as follows (dollars in thousands): Lease Intangible Lease Intangible 2019 $ 21,367 $ 13,779 2020 17,822 12,221 2021 15,363 8,012 2022 14,427 7,269 2023 11,317 7,269 Thereafter 50,801 35,176 $ 131,097 $ 83,726 Weighted-average remaining amortization period 8.9 years 9.3 years

LOANS RECEIVABLE AND OTHER INVE

LOANS RECEIVABLE AND OTHER INVESTMENTS	12 Months Ended
	Dec. 31, 2018
REAL ESTATE LOANS RECEIVABLE [Abstract]
LOANS RECEIVABLE AND OTHER INVESTMENTS	LOANS RECEIVABLE AND OTHER INVESTMENTS As of December 31, 2018 and 2017 , the Company’s loans receivable and other investments consisted of the following (dollars in thousands): December 31, 2018 Investment Quantity Property Type Principal Balance as of December 31, 2018 (1) Book Value Book Value Weighted Average Contractual Interest Rate / Rate of Return Weighted Average Annualized Effective Interest Rate / Rate of Return Maturity Date Loans Receivable: Mortgage 1 Specialty Hospital $ 18,577 $ 18,577 $ 12,351 10.0 % 10.0 % 01/31/27 Construction 2 Senior Housing 4,569 4,629 2,733 8.0 % 7.7 % 04/30/21- 09/30/22 Mezzanine 1 Skilled Nursing 23,952 2,188 10,239 10.0 % 41.9 % 05/25/20 Pre-development — Senior Housing — — 2,357 N/A N/A N/A Other 18 Multiple 49,394 45,324 38,324 7.3 % 8.1 % 02/28/19- 08/31/28 22 96,492 70,718 66,004 8.5 % 9.7 % Loan loss reserve — (1,258 ) (97 ) $ 96,492 $ 69,460 $ 65,907 Other Investments: Preferred Equity 9 Skilled Nursing / Senior Housing 43,851 44,262 48,483 12.1 % 12.1 % N/A Total 31 $ 140,343 $ 113,722 $ 114,390 9.6 % 10.6 % (1) Principal balance includes amounts funded and accrued but unpaid interest/preferred return and excludes capitalizable fees. In connection with the CCP Merger, the Company acquired 18 loans receivable investments with a principal balance of $83.3 million and fair value of $58.2 million as of August 17, 2017. Of the loans acquired in connection with the CCP Merger, eight loans receivable investments with a principal balance of $36.3 million were considered to have deteriorated credit quality, and based on the collateral or expected cash flows, the fair value was determined to be $11.3 million and the accretable yield was $3.5 million as of August 17, 2017. During the year ended December 31, 2018 , one loan with deteriorated credit quality was repaid in full. As of December 31, 2018 and 2017 , the book value of these loans was $4.2 million and $10.0 million , respectively. The following table presents changes in the accretable yield for the years ended December 31, 2018 and 2017 (in thousands): Year Ended December 31, 2018 2017 Accretable yield, beginning of period $ 2,483 $ — Additions — 3,481 Accretion recognized in earnings (2,761 ) (998 ) Net reclassification from nonaccretable difference 727 — Accretable yield, end of period $ 449 $ 2,483 During the year ended December 31, 2018 , the Company recorded a $0.7 million provision for specific loan losses and increased its portfolio-based loan loss reserve by $0.5 million . As of December 31, 2018 , the Company had a $0.7 million specific loan loss reserve, and the portfolio-based loan loss reserve was $0.6 million . As of December 31, 2018 , the Company considered one loan receivable investment to be impaired, which had a principal balance of $1.3 million and $1.4 million as of December 31, 2018 and 2017 , respectively. As of December 31, 2018 , two loans receivable investments with an aggregate book value of $1.3 million were on nonaccrual status. Additionally, as of December 31, 2018 , the Company recognized interest income related to one loan receivable investment, with a book value of $4.3 million , that was more than 90 days past due. As of December 31, 2018 , the Company did not consider any preferred equity investments to be impaired, and no preferred equity investments were on nonaccrual status. During the year ended December 31, 2017 , the Company recorded a $4.8 million provision for specific loan losses related to two loans receivable investments, both of which were repaid as of December 31, 2017 , and reduced its portfolio-based loan loss reserve by $0.3 million . As of December 31, 2017 , the Company had no specific loan loss reserve, and the portfolio-based loan loss reserve was $0.1 million . As of December 31, 2017 , the Company did not consider any loans receivable investments to be impaired, and one loan receivable investment with a book value of $0 was on nonaccrual status.

DEBT

DEBT	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
DEBT	DEBT Secured Indebtedness The Company’s secured debt consists of the following (dollars in thousands): Interest Rate Type Principal Balance as of (1) Principal Balance as of (1) Weighted Average Effective Interest Rate at (2) Maturity Date Fixed Rate $ 117,464 $ 160,702 3.66 % December 2021 - Variable Rate — 98,500 NA NA $ 117,464 $ 259,202 3.66 % (1) Principal balance does not include deferred financing costs, net of $1.8 million and $2.8 million as of December 31, 2018 and 2017 , respectively. (2) Weighted average effective interest rate includes private mortgage insurance. On August 17, 2017, in connection with the CCP Merger (see Note 3, “CCP Merger and Recent Real Estate Acquisitions”), the Company assumed a $98.5 million variable rate secured term loan that bore interest at LIBOR plus 1.80% and was to mature in July 2019 . The loan was repaid during the fourth quarter of 2018, and the Company recognized a $2.0 million loss on extinguishment of debt related to prepayment penalty fees associated with the early repayment of the loan. The Company repaid $37.6 million of fixed rate debt secured by facilities sold during the fourth quarter of 2018. The Company recognized a $0.9 million loss on extinguishment of debt related to write-offs of deferred financing costs in connection with this repayment. Senior Unsecured Notes The Company’s senior unsecured notes consist of the following (dollars in thousands): Principal Balance as of December 31, Title Maturity Date 2018 (1) 2017 (1) 5.5% senior unsecured notes due 2021 (“2021 Notes”) February 1, 2021 $ 500,000 $ 500,000 5.375% senior unsecured notes due 2023 (“2023 Notes”) June 1, 2023 200,000 200,000 5.125% senior unsecured notes due 2026 (“2026 Notes”) August 15, 2026 500,000 500,000 5.38% senior unsecured notes due 2027 (“2027 Notes”) May 17, 2027 100,000 100,000 $ 1,300,000 $ 1,300,000 (1) Principal balance does not include premium, net of $14.5 million and deferred financing costs, net of $7.1 million as of December 31, 2018 and does not include premium, net of $15.9 million and deferred financing costs, net of $9.6 million as of December 31, 2017 . 5.5% Notes Due 2021 . On January 23, 2014, the Operating Partnership and Sabra Capital Corporation, wholly owned subsidiaries of the Company (the “Issuers”), issued $350.0 million aggregate principal amount of 5.5% senior unsecured notes due 2021 (the “Original 2021 Notes”), and on October 10, 2014, they issued $150.0 million aggregate principal amount of 5.5% senior unsecured notes due 2021, which are treated as a single class with, and have the same terms as, the Original 2021 Notes (the additional notes and the Original 2021 Notes, together, the “2021 Notes”). The 2021 Notes accrue interest at a rate of 5.5% per annum payable semiannually on February 1 and August 1 of each year. The 2021 Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, at the redemption prices set forth in the indenture governing the 2021 Notes, plus accrued and unpaid interest to the applicable redemption date. Assuming the 2021 Notes are not redeemed, the 2021 Notes mature on February 1, 2021. 5.375% Notes Due 2023. On May 23, 2013, the Issuers issued $200.0 million aggregate principal amount of 5.375% senior unsecured notes due 2023 (the “2023 Notes”). The 2023 Notes accrue interest at a rate of 5.375% per annum payable semiannually on June 1 and December 1 of each year. The 2023 Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, at the redemption prices set forth in the indenture governing the 2023 Notes, plus accrued and unpaid interest to the applicable redemption date. Assuming the 2023 Notes are not redeemed, the 2023 Notes mature on June 1, 2023. 5.125% Notes Due 2026 . In connection with the CCP Merger, on August 17, 2017, the Operating Partnership assumed $500.0 million aggregate principal amount of 5.125% senior unsecured notes due 2026 (the “2026 Notes”) issued by Care Capital Properties, LP in July 2016 (see Note 3, “CCP Merger and Recent Real Estate Acquisitions”). The 2026 Notes accrue interest at a rate of 5.125% per annum payable semiannually on February 15 and August 15 of each year. The Operating Partnership may, at its option, redeem the 2026 Notes at any time in whole or from time to time in part prior to their stated maturity. The redemption price for 2026 Notes that are redeemed will be equal to (i) 100% of their principal amount, together with accrued and unpaid interest thereon, if any, to (but excluding) the date of redemption, plus, (ii) if redeemed prior to May 15, 2026, a make-whole premium. Assuming the 2026 Notes are not redeemed, the 2026 Notes mature on August 15, 2026. 5.38% Notes Due 2027 . In connection with the CCP Merger, on August 17, 2017, the Operating Partnership assumed $100.0 million aggregate principal amount of unregistered 5.38% senior unsecured notes due 2027 (the “2027 Notes”) issued by Care Capital Properties, LP in May 2016 (see Note 3, “CCP Merger and Recent Real Estate Acquisitions”). The 2027 Notes accrue interest at a rate of 5.38% per annum payable semiannually on May 17 and November 17 of each year. The Operating Partnership may prepay the 2027 Notes, in whole at any time or in part from time to time, at 100% of the principal amount to be prepaid plus a make-whole premium. Assuming the 2027 Notes are not redeemed, the 2027 Notes mature on May 17, 2027. The obligations under the 2021 Notes, 2023 Notes and 2027 Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and certain subsidiaries of Sabra; provided, however, that such guarantees are subject to release under certain customary circumstances. The obligations under the 2026 Notes are fully and unconditionally guaranteed, on an unsecured basis, by Sabra; provided, however, that such guarantee is subject to release under certain customary circumstances. See Note 15, “Summarized Consolidating Information,” for additional information concerning the circumstances pursuant to which the guarantors will be automatically and unconditionally released from their obligations under the guarantees. The indenture governing the 2021 Notes and 2023 Notes contains restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their restricted subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; (iii) pay dividends or distributions on, or redeem or repurchase, their capital stock; (iv) make certain investments or other restricted payments; (v) sell assets; (vi) create liens on their assets; (vii) enter into transactions with affiliates; (viii) merge or consolidate or sell all or substantially all of their assets; and (ix) create restrictions on the ability of Sabra’s restricted subsidiaries to pay dividends or other amounts to Sabra. Such limitations on distributions also include a limitation on the extent of allowable cumulative distributions made, which shall not exceed the greater of (a) the sum of (x) 95% of cumulative Adjusted Funds from Operations and (y) the net proceeds from the issuance of common and preferred equity and (b) the minimum amount of distributions required for the Company to maintain its REIT status. The indenture governing the 2021 Notes and 2023 Notes also provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the 2021 Notes and 2023 Notes, the failure to comply with certain covenants and agreements specified in the indenture for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then-outstanding 2021 Notes and 2023 Notes may become due and payable immediately. The indenture governing the 2021 Notes and 2023 Notes requires us to maintain Total Unencumbered Assets (as defined in the indenture) of at least 150% of our unsecured indebtedness. The indenture governing the 2026 Notes contains certain covenants that, among other things, limits the ability of Sabra, the Issuer and our subsidiaries to: (i) consummate a merger, consolidate or sell all or substantially all of our consolidated assets and (ii) incur secured or unsecured indebtedness. In addition, we are required to maintain at all times consolidated unencumbered total asset value in an amount not less than 150% of the aggregate outstanding principal amount of our consolidated unsecured debt. The agreement governing the 2027 Notes provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the 2027 Notes, the failure to comply with certain covenants and agreements specified in the agreement governing the 2027 Notes for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. In addition, certain change of control events constitute an event of default under the agreement governing the 2027 Notes. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then-outstanding 2027 Notes may become due and payable immediately. The Company was in compliance with all applicable financial covenants under the indentures and agreements (the “Senior Notes Indentures”) governing the 2021 Notes, 2023 Notes, 2026 Notes and 2027 Notes (collectively, the “Senior Notes”) outstanding as of December 31, 2018 . Credit Facility Effective on August 17, 2017, the Operating Partnership and Sabra Canadian Holdings, LLC (together, the “Borrowers”), Sabra and the other parties thereto entered into a fourth amended and restated unsecured credit facility (the “Credit Facility”). The Credit Facility amends and restates the prior credit facility entered into by the Borrowers in January 2016 (the “Prior Credit Facility”). The Company recognized a $0.6 million loss on extinguishment of debt during the year ended December 31, 2017 related to write-offs of deferred financing costs in connection with amending and restating the Prior Credit Facility. The Credit Facility includes a $1.0 billion revolving credit facility (the “Revolving Credit Facility”), $1.1 billion in U.S. dollar term loans and a CAD $125.0 million Canadian dollar term loan (collectively, the “Term Loans”). Further, up to $175.0 million of the Revolving Credit Facility may be used for borrowings in certain foreign currencies. The Credit Facility also contains an accordion feature that can increase the total available borrowings to $2.5 billion , subject to terms and conditions. The Revolving Credit Facility has a maturity date of August 17, 2021, and includes two six -month extension options. $200 million of the U.S. dollar Term Loans has a maturity date of August 17, 2020, and the other Term Loans have a maturity date of August 17, 2022. As of December 31, 2018 , there was $624.0 million outstanding under the Revolving Credit Facility and $376.0 million available for borrowing. Borrowings under the Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to an applicable interest margin plus, at the Operating Partnership’s option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5% , (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (the “Base Rate”). On August 17, 2017, Sabra’s ratings met the Investment Grade Ratings Criteria (as defined in the credit agreement), and Sabra elected to use the ratings-based applicable interest margin for borrowings which will vary based on the Debt Ratings, as defined in the credit agreement, and will range from 0.875% to 1.65% per annum for LIBOR based borrowings and 0.00% to 0.65% per annum for borrowings at the Base Rate. As of December 31, 2018 , the interest rate on the Revolving Credit Facility was 3.75% . In addition, the Operating Partnership pays a facility fee ranging between 0.125% and 0.300% per annum based on the aggregate amount of commitments under the Revolving Credit Facility regardless of amounts outstanding thereunder. The U.S. dollar Term Loans bear interest on the outstanding principal amount at a rate equal to an applicable interest margin plus, at the Operating Partnership’s option, either (a) LIBOR or (b) the Base Rate. The ratings-based applicable interest margin for borrowings will vary based on the Debt Ratings, as defined in the credit agreement, and will range from 0.90% to 1.90% per annum for LIBOR based borrowings and 0.00% to 0.90% per annum for borrowings at the Base Rate. The Canadian dollar Term Loan bears interest on the outstanding principal amount at a rate equal to the Canadian Dollar Offered Rate (“CDOR”) plus an interest margin that will range from 0.90% to 1.90% depending on the Debt Ratings. On June 10, 2015, the Company entered into an interest rate swap agreement to fix the CDOR portion of the interest rate for CAD $90.0 million of its Canadian dollar Term Loan at 1.59% . In addition, CAD $90.0 million of the Canadian dollar Term Loan was designated as a net investment hedge. On August 10, 2016, the Company entered into two interest rate swap agreements to fix the LIBOR portion of the interest rate for $245.0 million of its U.S. dollar Term Loans at 0.90% and one interest rate swap agreement to fix the CDOR portion on CAD $35.0 million of its Canadian dollar Term Loan at 0.93% . See Note 9, “Derivative and Hedging Instruments,” for further information. As a result of the CCP Merger (see Note 3, “CCP Merger and Recent Real Estate Acquisitions”), the Company assumed eight interest rate swap agreements that fix the LIBOR portion of the interest rate for $600 million of the Company’s U.S. dollar Term Loans at a weighted average rate of 1.31% . See Note 9, “Derivative and Hedging Instruments,” for further information. The obligations of the Borrowers under the Credit Facility are guaranteed by Sabra and certain subsidiaries of Sabra. The Credit Facility contains customary covenants that include restrictions or limitations on the ability to make acquisitions and other investments, pay dividends, incur additional indebtedness, engage in non-healthcare related business activities, enter into transactions with affiliates and sell or otherwise transfer certain assets as well as customary events of default. The Credit Facility also requires Sabra, through the Operating Partnership, to comply with specified financial covenants, which include a maximum leverage ratio, a minimum fixed charge coverage ratio and a minimum tangible net worth requirement. As of December 31, 2018 , the Company was in compliance with all applicable financial covenants under the Credit Facility. Interest Expense During the years ended December 31, 2018 , 2017 and 2016 , the Company incurred interest expense of $147.1 million , $88.4 million and $64.9 million , respectively. Interest expense includes non-cash interest expense of $10.1 million , $7.8 million and $5.7 million for the years ended December 31, 2018 , 2017 and 2016 , respectively. As of December 31, 2018 and 2017 , the Company had $ 24.0 million and $ 24.7 million , respectively, of accrued interest included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. Maturities The following is a schedule of maturities for the Company’s outstanding debt as of December 31, 2018 (in thousands): Secured Indebtedness Revolving Credit Facility (1) Term Loans Senior Notes Total 2019 $ 3,421 $ — $ — $ — $ 3,421 2020 3,530 — 200,000 — 203,530 2021 18,130 624,000 — 500,000 1,142,130 2022 3,185 — 991,700 — 994,885 2023 3,282 — — 200,000 203,282 Thereafter 85,916 — — 600,000 685,916 Total Debt 117,464 624,000 1,191,700 1,300,000 3,233,164 Premium, net — — — 14,500 14,500 Deferred financing costs, net (1,785 ) — (6,770 ) (7,106 ) (15,661 ) Total Debt, Net $ 115,679 $ 624,000 $ 1,184,930 $ 1,307,394 $ 3,232,003 (1) Revolving Credit Facility is subject to two six -month extension options.

DERIVATIVE AND HEDGING INSTRUME

DERIVATIVE AND HEDGING INSTRUMENTS	12 Months Ended
	Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE AND HEDGING INSTRUMENTS	DERIVATIVE AND HEDGING INSTRUMENTS The Company is exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign exchange rates. The Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates and foreign exchange rates. The Company’s derivative financial instruments are used to manage differences in the amount of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s investments and borrowings. Certain of the Company’s foreign operations expose the Company to fluctuations of foreign interest rates and exchange rates. These fluctuations may impact the value in the Company’s functional currency, the U.S. dollar, of the Company’s investment in foreign operations, the cash receipts and payments related to these foreign operations and payments of interest and principal under Canadian dollar denominated debt. The Company enters into derivative financial instruments to protect the value of its foreign investments and fix a portion of the interest payments for certain debt obligations. The Company does not enter into derivatives for speculative purposes. Cash Flow Hedges The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. As of December 31, 2018 , approximately $8.4 million of gains, which are included in accumulated other comprehensive income, are expected to be reclassified into earnings in the next 12 months. Net Investment Hedges The Company is exposed to fluctuations in foreign exchange rates on investments it holds in Canada. The Company uses cross currency interest rate swaps to hedge its exposure to changes in foreign exchange rates on these foreign investments. The following presents the notional amount of derivative instruments as of the dates indicated (in thousands): December 31, 2018 December 31, 2017 Derivatives designated as cash flow hedges: Denominated in U.S. Dollars (1) $ 1,045,000 $ 845,000 Denominated in Canadian Dollars $ 125,000 $ 125,000 Derivatives designated as net investment hedges: Denominated in Canadian Dollars $ 55,401 $ 56,300 Financial instrument designated as net investment hedge: Denominated in Canadian Dollars $ 125,000 $ 125,000 Derivatives not designated as net investment hedges: Denominated in Canadian Dollars $ 899 $ — (1) Balance includes forward starting interest rate swaps having an effective date of June 2019 that have been entered into as of December 31, 2018 to hedge $200.0 million of anticipated fixed-rate debt issuance to occur sometime during 2019. Derivative and Financial Instruments Designated as Hedging Instruments The following is a summary of the derivative and financial instruments designated as hedging instruments held by the Company at December 31, 2018 and 2017 (dollars in thousands): Count as of December 31, 2018 Fair Value Maturity Dates December 31, Type Designation 2018 2017 Balance Sheet Location Assets: Interest rate swap Cash Flow 12 $ 25,184 $ 25,221 2020 - 2023 Accounts receivable, prepaid expenses and other assets, net Cross currency interest rate swaps Net Investment 2 4,160 674 2025 Accounts receivable, prepaid expenses and other assets, net $ 29,344 $ 25,895 Liabilities: Forward starting interest rate swap Cash Flow 2 $ 4,529 $ — 2029 Accounts payable and accrued liabilities CAD term loan Net Investment 1 91,700 99,588 2022 Term loans, net $ 96,229 $ 99,588 The following presents the effect of the Company’s derivative and financial instruments designated as hedging instruments on the consolidated statements of income and the consolidated statements of equity for years ended December 31, 2018 , 2017 and 2016 : Gain (Loss) Recognized in Other Comprehensive Income Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income Income Statement Location For the year ended December 31, 2018 2017 2016 2018 2017 2016 Cash Flow Hedges: Interest rate products $ 2,707 $ 10,807 $ 5,879 $ 3,099 $ (2,174 ) $ (1,360 ) Interest expense Net Investment Hedges: Foreign currency products 3,554 (2,378 ) (2,085 ) — — — N/A CAD term loan 7,888 (6,588 ) (3,750 ) — — — N/A $ 14,149 $ 1,841 $ 44 $ 3,099 $ (2,174 ) $ (1,360 ) The gain (loss) in the table above related to interest rate products reclassified from accumulated other comprehensive income into income are included in interest expense on the consolidated statements of income. Interest expense totaled $147.1 million , $88.4 million and $64.9 million for the years ended December 31, 2018 , 2017 and 2016 , respectively. During the year ended December 31, 2018 , no cash flow hedges were determined to be ineffective. During the year ended December 31, 2017 , the Company determined that a portion of a cash flow hedge was ineffective and recognized $22,000 of unrealized gains related to its interest rate swaps to other income on the consolidated statements of income. During the year ended December 31, 2016 , the Company determined that a portion of a cash flow hedge was ineffective and recognized $0.8 million of unrealized gains related to its interest rate swaps to other income on the consolidated statements of income. Derivatives Not Designated as Hedging Instruments As of December 31, 2018 , the Company had one outstanding cross currency interest rate swap not designated as a hedging instrument in an asset position with a fair value of $67,000 and included this amount in accounts receivable, prepaid expenses and other assets, net on the consolidated balance sheets. During the years ended December 31, 2018 and 2017 , the Company recorded $34,000 of other income and $8,000 of other expense, respectively, related to cross currency interest rate swaps not designated as hedging instruments. Offsetting Derivatives The Company enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with the same counterparty. The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2018 and 2017 (in thousands): As of December 31, 2018 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 29,344 $ — $ 29,344 $ (2,069 ) $ — $ 27,275 Offsetting Liabilities: Derivatives $ 4,529 $ — $ 4,529 $ (2,069 ) $ — $ 2,460 As of December 31, 2017 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 25,895 $ — $ 25,895 $ — $ — $ 25,895 Offsetting Liabilities: Derivatives $ — $ — $ — $ — $ — $ — Credit-risk-related Contingent Features The Company has agreements with each of its derivative counterparties that contain a provision pursuant to which the Company could be declared in default on the derivative obligation if the Company defaults on any of its indebtedness, including a default where repayment of the indebtedness has not been accelerated by the lender. As of December 31, 2018 , the fair value of derivatives in a net liability position, which includes accrued interest but excludes any adjustment for nonperformance risk, related to these agreements was $2.5 million . As of December 31, 2018 , the Company has not posted any collateral related to these agreements. If the Company had breached any of these provisions at December 31, 2018 , it could have been required to settle its obligations under the agreements at their termination value of $2.5 million .

FAIR VALUE DISCLOSURES

FAIR VALUE DISCLOSURES	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
FAIR VALUE DISCLOSURES	FAIR VALUE DISCLOSURES Financial Instruments The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments. Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable, accrued liabilities and the Credit Facility are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows: Loans receivable : These instruments are presented on the accompanying consolidated balance sheets at their amortized cost and not at fair value. The fair values of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, as well as the underlying collateral value and other credit enhancements as applicable. As such, the Company classifies these instruments as Level 3. Preferred equity investments : These instruments are presented on the accompanying consolidated balance sheets at their cost and not at fair value. The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investments, the underlying collateral value and other credit enhancements. As such, the Company classifies these instruments as Level 3. Derivative instruments : The Company’s derivative instruments are presented at fair value on the accompanying consolidated balance sheets. The Company estimates the fair value of derivative instruments, including its interest rate swaps and cross currency swaps, using the assistance of a third party using inputs that are observable in the market, which include forward yield curves and other relevant information. Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivative financial instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by itself and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company has determined that its derivative financial instruments valuations in their entirety are classified in Level 2 of the fair value hierarchy. Senior Notes : These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades. As such, the Company classifies these instruments as Level 2. Secured indebtedness : These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Company’s secured debt were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements. As such, the Company classifies these instruments as Level 3. The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2018 and 2017 whose carrying amounts do not approximate their fair value (in thousands): December 31, 2018 December 31, 2017 Face (1) Carrying (2) Fair Face (1) Carrying (2) Fair Financial assets: Loans receivable $ 96,492 $ 69,460 $ 65,797 $ 91,280 $ 65,907 $ 65,892 Preferred equity investments 43,851 44,262 43,825 48,035 48,483 47,064 Financial liabilities: Senior Notes 1,300,000 1,307,394 1,270,877 1,300,000 1,306,286 1,329,191 Secured indebtedness 117,464 115,679 101,820 259,202 256,430 246,461 (1) Face value represents amounts contractually due under the terms of the respective agreements. (2) Carrying amount represents the book value of financial instruments, including unamortized premiums/discounts and deferred financing costs. The Company determined the fair value of financial instruments as of December 31, 2018 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands): Fair Value Measurements Using Total Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Financial assets: Loans receivable $ 65,797 $ — $ — $ 65,797 Preferred equity investments 43,825 — — 43,825 Financial liabilities: Senior Notes 1,270,877 — 1,270,877 — Secured indebtedness 101,820 — — 101,820 Disclosure of the fair value of financial instruments is based on pertinent information available to the Company at the applicable dates and requires a significant amount of judgment. Despite increased capital market and credit market activity, transaction volume for certain financial instruments remains relatively low. This has made the estimation of fair values difficult and, therefore, both the actual results and the Company’s estimate of fair value at a future date could be materially different. Items Measured at Fair Value on a Recurring Basis During the year ended December 31, 2018 , the Company recorded the following amounts measured at fair value (in thousands): Fair Value Measurements Using Total Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Recurring Basis: Financial assets: Interest rate swap $ 25,184 $ — $ 25,184 $ — Cross currency swap 4,160 — 4,160 — Financial liabilities: Interest rate swap 4,529 — 4,529 —

EQUITY

EQUITY	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
EQUITY	EQUITY Preferred Stock On March 21, 2013, the Company completed an underwritten public offering of 5,750,000 shares of 7.125% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) at a price of $25.00 per share, pursuant to an effective registration statement. The Company received net proceeds of $138.3 million from the offering, after deducting underwriting discounts and other offering expenses. The Company classified the par value as preferred equity on its consolidated balance sheets with the balance of the liquidation preference, net of any issuance costs, recorded as an increase in paid-in capital. The Company redeemed all 5,750,000 shares of its Series A Preferred Stock on June 1, 2018 (the “Redemption Date”) for $25.00 per share, plus accrued and unpaid dividends to, but not including, the Redemption Date, without interest, in the amount of $0.4453125 per share of Series A Preferred Stock, for a total redemption price per share of Series A Preferred Stock equal to $25.4453125 . As a result of the redemption, the Company incurred a charge of $5.5 million related to the original issuance costs of the Series A Preferred Stock. The charge is presented as an additional preferred stock dividend in the Company’s consolidated statements of income for the year ended December 31, 2018. Common Stock As a result of the CCP Merger completed on August 17, 2017, the Company issued approximately 94.0 million shares of its common stock in exchange for shares of CCP common stock and shares underlying share-based awards assumed by the Company outstanding as of the effective time of the CCP Merger. On September 28, 2017, the Company completed an underwritten public offering of 16.0 million newly issued shares of its common stock pursuant to an effective registration statement. The underwriters exercised their option to purchase additional shares, and on October 2, 2017, the Company issued an additional 2.4 million newly issued shares of its common stock pursuant to an effective registration statement. The Company received net proceeds, before expenses, of $370.9 million from the offering, after giving effect to the issuance and sale of all 18.4 million shares of common stock, at a price of $21.00 per share. These proceeds were used to repay borrowings outstanding under the Revolving Credit Facility. Other Common Stock Issuances During the years ended December 31, 2018 and 2017 , the Company issued 0.1 million and 0.3 million shares of common stock as a result of restricted stock unit vestings. Upon any payment of shares as a result of restricted stock unit vestings, the related tax withholding obligation will generally be satisfied by the Company, reducing the number of shares to be delivered by a number of shares necessary to satisfy the related applicable tax withholding obligation. During the years ended December 31, 2018 , 2017 and 2016 , the Company incurred $0.4 million , $3.1 million and $1.5 million , respectively, in tax withholding obligations on behalf of its employees that were satisfied through a reduction in the number of shares delivered to those participants. Accumulated Other Comprehensive Income The following is a summary of the Company’s accumulated other comprehensive income (in thousands): Year Ended December 31, 2018 2017 Foreign currency translation loss $ (2,193 ) $ (2,913 ) Unrealized gains on cash flow hedges 14,494 14,202 Total accumulated other comprehensive income $ 12,301 $ 11,289

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION All stock-based awards are subject to the terms of the 2009 Performance Incentive Plan, which was assumed by the Company effective as of November 15, 2010 in connection with the Company’s separation from Sun and was most recently amended and restated in April 2017. The 2009 Performance Incentive Plan provides for the granting of stock-based compensation, including stock options, time-based stock units, funds from operations-based stock units (“FFO Units”), relative total stockholder return-based stock units (“TSR Units”) and performance-based restricted stock units to officers, employees and directors in connection with their employment with or services provided to the Company. Stock Options In connection with the CCP Merger, the Company assumed stock options outstanding as of the effective time of the CCP Merger. As of December 31, 2018 , these stock options, totaling 1.2 million shares underlying the stock options with exercise prices ranging from $24.24 to $34.09 per share, remained outstanding and are exercisable through February 13, 2019. As of December 31, 2018 , the weighted average exercise price per share was $28.04 and the stock options had no intrinsic value. As of December 31, 2017 , 1.7 million stock options with a weighted average exercise price per share of $27.92 were outstanding. During the year ended December 31, 2018 , no stock options were exercised and 0.5 million stock options expired. Restricted Stock Units and Performance-Based Restricted Stock Units Under the 2009 Performance Incentive Plan, restricted stock units and performance-based restricted stock units generally have a contractual life or vest over a three - to five -year period. The vesting of certain restricted stock units may accelerate, as defined in the grant, upon retirement, a change in control and other events. When vested (and subject to any applicable deferral or holdback period), each performance-based restricted stock unit is convertible into one share of common stock, subject to any deferrals in issuance pursuant to the grant. The restricted stock units are valued on the grant date based on the market price of the Company’s common stock on that date. Generally, the Company recognizes the fair value of the awards over the applicable vesting period as compensation expense. In addition, since the shares to be issued may vary based on the performance of the Company, the Company must make assumptions regarding the projected performance criteria and the shares that will ultimately be issued. The amount of FFO Units that will ultimately vest is dependent on the amount by which the Company’s funds from operations as adjusted (“FFO”) differs from a target FFO amount for a period specified in each grant and will range from 0% to 250% of the FFO Units initially granted. Similarly, the amount of TSR Units that will ultimately vest is dependent on the amount by which the total shareholder return (“TSR”) of the Company’s common stock differs from a predefined peer group for a period specified in each grant and will range from 0% to 200% of the TSR Units initially granted. Upon any payment of shares as a result of restricted stock unit vestings, the related tax withholding obligation will generally be satisfied by the Company, reducing the number of shares to be delivered by a number of shares necessary to satisfy the related applicable tax withholding obligation. The value of the shares withheld is dependent on the closing price of the Company’s common stock on the date the relevant transaction occurs. The following table summarizes additional information concerning restricted stock units at December 31, 2018 : Restricted Stock Units Weighted Average Grant Date Fair Value Per Unit Unvested as of December 31, 2017 1,125,487 $ 19.71 Granted 601,696 16.02 Vested (170,951 ) 21.35 Dividends reinvested 118,797 19.06 Cancelled/forfeited (197,711 ) 20.34 Unvested as of December 31, 2018 1,477,318 $ 17.88 As of December 31, 2018 , the weighted average remaining vesting period of restricted stock units was 2.5 years. The weighted average fair value per share at the date of grant for restricted stock units for the years ended December 31, 2018 , 2017 and 2016 was $16.02 , $19.38 and $22.05 , respectively. The total fair value of units vested during the years ended December 31, 2018 , 2017 and 2016 was $3.6 million , $8.4 million and $4.7 million , respectively. The fair value of the TSR Units is estimated on the date of grant using a Monte Carlo valuation model that uses the assumptions noted in the table below. The risk-free rate is based on the U.S. Treasury yield curve in effect at the grant date for the expected performance period. Expected volatility is based on historical volatility for the most recent 3 -year period ending on the grant date for the Company and the selected peer companies, and is calculated on a daily basis. The following are the key assumptions used in this valuation: 2018 2017 2016 Risk free interest rate 2.36% - 2.59% 1.42% - 1.99% 0.78% - 1.60% Expected stock price volatility 28.57% - 30.02% 28.86% - 30.97% 27.40% - 28.42% Expected service period 2.5 - 3.0 years 2.2 - 3.0 years 2.3 - 3.0 years Expected dividend yield (assuming full reinvestment) — % — % — % During the years ended December 31, 2018 , 2017 and 2016 , the Company recognized $7.6 million , $7.0 million and $7.5 million , respectively, of stock-based compensation expense included in general and administrative expense in the consolidated statements of income. During the year ended December 31, 2017, the Company recognized $1.4 million of stock-based compensation expense related to former CCP employees included in merger and acquisition costs in the consolidated statements of income. As of December 31, 2018 , there was $19.3 million of total unrecognized stock-based compensation expense related to unvested awards, which is expected to be recognized over a weighted average period of 2.5 years. Employee Benefit Plan The Company maintains a 401(k) plan that allows for eligible participants to defer compensation, subject to certain limitations imposed by the Internal Revenue Code of 1986, as amended (the “Code”). The Company provides a discretionary matching contribution of up to 3% of each participant’s eligible compensation. During the years ended December 31, 2018 , 2017 and 2016 , the Company’s matching contributions were approximately $171,000 , $143,000 and $73,000 , respectively.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement to distribute at least 90% of its taxable ordinary income. In addition, the Company is required to meet certain asset and income tests. As a REIT, the Company generally will not be subject to corporate level federal income tax on taxable income that it distributes to its stockholders. The Company also elected to treat certain of its consolidated subsidiaries as taxable REIT subsidiaries, which are subject to federal, state and foreign income taxes. The Company is subject to corporate income tax on built-in gains (the excess of fair market value over tax basis on properties held by Sabra as of the date Sabra elected to be taxed as a REIT, or January 1, 2011) on taxable dispositions of properties acquired in the Company’s separation from Sun occurring within a specified period (generally five years) following the election to be taxed as a REIT. This built-in gains tax is generally not payable on dispositions of property to the extent the proceeds from such dispositions are reinvested in qualifying like-kind replacement property as defined under various provisions of the Code. The Company does not expect to dispose of any properties held by Sabra at the Separation Date if such a disposition would result in the imposition of a material tax liability. Gains from asset dispositions occurring more than five years after the acquisition will not be subject to this corporate-level tax. As a result, the Company has not recorded a deferred tax liability associated with this corporate-level tax. As a result of acquisitions in Canada during 2015, the Company is subject to income taxes under the laws of Canada. The Company recorded a $0.6 million , $1.3 million and $0.7 million income tax benefit during the years ended December 31, 2018 , 2017 and 2016 , respectively, with respect to its Canadian operations. Due to uncertainty over the Company’s ability to utilize this income tax benefit in future periods, the Company recorded a valuation allowance of $0.7 million , $1.2 million and $0.7 million against the deferred tax benefit during the years ended December 31, 2018 , 2017 and 2016 , respectively. The following is a reconciliation of the Company’s beginning and ending unrecognized tax benefits (in thousands): Balance at December 31, 2015 $ 24,212 Additions (reductions) based on prior years’ tax positions (24,212 ) Additions (reductions) based on 2016 tax positions — Balance at December 31, 2016 $ — Additions (reductions) based on prior years’ tax positions — Additions (reductions) based on 2017 tax positions — Balance at December 31, 2017 $ — Additions (reductions) based on prior years’ tax positions — Additions (reductions) based on 2018 tax positions — Balance at December 31, 2018 $ — During the 2016 fiscal year, the full amount of unrecognized tax benefits was released due to the lapse of applicable statute of limitations. The balance of unrecognized tax benefits did not change in fiscal years 2017 and 2018, and the Company does not anticipate that the balance of unrecognized tax benefits will change materially in fiscal year 2019. The Company classifies interest and penalties from significant uncertain tax positions as interest expense and operating expenses, respectively, in its consolidated financial statements. During the years ended December 31, 2018 , 2017 and 2016 , the Company did not incur any such interest or penalties. With certain exceptions, the tax years 2015 and thereafter remain open to examination by the major taxing jurisdictions with which the Company files tax returns.

EARNINGS PER COMMON SHARE

EARNINGS PER COMMON SHARE	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
EARNINGS PER COMMON SHARE	EARNINGS PER COMMON SHARE The following table illustrates the computation of basic and diluted earnings per share (in thousands, except share and per share amounts): Year Ended December 31, 2018 2017 2016 Numerator Net income attributable to common stockholders $ 269,314 $ 148,141 $ 60,034 Denominator Basic weighted average common shares and common equivalents 178,305,738 105,621,242 65,284,251 Dilutive stock options and restricted stock units 416,006 221,192 236,421 Diluted weighted average common shares 178,721,744 105,842,434 65,520,672 Net income attributable to common stockholders, per: Basic common share $ 1.51 $ 1.40 $ 0.92 Diluted common share $ 1.51 $ 1.40 $ 0.92 During the years ended December 31, 2018 , 2017 and 2016 , approximately 121,000 , 132,000 and 128,000 restricted stock units, respectively, were not included in computing diluted earnings per share because they were considered anti-dilutive. No stock options were considered anti-dilutive during the years ended December 31, 2018 and 2017 , and no stock options were outstanding during the year ended December 31, 2016 .

SUMMARIZED CONSOLIDATING INFORM

SUMMARIZED CONSOLIDATING INFORMATION	12 Months Ended
	Dec. 31, 2018
Summarized Condensed Consolidating Information [Abstract]
SUMMARIZED CONSOLIDATING INFORMATION	SUMMARIZED CONSOLIDATING INFORMATION In connection with the offerings of the 2021 Notes and the 2023 Notes by the Issuers, the Company and certain 100% owned subsidiaries of the Company (the “Guarantors”) have, jointly and severally, fully and unconditionally guaranteed the 2021 Notes and the 2023 Notes, subject to release under certain customary circumstances as described below. In connection with the assumption of the 2026 Notes as a result of the CCP Merger (see Note 3, “CCP Merger and Recent Real Estate Acquisitions”), the Company has fully and unconditionally guaranteed the 2026 Notes, subject to release under certain circumstances as described below. These guarantees are subordinated to all existing and future senior debt and senior guarantees of the Guarantors and are unsecured. The Company conducts all of its business through and derives virtually all of its income from its subsidiaries. Therefore, the Company’s ability to make required payments with respect to its indebtedness (including the Senior Notes) and other obligations depends on the financial results and condition of its subsidiaries and its ability to receive funds from its subsidiaries. A Guarantor will be automatically and unconditionally released from its obligations under the guarantees with respect to the 2021 Notes and the 2023 Notes in the event of: • Any sale of the subsidiary Guarantor or of all or substantially all of its assets; • A merger or consolidation of a subsidiary Guarantor with an issuer of the 2021 Notes or the 2023 Notes or another Guarantor, provided that the surviving entity remains a Guarantor; • A subsidiary Guarantor is declared “unrestricted” for covenant purposes under the indentures governing the 2021 Notes or the 2023 Notes; • The requirements for legal defeasance or covenant defeasance or to discharge the indentures governing the 2021 Notes or the 2023 Notes have been satisfied; • A liquidation or dissolution, to the extent permitted under the indentures governing the 2021 Notes or the 2023 Notes, of a subsidiary Guarantor; or • The release or discharge of the guaranty that resulted in the creation of the subsidiary guaranty, except a discharge or release by or as a result of payment under such guaranty. The Company will be automatically and unconditionally released from its obligations under the guarantees with respect to the 2026 Notes in the event of: • A liquidation or dissolution, to the extent permitted under the indenture governing the 2026 Notes; • A merger or consolidation, provided that the surviving entity remains a Guarantor; or • The requirements for legal defeasance or covenant defeasance or to discharge the indenture governing the 2026 Notes have been satisfied. Pursuant to Rule 3-10 of Regulation S-X, the following summarized consolidating information is provided for the Company (the “Parent Company”), the Operating Partnership, Sabra Capital Corporation, the Guarantors, and the Company’s non-Guarantor subsidiaries with respect to the 2021 Notes and the 2023 Notes. This summarized financial information has been prepared from the books and records maintained by the Company, the Operating Partnership, Sabra Capital Corporation, the Guarantors and the non-Guarantor subsidiaries. The summarized financial information may not necessarily be indicative of the results of operations or financial position had the Operating Partnership, Sabra Capital Corporation, the Guarantors or non-Guarantor subsidiaries operated as independent entities. Sabra’s investments in its consolidated subsidiaries are presented based upon Sabra’s proportionate share of each subsidiary’s net assets. The Guarantor subsidiaries’ investments in the non-Guarantor subsidiaries and non-Guarantor subsidiaries’ investments in Guarantor subsidiaries are presented under the equity method of accounting. Intercompany activities between subsidiaries and the Parent Company are presented within operating activities on the consolidating statement of cash flows. Consolidating financial statements for the Company and its subsidiaries, including the Parent Company only, the Operating Partnership only, Sabra Capital Corporation only, the combined Guarantor subsidiaries and the combined non-Guarantor subsidiaries, are as follows: CONSOLIDATING BALANCE SHEET December 31, 2018 (in thousands, except share and per share amounts) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Assets Real estate investments, net of accumulated depreciation $ 317 $ — $ — $ 1,609,861 $ 4,243,367 $ — $ 5,853,545 Loans receivable and other investments, net (560 ) — — 50,534 63,748 — 113,722 Investment in unconsolidated joint venture — — — — 340,120 — 340,120 Cash and cash equivalents 40,835 — — 3,508 5,887 — 50,230 Restricted cash — — — 1,820 7,608 — 9,428 Lease intangible assets, net — — — 15,892 115,205 — 131,097 Accounts receivable, prepaid expenses and other assets, net 798 37,075 — 58,710 81,597 (11,019 ) 167,161 Intercompany 1,972,059 2,646,669 — — — (4,618,728 ) — Investment in subsidiaries 1,258,715 1,629,795 — 33,083 — (2,921,593 ) — Total assets $ 3,272,164 $ 4,313,539 $ — $ 1,773,408 $ 4,857,532 $ (7,551,340 ) $ 6,665,303 Liabilities Secured debt, net $ — $ — $ — $ — $ 115,679 $ — $ 115,679 Revolving credit facility — 624,000 — — — — 624,000 Term loans, net — 1,094,177 — 90,753 — — 1,184,930 Senior unsecured notes, net — 1,307,394 — — — — 1,307,394 Accounts payable and accrued liabilities 21,750 29,253 — 2,695 52,148 (11,019 ) 94,827 Lease intangible liabilities, net — — — — 83,726 — 83,726 Intercompany — — — 399,912 4,218,816 (4,618,728 ) — Total liabilities 21,750 3,054,824 — 493,360 4,470,369 (4,629,747 ) 3,410,556 Total Sabra Health Care REIT, Inc. stockholders’ equity 3,250,414 1,258,715 — 1,280,048 382,830 (2,921,593 ) 3,250,414 Noncontrolling interests — — — — 4,333 — 4,333 Total equity 3,250,414 1,258,715 — 1,280,048 387,163 (2,921,593 ) 3,254,747 Total liabilities and equity $ 3,272,164 $ 4,313,539 $ — $ 1,773,408 $ 4,857,532 $ (7,551,340 ) $ 6,665,303 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING BALANCE SHEET December 31, 2017 (in thousands, except share and per share amounts) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Assets Real estate investments, net of accumulated depreciation $ 324 $ — $ — $ 1,756,933 $ 4,237,175 $ — $ 5,994,432 Loans receivable and other investments, net (97 ) — — 55,297 59,190 — 114,390 Cash and cash equivalents 511,670 — — 449 6,513 — 518,632 Restricted cash — — — 36,910 31,907 — 68,817 Lease intangible assets, net — — — 17,577 149,542 — 167,119 Accounts receivable, prepaid expenses and other assets, net 3,499 36,073 — 80,739 53,765 (5,189 ) 168,887 Intercompany 2,043,402 2,721,979 — — — (4,765,381 ) — Investment in subsidiaries 890,462 1,198,305 — 14,661 — (2,103,428 ) — Total assets $ 3,449,260 $ 3,956,357 $ — $ 1,962,566 $ 4,538,092 $ (6,873,998 ) $ 7,032,277 Liabilities Secured debt, net $ — $ — $ — $ — $ 256,430 $ — $ 256,430 Revolving credit facility — 641,000 — — — — 641,000 Term loans, net — 1,092,397 — 98,377 — — 1,190,774 Senior unsecured notes, net — 1,306,286 — — — — 1,306,286 Accounts payable and accrued liabilities 16,453 26,212 — 3,560 61,487 (5,189 ) 102,523 Lease intangible liabilities, net — — — — 98,015 — 98,015 Intercompany — — — 785,120 3,980,261 (4,765,381 ) — Total liabilities 16,453 3,065,895 — 887,057 4,396,193 (4,770,570 ) 3,595,028 Total Sabra Health Care REIT, Inc. stockholders’ equity 3,432,807 890,462 — 1,075,509 137,457 (2,103,428 ) 3,432,807 Noncontrolling interests — — — — 4,442 — 4,442 Total equity 3,432,807 890,462 — 1,075,509 141,899 (2,103,428 ) 3,437,249 Total liabilities and equity $ 3,449,260 $ 3,956,357 $ — $ 1,962,566 $ 4,538,092 $ (6,873,998 ) $ 7,032,277 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2018 (in thousands, except share and per share amounts) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Revenues: Rental income $ — $ — $ — $ 170,400 $ 383,630 $ (17,425 ) $ 536,605 Interest and other income 110 399 — 5,632 10,925 (399 ) 16,667 Resident fees and services — — — — 70,137 — 70,137 Total revenues 110 399 — 176,032 464,692 (17,824 ) 623,409 Expenses: Depreciation and amortization 887 — — 57,143 133,349 — 191,379 Interest — 134,096 — 3,334 10,075 (399 ) 147,106 Operating expenses — — — — 66,971 (17,425 ) 49,546 General and administrative 26,801 71 — 2,078 7,508 — 36,458 Merger and acquisition costs 642 — — — (6 ) — 636 Provision for doubtful accounts, straight-line rental income and loan losses 822 — — 30,710 7,543 — 39,075 Impairment of real estate — — — 1,413 — — 1,413 Total expenses 29,152 134,167 — 94,678 225,440 (17,824 ) 465,613 Other income (expense): Loss on extinguishment of debt — — — — (2,917 ) — (2,917 ) Other income 1,977 (55 ) — 990 1,568 — 4,480 Net gain on sales of real estate — — — 108,697 19,501 — 128,198 Total other income 1,977 (55 ) — 109,687 18,152 — 129,761 Income in subsidiary 307,736 441,560 — 24,316 — (773,612 ) — Income before loss from unconsolidated joint venture and income tax expense 280,671 307,737 — 215,357 257,404 (773,612 ) 287,557 Loss from unconsolidated joint venture — — — — (5,431 ) — (5,431 ) Income tax expense (1,589 ) (1 ) — (1,114 ) (307 ) — (3,011 ) Net income 279,082 307,736 — 214,243 251,666 (773,612 ) 279,115 Net income attributable to noncontrolling interests — — — — (33 ) — (33 ) Net income attributable to Sabra Health Care REIT, Inc. 279,082 307,736 — 214,243 251,633 (773,612 ) 279,082 Preferred stock dividends (9,768 ) — — — — — (9,768 ) Net income attributable to common stockholders $ 269,314 $ 307,736 $ — $ 214,243 $ 251,633 $ (773,612 ) $ 269,314 Net income attributable to common stockholders, per: Basic common share $ 1.51 Diluted common share $ 1.51 Weighted-average number of common shares outstanding, basic 178,305,738 Weighted-average number of common shares outstanding, diluted 178,721,744 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2017 (in thousands, except share and per share amounts) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Revenues: Rental income $ — $ — $ — $ 213,162 $ 158,542 $ (7,513 ) $ 364,191 Interest and other income 39 143 — 9,098 5,907 (161 ) 15,026 Resident fees and services — — — — 26,430 — 26,430 Total revenues 39 143 — 222,260 190,879 (7,674 ) 405,647 Expenses: Depreciation and amortization 867 — — 67,723 45,292 — 113,882 Interest — 77,767 — 2,989 7,827 (143 ) 88,440 Operating expenses — — — — 25,391 (7,531 ) 17,860 General and administrative 24,810 65 — 3,854 3,672 — 32,401 Merger and acquisition costs 30,208 — — 47 — — 30,255 Provision for doubtful accounts, straight-line rental income and loan losses 227 — — 16,886 — — 17,113 Impairment of real estate — — — 1,326 — — 1,326 Total expenses 56,112 77,832 — 92,825 82,182 (7,674 ) 301,277 Other income (expense): Loss on extinguishment of debt — (422 ) — (131 ) — — (553 ) Other income (expense) 2,634 1,130 — (617 ) 23 — 3,170 Net gain (loss) on sales of real estate — — — 54,627 (2,598 ) — 52,029 Total other income (expense) 2,634 708 — 53,879 (2,575 ) — 54,646 Income in subsidiary 212,432 289,414 — 7,199 — (509,045 ) — Income before income tax (expense) benefit 158,993 212,433 — 190,513 106,122 (509,045 ) 159,016 Income tax (expense) benefit (610 ) (1 ) — (139 ) 99 — (651 ) Net income 158,383 212,432 — 190,374 106,221 (509,045 ) 158,365 Net loss attributable to noncontrolling interests — — — — 18 — 18 Net income attributable to Sabra Health Care REIT, Inc. 158,383 212,432 — 190,374 106,239 (509,045 ) 158,383 Preferred stock dividends (10,242 ) — — — — — (10,242 ) Net income attributable to common stockholders $ 148,141 $ 212,432 $ — $ 190,374 $ 106,239 $ (509,045 ) $ 148,141 Net income attributable to common stockholders, per: Basic common share $ 1.40 Diluted common share $ 1.40 Weighted-average number of common shares outstanding, basic 105,621,242 Weighted-average number of common shares outstanding, diluted 105,842,434 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2016 (in thousands, except share and per share amounts) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Revenues: Rental income $ — $ — $ — $ 206,897 $ 20,706 $ (2,328 ) $ 225,275 Interest and other income 3 — — 27,712 1 (253 ) 27,463 Resident fee and services — — — — 7,788 — 7,788 Total revenues 3 — — 234,609 28,495 (2,581 ) 260,526 Expenses: Depreciation and amortization 816 — — 61,371 6,285 — 68,472 Interest — 54,589 — 3,497 6,787 — 64,873 Operating expenses — — — — 8,066 (2,363 ) 5,703 General and administrative 15,798 56 — 1,652 166 — 17,672 Merger and acquisition costs (7 ) — — 1,204 — — 1,197 (Recovery of) provision for doubtful accounts, straight-line rental income and loan losses (1,376 ) — — 6,498 421 — 5,543 Impairment of real estate — — — 29,811 — — 29,811 Total expenses 15,231 54,645 — 104,033 21,725 (2,363 ) 193,271 Other income (expense): Loss on extinguishment of debt — (468 ) — (88 ) — — (556 ) Other income (expense) 7,366 (196 ) — 3,507 — — 10,677 Net (loss) gain on sale of real estate — — — (6,143 ) 21 — (6,122 ) Total other income (expense) 7,366 (664 ) — (2,724 ) 21 — 3,999 Income in subsidiary 78,783 134,093 — 6,840 — (219,716 ) — Income before income tax expense 70,921 78,784 — 134,692 6,791 (219,934 ) 71,254 Income tax expense (427 ) (1 ) — (538 ) (83 ) — (1,049 ) Net income 70,494 78,783 — 134,154 6,708 (219,934 ) 70,205 Net loss attributable to noncontrolling interests — — — — 71 — 71 Net income attributable to Sabra Health Care REIT, Inc. 70,494 78,783 — 134,154 6,779 (219,934 ) 70,276 Preferred stock dividends (10,242 ) — — — — — (10,242 ) Net income attributable to common stockholders $ 60,252 $ 78,783 $ — $ 134,154 $ 6,779 $ (219,934 ) $ 60,034 Net income attributable to common stockholders, per: Basic common share $ 0.92 Diluted common share $ 0.92 Weighted-average number of common shares outstanding, basic 65,284,251 Weighted-average number of common shares outstanding, diluted 65,520,672 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2018 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net income $ 279,082 $ 307,736 $ — $ 214,243 $ 251,666 $ (773,612 ) $ 279,115 Other comprehensive income (loss): Unrealized gain (loss), net of tax: Foreign currency translation gain (loss) — 4,329 — (2,751 ) (858 ) — 720 Unrealized gain on cash flow hedge — 244 — 48 — — 292 Total other comprehensive income (loss) — 4,573 — (2,703 ) (858 ) — 1,012 Comprehensive income 279,082 312,309 — 211,540 250,808 (773,612 ) 280,127 Comprehensive income attributable to noncontrolling interests — — — — (33 ) — (33 ) Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 279,082 $ 312,309 $ — $ 211,540 $ 250,775 $ (773,612 ) $ 280,094 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2017 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net income $ 158,383 $ 212,432 $ — $ 190,374 $ 106,221 $ (509,045 ) $ 158,365 Other comprehensive income: Unrealized gain (loss), net of tax: Foreign currency translation (loss) gain — (2,821 ) — 2,233 742 — 154 Unrealized gain (loss) on cash flow hedge — 13,078 — (145 ) — — 12,933 Total other comprehensive income — 10,257 — 2,088 742 — 13,087 Comprehensive income 158,383 222,689 — 192,462 106,963 (509,045 ) 171,452 Comprehensive loss attributable to noncontrolling interests — — — — 18 — 18 Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 158,383 $ 222,689 $ — $ 192,462 $ 106,981 $ (509,045 ) $ 171,470 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2016 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net income $ 70,494 $ 78,783 $ — $ 134,154 $ 6,708 $ (219,934 ) $ 70,205 Other comprehensive income: Unrealized gain (loss), net of tax: Foreign currency translation (loss) gain — (2,080 ) — 364 82 — (1,634 ) Unrealized gain on cash flow hedges — 7,169 — — — — 7,169 Total other comprehensive income — 5,089 — 364 82 — 5,535 Comprehensive income 70,494 83,872 — 134,518 6,790 (219,934 ) 75,740 Comprehensive loss attributable to noncontrolling interests — — — — 71 — 71 Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 70,494 $ 83,872 $ — $ 134,518 $ 6,861 $ (219,934 ) $ 75,811 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2018 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net cash provided by operating activities $ 310,442 $ — $ — $ 1,639 $ 46,462 $ — $ 358,543 Cash flows from investing activities: Acquisition of real estate — — — (77,225 ) (184,286 ) — (261,511 ) Origination and fundings of loans receivable — — — (6,317 ) (44,414 ) — (50,731 ) Origination and fundings of preferred equity investments — — — (5,313 ) — — (5,313 ) Additions to real estate (40 ) — — (6,862 ) (20,795 ) — (27,697 ) Repayment of loans receivable — — — 8,946 42,843 — 51,789 Repayment of preferred equity investments — — — 6,870 — — 6,870 Investment in unconsolidated JV — — — — (354,461 ) — (354,461 ) Net proceeds from sales of real estate — — — 284,958 97,602 — 382,560 Distribution from subsidiaries 5,457 5,457 — — — (10,914 ) — Intercompany financing (317,225 ) (299,873 ) — — — 617,098 — Net cash (used in) provided by investing activities (311,808 ) (294,416 ) — 205,057 (463,511 ) 606,184 (258,494 ) Cash flows from financing activities: Net repayments of revolving credit facility — (17,000 ) — — — — (17,000 ) Principal payments on secured debt — — — — (140,338 ) — (140,338 ) Payments of deferred financing costs — (352 ) — — — — (352 ) Distributions to noncontrolling interest — — — — (142 ) — (142 ) Preferred stock redemption (143,750 ) — — — — — (143,750 ) Issuance of common stock, net (499 ) — — — — — (499 ) Dividends paid on common and preferred stock (325,220 ) — — — — — (325,220 ) Distribution to parent — (5,457 ) — — (5,457 ) 10,914 — Intercompany financing — 317,225 — (238,392 ) 538,265 (617,098 ) — Net cash (used in) provided by financing activities (469,469 ) 294,416 — (238,392 ) 392,328 (606,184 ) (627,301 ) Net decrease in cash, cash equivalents and restricted cash (470,835 ) — — (31,696 ) (24,721 ) — (527,252 ) Effect of foreign currency translation on cash, cash equivalents and restricted cash — — — (335 ) (204 ) — (539 ) Cash, cash equivalents and restricted cash, beginning of period 511,670 — — 37,359 38,420 — 587,449 Cash, cash equivalents and restricted cash, end of period $ 40,835 $ — $ — $ 5,328 $ 13,495 $ — $ 59,658 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2017 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net cash provided by operating activities $ 59,640 $ — $ — $ 41,085 $ 35,064 $ — $ 135,789 Cash flows from investing activities: Acquisition of real estate — — — (419,905 ) — — (419,905 ) Cash received in CCP Merger 77,859 — — — — — 77,859 Origination and fundings of loans receivable — — — (1,799 ) (15,440 ) — (17,239 ) Origination and fundings of preferred equity investments — — — (2,749 ) — — (2,749 ) Additions to real estate (181 ) — — (2,339 ) (4,434 ) — (6,954 ) Repayment of loans receivable — — — 12,441 19,989 — 32,430 Repayment of preferred equity investments — — — 3,755 — — 3,755 Net proceeds from sales of real estate — — — 149,849 394 — 150,243 Distribution from subsidiaries 2,474 2,474 — — — (4,948 ) — Intercompany financing 168,999 (249,664 ) — — — 80,665 — Net cash provided by (used in) investing activities 249,151 (247,190 ) — (260,747 ) 509 75,717 (182,560 ) Cash flows from financing activities: Net borrowings from revolving credit facility — 253,000 — — — — 253,000 Proceeds from term loans — 181,000 — — — — 181,000 Principal payments on secured debt — — — — (4,145 ) — (4,145 ) Payments of deferred financing costs — (15,337 ) — — — — (15,337 ) Payment of contingent consideration — — — (382 ) — — (382 ) Distributions to noncontrolling interests — — — — (30 ) — (30 ) Issuance of common stock, net 366,800 — — — — — 366,800 Dividends paid on common and preferred stock (182,089 ) — — — — — (182,089 ) Distribution to parent — (2,474 ) — — (2,474 ) 4,948 — Intercompany financing — (168,999 ) — 254,608 (4,944 ) (80,665 ) — Net cash provided by (used in) financing activities 184,711 247,190 — 254,226 (11,593 ) (75,717 ) 598,817 Net increase in cash, cash equivalents and restricted cash 493,502 — — 34,564 23,980 — 552,046 Effect of foreign currency translation on cash, cash equivalents and restricted cash — — — 63 675 — 738 Cash, cash equivalents and restricted cash, beginning of period 18,168 — — 2,732 13,765 — 34,665 Cash, cash equivalents and restricted cash, end of period $ 511,670 $ — $ — $ 37,359 $ 38,420 $ — $ 587,449 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2016 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net cash provided by operating activities $ 153,577 $ — $ — $ 10,343 $ 12,008 $ — $ 175,928 Cash flows from investing activities: Acquisition of real estate — — — (153,579 ) — — (153,579 ) Origination and fundings of loans receivable — — — (9,675 ) — — (9,675 ) Origination and fundings of preferred equity investments — — — (7,348 ) — — (7,348 ) Additions to real estate (124 ) — — (502 ) (377 ) — (1,003 ) Repayment of loans receivable — — — 215,962 — — 215,962 Net proceeds from the sales of real estate — — — 97,407 599 — 98,006 Investment in subsidiaries (200 ) (200 ) — — — 400 — Distribution from subsidiaries 6,404 6,404 — — — (12,808 ) — Intercompany financing (23,484 ) 165,842 — — — (142,358 ) — Net cash (used in) provided by investing activities (17,404 ) 172,046 — 142,265 222 (154,766 ) 142,363 Cash flows from financing activities: Net repayments of revolving credit facility — (229,000 ) — — — — (229,000 ) Proceeds from term loans — 45,000 — 24,360 — — 69,360 Principal payments on secured debt — — — (10,766 ) (4,002 ) — (14,768 ) Payments of deferred financing costs — (5,326 ) — (611 ) — — (5,937 ) Issuance of common stock, net (1,289 ) — — — — — (1,289 ) Dividends paid on common and preferred stock (119,264 ) — — — — — (119,264 ) Contribution from parent — 200 — — 200 (400 ) — Distribution to parent — (6,404 ) — — (6,404 ) 12,808 — Intercompany financing — 23,484 — (165,175 ) (667 ) 142,358 — Net cash used in financing activities (120,553 ) (172,046 ) — (152,192 ) (10,873 ) 154,766 (300,898 ) Net increase in cash, cash equivalents and restricted cash 15,620 — — 416 1,357 — 17,393 Effect of foreign currency translation on cash, cash equivalents and restricted cash — — — 72 (47 ) — 25 Cash, cash equivalents and restricted cash, beginning of period 2,548 — — 2,244 12,455 — 17,247 Cash, cash equivalents and restricted cash, end of period $ 18,168 $ — $ — $ 2,732 $ 13,765 $ — $ 34,665 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes.

PRO FORMA FINANCIAL INFORMATION

PRO FORMA FINANCIAL INFORMATION (UNAUDITED)	12 Months Ended
	Dec. 31, 2018
Pro Forma Financial Information [Abstract]
PRO FORMA FINANCIAL INFORMATION (UNAUDITED)	PRO FORMA FINANCIAL INFORMATION (UNAUDITED) The following table summarizes, on an unaudited pro forma basis, the consolidated results of operations of the Company for the year ended December 31, 2017 to give effect to the CCP Merger completed on August 17, 2017. The following unaudited pro forma information has been prepared to give effect to the CCP Merger as if it occurred on January 1, 2016. This pro forma information does not purport to represent what the actual results of operations of the Company would have been had the CCP Merger been completed on January 1, 2016, nor does it purport to predict the results of operations for future periods. The pro forma information for the year ended December 31, 2017 follows (in thousands, except share and per share amounts): Revenues $ 631,041 Net income attributable to common stockholders $ 292,551 Net income attributable to common stockholders, per: Basic common share $ 1.78 Diluted common share $ 1.78 Weighted-average number of common shares outstanding, basic 164,361,139 Weighted-average number of common shares outstanding, diluted 164,582,331 Merger and acquisition costs of $30.2 million related to the CCP Merger completed during year the ended December 31, 2017 are treated as if they were incurred on January 1, 2016. No business combinations were completed during the year ended December 31, 2018.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Environmental As an owner of real estate, the Company is subject to various environmental laws of federal, state and local governments. The Company is not aware of any environmental liability that could have a material adverse effect on its financial condition or results of operations. However, changes in applicable environmental laws and regulations, the uses and conditions of properties in the vicinity of the Company’s properties, the activities of its tenants and other environmental conditions of which the Company is unaware with respect to the properties could result in future environmental liabilities. As of December 31, 2018 , the Company does not expect that compliance with existing environmental laws will have a material adverse effect on the Company’s financial condition and results of operations. Legal Matters From time to time, the Company is party to legal proceedings that arise in the ordinary course of its business. Management is not aware of any legal proceedings where the likelihood of a loss contingency is reasonably possible and the amount or range of reasonably possible losses is material to the Company’s results of operations, financial condition or cash flows.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS The Company evaluates subsequent events up until the date the consolidated financial statements are issued. Dividend Declaration On February 5, 2019 , the Company announced that its board of directors declared a quarterly cash dividend of $0.45 per share of common stock. The dividend will be paid on February 28, 2019 to stockholders of record as of the close of business on February 15, 2019 .

SCHEDULE II - VALUATION AND QUA

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2018
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS For the Years Ended December 31, 2018, 2017 and 2016 (dollars in thousands) Balance at Beginning of Year Charged to Earnings Recoveries Uncollectible Accounts Written-off Foreign Currency Translation due to Charges Balance at End of Year Year ended December 31, 2018 Allowance for doubtful accounts $ 5,520 $ 986 $ (2,718 ) $ (82 ) $ — $ 3,706 Straight-line rent receivable allowance 12,355 39,646 — (16,223 ) — 35,778 Loan loss reserves 97 1,161 — — — 1,258 $ 17,972 $ 41,793 $ (2,718 ) $ (16,305 ) $ — $ 40,742 Year ended December 31, 2017 Allowance for doubtful accounts $ 3,693 $ 2,485 $ (385 ) $ (273 ) $ — $ 5,520 Straight-line rent receivable allowance 3,668 10,487 — (1,800 ) — 12,355 Loan loss reserves 2,750 4,526 — (7,179 ) — 97 $ 10,111 $ 17,498 $ (385 ) $ (9,252 ) $ — $ 17,972 Year ended December 31, 2016 Allowance for doubtful accounts $ 3,811 $ 235 $ — $ (353 ) $ — $ 3,693 Straight-line rent receivable allowance 5,331 3,540 — (5,191 ) (12 ) 3,668 Loan loss reserves 4,300 1,768 — (3,318 ) — 2,750 $ 13,442 $ 5,543 $ — $ (8,862 ) $ (12 ) $ 10,111

SCHEDULE III - REAL ESTATE ASSE

SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION	12 Months Ended
	Dec. 31, 2018
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]
SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION	SCHEDULE III REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION As of December 31, 2018 (dollars in thousands) Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Skilled Nursing/Transitional Care Facilities Forest Hills (SNF) Broken Arrow, OK 100% (4) $ 1,653 $ 11,259 $ 12,912 $ — $ 1,653 $ 10,269 $ 11,922 $ (4,074 ) 1994/2008, 2009/2010, 2015 11/15/10 40 Seminole Estates Seminole, OK 100% — 655 3,527 4,182 — 655 3,194 3,849 (1,046 ) 1987 11/15/10 32 Bedford Hills Bedford, NH 100% 5,964 1,911 12,245 14,156 — 1,911 11,164 13,075 (4,199 ) 1992/2010 11/15/10 36 The Elms Care Milford, NH 100% — 312 1,679 1,991 — 312 1,419 1,731 (904 ) 1890/2005 11/15/10 20 Missouri River Great Falls, MT 100% 10,609 2,023 16,967 18,990 — 2,023 15,816 17,839 (7,347 ) 1960/1990, 2010 11/15/10 30 Deer Lodge Deer Lodge, MT 100% 4,036 190 3,032 3,222 2 190 2,629 2,819 (1,153 ) 1973 11/15/10 30 Arden House Hamden, CT 100% 18,331 2,250 23,816 26,066 — 2,250 22,437 24,687 (9,395 ) 1973/2008, 2010 11/15/10 28 Lake Drive Henryetta, OK 100% — 160 549 709 — 160 64 224 (51 ) 1968 11/15/10 10 Mineral Springs North Conway, NH 100% 11,858 417 5,352 5,769 — 417 4,679 5,096 (1,743 ) 1988/2009 11/15/10 43 Wolfeboro Wolfeboro, NH 100% 9,989 454 4,531 4,985 — 454 4,074 4,528 (1,515 ) 1984/1986, 1987, 2009 11/15/10 41 Broadmeadow Healthcare Middletown, DE 100% — 1,650 21,730 23,380 — 1,650 21,730 23,380 (4,645 ) 2005 08/01/11 40 Capitol Healthcare Dover, DE 100% — 4,940 15,500 20,440 — 4,940 15,500 20,440 (3,465 ) 1996/2016 08/01/11 40 Pike Creek Healthcare Wilmington, DE 100% — 2,460 25,240 27,700 — 2,460 25,240 27,700 (5,455 ) 2009 08/01/11 40 Renaissance Healthcare Millsboro, DE 100% — 1,640 22,620 24,260 — 1,640 22,620 24,260 (4,984 ) 2008 08/01/11 40 Clara Burke Plymouth Meeting, PA 100% — 2,527 12,453 14,980 179 2,527 12,631 15,158 (2,661 ) 1927/1990, 2007/2016 03/30/12 40 Warrington Warrington, PA 100% — 2,617 11,662 14,279 106 2,617 11,768 14,385 (2,269 ) 1958/2009/2016 03/30/12 40 Ridgecrest Duffield, VA 100% — 509 5,018 5,527 1,333 509 6,351 6,860 (1,399 ) 1981/2013 05/10/12 40 Camden Care Center Minneapolis, MN 100% — 1,235 5,777 7,012 50 790 3,090 3,880 (89 ) 1990 11/30/12 40 Arbrook Plaza Arlington, TX 100% — 3,783 14,219 18,002 — 3,783 14,219 18,002 (2,486 ) 2002/2012 11/30/12 40 Northgate Plaza Irving, TX 100% — 4,901 10,299 15,200 — 4,901 10,299 15,200 (1,855 ) 2003/2012, 2015 11/30/12 40 Gulf Pointe Plaza Rockport, TX 100% — 1,005 6,628 7,633 — 1,005 6,628 7,633 (1,254 ) 2002/2012 11/30/12 40 Gateway Senior Living Lincoln, NE 100% — 6,368 29,919 36,287 — 6,368 29,919 36,287 (4,140 ) 1962/1996/2013 02/14/14 40 Legacy Fremont, NE 100% — 615 16,176 16,791 — 615 16,176 16,791 (2,456 ) 2008 02/14/14 40 Pointe Fremont, NE 100% — 615 2,943 3,558 — 615 2,943 3,558 (530 ) 1970/1979/1983/1994 02/14/14 40 Regency South Sioux City, NE 100% — 246 6,206 6,452 — 246 6,206 6,452 (1,147 ) 1962/1968/1975/2000/2004 02/14/14 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Parkmoor Village Colorado Springs, CO 100% — 430 13,703 14,133 — 430 13,703 14,133 (2,185 ) 1985/2017, 2018 03/05/14 40 Onion Creek Austin, TX 100% — 871 12,843 13,714 — 871 12,843 13,714 (1,769 ) 2011 10/21/14 40 Adams PARC Barlesville, OK 100% — 1,332 6,904 8,236 — 1,332 6,904 8,236 (904 ) 1989 10/29/14 40 PARCway Oklahoma City, OK 100% — 2,189 23,567 25,756 703 2,189 24,271 26,460 (2,759 ) 1963/1984 10/29/14 40 Brookhaven Extensive Care Norman, OK 100% — 869 5,236 6,105 — 869 5,237 6,106 (766 ) 2001/2013 10/29/14 40 Cadia Healthcare of Hyattsville Hyattsville, MD 100% — 6,343 65,573 71,916 14 6,343 65,586 71,929 (6,913 ) 1950/1976, 2008 06/30/15 40 Cadia Healthcare of Annapolis Annapolis, MD 100% — 1,548 40,773 42,321 103 1,548 40,876 42,424 (3,996 ) 1964/1993, 2012 06/30/15 40 Cadia Healthcare of Wheaton Wheaton, MD 100% — 676 56,897 57,573 22 676 56,918 57,594 (5,482 ) 1966/1991, 2012 06/30/15 40 Cadia Healthcare of Hagerstown Hagerstown, MD 100% — 1,475 56,237 57,712 500 1,475 56,738 58,213 (4,841 ) 1953/1975, 2014 11/25/15 40 Cadia Healthcare of Spring Brook Silver Spring, MD 100% — 963 48,085 49,048 7 963 48,090 49,053 (3,253 ) 1965/2015 07/26/16 40 Andrew Residence Minneapolis, MN 100% — 2,931 6,943 9,874 192 2,931 7,135 10,066 (335 ) 1941/2014 08/17/17 40 Atrium Post Acute Care of Chilton Chilton, WI 100% — 230 3,645 3,875 — 230 3,645 3,875 (135 ) 1963/2010 08/17/17 40 Fox River Nursing and Rehab Center Appleton, WI 100% — 1,220 2,351 3,571 — 1,220 2,351 3,571 (90 ) 1968/1992 08/17/17 40 Bridgewood Nursing and Rehab Center Neenah, WI 100% — 890 2,985 3,875 — 890 2,985 3,875 (121 ) 1965 08/17/17 40 Kennedy Park Nursing and Rehab Center Schofield, WI 100% — 1,000 2,875 3,875 — 1,000 2,875 3,875 (113 ) 1966/1997 08/17/17 40 Avamere Riverpark of Eugene Eugene, OR 100% — 2,205 28,700 30,905 2,252 2,205 30,952 33,157 (1,238 ) 1988/2016 08/17/17 40 Avamere Rehab of Lebanon Lebanon, OR 100% — 958 14,176 15,134 — 958 14,176 15,134 (511 ) 1974 08/17/17 40 Avamere Crestview of Portland Portland, OR 100% — 1,791 12,833 14,624 2,761 1,791 15,594 17,385 (730 ) 1964/2016 08/17/17 40 Avamere Rehabilitation of King City Tigard, OR 100% — 2,011 11,667 13,678 — 2,011 11,667 13,678 (435 ) 1975 08/17/17 40 Avamere Rehabilitation of Hillsboro Hillsboro, OR 100% — 1,387 14,028 15,415 — 1,387 14,028 15,415 (505 ) 1973 08/17/17 40 Avamere Rehab of Junction City Junction City, OR 100% — 584 7,901 8,485 — 584 7,901 8,485 (295 ) 1966/2015 08/17/17 40 Avamere Rehab of Eugene Eugene, OR 100% — 1,380 14,921 16,301 1,791 1,380 16,712 18,092 (720 ) 1966/2016 08/17/17 40 Avamere Rehab of Coos Bay Coos Bay, OR 100% — 829 8,518 9,347 — 829 8,518 9,347 (330 ) 1968 08/17/17 40 Avamere Twin Oaks of Sweet Home Sweet Home, OR 100% — 238 3,338 3,576 — 238 3,338 3,576 (129 ) 1972 08/17/17 40 Avamere Rehab of Clackamas Gladstone, OR 100% — 792 5,000 5,792 — 792 5,000 5,792 (191 ) 1961 08/17/17 40 Avamere Rehab of Newport Newport, OR 100% — 406 5,001 5,407 — 406 5,001 5,407 (182 ) 1973/2014 08/17/17 40 Avamere Rehab of Oregon City Oregon City, OR 100% — 1,496 12,142 13,638 — 1,496 12,142 13,638 (437 ) 1974 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Avamere Transitional Care of Puget Sound Tacoma, WA 100% — 1,771 11,595 13,366 15 1,771 11,610 13,381 (487 ) 2017 08/17/17 40 Richmond Beach Rehab Shoreline, WA 100% — 4,703 14,444 19,147 — 4,703 14,444 19,147 (539 ) 1993/2014 08/17/17 40 St. Francis of Bellingham Bellingham, WA 100% — — 15,330 15,330 — — 15,330 15,330 (577 ) 1984/2015 08/17/17 40 Avamere Olympic Rehabilitation of Sequim Sequim, WA 100% — 427 4,450 4,877 — 427 4,450 4,877 (201 ) 1974 08/17/17 40 Avamere Heritage Rehabilitation of Tacoma Tacoma, WA 100% — 1,705 4,952 6,657 — 1,705 4,952 6,657 (195 ) 1968 08/17/17 40 Avamere at Pacific Ridge Tacoma, WA 100% — 2,195 1,956 4,151 — 2,195 1,956 4,151 (102 ) 1972/2014 08/17/17 40 Avamere Rehabilitation of Cascade Park Vancouver, WA 100% — 1,782 15,116 16,898 — 1,782 15,116 16,898 (589 ) 1991 08/17/17 40 The Pearl at Kruse Way Lake Oswego, OR 100% — 5,947 13,401 19,348 — 5,947 13,401 19,348 (504 ) 2005/2016 08/17/17 40 Avamere at Medford Medford, OR 100% — 2,043 38,485 40,528 2,960 2,043 41,445 43,488 (1,636 ) 1974/2016 08/17/17 40 Avamere Bellingham Healthcare and Rehab Services Bellingham, WA 100% — 2,908 2,058 4,966 — 2,908 2,058 4,966 (104 ) 1972/2015 08/17/17 40 Queen Anne Healthcare Seattle, WA 100% — 2,508 6,401 8,909 — 2,508 6,401 8,909 (244 ) 1970 08/17/17 40 Avamere Transitional Care and Rehab - Boise Boise, ID 100% — 681 9,348 10,029 — 681 9,348 10,029 (356 ) 1979 08/17/17 40 Avamere Transitional Care at Sunnyside Salem, OR 100% — 2,114 15,651 17,765 — 2,114 15,651 17,765 (581 ) 1981 08/17/17 40 Avamere Health Services of Rogue Valley Medford, OR 100% — 1,375 23,808 25,183 — 1,375 23,808 25,183 (891 ) 1961/2016 08/17/17 40 Avamere Transitional Care and Rehab - Malley Northglenn, CO 100% — 1,662 26,014 27,676 3,258 1,662 29,273 30,935 (1,245 ) 1972/2016 08/17/17 40 Avamere Transitional Care and Rehab - Brighton Brighton, CO 100% — 1,933 11,624 13,557 — 1,933 11,624 13,557 (445 ) 1971 08/17/17 40 Phoenix Rehabilitation Services Phoenix, AZ 100% — 1,270 11,502 12,772 — 1,270 11,502 12,772 (415 ) 2008 08/17/17 40 Tustin Subacute Care Facility Santa Ana, CA 100% — 1,889 11,682 13,571 — 1,889 11,682 13,571 (410 ) 2008 08/17/17 40 La Mesa Inpatient Rehabilitation Facility La Mesa, CA 100% — 1,276 8,177 9,453 — 1,276 8,177 9,453 (298 ) 2012 08/17/17 40 Golden Living Center - Westminster Westminster, MD 100% — 2,128 6,614 8,742 413 2,128 7,028 9,156 (347 ) 1973/2010 08/17/17 40 Maple Wood Care Center Kansas City, MO 100% — 1,142 3,226 4,368 653 1,142 3,878 5,020 (295 ) 1983 08/17/17 40 Garden Valley Nursing & Rehab Kansas City, MO 100% — 1,985 2,714 4,699 303 1,985 3,017 5,002 (270 ) 1983 08/17/17 40 Worthington Nursing & Rehab Parkersburg, WV 100% — 697 10,688 11,385 76 697 10,764 11,461 (494 ) 1974/1999 08/17/17 40 Burlington House Rehabilitative and Alzheimers Care Center Cincinnati, OH 100% — 2,686 10,062 12,748 — 2,686 10,062 12,748 (433 ) 1989/2015 08/17/17 40 Golden Living Center - Charlottesville Charlottesville, VA 100% — 2,840 8,450 11,290 626 2,840 9,076 11,916 (413 ) 1964/2009 08/17/17 40 Golden Living Center - Sleepy Hollow Annandale, VA 100% — 7,241 17,727 24,968 712 7,241 18,439 25,680 (768 ) 1963/2013 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Golden Living Center - Petersburg Petersburg, VA 100% — 988 8,416 9,404 141 988 8,557 9,545 (359 ) 1970/2009 08/17/17 40 Golden Living Center - Battlefield Park Petersburg, VA 100% — 1,174 8,858 10,032 151 1,174 9,009 10,183 (374 ) 1976/2010 08/17/17 40 Golden Living Center - Hagerstown Hagerstown, MD 100% — 1,393 13,438 14,831 149 1,393 13,587 14,980 (542 ) 1971/2010 08/17/17 40 Golden Living Center - Cumberland Cumberland, MD 100% — 800 16,973 17,773 429 800 17,403 18,203 (680 ) 1968 08/17/17 40 Gilroy Healthcare and Rehabilitiation Center Gilroy, CA 100% — 662 23,775 24,437 — 662 23,775 24,437 (847 ) 1968 08/17/17 40 North Cascades Health and Rehabilitation Center Bellingham, WA 100% — 1,437 14,196 15,633 — 1,437 14,196 15,633 (529 ) 1999 08/17/17 40 Granite Rehabilitation & Wellness Cheyenne, WY 100% — 387 13,613 14,000 1,979 387 15,593 15,980 (530 ) 1967/2017 08/17/17 40 Rawlins Rehabilitation & Wellness Rawlins, WY 100% — 281 6,007 6,288 — 281 6,007 6,288 (222 ) 1967 08/17/17 40 Wind River Rehabilitation & Wellness Riverton, WY 100% — 199 11,398 11,597 — 199 11,398 11,597 (411 ) 1967 08/17/17 40 Sage View Care Center Rock Springs, WY 100% — 420 8,665 9,085 — 420 8,665 9,085 (326 ) 1964/2017 08/17/17 40 Shelton Health and Rehabilitation Center Shelton, WA 51% — 415 8,965 9,380 — 415 8,965 9,380 (359 ) 1998 08/17/17 40 Dundee Nursing Home Bennettsville, SC 100% — 1,437 4,631 6,068 — 1,437 4,631 6,068 (191 ) 1958 08/17/17 40 Mt. Pleasant Nursing Center Mount Pleasant, SC 100% — 2,689 3,942 6,631 — 2,689 3,942 6,631 (173 ) 1977/2015 08/17/17 40 Tri-State Comp Care Center Harrogate, TN 100% — 1,811 4,963 6,774 — 1,811 4,963 6,774 (222 ) 1990/2005 08/17/17 40 Emporia Manor Emporia, VA 100% — 1,656 478 2,134 — 1,656 478 2,134 (26 ) 1971 08/17/17 40 Epic-Conway Conway, SC 100% — 1,408 10,784 12,192 — 1,408 10,784 12,192 (433 ) 1975 08/17/17 40 Epic- Bayview Beaufort, SC 100% — 1,842 11,389 13,231 — 1,842 11,389 13,231 (444 ) 1970 08/17/17 40 Green Acres of Baytown Baytown, TX 100% — 479 6,351 6,830 209 479 6,561 7,040 (347 ) 1970 08/17/17 40 Allenbrook Healthcare Center Baytown, TX 100% — 426 3,236 3,662 173 426 3,409 3,835 (199 ) 1975 08/17/17 40 Green Acres of Huntsville Huntsville, TX 100% — 302 3,153 3,455 75 302 3,229 3,531 (168 ) 1968 08/17/17 40 Green Acres of Center Center, TX 100% — 231 1,335 1,566 312 231 1,648 1,879 (180 ) 1972 08/17/17 40 Humble Healthcare Center Humble, TX 100% — 2,114 1,643 3,757 596 2,114 2,239 4,353 (273 ) 1972 08/17/17 40 Beechnut Manor Houston, TX 100% — 1,019 5,734 6,753 318 1,019 6,052 7,071 (407 ) 1982 08/17/17 40 Linden Healthcare Center Linden, TX 100% — 112 256 368 133 112 389 501 (85 ) 1968 08/17/17 40 Sherman Healthcare Center Sherman, TX 100% — 469 6,310 6,779 255 469 6,565 7,034 (411 ) 1971 08/17/17 40 Mount Pleasant Healthcare Center Mount Pleasant, TX 100% — 250 6,913 7,163 345 250 7,258 7,508 (305 ) 1970 08/17/17 40 Renfro Healthcare Center Waxahachie, TX 100% — 416 7,259 7,675 205 416 7,464 7,880 (351 ) 1976 08/17/17 40 Upshur Manor Nursing Home Gilmer, TX 100% — 707 4,552 5,259 93 707 4,647 5,354 (237 ) 1990 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Hearthstone of Northern Nevada Sparks, NV 100% — 1,986 9,004 10,990 — 1,986 9,004 10,990 (361 ) 1988 08/17/17 40 Sunset Hills Healthcare and Rehabilitation Center St. Louis, MO 100% — 1,595 5,822 7,417 — 1,595 5,822 7,417 (348 ) 1954/2016 08/17/17 40 Mountainview Specialty Care Center Greensburg, PA 100% — 549 9,926 10,475 — 549 9,926 10,475 (471 ) 1971/2016 08/17/17 40 Golden Living Center - Richmond Richmond, IN 100% — 259 9,819 10,078 — 259 9,819 10,078 (374 ) 1975 08/17/17 40 Golden Living Center - Petersburg Petersburg, IN 100% — 581 5,367 5,948 — 581 5,367 5,948 (219 ) 1970/2009 08/17/17 40 Beverly Health - Ft. Pierce Fort Pierce, FL 100% — 787 16,648 17,435 — 787 16,648 17,435 (610 ) 1960/2011 08/17/17 40 Maryville Maryville, MO 100% — 114 5,955 6,069 — 114 5,955 6,069 (250 ) 1972 08/17/17 40 Ashland Healthcare Ashland, MO 100% — 765 2,669 3,434 — 765 2,669 3,434 (120 ) 1993 08/17/17 40 Bellefontaine Gardens St. Louis, MO 100% — 2,071 5,739 7,810 — 2,071 5,739 7,810 (258 ) 1988/1991 08/17/17 40 Current River Nursing Center Doniphan, MO 100% — 657 8,251 8,908 — 657 8,251 8,908 (327 ) 1991 08/17/17 40 Dixon Nursing & Rehab Dixon, MO 100% — 521 3,358 3,879 — 521 3,358 3,879 (144 ) 1989/2011 08/17/17 40 Forsyth Nursing & Rehab Forsyth, MO 100% — 594 8,549 9,143 — 594 8,549 9,143 (343 ) 1993/2007 08/17/17 40 Glenwood Healthcare Seymour, MO 100% — 658 901 1,559 — 658 901 1,559 (51 ) 1990 08/17/17 40 Silex Community Care Silex, MO 100% — 807 4,990 5,797 — 807 4,990 5,797 (203 ) 1991 08/17/17 40 South Hampton Place Columbia, MO 100% — 2,322 6,547 8,869 — 2,322 6,547 8,869 (271 ) 1994 08/17/17 40 Strafford Care Center Strafford, MO 100% — 1,634 6,518 8,152 — 1,634 6,518 8,152 (264 ) 1995 08/17/17 40 Windsor Healthcare & Rehab Windsor, MO 100% — 471 6,819 7,290 — 471 6,819 7,290 (250 ) 1996 08/17/17 40 Park Manor of Conroe Conroe, TX 100% — 1,222 19,099 20,321 — 1,222 19,099 20,321 (684 ) 2001 08/17/17 40 Park Manor of Cypress Station Houston, TX 100% — 1,334 11,615 12,949 — 1,334 11,615 12,949 (434 ) 2003/2013 08/17/17 40 Park Manor of Humble Humble, TX 100% — 1,541 12,332 13,873 — 1,541 12,332 13,873 (459 ) 2003 08/17/17 40 Park Manor of Quail Valley Missouri City, TX 100% — 1,825 9,681 11,506 — 1,825 9,681 11,506 (376 ) 2005 08/17/17 40 Park Manor of Westchase Houston, TX 100% — 2,676 7,396 10,072 — 2,676 7,396 10,072 (294 ) 2005 08/17/17 40 Park Manor of CyFair Houston, TX 100% — 1,732 12,921 14,653 — 1,732 12,921 14,653 (479 ) 1999 08/17/17 40 Park Manor of McKinney McKinney, TX 100% — 1,441 9,017 10,458 — 1,441 9,017 10,458 (364 ) 1993/2012 08/17/17 40 Tanglewood Health and Rehabilitation Topeka, KS 100% — 176 2,340 2,516 — 176 2,340 2,516 (100 ) 1973/2013 08/17/17 40 Smoky Hill Health and Rehbilitation Salina, KS 100% — 301 4,201 4,502 — 301 4,201 4,502 (171 ) 1981 08/17/17 40 Belleville Health Center Belleville, KS 100% — 600 1,664 2,264 — 600 1,664 2,264 (85 ) 1977 08/17/17 40 Westridge Healthcare Center Terre Haute, IN 100% — 1,067 7,061 8,128 — 1,067 7,061 8,128 (271 ) 1965/1984 08/17/17 40 Willow Bend Living Center Muncie, IN 100% — 1,168 9,562 10,730 — 1,168 9,562 10,730 (350 ) 1976/1986 08/17/17 40 Twin City Healthcare Gas City, IN 100% — 345 8,852 9,197 — 345 8,852 9,197 (323 ) 1974 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Pine Knoll Rehabilitation Center Winchester, IN 100% — 711 5,554 6,265 — 711 5,554 6,265 (214 ) 1986/1998 08/17/17 40 Willow Crossing Health & Rehab Center Columbus, IN 100% — 1,290 10,714 12,004 — 1,290 10,714 12,004 (393 ) 1988/2004 08/17/17 40 Persimmon Ridge Center Portland, IN 100% — 315 9,848 10,163 — 315 9,848 10,163 (367 ) 1964 08/17/17 40 Vermillion Convalescent Center Clinton, IN 100% — 884 9,839 10,723 — 884 9,839 10,723 (385 ) 1971 08/17/17 40 Las Vegas Post Acute & Rehabilitation Las Vegas, NV 100% — 509 18,216 18,725 — 509 18,216 18,725 (639 ) 1964 08/17/17 40 Torey Pines Rehabilitation Hospital Las Vegas, NV 100% — 3,169 7,863 11,032 — 3,169 7,863 11,032 (311 ) 1972/1997 08/17/17 40 Villa Campana Rehabiitation Hospital Tucson, AZ 100% — 1,800 4,387 6,187 — 1,800 4,387 6,187 (201 ) 1983/2011 08/17/17 40 Kachina Point Rehabilitation Hospital Sedona, AZ 100% — 2,035 10,981 13,016 — 2,035 10,981 13,016 (440 ) 1984/2011 08/17/17 40 Bay View Rehabilitation Hospital Alameda, CA 100% — 3,078 22,328 25,406 — 3,078 22,328 25,406 (801 ) 1967 08/17/17 40 Dover Center for Health & Rehabilitation Dover, NH 100% — 522 5,839 6,361 — 522 5,839 6,361 (292 ) 1969/1992, 2017 08/17/17 40 Augusta Center for Health & Rehabilitation Augusta, ME 100% — 135 6,470 6,605 — 135 6,470 6,605 (254 ) 1967 08/17/17 40 Eastside Center for Health & Rehabilitation Bangor, ME 100% — 302 1,811 2,113 20 302 1,832 2,134 (84 ) 1967/1993 08/17/17 40 Winship Green Center for Health & Rehabilitation Bath, ME 100% — 250 1,934 2,184 — 250 1,934 2,184 (85 ) 1974 08/17/17 40 Brewer Center for Health & Rehabilitation Brewer, ME 100% — 177 14,497 14,674 3 177 14,501 14,678 (552 ) 1974/1990 08/17/17 40 Kennebunk Center for Health & Rehabilitation Kennebunk, ME 100% — 198 6,822 7,020 — 198 6,822 7,020 (264 ) 1977 08/17/17 40 Norway Center for Health & Rehabilitation Norway, ME 100% — 791 3,680 4,471 — 791 3,680 4,471 (154 ) 1976 08/17/17 40 Brentwood Center for Health & Rehabilitation Yarmouth, ME 100% — 134 2,072 2,206 — 134 2,072 2,206 (93 ) 1952 08/17/17 40 Country Center for Health & Rehabilitation Newburyport, MA 100% — 269 4,436 4,705 12 269 4,448 4,717 (230 ) 1968/2009 08/17/17 40 Sachem Center for Health & Rehabilitation E. Bridgewater, MA 100% — 447 1,357 1,804 — 447 1,357 1,804 (86 ) 1968 08/17/17 40 Eliot Center for Health & Rehabilitation Natick, MA 100% — 475 1,491 1,966 — 475 1,491 1,966 (82 ) 1964 08/17/17 40 The Reservoir Center for Health & Rehabilitation Marlborough, MA 100% — 942 1,541 2,483 6,013 942 7,554 8,496 (92 ) 1973/2018 08/17/17 40 Newton Wellesley Center for Alzheimer’s Care Wellesley, MA 100% — 1,186 13,917 15,103 — 1,186 13,917 15,103 (511 ) 1971 08/17/17 40 Colony Center for Health & Rehabilitation Abington, MA 100% — 1,727 2,103 3,830 19 1,727 2,123 3,850 (107 ) 1965 08/17/17 40 Westgate Center for Rehab & Alzheimer’s Care Bangor, ME 100% — 229 7,171 7,400 10 229 7,181 7,410 (286 ) 1969/1993 08/17/17 40 New Orange Hills Orange, CA 100% — 4,163 14,755 18,918 — 4,163 14,755 18,918 (556 ) 1987 08/17/17 40 Millbrook Healthcare & Rehabilitation Center Lancaster, TX 100% — 548 5,794 6,342 — 548 5,794 6,342 (240 ) 2008 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Pleasant Valley Health & Rehab Garland, TX 100% — 1,118 7,490 8,608 — 1,118 7,490 8,608 (295 ) 2008 08/17/17 40 Focused Care at Clarksville Clarksville, TX 100% — 279 4,269 4,548 — 279 4,269 4,548 (190 ) 1989 08/17/17 40 McKinney Healthcare & Rehab McKinney, TX 100% — 1,272 6,047 7,319 — 1,272 6,047 7,319 (256 ) 2006 08/17/17 40 Nicholas County Nursing and Rehabilitation Richwood, WV 100% — 10 — 10 — 10 — 10 — 1980 08/17/17 40 Golden Living Center - Hopkins Hopkins, MN 100% — 807 4,668 5,475 — 807 4,668 5,475 (222 ) 1961/2008 08/17/17 40 Golden Living Center - Village Gardens Green Bay, WI 100% — 1,299 1,247 2,546 — 1,299 1,247 2,546 (81 ) 1965/2012 08/17/17 40 Golden Living Center - Florence Florence, WI 100% — 291 3,778 4,069 — 291 3,778 4,069 (167 ) 1970 08/17/17 40 Golden Living Center - South Shore St. Francis, WI 100% — 166 1,887 2,053 — 166 1,887 2,053 (87 ) 1960/1997 08/17/17 40 Golden Living Center - Rochester East Rochester, MN 100% — 645 7,067 7,712 — 645 7,067 7,712 (273 ) 1967/2011 08/17/17 40 Golden Living Center - Wisconsin Dells Wisconsin Dells, WI 100% — 1,640 1,599 3,239 — 1,640 1,599 3,239 (95 ) 1972/2006 08/17/17 40 Golden Living Center - Sheboygan Sheboygan, WI 100% — 1,038 2,839 3,877 — 1,038 2,839 3,877 (143 ) 1967/2012 08/17/17 40 Azalea Gardens of Mobile Mobile, AL 100% — — 2,540 2,540 — — 2,540 2,540 (125 ) 1967 08/17/17 40 Golden Living Center - Hendersonville Hendersonville, NC 100% — 1,611 3,503 5,114 — 1,611 3,503 5,114 (163 ) 1979 08/17/17 40 Trisun Care Center Coastal Palms Portland, TX 100% — 610 11,296 11,906 — 610 11,296 11,906 (414 ) 1998 08/17/17 40 Trisun Care Center Westwood Corpus Christi, TX 100% — 366 6,961 7,327 — 366 6,961 7,327 (263 ) 1973/2010 08/17/17 40 Trisun Care Center River Ridge Corpus Christi, TX 100% — 792 7,450 8,242 — 792 7,450 8,242 (291 ) 1994/2012 08/17/17 40 Trisun Care Center - Northeast El Paso El Paso, TX 100% — 1,331 10,117 11,448 — 1,331 10,117 11,448 (442 ) 2011 08/17/17 40 Lakeside Care Center San Antonio, TX 100% — 1,280 11,705 12,985 — 1,280 11,705 12,985 (487 ) 2012 08/17/17 40 Riverside Nursing & Rehab Center Austin, TX 100% — 1,626 4,659 6,285 — 1,626 4,659 6,285 (191 ) 2010 08/17/17 40 Senior Care of West Oaks Austin, TX 100% — 2,743 11,189 13,932 — 2,743 11,189 13,932 (434 ) 2006 08/17/17 40 Baytown Nursing & Rehab Center Baytown, TX 100% — 579 22,317 22,896 — 579 22,317 22,896 (805 ) 2000/2013 08/17/17 40 Cedar Bayou Nursing & Rehab Center Baytown, TX 100% — 589 20,475 21,064 — 589 20,475 21,064 (763 ) 2008 08/17/17 40 Mystic Park Nursing & Rehab Center San Antonio, TX 100% — 721 7,979 8,700 — 721 7,979 8,700 (314 ) 2004 08/17/17 40 Paramount Senior Care Centers at San Antonio San Antonio, TX 100% — 914 12,823 13,737 — 914 12,823 13,737 (490 ) 2000 08/17/17 40 Senior Care of Westwood Houston, TX 100% — 1,300 13,353 14,653 — 1,300 13,353 14,653 (518 ) 2006 08/17/17 40 Paramounty Senior Care Centers at Pasadena Pasadena, TX 100% — 1,148 23,579 24,727 — 1,148 23,579 24,727 (866 ) 2004 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired The Pointe Nursing & Rehab Center Webster, TX 100% — 904 10,315 11,219 — 904 10,315 11,219 (409 ) 2000/2009 08/17/17 40 Brodie Ranch Nursing & Rehab Center Austin, TX 100% — 610 8,549 9,159 — 610 8,549 9,159 (323 ) 2010 08/17/17 40 Bandera Nursing & Rehab Center Bandera, TX 100% — 691 4,987 5,678 — 691 4,987 5,678 (210 ) 2009 08/17/17 40 West Oaks Nursing & Rehab Center Houston, TX 100% — 1,168 11,195 12,363 — 1,168 11,195 12,363 (440 ) 1994 08/17/17 40 Pilgrim Manor Bossier City, LA 100% — 772 23,497 24,269 — 772 23,497 24,269 (921 ) 1973/2000 08/17/17 40 Spring Lake Campus Shreveport, LA 100% — 975 30,437 31,412 — 975 30,437 31,412 (1,188 ) 1984/1998 08/17/17 40 The Bradford Shreveport, LA 100% — 1,402 21,494 22,896 — 1,402 21,494 22,896 (862 ) 1980/2008 08/17/17 40 The Guest House Shreveport, LA 100% — 1,067 21,983 23,050 — 1,067 21,983 23,050 (896 ) 1964/2006 08/17/17 40 Alpine Ruston, LA 100% — 691 22,205 22,896 — 691 22,205 22,896 (878 ) 2014 08/17/17 40 Colonial Oaks Bossier City, LA 100% — 498 13,240 13,738 — 498 13,240 13,738 (538 ) 2001 08/17/17 40 Shreveport Manor Shreveport, LA 100% — 457 14,125 14,582 — 457 14,125 14,582 (565 ) 1969/2008 08/17/17 40 Booker T. Washington Shreveport, LA 100% — 864 9,286 10,150 — 864 9,286 10,150 (380 ) 2001/2012 08/17/17 40 Hill Country Care Dripping Springs, TX 100% — 1,107 5,402 6,509 — 1,107 5,402 6,509 (210 ) 1986 08/17/17 40 Pecan Tree Rehab & Healthcare Gainesville, TX 100% — 315 9,759 10,074 — 315 9,759 10,074 (364 ) 1990 08/17/17 40 Senior Care of Jacksonville Jacksonville, TX 100% — 569 6,300 6,869 — 569 6,300 6,869 (251 ) 2006 08/17/17 40 Senior Care of San Angelo San Angelo, TX 100% — 1,565 12,936 14,501 — 1,565 12,936 14,501 (478 ) 2006 08/17/17 40 Senior Care of Midland Midland, TX 100% — 528 2,311 2,839 — 528 2,311 2,839 (105 ) 2008 08/17/17 40 Summer Place Nursing and Rehab Beaumont, TX 100% — 945 20,424 21,369 — 945 20,424 21,369 (740 ) 2009 08/17/17 40 The Meadows Nursing and Rehab Orange, TX 100% — 711 10,737 11,448 — 711 10,737 11,448 (406 ) 2006 08/17/17 40 Heritage Oaks West Retirement Village Corsicana, TX 100% — 823 4,214 5,037 — 823 4,214 5,037 (183 ) 1995 08/17/17 40 Cypress Glen Port Arthur, TX 100% — 1,209 13,444 14,653 — 1,209 13,444 14,653 (522 ) 2000/2008 08/17/17 40 Lake Arthur Port Arthur, TX 100% — 396 7,846 8,242 — 396 7,846 8,242 (301 ) 1986/1992 08/17/17 40 Signature Healthcare of Whitesburg Gardens Huntsville, AL 100% — 634 28,071 28,705 — 634 28,071 28,705 (992 ) 1968/2012 08/17/17 40 Signature Healthcare of Terre Haute Terre Haute, IN 100% — 644 37,451 38,095 — 644 37,451 38,095 (1,486 ) 1996/2013 08/17/17 40 Signature Healthcare at Larkin Springs Madison, TN 100% — 902 3,850 4,752 — 902 3,850 4,752 (186 ) 1969/2016 08/17/17 40 Signature Healthcare of Savannah Savannah, GA 100% — 1,235 3,765 5,000 — 1,235 3,765 5,000 (191 ) 1970/2015 08/17/17 40 Signature Healthcare of Bluffton Bluffton, IN 100% — 254 5,105 5,359 — 254 5,105 5,359 (219 ) 1970 08/17/17 40 Signature Healthcare of Bowling Green Bowling Green, KY 100% — 280 13,975 14,255 — 280 13,975 14,255 (546 ) 1970/2015 08/17/17 40 Oakview Nursing and Rehabilitation Center Calvert City, KY 100% — 1,176 7,012 8,188 — 1,176 7,012 8,188 (291 ) 1962/2015 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Fountain Circle Care and Rehabilitation Center Winchester, KY 100% — 554 13,207 13,761 — 554 13,207 13,761 (526 ) 1967/2015 08/17/17 40 Riverside Care & Rehabilitation Center Calhoun, KY 100% — 613 7,643 8,256 — 613 7,643 8,256 (326 ) 1963/2015 08/17/17 40 Signature Healthcare of Bremen Bremen, IN 100% — 173 7,393 7,566 — 173 7,393 7,566 (288 ) 1982/2015 08/17/17 40 Signature Healthcare of Muncie Muncie, IN 100% — 374 27,429 27,803 — 374 27,429 27,803 (990 ) 1980/2013 08/17/17 40 Signature Healthcare at Parkwood Lebanon, IN 100% — 612 11,755 12,367 — 612 11,755 12,367 (449 ) 1977/2012 08/17/17 40 Signature Healthcare at Tower Road Marietta, GA 100% — 364 16,116 16,480 — 364 16,116 16,480 (632 ) 1969/2015 08/17/17 40 Danville Centre for Health and Rehabilitation Danville, KY 100% — 790 9,356 10,146 — 790 9,356 10,146 (430 ) 1962/2015 08/17/17 40 Signature Healthcare at Hillcrest Owensboro, KY 100% — 1,048 22,587 23,635 — 1,048 22,587 23,635 (847 ) 1963/2011 08/17/17 40 Signature Healthcare of Elizabethtown Elizabethtown, KY 100% — 239 4,853 5,092 — 239 4,853 5,092 (204 ) 1969 08/17/17 40 Signature Healthcare of Primacy Memphis, TN 100% — 1,633 9,371 11,004 — 1,633 9,371 11,004 (385 ) 1981/2015 08/17/17 40 Signature Healthcare of Harbour Pointe Norfolk, VA 100% — 705 16,451 17,156 — 705 16,451 17,156 (698 ) 1969/2015 08/17/17 40 Harrodsburg Health & Rehabilitation Center Harrodsburg, KY 100% — 1,049 9,851 10,900 — 1,049 9,851 10,900 (431 ) 1975/2016 08/17/17 40 Signature Healthcare of Putnam County Cookeville, TN 100% — 1,034 15,555 16,589 — 1,034 15,555 16,589 (597 ) 1979/2016 08/17/17 40 Signature Healthcare of Fayette County Washington Court House, OH 100% — 405 4,839 5,244 — 405 4,839 5,244 (220 ) 1984/2015 08/17/17 40 Signature Healthcare of Warren Warren, OH 100% — 955 5,260 6,215 — 955 5,260 6,215 (280 ) 1967/2015 08/17/17 40 Signature Healthcare of Galion Galion, OH 100% — 836 668 1,504 — 836 668 1,504 (49 ) 1967/1985 08/17/17 40 Signature Healthcare of Roanoke Rapids Roanoke Rapids, NC 100% — 373 10,308 10,681 — 373 10,308 10,681 (435 ) 1967/2015 08/17/17 40 Signature Healthcare of Kinston Kinston, NC 100% — 954 7,987 8,941 — 954 7,987 8,941 (378 ) 1960/2015 08/17/17 40 Signature Healthcare of Chapel Hill Chapel Hill, NC 100% — 809 2,703 3,512 302 809 3,005 3,814 (181 ) 1984/2015 08/17/17 40 Signature Healthcare of Chillicothe Chillicothe, OH 100% — 260 8,924 9,184 — 260 8,924 9,184 (389 ) 1974/2015 08/17/17 40 Signature Healthcare of Coshocton Coshocton, OH 100% — 374 2,530 2,904 — 374 2,530 2,904 (149 ) 1974/2015 08/17/17 40 McCreary Health & Rehabilitation Center Pine Knot, KY 100% — 208 7,665 7,873 — 208 7,665 7,873 (304 ) 1990 08/17/17 40 Colonial Health & Rehabilitation Center Bardstown, KY 100% — 634 4,094 4,728 — 634 4,094 4,728 (190 ) 1968/2010 08/17/17 40 Glasgow Health & Rehabilitation Center Glasgow, KY 100% — 83 2,057 2,140 — 83 2,057 2,140 (115 ) 1968 08/17/17 40 Green Valley Health & Rehabilitation Center Carrollton, KY 100% — 124 1,693 1,817 — 124 1,693 1,817 (100 ) 1978/2016 08/17/17 40 Hart County Health & Rehabilitation Horse Cave, KY 100% — 208 7,070 7,278 — 208 7,070 7,278 (306 ) 1993 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Heritage Hall Health & Rehabilitation Center Lawrenceburg, KY 100% — 635 9,861 10,496 — 635 9,861 10,496 (397 ) 1973 08/17/17 40 Jackson Manor Annville, KY 100% — 479 6,078 6,557 — 479 6,078

SCHEDULE IV - MORTGAGE LOANS ON

SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE	12 Months Ended
	Dec. 31, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE	SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE As of December 31, 2018 (dollars in thousands) Description Contractual Interest Rate Maturity Date Periodic Payment Terms Prior Liens Principal Balance Book Value (1) Principal Amount of Loans Subject to Delinquent Principal or Interest Mortgages: River Vista 10.0 % 2027 (2) $ — $ 18,577 $ 18,577 N/A Construction Mortgages: McKinney 8.0 2021 (3) — 3,513 3,551 N/A Arlington 8.0 2022 (3) — 1,056 1,078 N/A $ — $ 23,146 $ 23,206 (1) The aggregate cost for federal income tax purposes was $23.3 million as of December 31, 2018 . (2) Interest is due monthly, and principal is due at the maturity date. (3) Interest and principal for the first 36 months is deferred and due at the maturity date. Interest after the first 36 months is due monthly. Changes in mortgage loans are summarized as follows: Year Ended December 31, 2018 2017 2016 Balance at the beginning of the year $ 16,033 $ 39,026 $ 241,038 Additions during period: Draws 10,943 1,738 — New mortgage loans — 12,987 3,767 Interest income added to principal 1,528 539 690 Deductions during period: Paydowns/repayments (5,358 ) (14,570 ) (193,075 ) Conversion to real property — (19,085 ) (10,100 ) Write-offs (1) — (4,602 ) (3,294 ) Balance at the end of the year $ 23,146 $ 16,033 $ 39,026 (1) During the year ended December 31, 2017, the Company wrote off uncollectible amounts related to one mortgage loan that was repaid. During the year ended December 31, 2016, the Company wrote off amounts in excess of the fair value upon conversion of one mortgage loan to real property.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries as of December 31, 2018 and 2017 and for the years ended December 31, 2018 , 2017 and 2016 . All significant intercompany transactions and balances have been eliminated in consolidation. The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
Variable Interest Entities	GAAP requires the Company to identify entities for which control is achieved through voting rights or other means and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity’s activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity’s activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity’s activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary. The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis. As of December 31, 2018 , the Company determined that it was the primary beneficiary of one VIE—a joint venture variable interest entity owning one skilled nursing/transitional care facility—and has consolidated the operations of this entity in the accompanying consolidated financial statements. As of December 31, 2018 , the Company determined that the operations of this entity were not material to the Company’s results of operations, financial condition or cash flows. As it relates to investments in loans, in addition to the Company’s assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine whether the loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower’s expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At December 31, 2018 and 2017 , none of the Company’s investments in loans were accounted for as real estate joint ventures. As it relates to investments in joint ventures, the Company assesses any limited partners’ rights and their impact on the presumption of control of the limited partnership by any single partner. The Company also applies this guidance to managing member interests in limited liability companies. The Company reassesses its determination of which entity controls the joint venture if: there is a change to the terms or in the exercisability of the rights of any partners or members, the sole general partner or managing member increases or decreases its ownership interests, or there is an increase or decrease in the number of outstanding ownership interests. As of December 31, 2018 , the Company’s determination of which entity controls its investments in joint ventures has not changed as a result of any reassessment.
Use of Estimates	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
Reclassifications	Certain amounts in the Company’s consolidated statements of cash flows for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.
Real Estate Investments	Real Estate Acquisition Valuation All assets acquired and liabilities assumed in an acquisition of real estate accounted for as a business combination are measured at their acquisition date fair values. For acquisitions of real estate accounted for as an asset acquisition, the fair value of consideration transferred by the Company (including transaction costs) is allocated to all assets acquired and liabilities assumed on a relative fair value basis. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of above market lease, tenant origination and absorption costs and tenant relationship intangible assets is included in lease intangible assets, net on the accompanying consolidated balance sheets. The acquisition value of below market lease intangible liabilities is included in lease intangible liabilities, net on the accompanying consolidated balance sheets. Acquisition costs associated with real estate acquisitions deemed asset acquisitions are capitalized, and costs associated with real estate acquisitions deemed business combinations are expensed as incurred. The Company capitalized $0.7 million and $1.0 million of acquisition costs during the years ended December 31, 2018 and 2017 , respectively. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the years ended December 31, 2018 , 2017 and 2016 , the Company expensed $0.6 million , $30.3 million and $1.2 million , respectively, of merger and acquisition costs. Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the Company’s evaluation of the specific characteristics of each tenant’s lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income. Depreciation and Amortization Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of tenant origination and absorption costs and tenant relationship lease intangibles are included in depreciation and amortization on the accompanying consolidated statements of income. Amortization of above and below market lease intangibles is included in rental income on the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, five to 20 years; buildings and building improvements, seven to 40 years; and furniture and equipment, three to 20 years. Intangibles are generally amortized over the remaining noncancellable lease terms, with tenant relationship intangible amortization periods including extension periods of up to 10 years . Impairment of Real Estate Investments The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through the undiscounted future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential future cash flows. In these instances, the undiscounted future cash flows used to assess recoverability are probability-weighted based on the Company’s best estimates as of the date of evaluation. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments.
Real Estate Investments, Inventory	Real Estate Acquisition Valuation All assets acquired and liabilities assumed in an acquisition of real estate accounted for as a business combination are measured at their acquisition date fair values. For acquisitions of real estate accounted for as an asset acquisition, the fair value of consideration transferred by the Company (including transaction costs) is allocated to all assets acquired and liabilities assumed on a relative fair value basis. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of above market lease, tenant origination and absorption costs and tenant relationship intangible assets is included in lease intangible assets, net on the accompanying consolidated balance sheets. The acquisition value of below market lease intangible liabilities is included in lease intangible liabilities, net on the accompanying consolidated balance sheets. Acquisition costs associated with real estate acquisitions deemed asset acquisitions are capitalized, and costs associated with real estate acquisitions deemed business combinations are expensed as incurred. The Company capitalized $0.7 million and $1.0 million of acquisition costs during the years ended December 31, 2018 and 2017 , respectively. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the years ended December 31, 2018 , 2017 and 2016 , the Company expensed $0.6 million , $30.3 million and $1.2 million , respectively, of merger and acquisition costs. Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the Company’s evaluation of the specific characteristics of each tenant’s lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income. Depreciation and Amortization Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of tenant origination and absorption costs and tenant relationship lease intangibles are included in depreciation and amortization on the accompanying consolidated statements of income. Amortization of above and below market lease intangibles is included in rental income on the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, five to 20 years; buildings and building improvements, seven to 40 years; and furniture and equipment, three to 20 years. Intangibles are generally amortized over the remaining noncancellable lease terms, with tenant relationship intangible amortization periods including extension periods of up to 10 years . Impairment of Real Estate Investments The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through the undiscounted future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential future cash flows. In these instances, the undiscounted future cash flows used to assess recoverability are probability-weighted based on the Company’s best estimates as of the date of evaluation. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments.
Revenue Recognition	Revenue Recognition The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when collectability is reasonably assured. Certain of the Company’s leases provide for contingent rents equal to a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the applicable base amount or other threshold. The Company makes estimates of the collectability of its tenant receivables related to base rents, straight-line rent and other revenues. When the Company analyzes accounts receivable and evaluates the adequacy of the allowance for doubtful accounts, it considers such things as historical bad debts, tenant creditworthiness, current economic trends, facility operating performance, lease structure, credit enhancements (including guarantees), current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. Specifically for straight-line rent receivables, the Company’s assessment includes an estimation of a tenant’s ability to fulfill its rental obligations over the remaining lease term. In addition, with respect to tenants in bankruptcy, management makes estimates of the expected recovery of pre-petition and post-petition claims in assessing the estimated collectability of the related receivable. When a tenant is in bankruptcy, the Company records a provision for doubtful accounts for management’s estimate of the tenant’s receivable balance that is uncollectible and generally will not recognize subsequent rental revenue until cash is received or until the tenant is no longer in bankruptcy and has the ability to make rental payments. The Company’s collectability estimates for straight-line rent receivables include an assessment at the individual or master lease level as well as at an overall portfolio level. Revenue from resident fees and services is recorded monthly as services are provided and includes resident room and care charges and other resident charges.
Assets Held for Sale, DIspositions and Discontinued Operations	The Company generally considers real estate to be “held for sale” when the following criteria are met: (i) management commits to a plan to sell the property, (ii) the property is available for sale immediately, (iii) the property is actively being marketed for sale at a price that is reasonable in relation to its current fair value, (iv) the sale of the property within one year is considered probable and (v) significant changes to the plan to sell are not expected. Real estate that is held for sale and its related assets are classified as assets held for sale and are included in accounts receivable, prepaid expenses and other assets, net on the accompanying consolidated balance sheets. Secured indebtedness and other liabilities related to real estate held for sale are classified as liabilities related to assets held for sale and are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. Real estate classified as held for sale is no longer depreciated and is reported at the lower of its carrying value or its estimated fair value less estimated costs to sell. As of December 31, 2018 and 2017 , the Company did no t have any assets held for sale. For sales of real estate where the Company has collected the consideration to which it is entitled in exchange for transferring the real estate, the related assets and liabilities are removed from the balance sheet and the resultant gain or loss is recorded in the period in which the transaction closes. Any post-sale involvement is accounted for as separate performance obligations, and when the separate performance obligations are satisfied, the portion of the sales price allocated to each such obligation is recognized. Additionally, the Company records the operating results related to real estate that has been disposed of or classified as held for sale as discontinued operations for all periods presented if it represents a strategic shift that has or will have a major effect on the Company’s operations and financial results.
Net Investment in Direct Financing Lease	As of December 31, 2018 , the Company had a $23.4 million net investment in one skilled nursing/transitional care facility leased to an operator under a direct financing lease, as the tenant is obligated to purchase the property at the end of the lease term. The net investment in direct financing lease is recorded in accounts receivable, prepaid expenses and other assets, net on the accompanying consolidated balance sheets and represents the total undiscounted rental payments of $5.6 million , plus the estimated unguaranteed residual value of $24.7 million , less the unearned lease income of $6.9 million as of December 31, 2018 . Unearned lease income represents the excess of the minimum lease payments and residual value over the cost of the investment. Unearned lease income is deferred and amortized to income over the lease term to provide a constant yield when collectability of the lease payments is reasonably assured. Income from the Company’s net investment in direct financing lease was $2.6 million and $1.0 million for the years ended December 31, 2018 and 2017 , respectively, and is reflected in interest and other income on the accompanying consolidated statements of income. Future minimum lease payments contractually due under the direct financing lease at December 31, 2018 , were as follows: $2.2 million for 2019; $2.3 million for 2020; and $2.1 million for 2021.
Loans Receivable and Interest Income	Loans Receivable The Company’s loans receivable are reflected at amortized cost on the accompanying consolidated balance sheets. The amortized cost of a loan receivable is the outstanding unpaid principal balance, net of unamortized discounts, costs and fees directly associated with the origination of the loan. Loans acquired in connection with a business combination are recorded at their acquisition date fair value. The Company determines the fair value of loans receivable based on estimates of expected discounted cash flows, collateral, credit risk and other factors. The Company does not establish a valuation allowance at the acquisition date, as the amount of estimated future cash flows reflects its judgment regarding their uncertainty. The Company recognizes the difference between the acquisition date fair value and the total expected cash flows as interest income using the effective interest method over the life of the applicable loan. The Company immediately recognizes in income any unamortized balances if the loan is repaid before its contractual maturity. On a quarterly basis, the Company evaluates the collectability of its loan portfolio, including related interest income receivable, and establishes a reserve for loan losses. The Company’s evaluation includes reviewing credit quality indicators such as payment status, changes affecting the underlying real estate collateral (for collateral dependent loans), changes affecting the operations of the facilities securing the loans, and national and regional economic factors. The reserve for loan losses is a valuation allowance that reflects management’s estimate of loan losses inherent in the loan portfolio as of the balance sheet date. The reserve is adjusted through provision for doubtful accounts, straight-line rental income and loan losses on the Company’s consolidated statements of income and is decreased by charge-offs to specific loans when losses are confirmed. The reserve for loan losses includes an asset-specific component and a portfolio-based component. An asset-specific reserve relates to reserves for losses on loans considered impaired and interest income receivable that is deemed uncollectible. The Company considers a loan to be impaired when, based upon current information and events, management believes that it is probable that the Company will be unable to collect all amounts due under the contractual terms of the loan agreement resulting from the borrower’s failure to repay contractual amounts due, the granting of a concession by the Company or the expectation that the Company will receive assets with fair values less than the carrying value of the loan in satisfaction of the loan. If a loan is considered to be impaired, a reserve is established when the carrying value of that loan is greater than the present value of payments expected to be received, the observable market prices for similar instruments, the estimated fair value of the collateral (for loans that are dependent on the collateral for repayment) or other amounts expected to be received in satisfaction of the loan. A portfolio-based reserve covers the pool of loans that do not have asset-specific reserves. A provision for loan losses is recorded when available information as of each balance sheet date indicates that it is probable that a loss occurred in the pool of loans and the amount of the loss can be reasonably estimated, but the Company does not know which specific loans within the pool will ultimately result in losses. The required reserve balances for this pool of loans is derived based on estimated probabilities of default and estimated loss severities assuming a default occurs. Interest Income Interest income on the Company’s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status, and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan or through the receipts of assets in satisfaction of contractual amounts due is probable, the Company will resume the accrual of interest. In instances where borrowers are in default under the terms of their loans, the Company may continue recognizing interest income provided that all amounts owed under the contractual terms of the loan, including accrued and unpaid interest, do not exceed the estimated fair value of the collateral, less costs to sell.
Equity Method Investments and Preferred Equity Investments and Preferred Return	Preferred equity investments are accounted for at unreturned capital contributions, plus accrued and unpaid preferred returns. The Company recognizes preferred return income on a monthly basis based on the outstanding investment including any previously accrued and unpaid return. As a preferred member of the preferred equity joint ventures in which the Company participates, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to currently pay the accrued preferred return. The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting. Under this method of accounting, the Company’s share of the investee’s earnings or losses is included in the Company’s consolidated statements of income. The initial carrying value of the investment is based on the amount paid to purchase the joint venture interest. Differences between the Company’s cost basis and the basis reflected at the joint venture level are generally amortized over the lives of the related assets and liabilities, and such amortization is included in the Company’s share of earnings of the joint venture. The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its equity method investments may not be recoverable or realized. When indicators of potential impairment are identified, the Company evaluates its equity method investments for impairment based on a comparison of the fair value of the investment to its carrying value. The fair value is estimated based on discounted cash flows that include all estimated cash inflows and outflows over a specified holding period and any estimated debt premiums or discounts. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its equity method investment, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its equity method investment.
Cash and Cash Equivalents	The Company considers all short-term (with an original maturity of three months or less), highly-liquid investments utilized as part of the Company’s cash-management activities to be cash equivalents. Cash equivalents may include cash and short-term investments. Short-term investments are stated at cost, which approximates fair value. The Company’s cash and cash equivalents balance exceeded federally insurable limits as of December 31, 2018 . To date, the Company has experienced no loss or lack of access to cash in its operating accounts. The Company has a corporate banking relationship with Bank of America, N.A. in which it deposits the majority of its cash.
Restricted Cash	Restricted cash primarily consists of amounts held by an exchange accommodation titleholder or by secured debt lenders to provide for future real estate tax expenditures, tenant improvements and capital expenditures. Pursuant to the terms of the Company’s leases with certain tenants, the Company has assigned its interests in certain of these restricted cash accounts with secured debt lenders to the tenants, and this amount is included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.
Stock-Based Compensation	Stock-based compensation expense for stock-based awards granted to Sabra’s employees and its non-employee directors is recognized in the statements of income based on the estimated grant date fair value, as adjusted. Compensation expense for awards with graded vesting schedules is generally recognized ratably over the period from the grant date to the date when the award is no longer contingent on the employee providing additional services. Compensation expense for awards with performance-based vesting conditions is recognized based on the Company’s estimate of the ultimate value of such award after considering the Company’s expectations of future performance. Forfeitures of stock-based awards are recognized as they occur.
Deferred Financing Costs	Deferred financing costs representing fees paid to third parties are amortized over the terms of the respective financing agreements using the interest method. Deferred financing costs related to secured debt, term loans and senior unsecured notes are recorded as a reduction of the related debt liability, and deferred financing costs related to the revolving credit facility are recorded in accounts receivable, prepaid expenses and other assets, net. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financings that do not close are expensed in the period in which it is determined that the financing will not close.
Income Taxes	The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. The Company believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of the Company’s annual REIT taxable income to stockholders (which is computed without regard to the dividends-paid deduction or net capital gains and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax on income that it distributes as dividends to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to U.S. federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Such an event could materially and adversely affect the Company’s net income and net cash available for distribution to stockholders. However, the Company believes that it is organized and operates in such a manner as to qualify for treatment as a REIT. As a result of certain investments, the Company now records income tax expense or benefit with respect to certain of its entities that are taxed as taxable REIT subsidiaries under provisions similar to those applicable to regular corporations and not under the REIT provisions. The Company accounts for deferred income taxes using the asset and liability method and recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the Company’s financial statements or tax returns. Under this method, the Company determines deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes a change in the Company’s judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carryforwards. A valuation allowance is provided if the Company believes it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes a change in the Company’s judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur. The Company evaluates its tax positions using a two step approach: step one (recognition) occurs when the Company concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination, and step two (measurement) is only addressed if step one has been satisfied (i.e., the position is more likely than not to be sustained). Under step two, the tax benefit is measured as the largest amount of benefit (determined on a cumulative probability basis) that is more likely than not to be realized upon ultimate settlement. The Company will recognize tax penalties relating to unrecognized tax benefits as additional tax expense.
Foreign Currency	Certain of the Company’s subsidiaries’ functional currencies are the local currencies of their respective foreign jurisdictions. The Company translates the results of operations of its foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period presented, and it translates balance sheet accounts using exchange rates in effect at the end of the period presented. The Company records resulting currency translation adjustments in accumulated other comprehensive income (loss), a component of stockholders’ equity, on its consolidated balance sheets, and it records foreign currency transaction gains and losses as a component of interest and other income on its consolidated statements of income.
Derivative Instruments	The Company uses certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception, the Company must make an assessment that the transaction that the Company intends to hedge is probable of occurring, and this assessment must be updated each reporting period. The Company recognizes all derivative instruments as assets or liabilities on the consolidated balance sheets at their fair value. For derivatives designated and qualified as a hedge, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive income (loss). Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria for hedge accounting would be recognized in earnings. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific transactions, as well as recognizing obligations or assets on the consolidated balance sheets. The Company also assesses and documents, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying transaction will not occur, the Company would discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the then-current fair value of the derivative.
Fair Value Measurements	Under GAAP, the Company is required to measure certain financial instruments at fair value on a recurring basis. In addition, the Company is required to measure other financial instruments and balances at fair value on a non-recurring basis (e.g., carrying value of impaired loans receivable and long-lived assets). Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The GAAP fair value framework uses a three-tiered approach. Fair value measurements are classified and disclosed in one of the following three categories: • Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities; • Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable. When available, the Company utilizes quoted market prices from an independent third-party source to determine fair value and classifies such items as Level 1 or Level 2. In instances where the market for a financial instrument is not active, regardless of the availability of a nonbinding quoted market price, observable inputs might not be relevant and could require the Company to make a significant adjustment to derive a fair value measurement. Additionally, in an inactive market, a market price quoted from an independent third party may rely more on models with inputs based on information available only to that independent third party. When the Company determines the market for a financial instrument owned by the Company to be illiquid or when market transactions for similar instruments do not appear orderly, the Company may use several valuation sources (including internal valuations, discounted cash flow analysis and quoted market prices) to establish a fair value. If more than one valuation source is used, the Company will assign weights to the various valuation sources. Additionally, when determining the fair value of liabilities in circumstances in which a quoted price in an active market for an identical liability is not available, the Company measures fair value using (i) a valuation technique that uses the quoted price of the identical liability when traded as an asset or quoted prices for similar liabilities or similar liabilities when traded as assets or (ii) another valuation technique that is consistent with the principles of fair value measurement, such as the income approach or the market approach. Changes in assumptions or estimation methodologies can have a material effect on these estimated fair values. In this regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, may not be realized in an immediate settlement of the instrument. The Company considers the following factors to be indicators of an inactive market: (i) there are few recent transactions, (ii) price quotations are not based on current information, (iii) price quotations vary substantially either over time or among market makers (for example, some brokered markets), (iv) indexes that previously were highly correlated with the fair values of the asset or liability are demonstrably uncorrelated with recent indications of fair value for that asset or liability, (v) there is a significant increase in implied liquidity risk premiums, yields, or performance indicators (such as delinquency rates or loss severities) for observed transactions or quoted prices when compared with the Company’s estimate of expected cash flows, considering all available market data about credit and other nonperformance risk for the asset or liability, (vi) there is a wide bid-ask spread or significant increase in the bid-ask spread, (vii) there is a significant decline or absence of a market for new issuances (that is, a primary market) for the asset or liability or similar assets or liabilities, and (viii) little information is released publicly (for example, a principal-to-principal market). The Company considers the following factors to be indicators of non-orderly transactions: (i) there was not adequate exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities under current market conditions, (ii) there was a usual and customary marketing period, but the seller marketed the asset or liability to a single market participant, (iii) the seller is in or near bankruptcy or receivership (that is, distressed), or the seller was required to sell to meet regulatory or legal requirements (that is, forced), and (iv) the transaction price is an outlier when compared with other recent transactions for the same or similar assets or liabilities. The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments. Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable, accrued liabilities and the Credit Facility are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows: Loans receivable : These instruments are presented on the accompanying consolidated balance sheets at their amortized cost and not at fair value. The fair values of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, as well as the underlying collateral value and other credit enhancements as applicable. As such, the Company classifies these instruments as Level 3. Preferred equity investments : These instruments are presented on the accompanying consolidated balance sheets at their cost and not at fair value. The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investments, the underlying collateral value and other credit enhancements. As such, the Company classifies these instruments as Level 3. Derivative instruments : The Company’s derivative instruments are presented at fair value on the accompanying consolidated balance sheets. The Company estimates the fair value of derivative instruments, including its interest rate swaps and cross currency swaps, using the assistance of a third party using inputs that are observable in the market, which include forward yield curves and other relevant information. Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivative financial instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by itself and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company has determined that its derivative financial instruments valuations in their entirety are classified in Level 2 of the fair value hierarchy. Senior Notes : These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades. As such, the Company classifies these instruments as Level 2. Secured indebtedness : These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Company’s secured debt were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements. As such, the Company classifies these instruments as Level 3.
Per Share Data	Basic earnings per common share is computed by dividing net income applicable to common stockholders by the weighted average number of shares of common stock and common equivalents outstanding during the period. Diluted earnings per common share is calculated by including the effect of dilutive securities.
Industry Segments	The Company has one reportable segment consisting of investments in healthcare-related real estate properties.
Recently Issued Accounting Standards Update	Adopted Between May 2014 and February 2017, the Financial Accounting Standards Board (“FASB”) issued four Accounting Standards Updates (each, an “ASU”) changing the requirements for recognizing and reporting revenue (together, herein referred to as the “Revenue ASUs”): (i) ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), (ii) ASU No. 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2016-08”), (iii) ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients (“ASU 2016-12”) and (iv) ASU No. 2017-05, Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets (“ASU 2017-05”). ASU 2014-09 provides guidance for revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2016-08 is intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. ASU 2016-12 provides practical expedients and improvements on the previously narrow scope of ASU 2014-09. The Revenue ASUs became effective for the Company on January 1, 2018 with the Company electing to use the modified retrospective approach for its adoption. Further, the Company elected to reassess only contracts that were not completed as of the adoption date. The adoption of these ASUs did not have a material impact to beginning retained earnings as of January 1, 2018. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). ASU 2016-15 provides specific guidance clarifying how certain cash receipts and payments should be classified. In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”). ASU 2016-18 requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. The Company adopted ASU 2016-15 and ASU 2016-18 effective beginning January 1, 2018. The full retrospective approach of adoption is required for both ASUs and, accordingly, certain line items in the Company’s consolidated statements of cash flows have been reclassified to conform to the current period presentation. The following table illustrates changes in the Company’s cash flows as reported in the accompanying consolidated statements of cash flows and as previously reported prior to the adoption (in thousands): Year Ended December 31, 2017 Year Ended December 31, 2016 As Reported As Previously Reported As Reported As Previously Reported Net cash provided by operating activities $ 135,789 $ 133,486 $ 175,928 $ 176,739 Net increase in balance 552,046 492,231 17,393 18,204 Balance - beginning of the year 34,665 25,663 17,247 7,434 Balance - end of the year 587,449 518,632 34,665 25,663 In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities (“ASU 2017-12”). ASU 2017-12 is intended to improve the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements and to simplify the application of the hedge accounting guidance under previous GAAP. ASU 2017-12 is effective for fiscal years and interim periods within those years beginning after December 15, 2018, with early adoption permitted. The Company adopted ASU 2017-12 effective beginning January 1, 2018. ASU 2017-12 requires a modified retrospective transition method in which the Company recognized the cumulative effect of the change on the opening balance of each affected component of equity in the consolidated balance sheet as of the date of adoption, which resulted in a decrease to cumulative distributions in excess of net income and an increase to accumulated other comprehensive income of $0.8 million . In February 2016, the FASB issued ASU 2016-02, Leases, as amended by subsequent ASUs (“Topic 842”). Topic 842 supersedes guidance related to accounting for leases and provides for the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. The objective of Topic 842 is to establish the principles that lessees and lessors shall apply to report useful information to users of financial statements about the amount, timing and uncertainty of cash flows arising from a lease. Topic 842 does not fundamentally change lessor accounting; however, some changes have been made to lessor accounting to conform and align that guidance with the lessee guidance and other areas within GAAP. Topic 842 is effective for fiscal years and interim periods within those years beginning after December 15, 2018, with early adoption permitted. The Company elected to adopt Topic 842 on January 1, 2019 using the modified retrospective transition method, which permits application of the new standard on the adoption date as opposed to the earliest comparative period presented in the financial statements. In addition, the Company elected to use the available practical expedient package, and therefore did not reassess classification of its existing leases. Additionally, the Company has elected a practical expedient not to separate lease and nonlease components (such as services rendered), which can only be applied to leasing arrangements for which (i) the timing and pattern of transfer are the same for the lease and nonlease components and (ii) the lease component, if accounted for separately, would be classified as an operating lease. Under this practical expedient, contracts that are predominantly lease-based would be accounted for under Topic 842, and contracts that are predominantly service-based would be accounted for under Topic 606, Revenue from Contracts with Customers. As a result of electing this practical expedient, the Company, beginning January 1, 2019, will recognize revenue from its leased skilled nursing/transitional care facilities, senior housing communities, and specialty hospitals and other facilities under Topic 842 and will recognize revenue from its Senior Housing - Managed communities under the Revenue ASUs (codified under Topic 606). Upon adoption of Topic 842, the Company will recognize its operating leases for which it is the lessee, mainly its corporate office lease and ground leases, on its consolidated balance sheets, as a lease liability of approximately $10 million and a corresponding right-of-use asset. Furthermore, Topic 842 requires lessors to exclude from variable payments lessor costs paid by lessees directly to third parties. In contrast, lessor costs that are paid by the lessor and reimbursed by the lessee will be included in the measurement of variable lease revenue and the associated expense. Issued but Not Yet Adopted In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires that a financial asset (or a group of financial assets) measured at amortized cost basis be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The amendments in ASU 2016-13 are an improvement because they eliminate the probable initial recognition threshold under current GAAP and, instead, reflect an entity’s current estimate of all expected credit losses. Previously, when credit losses were measured under GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. In November 2018, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments—Credit Losses (“ASU 2018-19”), which amends ASU 2016-13 to clarify that receivables arising from operating leases are not within the scope of Subtopic 326-20, and instead, impairment of such receivables should be accounted for in accordance with Topic 842, Leases. ASU 2016-13 and ASU 2018-19 are effective for fiscal years and interim periods within those years beginning after December 15, 2019, with early adoption permitted as of the fiscal years beginning after December 15, 2018. An entity will apply the amendments in these updates through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). The Company is currently evaluating the impact this guidance will have on its consolidated financial statements when adopted. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). ASU 2018-13 updates the fair value measurement disclosure requirements by (i) eliminating certain requirements, including disclosure of the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and the valuation processes for Level 3 fair value measurements, (ii) modifying certain requirements, including clarifying that the measurement uncertainty disclosure is to communicate information about the uncertainty in measurement as of the reporting date and (iii) adding certain requirements, including disclosure of the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for fiscal years and interim periods within those years beginning after December 15, 2019, with early adoption permitted for any eliminated or modified disclosures. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements when adopted.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Changes in Cash Flows Due to Adoption of ASU 2016-15	The following table illustrates changes in the Company’s cash flows as reported in the accompanying consolidated statements of cash flows and as previously reported prior to the adoption (in thousands): Year Ended December 31, 2017 Year Ended December 31, 2016 As Reported As Previously Reported As Reported As Previously Reported Net cash provided by operating activities $ 135,789 $ 133,486 $ 175,928 $ 176,739 Net increase in balance 552,046 492,231 17,393 18,204 Balance - beginning of the year 34,665 25,663 17,247 7,434 Balance - end of the year 587,449 518,632 34,665 25,663

CCP MERGER AND RECENT REAL ES_2

CCP MERGER AND RECENT REAL ESTATE ACQUISITIONS (Tables)	12 Months Ended
	Dec. 31, 2018
Business Combinations [Abstract]
Purchase Price Allocation	During the year ended December 31, 2018 , the Company acquired 11 Senior Housing - Managed communities, eight senior housing communities and two skilled nursing/transitional care facilities. During the year ended December 31, 2017 , in addition to the properties acquired as a result of the CCP Merger, the Company acquired 22 skilled nursing/transitional care facilities and two senior housing communities. The consideration was allocated as follows (in thousands): Year Ended December 31, 2018 2017 Land $ 29,712 $ 58,771 Building and improvements 232,893 359,310 Tenant origination and absorption costs intangible assets 2,046 6,684 Tenant relationship intangible assets 677 2,053 Total consideration $ 265,328 $ 426,818 The following table summarizes the purchase price allocation for the CCP Merger based on the Company’s valuation, including estimates and assumptions of the acquisition date fair value of the tangible and intangible assets acquired and liabilities assumed on August 17, 2017 (in thousands): Real estate investments $ 3,727,310 Loans receivable and other investments 58,244 Cash and cash equivalents 77,859 Restricted cash 779 Lease intangible assets, net 145,786 Accounts receivable, prepaid expenses and other assets, net 35,873 Secured debt, net (98,500 ) Revolving credit facility (362,000 ) Unsecured term loans (674,000 ) Senior unsecured notes, net (616,873 ) Accounts payable and accrued liabilities (134,802 ) Lease intangible liabilities, net (102,643 ) Noncontrolling interests (4,455 ) Total consideration $ 2,052,578

REAL ESTATE PROPERTIES HELD F_2

REAL ESTATE PROPERTIES HELD FOR INVESTMENT (Tables)	12 Months Ended
	Dec. 31, 2018
Real Estate Investments, Net [Abstract]
Real Estate Properties Held for Investment	The Company’s real estate properties held for investment consisted of the following (dollars in thousands): As of December 31, 2018 Property Type Number of Properties Number of Beds/Units Total Real Estate at Cost Accumulated Depreciation Total Real Estate Investments, Net Skilled Nursing/Transitional Care 335 37,628 $ 4,094,484 $ (224,942 ) $ 3,869,542 Senior Housing - Leased 90 7,332 1,237,790 (125,902 ) 1,111,888 Senior Housing - Managed 23 1,603 301,739 (19,537 ) 282,202 Specialty Hospitals and Other 22 1,085 621,236 (31,640 ) 589,596 470 47,648 6,255,249 (402,021 ) 5,853,228 Corporate Level 634 (317 ) 317 $ 6,255,883 $ (402,338 ) $ 5,853,545 As of December 31, 2017 Property Type Number of Properties Number of Beds/Units Total Real Estate at Cost Accumulated Depreciation Total Real Estate Investments, Net Skilled Nursing/Transitional Care 384 43,223 $ 4,364,387 $ (209,039 ) $ 4,155,348 Senior Housing - Leased 88 8,137 1,166,687 (102,370 ) 1,064,317 Senior Housing - Managed 13 1,113 189,120 (12,125 ) 176,995 Specialty Hospitals and Other 22 1,085 614,068 (16,620 ) 597,448 507 53,558 6,334,262 (340,154 ) 5,994,108 Corporate Level 593 (269 ) 324 $ 6,334,855 $ (340,423 ) $ 5,994,432 December 31, 2018 December 31, 2017 Building and improvements $ 5,388,102 $ 5,449,415 Furniture and equipment 237,145 232,889 Land improvements 1,254 3,456 Land 629,382 649,095 6,255,883 6,334,855 Accumulated depreciation (402,338 ) (340,423 ) $ 5,853,545 $ 5,994,432
Future Minimum Rental Payments from Non-Cancelable Operating Leases	As of December 31, 2018 , the future minimum rental payments from the Company’s properties held for investment under non-cancelable operating leases were as follows (in thousands): 2019 $ 465,766 2020 456,207 2021 452,346 2022 454,216 2023 437,277 Thereafter 2,407,064 $ 4,672,876

INTANGIBLE ASSETS AND LIABILI_2

INTANGIBLE ASSETS AND LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Intangible Assets and Liabilities	The following table summarizes the Company’s intangible assets and liabilities as of December 31, 2018 and 2017 (in thousands): December 31, 2018 2017 Lease Intangible Assets: Above market leases $ 61,572 $ 76,443 Tenant origination and absorption costs 73,323 76,336 Tenant relationship 26,936 27,436 Gross lease intangible assets 161,831 180,215 Accumulated amortization (30,734 ) (13,096 ) Lease intangible assets, net $ 131,097 $ 167,119 Lease Intangible Liabilities: Below market leases $ 102,098 $ 102,643 Accumulated amortization (18,372 ) (4,628 ) Lease intangible liabilities, net $ 83,726 $ 98,015
Summary of Real Estate Intangible Amortization	The following is a summary of real estate intangible amortization income (expense) for the years ended December 31, 2018 , 2017 and 2016 (in thousands): Year Ended December 31, 2018 2017 2016 (Decrease) increase to rental income related to above/below market leases, net $ (7,701 ) $ 912 $ — Depreciation and amortization related to tenant origination and absorption costs and tenant relationship (16,118 ) (11,822 ) (3,182 )
Remaining Unamortized Balance for Outstanding Intangible Assets and Liabilities	The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2018 will be amortized for the years ending December 31 as follows (dollars in thousands): Lease Intangible Lease Intangible 2019 $ 21,367 $ 13,779 2020 17,822 12,221 2021 15,363 8,012 2022 14,427 7,269 2023 11,317 7,269 Thereafter 50,801 35,176 $ 131,097 $ 83,726 Weighted-average remaining amortization period 8.9 years 9.3 years

LOANS RECEIVABLE AND OTHER IN_2

LOANS RECEIVABLE AND OTHER INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2018
REAL ESTATE LOANS RECEIVABLE [Abstract]
Loans Receivable and Other Investments	As of December 31, 2018 and 2017 , the Company’s loans receivable and other investments consisted of the following (dollars in thousands): December 31, 2018 Investment Quantity Property Type Principal Balance as of December 31, 2018 (1) Book Value Book Value Weighted Average Contractual Interest Rate / Rate of Return Weighted Average Annualized Effective Interest Rate / Rate of Return Maturity Date Loans Receivable: Mortgage 1 Specialty Hospital $ 18,577 $ 18,577 $ 12,351 10.0 % 10.0 % 01/31/27 Construction 2 Senior Housing 4,569 4,629 2,733 8.0 % 7.7 % 04/30/21- 09/30/22 Mezzanine 1 Skilled Nursing 23,952 2,188 10,239 10.0 % 41.9 % 05/25/20 Pre-development — Senior Housing — — 2,357 N/A N/A N/A Other 18 Multiple 49,394 45,324 38,324 7.3 % 8.1 % 02/28/19- 08/31/28 22 96,492 70,718 66,004 8.5 % 9.7 % Loan loss reserve — (1,258 ) (97 ) $ 96,492 $ 69,460 $ 65,907 Other Investments: Preferred Equity 9 Skilled Nursing / Senior Housing 43,851 44,262 48,483 12.1 % 12.1 % N/A Total 31 $ 140,343 $ 113,722 $ 114,390 9.6 % 10.6 % (1) Principal balance includes amounts funded and accrued but unpaid interest/preferred return and excludes capitalizable fees.
Changes in Accretable Yield	The following table presents changes in the accretable yield for the years ended December 31, 2018 and 2017 (in thousands): Year Ended December 31, 2018 2017 Accretable yield, beginning of period $ 2,483 $ — Additions — 3,481 Accretion recognized in earnings (2,761 ) (998 ) Net reclassification from nonaccretable difference 727 — Accretable yield, end of period $ 449 $ 2,483

DEBT (Tables)

DEBT (Tables)	12 Months Ended
	Dec. 31, 2018
Debt Instrument [Line Items]
Schedule of Maturities for Outstanding Debt	The following is a schedule of maturities for the Company’s outstanding debt as of December 31, 2018 (in thousands): Secured Indebtedness Revolving Credit Facility (1) Term Loans Senior Notes Total 2019 $ 3,421 $ — $ — $ — $ 3,421 2020 3,530 — 200,000 — 203,530 2021 18,130 624,000 — 500,000 1,142,130 2022 3,185 — 991,700 — 994,885 2023 3,282 — — 200,000 203,282 Thereafter 85,916 — — 600,000 685,916 Total Debt 117,464 624,000 1,191,700 1,300,000 3,233,164 Premium, net — — — 14,500 14,500 Deferred financing costs, net (1,785 ) — (6,770 ) (7,106 ) (15,661 ) Total Debt, Net $ 115,679 $ 624,000 $ 1,184,930 $ 1,307,394 $ 3,232,003 (1) Revolving Credit Facility is subject to two six -month extension options
Secured Indebtedness
Debt Instrument [Line Items]
Debt	The Company’s secured debt consists of the following (dollars in thousands): Interest Rate Type Principal Balance as of (1) Principal Balance as of (1) Weighted Average Effective Interest Rate at (2) Maturity Date Fixed Rate $ 117,464 $ 160,702 3.66 % December 2021 - Variable Rate — 98,500 NA NA $ 117,464 $ 259,202 3.66 % (1) Principal balance does not include deferred financing costs, net of $1.8 million and $2.8 million as of December 31, 2018 and 2017 , respectively. (2) Weighted average effective interest rate includes private mortgage insurance.
Senior Unsecured Notes
Debt Instrument [Line Items]
Debt	The Company’s senior unsecured notes consist of the following (dollars in thousands): Principal Balance as of December 31, Title Maturity Date 2018 (1) 2017 (1) 5.5% senior unsecured notes due 2021 (“2021 Notes”) February 1, 2021 $ 500,000 $ 500,000 5.375% senior unsecured notes due 2023 (“2023 Notes”) June 1, 2023 200,000 200,000 5.125% senior unsecured notes due 2026 (“2026 Notes”) August 15, 2026 500,000 500,000 5.38% senior unsecured notes due 2027 (“2027 Notes”) May 17, 2027 100,000 100,000 $ 1,300,000 $ 1,300,000 (1) Principal balance does not include premium, net of $14.5 million and deferred financing costs, net of $7.1 million as of December 31, 2018 and does not include premium, net of $15.9 million and deferred financing costs, net of $9.6 million as of December 31, 2017 .

DERIVATIVE AND HEDGING INSTRU_2

DERIVATIVE AND HEDGING INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Notional Amounts of Derivative Instruments	The following presents the notional amount of derivative instruments as of the dates indicated (in thousands): December 31, 2018 December 31, 2017 Derivatives designated as cash flow hedges: Denominated in U.S. Dollars (1) $ 1,045,000 $ 845,000 Denominated in Canadian Dollars $ 125,000 $ 125,000 Derivatives designated as net investment hedges: Denominated in Canadian Dollars $ 55,401 $ 56,300 Financial instrument designated as net investment hedge: Denominated in Canadian Dollars $ 125,000 $ 125,000 Derivatives not designated as net investment hedges: Denominated in Canadian Dollars $ 899 $ — (1) Balance includes forward starting interest rate swaps having an effective date of June 2019 that have been entered into as of December 31, 2018 to hedge $200.0 million of anticipated fixed-rate debt issuance to occur sometime during 2019.
Summary of Derivative and Financial Instruments Designated as Hedging Instruments	The following is a summary of the derivative and financial instruments designated as hedging instruments held by the Company at December 31, 2018 and 2017 (dollars in thousands): Count as of December 31, 2018 Fair Value Maturity Dates December 31, Type Designation 2018 2017 Balance Sheet Location Assets: Interest rate swap Cash Flow 12 $ 25,184 $ 25,221 2020 - 2023 Accounts receivable, prepaid expenses and other assets, net Cross currency interest rate swaps Net Investment 2 4,160 674 2025 Accounts receivable, prepaid expenses and other assets, net $ 29,344 $ 25,895 Liabilities: Forward starting interest rate swap Cash Flow 2 $ 4,529 $ — 2029 Accounts payable and accrued liabilities CAD term loan Net Investment 1 91,700 99,588 2022 Term loans, net $ 96,229 $ 99,588
Effect of Derivatives and Financial Instruments Designated as Hedging Instruments on Income and Equity	The following presents the effect of the Company’s derivative and financial instruments designated as hedging instruments on the consolidated statements of income and the consolidated statements of equity for years ended December 31, 2018 , 2017 and 2016 : Gain (Loss) Recognized in Other Comprehensive Income Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income Income Statement Location For the year ended December 31, 2018 2017 2016 2018 2017 2016 Cash Flow Hedges: Interest rate products $ 2,707 $ 10,807 $ 5,879 $ 3,099 $ (2,174 ) $ (1,360 ) Interest expense Net Investment Hedges: Foreign currency products 3,554 (2,378 ) (2,085 ) — — — N/A CAD term loan 7,888 (6,588 ) (3,750 ) — — — N/A $ 14,149 $ 1,841 $ 44 $ 3,099 $ (2,174 ) $ (1,360 )
Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives, Assets	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2018 and 2017 (in thousands): As of December 31, 2018 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 29,344 $ — $ 29,344 $ (2,069 ) $ — $ 27,275 Offsetting Liabilities: Derivatives $ 4,529 $ — $ 4,529 $ (2,069 ) $ — $ 2,460 As of December 31, 2017 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 25,895 $ — $ 25,895 $ — $ — $ 25,895 Offsetting Liabilities: Derivatives $ — $ — $ — $ — $ — $ —
Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives, Liabilities	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2018 and 2017 (in thousands): As of December 31, 2018 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 29,344 $ — $ 29,344 $ (2,069 ) $ — $ 27,275 Offsetting Liabilities: Derivatives $ 4,529 $ — $ 4,529 $ (2,069 ) $ — $ 2,460 As of December 31, 2017 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 25,895 $ — $ 25,895 $ — $ — $ 25,895 Offsetting Liabilities: Derivatives $ — $ — $ — $ — $ — $ —

FAIR VALUE DISCLOSURES (Tables)

FAIR VALUE DISCLOSURES (Tables)	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Face Values, Carrying Amounts and Fair Values of Financial Instruments	The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2018 and 2017 whose carrying amounts do not approximate their fair value (in thousands): December 31, 2018 December 31, 2017 Face (1) Carrying (2) Fair Face (1) Carrying (2) Fair Financial assets: Loans receivable $ 96,492 $ 69,460 $ 65,797 $ 91,280 $ 65,907 $ 65,892 Preferred equity investments 43,851 44,262 43,825 48,035 48,483 47,064 Financial liabilities: Senior Notes 1,300,000 1,307,394 1,270,877 1,300,000 1,306,286 1,329,191 Secured indebtedness 117,464 115,679 101,820 259,202 256,430 246,461 (1) Face value represents amounts contractually due under the terms of the respective agreements. (2) Carrying amount represents the book value of financial instruments, including unamortized premiums/discounts and deferred financing costs.
Inputs Used for Valuation of Financial Instruments	The Company determined the fair value of financial instruments as of December 31, 2018 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands): Fair Value Measurements Using Total Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Financial assets: Loans receivable $ 65,797 $ — $ — $ 65,797 Preferred equity investments 43,825 — — 43,825 Financial liabilities: Senior Notes 1,270,877 — 1,270,877 — Secured indebtedness 101,820 — — 101,820
Amounts Measured at Fair Value	During the year ended December 31, 2018 , the Company recorded the following amounts measured at fair value (in thousands): Fair Value Measurements Using Total Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Recurring Basis: Financial assets: Interest rate swap $ 25,184 $ — $ 25,184 $ — Cross currency swap 4,160 — 4,160 — Financial liabilities: Interest rate swap 4,529 — 4,529 —

EQUITY (Tables)

EQUITY (Tables)	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Summary of Accumulated Other Comprehensive Income	The following is a summary of the Company’s accumulated other comprehensive income (in thousands): Year Ended December 31, 2018 2017 Foreign currency translation loss $ (2,193 ) $ (2,913 ) Unrealized gains on cash flow hedges 14,494 14,202 Total accumulated other comprehensive income $ 12,301 $ 11,289

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of Additional Information Concerning Restricted Stock Units	The following table summarizes additional information concerning restricted stock units at December 31, 2018 : Restricted Stock Units Weighted Average Grant Date Fair Value Per Unit Unvested as of December 31, 2017 1,125,487 $ 19.71 Granted 601,696 16.02 Vested (170,951 ) 21.35 Dividends reinvested 118,797 19.06 Cancelled/forfeited (197,711 ) 20.34 Unvested as of December 31, 2018 1,477,318 $ 17.88
Summary of Assumptions Used in Total Stockholder Return-Based Stock Units Valuation	The following are the key assumptions used in this valuation: 2018 2017 2016 Risk free interest rate 2.36% - 2.59% 1.42% - 1.99% 0.78% - 1.60% Expected stock price volatility 28.57% - 30.02% 28.86% - 30.97% 27.40% - 28.42% Expected service period 2.5 - 3.0 years 2.2 - 3.0 years 2.3 - 3.0 years Expected dividend yield (assuming full reinvestment) — % — % — %

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Reconciliation of Unrecognized Tax Benefits	The following is a reconciliation of the Company’s beginning and ending unrecognized tax benefits (in thousands): Balance at December 31, 2015 $ 24,212 Additions (reductions) based on prior years’ tax positions (24,212 ) Additions (reductions) based on 2016 tax positions — Balance at December 31, 2016 $ — Additions (reductions) based on prior years’ tax positions — Additions (reductions) based on 2017 tax positions — Balance at December 31, 2017 $ — Additions (reductions) based on prior years’ tax positions — Additions (reductions) based on 2018 tax positions — Balance at December 31, 2018 $ —

EARNINGS PER COMMON SHARE (Tabl

EARNINGS PER COMMON SHARE (Tables)	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table illustrates the computation of basic and diluted earnings per share (in thousands, except share and per share amounts): Year Ended December 31, 2018 2017 2016 Numerator Net income attributable to common stockholders $ 269,314 $ 148,141 $ 60,034 Denominator Basic weighted average common shares and common equivalents 178,305,738 105,621,242 65,284,251 Dilutive stock options and restricted stock units 416,006 221,192 236,421 Diluted weighted average common shares 178,721,744 105,842,434 65,520,672 Net income attributable to common stockholders, per: Basic common share $ 1.51 $ 1.40 $ 0.92 Diluted common share $ 1.51 $ 1.40 $ 0.92

SUMMARIZED CONSOLIDATING INFO_2

SUMMARIZED CONSOLIDATING INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2018
Summarized Condensed Consolidating Information [Abstract]
Consolidating Balance Sheet	CONSOLIDATING BALANCE SHEET December 31, 2018 (in thousands, except share and per share amounts) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Assets Real estate investments, net of accumulated depreciation $ 317 $ — $ — $ 1,609,861 $ 4,243,367 $ — $ 5,853,545 Loans receivable and other investments, net (560 ) — — 50,534 63,748 — 113,722 Investment in unconsolidated joint venture — — — — 340,120 — 340,120 Cash and cash equivalents 40,835 — — 3,508 5,887 — 50,230 Restricted cash — — — 1,820 7,608 — 9,428 Lease intangible assets, net — — — 15,892 115,205 — 131,097 Accounts receivable, prepaid expenses and other assets, net 798 37,075 — 58,710 81,597 (11,019 ) 167,161 Intercompany 1,972,059 2,646,669 — — — (4,618,728 ) — Investment in subsidiaries 1,258,715 1,629,795 — 33,083 — (2,921,593 ) — Total assets $ 3,272,164 $ 4,313,539 $ — $ 1,773,408 $ 4,857,532 $ (7,551,340 ) $ 6,665,303 Liabilities Secured debt, net $ — $ — $ — $ — $ 115,679 $ — $ 115,679 Revolving credit facility — 624,000 — — — — 624,000 Term loans, net — 1,094,177 — 90,753 — — 1,184,930 Senior unsecured notes, net — 1,307,394 — — — — 1,307,394 Accounts payable and accrued liabilities 21,750 29,253 — 2,695 52,148 (11,019 ) 94,827 Lease intangible liabilities, net — — — — 83,726 — 83,726 Intercompany — — — 399,912 4,218,816 (4,618,728 ) — Total liabilities 21,750 3,054,824 — 493,360 4,470,369 (4,629,747 ) 3,410,556 Total Sabra Health Care REIT, Inc. stockholders’ equity 3,250,414 1,258,715 — 1,280,048 382,830 (2,921,593 ) 3,250,414 Noncontrolling interests — — — — 4,333 — 4,333 Total equity 3,250,414 1,258,715 — 1,280,048 387,163 (2,921,593 ) 3,254,747 Total liabilities and equity $ 3,272,164 $ 4,313,539 $ — $ 1,773,408 $ 4,857,532 $ (7,551,340 ) $ 6,665,303 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING BALANCE SHEET December 31, 2017 (in thousands, except share and per share amounts) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Assets Real estate investments, net of accumulated depreciation $ 324 $ — $ — $ 1,756,933 $ 4,237,175 $ — $ 5,994,432 Loans receivable and other investments, net (97 ) — — 55,297 59,190 — 114,390 Cash and cash equivalents 511,670 — — 449 6,513 — 518,632 Restricted cash — — — 36,910 31,907 — 68,817 Lease intangible assets, net — — — 17,577 149,542 — 167,119 Accounts receivable, prepaid expenses and other assets, net 3,499 36,073 — 80,739 53,765 (5,189 ) 168,887 Intercompany 2,043,402 2,721,979 — — — (4,765,381 ) — Investment in subsidiaries 890,462 1,198,305 — 14,661 — (2,103,428 ) — Total assets $ 3,449,260 $ 3,956,357 $ — $ 1,962,566 $ 4,538,092 $ (6,873,998 ) $ 7,032,277 Liabilities Secured debt, net $ — $ — $ — $ — $ 256,430 $ — $ 256,430 Revolving credit facility — 641,000 — — — — 641,000 Term loans, net — 1,092,397 — 98,377 — — 1,190,774 Senior unsecured notes, net — 1,306,286 — — — — 1,306,286 Accounts payable and accrued liabilities 16,453 26,212 — 3,560 61,487 (5,189 ) 102,523 Lease intangible liabilities, net — — — — 98,015 — 98,015 Intercompany — — — 785,120 3,980,261 (4,765,381 ) — Total liabilities 16,453 3,065,895 — 887,057 4,396,193 (4,770,570 ) 3,595,028 Total Sabra Health Care REIT, Inc. stockholders’ equity 3,432,807 890,462 — 1,075,509 137,457 (2,103,428 ) 3,432,807 Noncontrolling interests — — — — 4,442 — 4,442 Total equity 3,432,807 890,462 — 1,075,509 141,899 (2,103,428 ) 3,437,249 Total liabilities and equity $ 3,449,260 $ 3,956,357 $ — $ 1,962,566 $ 4,538,092 $ (6,873,998 ) $ 7,032,277 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes.
Consolidating Statement of Income	CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2018 (in thousands, except share and per share amounts) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Revenues: Rental income $ — $ — $ — $ 170,400 $ 383,630 $ (17,425 ) $ 536,605 Interest and other income 110 399 — 5,632 10,925 (399 ) 16,667 Resident fees and services — — — — 70,137 — 70,137 Total revenues 110 399 — 176,032 464,692 (17,824 ) 623,409 Expenses: Depreciation and amortization 887 — — 57,143 133,349 — 191,379 Interest — 134,096 — 3,334 10,075 (399 ) 147,106 Operating expenses — — — — 66,971 (17,425 ) 49,546 General and administrative 26,801 71 — 2,078 7,508 — 36,458 Merger and acquisition costs 642 — — — (6 ) — 636 Provision for doubtful accounts, straight-line rental income and loan losses 822 — — 30,710 7,543 — 39,075 Impairment of real estate — — — 1,413 — — 1,413 Total expenses 29,152 134,167 — 94,678 225,440 (17,824 ) 465,613 Other income (expense): Loss on extinguishment of debt — — — — (2,917 ) — (2,917 ) Other income 1,977 (55 ) — 990 1,568 — 4,480 Net gain on sales of real estate — — — 108,697 19,501 — 128,198 Total other income 1,977 (55 ) — 109,687 18,152 — 129,761 Income in subsidiary 307,736 441,560 — 24,316 — (773,612 ) — Income before loss from unconsolidated joint venture and income tax expense 280,671 307,737 — 215,357 257,404 (773,612 ) 287,557 Loss from unconsolidated joint venture — — — — (5,431 ) — (5,431 ) Income tax expense (1,589 ) (1 ) — (1,114 ) (307 ) — (3,011 ) Net income 279,082 307,736 — 214,243 251,666 (773,612 ) 279,115 Net income attributable to noncontrolling interests — — — — (33 ) — (33 ) Net income attributable to Sabra Health Care REIT, Inc. 279,082 307,736 — 214,243 251,633 (773,612 ) 279,082 Preferred stock dividends (9,768 ) — — — — — (9,768 ) Net income attributable to common stockholders $ 269,314 $ 307,736 $ — $ 214,243 $ 251,633 $ (773,612 ) $ 269,314 Net income attributable to common stockholders, per: Basic common share $ 1.51 Diluted common share $ 1.51 Weighted-average number of common shares outstanding, basic 178,305,738 Weighted-average number of common shares outstanding, diluted 178,721,744 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2017 (in thousands, except share and per share amounts) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Revenues: Rental income $ — $ — $ — $ 213,162 $ 158,542 $ (7,513 ) $ 364,191 Interest and other income 39 143 — 9,098 5,907 (161 ) 15,026 Resident fees and services — — — — 26,430 — 26,430 Total revenues 39 143 — 222,260 190,879 (7,674 ) 405,647 Expenses: Depreciation and amortization 867 — — 67,723 45,292 — 113,882 Interest — 77,767 — 2,989 7,827 (143 ) 88,440 Operating expenses — — — — 25,391 (7,531 ) 17,860 General and administrative 24,810 65 — 3,854 3,672 — 32,401 Merger and acquisition costs 30,208 — — 47 — — 30,255 Provision for doubtful accounts, straight-line rental income and loan losses 227 — — 16,886 — — 17,113 Impairment of real estate — — — 1,326 — — 1,326 Total expenses 56,112 77,832 — 92,825 82,182 (7,674 ) 301,277 Other income (expense): Loss on extinguishment of debt — (422 ) — (131 ) — — (553 ) Other income (expense) 2,634 1,130 — (617 ) 23 — 3,170 Net gain (loss) on sales of real estate — — — 54,627 (2,598 ) — 52,029 Total other income (expense) 2,634 708 — 53,879 (2,575 ) — 54,646 Income in subsidiary 212,432 289,414 — 7,199 — (509,045 ) — Income before income tax (expense) benefit 158,993 212,433 — 190,513 106,122 (509,045 ) 159,016 Income tax (expense) benefit (610 ) (1 ) — (139 ) 99 — (651 ) Net income 158,383 212,432 — 190,374 106,221 (509,045 ) 158,365 Net loss attributable to noncontrolling interests — — — — 18 — 18 Net income attributable to Sabra Health Care REIT, Inc. 158,383 212,432 — 190,374 106,239 (509,045 ) 158,383 Preferred stock dividends (10,242 ) — — — — — (10,242 ) Net income attributable to common stockholders $ 148,141 $ 212,432 $ — $ 190,374 $ 106,239 $ (509,045 ) $ 148,141 Net income attributable to common stockholders, per: Basic common share $ 1.40 Diluted common share $ 1.40 Weighted-average number of common shares outstanding, basic 105,621,242 Weighted-average number of common shares outstanding, diluted 105,842,434 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF INCOME For the Year Ended December 31, 2016 (in thousands, except share and per share amounts) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Revenues: Rental income $ — $ — $ — $ 206,897 $ 20,706 $ (2,328 ) $ 225,275 Interest and other income 3 — — 27,712 1 (253 ) 27,463 Resident fee and services — — — — 7,788 — 7,788 Total revenues 3 — — 234,609 28,495 (2,581 ) 260,526 Expenses: Depreciation and amortization 816 — — 61,371 6,285 — 68,472 Interest — 54,589 — 3,497 6,787 — 64,873 Operating expenses — — — — 8,066 (2,363 ) 5,703 General and administrative 15,798 56 — 1,652 166 — 17,672 Merger and acquisition costs (7 ) — — 1,204 — — 1,197 (Recovery of) provision for doubtful accounts, straight-line rental income and loan losses (1,376 ) — — 6,498 421 — 5,543 Impairment of real estate — — — 29,811 — — 29,811 Total expenses 15,231 54,645 — 104,033 21,725 (2,363 ) 193,271 Other income (expense): Loss on extinguishment of debt — (468 ) — (88 ) — — (556 ) Other income (expense) 7,366 (196 ) — 3,507 — — 10,677 Net (loss) gain on sale of real estate — — — (6,143 ) 21 — (6,122 ) Total other income (expense) 7,366 (664 ) — (2,724 ) 21 — 3,999 Income in subsidiary 78,783 134,093 — 6,840 — (219,716 ) — Income before income tax expense 70,921 78,784 — 134,692 6,791 (219,934 ) 71,254 Income tax expense (427 ) (1 ) — (538 ) (83 ) — (1,049 ) Net income 70,494 78,783 — 134,154 6,708 (219,934 ) 70,205 Net loss attributable to noncontrolling interests — — — — 71 — 71 Net income attributable to Sabra Health Care REIT, Inc. 70,494 78,783 — 134,154 6,779 (219,934 ) 70,276 Preferred stock dividends (10,242 ) — — — — — (10,242 ) Net income attributable to common stockholders $ 60,252 $ 78,783 $ — $ 134,154 $ 6,779 $ (219,934 ) $ 60,034 Net income attributable to common stockholders, per: Basic common share $ 0.92 Diluted common share $ 0.92 Weighted-average number of common shares outstanding, basic 65,284,251 Weighted-average number of common shares outstanding, diluted 65,520,672 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes.
Consolidating Statement of Comprehensive Income	CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2018 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net income $ 279,082 $ 307,736 $ — $ 214,243 $ 251,666 $ (773,612 ) $ 279,115 Other comprehensive income (loss): Unrealized gain (loss), net of tax: Foreign currency translation gain (loss) — 4,329 — (2,751 ) (858 ) — 720 Unrealized gain on cash flow hedge — 244 — 48 — — 292 Total other comprehensive income (loss) — 4,573 — (2,703 ) (858 ) — 1,012 Comprehensive income 279,082 312,309 — 211,540 250,808 (773,612 ) 280,127 Comprehensive income attributable to noncontrolling interests — — — — (33 ) — (33 ) Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 279,082 $ 312,309 $ — $ 211,540 $ 250,775 $ (773,612 ) $ 280,094 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2017 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net income $ 158,383 $ 212,432 $ — $ 190,374 $ 106,221 $ (509,045 ) $ 158,365 Other comprehensive income: Unrealized gain (loss), net of tax: Foreign currency translation (loss) gain — (2,821 ) — 2,233 742 — 154 Unrealized gain (loss) on cash flow hedge — 13,078 — (145 ) — — 12,933 Total other comprehensive income — 10,257 — 2,088 742 — 13,087 Comprehensive income 158,383 222,689 — 192,462 106,963 (509,045 ) 171,452 Comprehensive loss attributable to noncontrolling interests — — — — 18 — 18 Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 158,383 $ 222,689 $ — $ 192,462 $ 106,981 $ (509,045 ) $ 171,470 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME For the Year Ended December 31, 2016 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net income $ 70,494 $ 78,783 $ — $ 134,154 $ 6,708 $ (219,934 ) $ 70,205 Other comprehensive income: Unrealized gain (loss), net of tax: Foreign currency translation (loss) gain — (2,080 ) — 364 82 — (1,634 ) Unrealized gain on cash flow hedges — 7,169 — — — — 7,169 Total other comprehensive income — 5,089 — 364 82 — 5,535 Comprehensive income 70,494 83,872 — 134,518 6,790 (219,934 ) 75,740 Comprehensive loss attributable to noncontrolling interests — — — — 71 — 71 Comprehensive income attributable to Sabra Health Care REIT, Inc. $ 70,494 $ 83,872 $ — $ 134,518 $ 6,861 $ (219,934 ) $ 75,811 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes.
Consolidating Statement of Cash Flows	CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2018 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net cash provided by operating activities $ 310,442 $ — $ — $ 1,639 $ 46,462 $ — $ 358,543 Cash flows from investing activities: Acquisition of real estate — — — (77,225 ) (184,286 ) — (261,511 ) Origination and fundings of loans receivable — — — (6,317 ) (44,414 ) — (50,731 ) Origination and fundings of preferred equity investments — — — (5,313 ) — — (5,313 ) Additions to real estate (40 ) — — (6,862 ) (20,795 ) — (27,697 ) Repayment of loans receivable — — — 8,946 42,843 — 51,789 Repayment of preferred equity investments — — — 6,870 — — 6,870 Investment in unconsolidated JV — — — — (354,461 ) — (354,461 ) Net proceeds from sales of real estate — — — 284,958 97,602 — 382,560 Distribution from subsidiaries 5,457 5,457 — — — (10,914 ) — Intercompany financing (317,225 ) (299,873 ) — — — 617,098 — Net cash (used in) provided by investing activities (311,808 ) (294,416 ) — 205,057 (463,511 ) 606,184 (258,494 ) Cash flows from financing activities: Net repayments of revolving credit facility — (17,000 ) — — — — (17,000 ) Principal payments on secured debt — — — — (140,338 ) — (140,338 ) Payments of deferred financing costs — (352 ) — — — — (352 ) Distributions to noncontrolling interest — — — — (142 ) — (142 ) Preferred stock redemption (143,750 ) — — — — — (143,750 ) Issuance of common stock, net (499 ) — — — — — (499 ) Dividends paid on common and preferred stock (325,220 ) — — — — — (325,220 ) Distribution to parent — (5,457 ) — — (5,457 ) 10,914 — Intercompany financing — 317,225 — (238,392 ) 538,265 (617,098 ) — Net cash (used in) provided by financing activities (469,469 ) 294,416 — (238,392 ) 392,328 (606,184 ) (627,301 ) Net decrease in cash, cash equivalents and restricted cash (470,835 ) — — (31,696 ) (24,721 ) — (527,252 ) Effect of foreign currency translation on cash, cash equivalents and restricted cash — — — (335 ) (204 ) — (539 ) Cash, cash equivalents and restricted cash, beginning of period 511,670 — — 37,359 38,420 — 587,449 Cash, cash equivalents and restricted cash, end of period $ 40,835 $ — $ — $ 5,328 $ 13,495 $ — $ 59,658 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2017 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net cash provided by operating activities $ 59,640 $ — $ — $ 41,085 $ 35,064 $ — $ 135,789 Cash flows from investing activities: Acquisition of real estate — — — (419,905 ) — — (419,905 ) Cash received in CCP Merger 77,859 — — — — — 77,859 Origination and fundings of loans receivable — — — (1,799 ) (15,440 ) — (17,239 ) Origination and fundings of preferred equity investments — — — (2,749 ) — — (2,749 ) Additions to real estate (181 ) — — (2,339 ) (4,434 ) — (6,954 ) Repayment of loans receivable — — — 12,441 19,989 — 32,430 Repayment of preferred equity investments — — — 3,755 — — 3,755 Net proceeds from sales of real estate — — — 149,849 394 — 150,243 Distribution from subsidiaries 2,474 2,474 — — — (4,948 ) — Intercompany financing 168,999 (249,664 ) — — — 80,665 — Net cash provided by (used in) investing activities 249,151 (247,190 ) — (260,747 ) 509 75,717 (182,560 ) Cash flows from financing activities: Net borrowings from revolving credit facility — 253,000 — — — — 253,000 Proceeds from term loans — 181,000 — — — — 181,000 Principal payments on secured debt — — — — (4,145 ) — (4,145 ) Payments of deferred financing costs — (15,337 ) — — — — (15,337 ) Payment of contingent consideration — — — (382 ) — — (382 ) Distributions to noncontrolling interests — — — — (30 ) — (30 ) Issuance of common stock, net 366,800 — — — — — 366,800 Dividends paid on common and preferred stock (182,089 ) — — — — — (182,089 ) Distribution to parent — (2,474 ) — — (2,474 ) 4,948 — Intercompany financing — (168,999 ) — 254,608 (4,944 ) (80,665 ) — Net cash provided by (used in) financing activities 184,711 247,190 — 254,226 (11,593 ) (75,717 ) 598,817 Net increase in cash, cash equivalents and restricted cash 493,502 — — 34,564 23,980 — 552,046 Effect of foreign currency translation on cash, cash equivalents and restricted cash — — — 63 675 — 738 Cash, cash equivalents and restricted cash, beginning of period 18,168 — — 2,732 13,765 — 34,665 Cash, cash equivalents and restricted cash, end of period $ 511,670 $ — $ — $ 37,359 $ 38,420 $ — $ 587,449 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes. CONSOLIDATING STATEMENT OF CASH FLOWS For the Year Ended December 31, 2016 (in thousands) Combined Non-Guarantor Subsidiaries of 2026 Notes (6) Parent (1) Operating (2) Sabra Capital (3) Combined (4) Combined Non- (5) Elimination Consolidated Net cash provided by operating activities $ 153,577 $ — $ — $ 10,343 $ 12,008 $ — $ 175,928 Cash flows from investing activities: Acquisition of real estate — — — (153,579 ) — — (153,579 ) Origination and fundings of loans receivable — — — (9,675 ) — — (9,675 ) Origination and fundings of preferred equity investments — — — (7,348 ) — — (7,348 ) Additions to real estate (124 ) — — (502 ) (377 ) — (1,003 ) Repayment of loans receivable — — — 215,962 — — 215,962 Net proceeds from the sales of real estate — — — 97,407 599 — 98,006 Investment in subsidiaries (200 ) (200 ) — — — 400 — Distribution from subsidiaries 6,404 6,404 — — — (12,808 ) — Intercompany financing (23,484 ) 165,842 — — — (142,358 ) — Net cash (used in) provided by investing activities (17,404 ) 172,046 — 142,265 222 (154,766 ) 142,363 Cash flows from financing activities: Net repayments of revolving credit facility — (229,000 ) — — — — (229,000 ) Proceeds from term loans — 45,000 — 24,360 — — 69,360 Principal payments on secured debt — — — (10,766 ) (4,002 ) — (14,768 ) Payments of deferred financing costs — (5,326 ) — (611 ) — — (5,937 ) Issuance of common stock, net (1,289 ) — — — — — (1,289 ) Dividends paid on common and preferred stock (119,264 ) — — — — — (119,264 ) Contribution from parent — 200 — — 200 (400 ) — Distribution to parent — (6,404 ) — — (6,404 ) 12,808 — Intercompany financing — 23,484 — (165,175 ) (667 ) 142,358 — Net cash used in financing activities (120,553 ) (172,046 ) — (152,192 ) (10,873 ) 154,766 (300,898 ) Net increase in cash, cash equivalents and restricted cash 15,620 — — 416 1,357 — 17,393 Effect of foreign currency translation on cash, cash equivalents and restricted cash — — — 72 (47 ) — 25 Cash, cash equivalents and restricted cash, beginning of period 2,548 — — 2,244 12,455 — 17,247 Cash, cash equivalents and restricted cash, end of period $ 18,168 $ — $ — $ 2,732 $ 13,765 $ — $ 34,665 (1) The Parent Company guarantees the 2021 Notes, the 2023 Notes and the 2026 Notes. (2) The Operating Partnership is the co-issuer of the 2021 Notes and the 2023 Notes and the issuer of the 2026 Notes. (3) Sabra Capital Corporation is the co-issuer of the 2021 Notes and the 2023 Notes. (4) The Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2021 Notes and the 2023 Notes. (5) The Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes consist of the subsidiaries that do not guarantee the 2021 Notes and the 2023 Notes. (6) None of Sabra Capital Corporation, the Combined Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes, nor the Combined Non-Guarantor Subsidiaries of the 2021 Notes and the 2023 Notes guarantee the 2026 Notes.

PRO FORMA FINANCIAL INFORMATI_2

PRO FORMA FINANCIAL INFORMATION (UNAUDITED) (Tables)	12 Months Ended
	Dec. 31, 2018
Pro Forma Financial Information [Abstract]
Summary of Pro Forma Information	This pro forma information does not purport to represent what the actual results of operations of the Company would have been had the CCP Merger been completed on January 1, 2016, nor does it purport to predict the results of operations for future periods. The pro forma information for the year ended December 31, 2017 follows (in thousands, except share and per share amounts): Revenues $ 631,041 Net income attributable to common stockholders $ 292,551 Net income attributable to common stockholders, per: Basic common share $ 1.78 Diluted common share $ 1.78 Weighted-average number of common shares outstanding, basic 164,361,139 Weighted-average number of common shares outstanding, diluted 164,582,331

BUSINESS (Details)

BUSINESS (Details) - $ / shares	Aug. 17, 2017	Dec. 31, 2018	Dec. 31, 2017
Business [Line Items]
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Care Capital Properties
Business [Line Items]
Common stock, par value (in dollars per share)	$ 0.01
Shares of Sabra common stock issued per share of CCP common stock (in shares)	1.123

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	Jan. 02, 2018USD ($)Propertydirector	Dec. 31, 2018USD ($)Propertyvariable_interest_entitySegmentInvestment	Dec. 31, 2017USD ($)Investment	Dec. 31, 2016USD ($)	Jan. 01, 2019USD ($)
Property, Plant and Equipment [Line Items]
Number of investments in loans accounted for as real estate joint ventures | Investment		0	0
Acquisition costs capitalized		$ 700,000	$ 1,000,000
Merger and acquisition costs		$ 636,000	30,255,000	$ 1,197,000
Extension period for tenant relationship intangible assets		10 years
Assets held for sale		$ 0	0
Book value of investment in the joint venture		340,120,000	0
Restricted cash		$ 9,428,000	68,817,000
Restricted cash held by exchange accommodation titleholder			57,500,000
Number of reportable segments | Segment		1
Subsequent Event | Forecast
Property, Plant and Equipment [Line Items]
Operating lease liability					$ 10,000,000
Operating lease right-of-use asset					$ 10,000,000
Accumulated Other Comprehensive (Loss) Income
Property, Plant and Equipment [Line Items]
Cumulative effect of ASU 2017-12 adoption			795,000
ASU 2017-12 | Accumulated Other Comprehensive (Loss) Income
Property, Plant and Equipment [Line Items]
Cumulative effect of ASU 2017-12 adoption			800,000
Restricted Cash Obligations
Property, Plant and Equipment [Line Items]
Restricted cash		$ 5,500,000	6,500,000
Skilled Nursing/Transitional Care
Property, Plant and Equipment [Line Items]
Net investment in direct financing lease		$ 23,400,000
Properties in direct financing lease | Property		1
Undiscounted rental payments		$ 5,600,000
Estimated unguaranteed residual value		24,700,000
Unearned lease income		6,900,000
Income from direct financing lease		2,600,000	$ 1,000,000
Future minimum lease payments contractually due under direct financing lease, 2019		2,200,000
Future minimum lease payments contractually due under direct financing lease, 2020		2,300,000
Future minimum lease payments contractually due under direct financing lease, 2021		$ 2,100,000
Land Improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		5 years
Land Improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		20 years
Buildings and Building Improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		7 years
Buildings and Building Improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		40 years
Furniture and Equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		3 years
Furniture and Equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets		20 years
Enlivant Joint Venture
Property, Plant and Equipment [Line Items]
Number of real estate properties acquired | Property	172
Enlivant Joint Venture
Property, Plant and Equipment [Line Items]
Payments to acquire equity interest, before closing costs	$ 352,700,000
Equity interest acquired	49.00%
Outstanding indebtedness	$ 791,300,000
Net working capital	$ 22,900,000
Number of directors appointed by minority interest | director	3
Total number of directors | director	7
Book value of investment in the joint venture		$ 340,100,000
Primary Beneficiary
Property, Plant and Equipment [Line Items]
Number of variable interest entities | variable_interest_entity		1
Primary Beneficiary | Skilled Nursing/Transitional Care
Property, Plant and Equipment [Line Items]
Number of variable interest entities | variable_interest_entity		1

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Changes in Cash Flows Due to Adoption of ASU 2016-15 (Details) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net cash provided by operating activities	$ 358,543	$ 135,789	$ 175,928
Net increase in balance	(527,252)	552,046	17,393
Cash, cash equivalents and restricted cash, beginning of period	587,449	34,665	17,247
Cash, cash equivalents and restricted cash, end of period	59,658	587,449	34,665
Previously Reported [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net cash provided by operating activities		133,486	176,739
Net increase in balance		492,231	18,204
Cash, cash equivalents and restricted cash, beginning of period	$ 518,632	25,663	7,434
Cash, cash equivalents and restricted cash, end of period		$ 518,632	$ 25,663

CCP MERGER AND RECENT REAL ES_3

CCP MERGER AND RECENT REAL ESTATE ACQUISITIONS - Narrative (Details) $ in Thousands	Aug. 17, 2017USD ($)PropertyfirmInvestmentshares	Dec. 31, 2018USD ($)PropertyFacilitiy	Dec. 31, 2017USD ($)Facilitiy	Dec. 31, 2016USD ($)
Business Acquisition [Line Items]
Total revenues		$ 623,409	$ 405,647	$ 260,526
Net income attributable to common stockholders		269,314	148,141	60,034
Merger and acquisition costs		636	30,255	$ 1,197
Care Capital Properties
Business Acquisition [Line Items]
Shares of Sabra common stock issued per share of CCP common stock (in shares) | shares	1.123
Shares of common stock issued in merger (in shares) | shares	94,000,000
Number of acquired properties | Property	330
Number of loan receivable investments acquired | Investment	18
Number of specialty valuation firms | firm	1
Purchase price	$ 2,100,000
Total revenues			135,400
Net income attributable to common stockholders			87,000
Merger and acquisition costs			30,200
Care Capital Properties | Lease Intangible Assets
Business Acquisition [Line Items]
Finite-lived intangible assets, weighted average amortization period as of date of acquisition	10 years
Care Capital Properties | Senior Housing Communities
Business Acquisition [Line Items]
Number of acquired properties | Property	13
Care Capital Properties | Specialty Hospitals and Other
Business Acquisition [Line Items]
Number of acquired properties | Property	21
Care Capital Properties | Skilled Nursing/Transitional Care
Business Acquisition [Line Items]
Number of acquired properties | Property	296
Number of acquired properties leased | Property	1
Recent Real Estate Acquisitions
Business Acquisition [Line Items]
Revenues from the properties acquired		44,000	10,600
Net income attributable to common stockholders from the properties acquired		$ 14,000	$ 7,700
Recent Real Estate Acquisitions | Tenant Origination and Absorption Costs
Business Acquisition [Line Items]
Finite-lived intangible assets, weighted average amortization period as of date of acquisition		13 years	13 years
Recent Real Estate Acquisitions | Tenant Relationship
Business Acquisition [Line Items]
Finite-lived intangible assets, weighted average amortization period as of date of acquisition		22 years	23 years
Recent Real Estate Acquisitions | Senior Housing Communities
Business Acquisition [Line Items]
Number of real estate properties acquired | Property		8
Number of real estate properties and businesses acquired | Facilitiy			2
Recent Real Estate Acquisitions | Skilled Nursing/Transitional Care
Business Acquisition [Line Items]
Number of real estate properties acquired | Facilitiy		2	22
Recent Real Estate Acquisitions | Senior Housing - Managed
Business Acquisition [Line Items]
Number of real estate properties acquired | Property		11

CCP MERGER AND RECENT REAL ES_4

CCP MERGER AND RECENT REAL ESTATE ACQUISITIONS - CCP Merger Purchase Price Allocation (Details) - Care Capital Properties $ in Thousands	Aug. 17, 2017USD ($)
Business Acquisition [Line Items]
Real estate investments	$ 3,727,310
Loans receivable and other investments	58,244
Cash and cash equivalents	77,859
Restricted cash	779
Lease intangible assets, net	145,786
Accounts receivable, prepaid expenses and other assets, net	35,873
Secured debt, net	(98,500)
Revolving credit facility	(362,000)
Unsecured term loans	(674,000)
Senior unsecured notes, net	(616,873)
Accounts payable and accrued liabilities	(134,802)
Lease intangible liabilities, net	(102,643)
Noncontrolling interests	(4,455)
Total consideration	$ 2,052,578

CCP MERGER AND RECENT REAL ES_5

CCP MERGER AND RECENT REAL ESTATE ACQUISITIONS - Recent Real Estate Acquisitions Purchase Price Allocation (Details) - Recent Real Estate Acquisitions - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Business Acquisition [Line Items]
Land	$ 29,712	$ 58,771
Building and improvements	232,893	359,310
Total consideration	265,328	426,818
Tenant origination and absorption costs intangible assets
Business Acquisition [Line Items]
Lease intangible assets, net	2,046	6,684
Tenant relationship intangible assets
Business Acquisition [Line Items]
Lease intangible assets, net	$ 677	$ 2,053

REAL ESTATE PROPERTIES HELD F_3

REAL ESTATE PROPERTIES HELD FOR INVESTMENT - Real Estate Properties Held for Investment (Details) $ in Thousands	Dec. 31, 2018USD ($)BedFacilitiy	Dec. 31, 2017USD ($)BedFacilitiy
Real Estate Properties [Line Items]
Building and improvements	$ 5,388,102	$ 5,449,415
Furniture and equipment	237,145	232,889
Land improvements	1,254	3,456
Land	629,382	649,095
Total Real Estate at Cost	6,255,883	6,334,855
Accumulated Depreciation	(402,338)	(340,423)
Total Real Estate Investments, Net	$ 5,853,545	$ 5,994,432
Operating Segments
Real Estate Properties [Line Items]
Number of Properties | Facilitiy	470	507
Number of Beds/Units | Bed	47,648	53,558
Total Real Estate at Cost	$ 6,255,249	$ 6,334,262
Accumulated Depreciation	(402,021)	(340,154)
Total Real Estate Investments, Net	$ 5,853,228	$ 5,994,108
Operating Segments | Skilled Nursing/Transitional Care
Real Estate Properties [Line Items]
Number of Properties | Facilitiy	335	384
Number of Beds/Units | Bed	37,628	43,223
Total Real Estate at Cost	$ 4,094,484	$ 4,364,387
Accumulated Depreciation	(224,942)	(209,039)
Total Real Estate Investments, Net	$ 3,869,542	$ 4,155,348
Operating Segments | Senior Housing - Leased
Real Estate Properties [Line Items]
Number of Properties | Facilitiy	90	88
Number of Beds/Units | Bed	7,332	8,137
Total Real Estate at Cost	$ 1,237,790	$ 1,166,687
Accumulated Depreciation	(125,902)	(102,370)
Total Real Estate Investments, Net	$ 1,111,888	$ 1,064,317
Operating Segments | Senior Housing - Managed
Real Estate Properties [Line Items]
Number of Properties | Facilitiy	23	13
Number of Beds/Units | Bed	1,603	1,113
Total Real Estate at Cost	$ 301,739	$ 189,120
Accumulated Depreciation	(19,537)	(12,125)
Total Real Estate Investments, Net	$ 282,202	$ 176,995
Operating Segments | Specialty Hospitals and Other
Real Estate Properties [Line Items]
Number of Properties | Facilitiy	22	22
Number of Beds/Units | Bed	1,085	1,085
Total Real Estate at Cost	$ 621,236	$ 614,068
Accumulated Depreciation	(31,640)	(16,620)
Total Real Estate Investments, Net	589,596	597,448
Corporate Level
Real Estate Properties [Line Items]
Total Real Estate at Cost	634	593
Accumulated Depreciation	(317)	(269)
Total Real Estate Investments, Net	$ 317	$ 324

REAL ESTATE PROPERTIES HELD F_4

REAL ESTATE PROPERTIES HELD FOR INVESTMENT - Narrative (Details) $ in Millions	Feb. 15, 2019USD ($)	Feb. 25, 2019USD ($)Facilitiy	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)Facilitiy	Dec. 31, 2018USD ($)Facilitiy	Jan. 31, 2019USD ($)Facilitiy	Dec. 05, 2018Facilitiy	Jan. 01, 2018USD ($)	Dec. 31, 2017USD ($)Facilitiy
Real Estate Properties [Line Items]
Weighted average expiration period					9 years
Security deposit liability				$ 12.4	$ 12.4				$ 20.3
Letters of credit deposited				98	98				96
Deposits held for future real estate taxes, insurance expenditures and tenant improvement				17.5	17.5				28.3
Reserve for unpaid cash rents				1.3	1.3				3.2
Reserve associated with straight-line rental income				35.8	$ 35.8				$ 12.4
Minimum
Real Estate Properties [Line Items]
Operating lease expiration period					1 year
Maximum
Real Estate Properties [Line Items]
Operating lease expiration period					15 years
Weighted Average
Real Estate Properties [Line Items]
Operating lease expiration period					9 years
Holiday Retirement
Real Estate Properties [Line Items]
Straight-line rent receivable				$ 28.9	$ 28.9
Forecast | Holiday Retirement
Real Estate Properties [Line Items]
Senior housing communities subject to the master lease | Facilitiy		21
Total consideration received upon termination		$ 57.2
Security deposits retained upon termination		15.1
Termination fees received upon termination		$ 42.1
Senior Care Centers Sale Facilities | Subsequent Event
Real Estate Properties [Line Items]
Aggregate sales price						$ 282.5
Genesis Healthcare, Inc.
Real Estate Properties [Line Items]
Number of properties | Facilitiy				11	11
Reduction of annual base rent								$ 19
Number of properties sold | Facilitiy					43
Number of properties to be sold | Facilitiy				3	3
Number of properties to be retained | Facilitiy				8	8
Senior Care Centers
Real Estate Properties [Line Items]
Net shortfall in cash rents				$ 16.5
Straight-line rent receivable				5.3	$ 5.3
Annual lease rate				$ 58.5
Senior Care Centers | Subsequent Event
Real Estate Properties [Line Items]
Portion of settlement applied to post-petition rent	$ 5.7
Senior Care Centers | Forecast | Minimum
Real Estate Properties [Line Items]
Impairment charge			$ 60.1
Senior Care Centers | Forecast | Maximum
Real Estate Properties [Line Items]
Impairment charge			$ 76
Skilled Nursing/Transitional Care | Senior Care Centers Sale Facilities
Real Estate Properties [Line Items]
Number of properties to be sold | Facilitiy							36
Skilled Nursing/Transitional Care | Senior Care Centers Sale Facilities | Subsequent Event
Real Estate Properties [Line Items]
Number of properties to be sold | Facilitiy						26
Number of properties to be retained | Facilitiy						10
Senior Housing Communities | Senior Care Centers Sale Facilities
Real Estate Properties [Line Items]
Number of properties to be sold | Facilitiy							2
Senior Housing Communities | Senior Care Centers Sale Facilities | Subsequent Event
Real Estate Properties [Line Items]
Number of properties to be sold | Facilitiy						2
Operating Segments
Real Estate Properties [Line Items]
Number of properties | Facilitiy				470	470				507
Operating Segments | Senior Housing - Managed
Real Estate Properties [Line Items]
Number of properties | Facilitiy				23	23				13

REAL ESTATE PROPERTIES HELD F_5

REAL ESTATE PROPERTIES HELD FOR INVESTMENT - Future Minimum Rental Payments from Non-Cancelable Operating Leases (Details) $ in Thousands	Dec. 31, 2018USD ($)
Future Minimum Rental Payments Receivable
2,019	$ 465,766
2,020	456,207
2,021	452,346
2,022	454,216
2,023	437,277
Thereafter	2,407,064
Total	$ 4,672,876

IMPAIRMENT OF REAL ESTATE AND_2

IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)Facilitiy	Dec. 31, 2017USD ($)Facilitiy	Dec. 31, 2016USD ($)Facilitiy
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Impairment losses on real estate investments	$ 1,413	$ 1,326	$ 29,811
2018 Dispositions | Disposed by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate consideration received	382,600
Carrying value of assets and liabilities received	254,400
Gain (loss) on sale	128,200
Net income (loss) on discontinued operations	23,600	47,100	39,400
2018 Dispositions | Disposed by Sale | Skilled Nursing/Transitional Care
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Impairment losses on real estate investments	$ 900
Number of properties with impairment | Facilitiy	1
Number of properties sold | Facilitiy	51
2018 Dispositions | Disposed by Sale | Senior Housing Communities
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Impairment losses on real estate investments	$ 500
Number of properties with impairment | Facilitiy	1
Number of properties sold | Facilitiy	6
2018 Dispositions | Disposed by Sale | Senior Housing - Managed
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties sold | Facilitiy	1
2017 Dispositions | Disposed by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate consideration received		150,200
Carrying value of assets and liabilities received		98,200
Gain (loss) on sale		52,000
Net income (loss) on discontinued operations		$ 12,600	15,200
2017 Dispositions | Disposed by Sale | Skilled Nursing/Transitional Care
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties with impairment | Facilitiy		1
Number of properties sold | Facilitiy		31
2017 Dispositions | Disposed by Sale | Senior Housing Communities
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties sold | Facilitiy		1
2016 Dispositions | Disposed by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Aggregate consideration received			98,000
Carrying value of assets and liabilities received			104,100
Gain (loss) on sale			$ (6,100)
2016 Dispositions | Disposed by Sale | Skilled Nursing/Transitional Care
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties sold | Facilitiy			4
2016 Dispositions | Disposed by Sale | Acute Care Hospitals
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties sold | Facilitiy			1
2016 Dispositions | Disposed by Sale | Land
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties sold | Facilitiy			1
2016 Dispositions | Disposed by Sale | Senior Nursing Facilities and Land
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net income (loss) on discontinued operations			$ 700

INTANGIBLE ASSETS AND LIABILI_3

INTANGIBLE ASSETS AND LIABILITIES - Summary of Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Lease Intangible Assets:
Gross lease intangible assets	$ 161,831	$ 180,215
Accumulated amortization	(30,734)	(13,096)
Lease intangible assets, net	131,097	167,119
Lease Intangible Liabilities:
Below market leases	102,098	102,643
Accumulated amortization	(18,372)	(4,628)
Lease intangible liabilities, net	83,726	98,015
Above market leases
Lease Intangible Assets:
Gross lease intangible assets	61,572	76,443
Tenant origination and absorption costs
Lease Intangible Assets:
Gross lease intangible assets	73,323	76,336
Tenant relationship
Lease Intangible Assets:
Gross lease intangible assets	$ 26,936	$ 27,436

INTANGIBLE ASSETS AND LIABILI_4

INTANGIBLE ASSETS AND LIABILITIES - Summary of Real Estate Intangible Amortization (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Finite-Lived Intangible Assets
(Decrease) increase to rental income related to above/below market leases, net	$ 7,701	$ (912)	$ 0
(Decrease) increase to rental income related to above/below market leases, net
Finite-Lived Intangible Assets
(Decrease) increase to rental income related to above/below market leases, net	7,701	(912)	0
Depreciation and amortization related to tenant origination and absorption costs and tenant relationship
Finite-Lived Intangible Assets
Depreciation and amortization related to tenant origination and absorption costs and tenant relationship	$ (16,118)	$ (11,822)	$ (3,182)

INTANGIBLE ASSETS AND LIABILI_5

INTANGIBLE ASSETS AND LIABILITIES - Remaining Unamortized Balance for Outstanding Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets
Lease intangible assets, net	$ 131,097	$ 167,119
Lease Intangible Assets
Finite-Lived Intangible Assets
2,019	21,367
2,020	17,822
2,021	15,363
2,022	14,427
2,023	11,317
Thereafter	50,801
Lease intangible assets, net	$ 131,097
Lease Intangible Assets | Weighted Average
Finite-Lived Intangible Assets
Weighted-average remaining amortization period	8 years 11 months
Lease Intangible Liabilities
Finite-Lived Intangible Assets
2,019	$ 13,779
2,020	12,221
2,021	8,012
2,022	7,269
2,023	7,269
Thereafter	35,176
Lease intangible assets, net	$ 83,726
Lease Intangible Liabilities | Weighted Average
Finite-Lived Intangible Assets
Weighted-average remaining amortization period	9 years 3 months

LOANS RECEIVABLE AND OTHER IN_3

LOANS RECEIVABLE AND OTHER INVESTMENTS - Loans Receivable and Other Investments (Details)	Dec. 31, 2018USD ($)Investment	Dec. 31, 2017USD ($)
Loans Receivable:
Quantity | Investment	22
Principal Balance	$ 96,492,000
Book Value	$ 70,718,000	$ 66,004,000
Weighted Average Contractual Interest Rate / Rate of Return	8.50%
Weighted Average Annualized Effective Interest Rate / Rate of Return	9.70%
Loan loss reserve	$ (1,258,000)	(97,000)
Loans Receivable, Net Amount	$ 69,460,000	65,907,000
Preferred Equity
Quantity | Investment	9
Principal Balance	$ 43,851,000	48,035,000
Book Value	$ 44,262,000	48,483,000
Weighted Average Contractual Interest Rate / Rate of Return	12.10%
Weighted Average Annualized Effective Interest Rate / Rate of Return	12.10%
Total Quantity | Investment	31
Total Principal Balance	$ 140,343,000
Total Book Value	$ 113,722,000	114,390,000
Total Weighted Average Contractual Interest Rate / Rate of Return	9.60%
Total Weighted Average Annualized Effective Interest Rate / Rate of Return	10.60%
Mortgage
Loans Receivable:
Quantity | Investment	1
Principal Balance	$ 18,577,000
Book Value	$ 18,577,000	12,351,000
Weighted Average Contractual Interest Rate / Rate of Return	10.00%
Weighted Average Annualized Effective Interest Rate / Rate of Return	10.00%
Construction
Loans Receivable:
Quantity | Investment	2
Principal Balance	$ 4,569,000
Book Value	$ 4,629,000	2,733,000
Weighted Average Contractual Interest Rate / Rate of Return	8.00%
Weighted Average Annualized Effective Interest Rate / Rate of Return	7.70%
Mezzanine
Loans Receivable:
Quantity | Investment	1
Principal Balance	$ 23,952,000
Book Value	$ 2,188,000	10,239,000
Weighted Average Contractual Interest Rate / Rate of Return	10.00%
Weighted Average Annualized Effective Interest Rate / Rate of Return	41.90%
Pre-development
Loans Receivable:
Quantity | Investment	0
Principal Balance	$ 0
Book Value	$ 0	2,357,000
Other
Loans Receivable:
Quantity | Investment	18
Principal Balance	$ 49,394,000
Book Value	$ 45,324,000	$ 38,324,000
Weighted Average Contractual Interest Rate / Rate of Return	7.30%
Weighted Average Annualized Effective Interest Rate / Rate of Return	8.10%

LOANS RECEIVABLE AND OTHER IN_4

LOANS RECEIVABLE AND OTHER INVESTMENTS - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)Investmentloan	Dec. 31, 2017USD ($)loan	Aug. 17, 2017USD ($)loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of loans | Investment	22
Book value of loans	$ 96,492
Loan loss reserve	1,258	$ 97
Principal balance of impaired loan	$ 1,300	$ 1,400
Loan receivable investment with recognized interest income | loan	1
Book value of loan receivable investment with recognized interest income	$ 4,300
Nonperforming Financial Instruments
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of loans | loan	1	0
Provision for loan losses	$ 700	$ 4,800
Number of loans with provisions recorded | loan		2
Number of loans on nonaccrual status | loan	2	1
Value of loans on nonaccrual status	$ 1,300	$ 0
Portfolio-Based Loan Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Decrease in provision	500	300
Loan loss reserve	600	100
Specific Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loan loss reserve	$ 700	0
Care Capital Properties
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of loans | loan			18
Book value of loans			$ 83,300
Fair value of loans receivable			$ 58,200
Care Capital Properties | Receivables Acquired with Deteriorated Credit Quality
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of loans | loan			8
Book value of loans			$ 36,300
Fair value of loans receivable			11,300
Accretable yield			$ 3,500
Number of loans with deteriorated credit quality repaid | loan	1
Outstanding principal balance	$ 4,200	$ 10,000

LOANS RECEIVABLE AND OTHER IN_5

LOANS RECEIVABLE AND OTHER INVESTMENTS - Changes in Accretable Yield (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Accretable Yield Movement Schedule [Roll Forward]
Accretable yield, beginning of period	$ 2,483	$ 0
Additions	0	3,481
Accretion recognized in earnings	(2,761)	(998)
Net reclassification from nonaccretable difference	727	0
Accretable yield, end of period	$ 449	$ 2,483

DEBT - Secured Debt (Details)

DEBT - Secured Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Deferred financing costs, net	$ 15,661
Secured Debt
Debt Instrument [Line Items]
Principal	$ 117,464	$ 259,202
Weighted average effective interest rate	3.66%
Deferred financing costs, net	$ 1,785	2,800
Secured Debt | Fixed Rate
Debt Instrument [Line Items]
Principal, fixed rate	$ 117,464	160,702
Weighted average effective interest rate	3.66%
Secured Debt | Variable Rate
Debt Instrument [Line Items]
Principal, variable rate	$ 0	$ 98,500

DEBT - Narrative (Details)

DEBT - Narrative (Details)

Aug. 17, 2017USD ($)

Dec. 31, 2018USD ($)instrumentextension_option

Dec. 31, 2018USD ($)instrumentextension_option

Dec. 31, 2017USD ($)

Dec. 31, 2016USD ($)

Aug. 17, 2017CAD ($)

Aug. 10, 2016USD ($)agreement

Aug. 10, 2016CAD ($)agreement

Jun. 10, 2015CAD ($)

Oct. 10, 2014USD ($)

Jan. 23, 2014USD ($)

May 23, 2013USD ($)

Debt Instrument [Line Items]

Loss on extinguishment of debt

$ 2,917,000

$ 553,000

$ 556,000

Repayments of fixed rate secured debt

140,338,000

4,145,000

14,768,000

Long-term debt

$ 3,233,164,000

3,233,164,000

Interest expense

147,106,000

88,440,000

64,873,000

Non-cash interest expense

10,137,000

7,776,000

$ 5,678,000

Interest payable

$ 24,000,000

$ 24,000,000

24,700,000

Care Capital Properties | Interest Rate Swap

Debt Instrument [Line Items]

Derivative instruments | instrument

8

8

5.5% Senior Unsecured Notes due 2021

Debt Instrument [Line Items]

Interest rate

5.50%

5.50%

5.50%

5.5% Senior Unsecured Notes due 2021, Issued January 2014

Debt Instrument [Line Items]

Debt amount

$ 350,000,000

Interest rate

5.50%

5.5% Senior Unsecured Notes due 2021, Issued October 2014

Debt Instrument [Line Items]

Debt amount

$ 150,000,000

Interest rate

5.50%

5.375% Senior Unsecured Notes Due 2023

Debt Instrument [Line Items]

Debt amount

$ 200,000,000

Interest rate

5.375%

5.375%

5.375%

Senior Unsecured Notes Due 2026

Debt Instrument [Line Items]

Debt amount

$ 500,000,000

Interest rate

5.125%

5.125%

5.125%

5.125%

Required ratio of total unencumbered assets to unsecured debt

150.00%

Senior Unsecured Notes Due 2027

Debt Instrument [Line Items]

Debt amount

$ 100,000,000

Interest rate

5.38%

5.38%

5.38%

5.38%

Senior Unsecured Notes due 2021 and 2023

Debt Instrument [Line Items]

Maximum percentage of cumulative Adjusted Funds from Operations permitted to be distributed

95.00%

Required ratio of total unencumbered assets to unsecured debt

150.00%

Prior Revolving Credit Facility

Debt Instrument [Line Items]

Loss on extinguishment of debt

600,000

Prior Revolving Credit Facility | Revolving Credit Facility

Debt Instrument [Line Items]

Available borrowing capacity

$ 376,000,000

$ 376,000,000

Prior Revolving Credit Facility | Revolving Credit Facility | LIBOR

Debt Instrument [Line Items]

Basis spread on variable rate

1.00%

Prior Revolving Credit Facility | Revolving Credit Facility | Federal Funds Rate

Debt Instrument [Line Items]

Basis spread on variable rate

0.50%

Fourth Amended and Restated Credit Agreement | Revolving Credit Facility

Debt Instrument [Line Items]

Borrowing capacity (up to)

$ 1,000,000,000

Borrowing capacity in certain foreign currencies (up to)

$ 175,000,000

Number of optional extensions | extension_option

2

2

Optional extension period

6 months

Interest rate

3.75%

3.75%

Fourth Amended and Restated Credit Agreement | Revolving Credit Facility | Minimum

Debt Instrument [Line Items]

Annum percent unused borrowing fee

0.125%

Fourth Amended and Restated Credit Agreement | Revolving Credit Facility | Maximum

Debt Instrument [Line Items]

Annum percent unused borrowing fee

0.30%

Fourth Amended and Restated Credit Agreement | Revolving Credit Facility | LIBOR | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

0.875%

Fourth Amended and Restated Credit Agreement | Revolving Credit Facility | LIBOR | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

1.65%

Fourth Amended and Restated Credit Agreement | Revolving Credit Facility | Base Rate | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

0.00%

Fourth Amended and Restated Credit Agreement | Revolving Credit Facility | Base Rate | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

0.65%

Fourth Amended and Restated Credit Agreement | Line of Credit

Debt Instrument [Line Items]

Borrowing capacity (up to)

$ 2,500,000,000

U.S. Dollar Term Loan

Debt Instrument [Line Items]

Debt amount

$ 245,000,000

U.S. Dollar Term Loan | LIBOR | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

0.90%

U.S. Dollar Term Loan | LIBOR | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

1.90%

U.S. Dollar Term Loan | Base Rate | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

0.00%

U.S. Dollar Term Loan | Base Rate | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

0.90%

U.S. Dollar Term Loan | CDOR | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

0.90%

U.S. Dollar Term Loan | CDOR | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

1.90%

U.S. Dollar Term Loan | Interest Rate Swap

Debt Instrument [Line Items]

Interest rate swap, fixed

0.90%

0.90%

Derivative instruments | agreement

2

2

U.S. Dollar Term Loan | Redemption Period One

Debt Instrument [Line Items]

Debt amount

$ 1,100,000,000

U.S. Dollar Term Loan | Redemption Period Two

Debt Instrument [Line Items]

Debt amount

200,000,000

U.S. Dollar Term Loan | Care Capital Properties

Debt Instrument [Line Items]

Debt amount

$ 600,000,000

$ 600,000,000

Canadian Term Loan

Debt Instrument [Line Items]

Debt amount

$ 125,000,000

$ 35,000,000

Canadian Term Loan | Interest Rate Swap

Debt Instrument [Line Items]

Interest rate swap, fixed

1.31%

1.31%

0.93%

0.93%

Derivative instruments | agreement

1

1

Prior Canadian Term Loan

Debt Instrument [Line Items]

Debt amount

$ 90,000,000

Interest rate swap, fixed

1.59%

Secured Indebtedness

Debt Instrument [Line Items]

Debt amount

$ 117,464,000

$ 117,464,000

$ 259,202,000

Loss on extinguishment of debt

900,000

Repayments of fixed rate secured debt

37,600,000

Long-term debt

117,464,000

117,464,000

Secured Indebtedness | Variable Rate Secured Term Loan | Care Capital Properties

Debt Instrument [Line Items]

Debt amount

$ 98,500,000

Loss on extinguishment of debt

2,000,000

Secured Indebtedness | Variable Rate Secured Term Loan | Care Capital Properties | LIBOR

Debt Instrument [Line Items]

Basis spread on variable rate

1.80%

Line of Credit

Debt Instrument [Line Items]

Long-term debt

$ 624,000,000

$ 624,000,000

DEBT - Senior Unsecured Notes (

DEBT - Senior Unsecured Notes (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017	Aug. 17, 2017	Jan. 23, 2014	May 23, 2013
Debt Instrument [Line Items]
Principal Balance	$ 1,300,000,000	$ 1,300,000,000
Deferred financing costs, net	15,661,000
5.5% Senior Unsecured Notes due 2021
Debt Instrument [Line Items]
Principal Balance	$ 500,000,000	500,000,000
Interest rate	5.50%			5.50%
5.375% Senior Unsecured Notes Due 2023
Debt Instrument [Line Items]
Principal Balance	$ 200,000,000	200,000,000
Interest rate	5.375%				5.375%
Senior Unsecured Notes Due 2026
Debt Instrument [Line Items]
Principal Balance	$ 500,000,000	500,000,000
Interest rate	5.125%		5.125%
Senior Unsecured Notes Due 2027
Debt Instrument [Line Items]
Principal Balance	$ 100,000,000	100,000,000
Interest rate	5.38%		5.38%
Senior Notes
Debt Instrument [Line Items]
Premium, net	$ 14,500,000	15,900,000
Deferred financing costs, net	$ 7,106,000	$ 9,600,000

DEBT - Schedule of Maturities o

DEBT - Schedule of Maturities of Debt (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)extension_option	Dec. 31, 2017USD ($)
Debt Instrument [Line Items]
2,019	$ 3,421
2,020	203,530
2,021	1,142,130
2,022	994,885
2,023	203,282
Thereafter	685,916
Total Debt	3,233,164
Premium, net	14,500
Deferred financing costs, net	(15,661)
Total Debt, Net	3,232,003
Secured Indebtedness
Debt Instrument [Line Items]
2,019	3,421
2,020	3,530
2,021	18,130
2,022	3,185
2,023	3,282
Thereafter	85,916
Total Debt	117,464
Premium, net	0
Deferred financing costs, net	(1,785)	$ (2,800)
Total Debt, Net	115,679
Revolving Credit Facility
Debt Instrument [Line Items]
2,019	0
2,020	0
2,021	624,000
2,022	0
2,023	0
Thereafter	0
Total Debt	624,000
Premium, net	0
Deferred financing costs, net	0
Total Debt, Net	624,000
Term Loans
Debt Instrument [Line Items]
2,019	0
2,020	200,000
2,021	0
2,022	991,700
2,023	0
Thereafter	0
Total Debt	1,191,700
Premium, net	0
Deferred financing costs, net	(6,770)
Total Debt, Net	1,184,930
Senior Notes
Debt Instrument [Line Items]
2,019	0
2,020	0
2,021	500,000
2,022	0
2,023	200,000
Thereafter	600,000
Total Debt	1,300,000
Premium, net	14,500
Deferred financing costs, net	(7,106)	$ (9,600)
Total Debt, Net	$ 1,307,394
Fourth Amended and Restated Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Optional extension period	6 months
Number of optional extensions | extension_option	2

DERIVATIVE AND HEDGING INSTRU_3

DERIVATIVE AND HEDGING INSTRUMENTS - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Derivative [Line Items]
Interest	$ 147,106,000	$ 88,440,000	$ 64,873,000
Fair value of derivatives in a net liability position	4,529,000	0
Credit-Risk-Related Contingent Features
Derivative [Line Items]
Fair value of derivatives in a net liability position	2,500,000
Termination value	2,500,000
Cash Flow Hedges | Interest Rate Swap
Derivative [Line Items]
Hedge ineffectiveness recorded in earnings	0	22,000	$ 800,000
Designated as Hedging Instrument
Derivative [Line Items]
Fair value of derivatives in a net liability position	96,229,000	99,588,000
Designated as Hedging Instrument | Cash Flow Hedges
Derivative [Line Items]
Losses included in accumulated other comprehensive loss which are expected to be reclassified into earnings in the next 12 months	8,400,000
Not Designated as Hedging Instrument | Cross Currency Interest Rate Swaps
Derivative [Line Items]
Fair value of derivative asset	67,000
Other expense	$ 34,000	$ 8,000

DERIVATIVE AND HEDGING INSTRU_4

DERIVATIVE AND HEDGING INSTRUMENTS - Notional Amounts of Derivative Instruments (Details)	12 Months Ended
	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2018CAD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2017CAD ($)
Forecast
Derivative [Line Items]
Issuance of debt	$ 200,000,000
Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swaps
Derivative [Line Items]
Notional amount		$ 1,045,000,000	$ 125,000,000	$ 845,000,000	$ 125,000,000
Net Investment Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swaps
Derivative [Line Items]
Notional amount			55,401,000		56,300,000
Notional amount			125,000,000		125,000,000
Net Investment Hedges | Not Designated as Hedging Instrument | Cross Currency Interest Rate Swaps
Derivative [Line Items]
Notional amount			$ 899,000		$ 0

DERIVATIVE AND HEDGING INSTRU_5

DERIVATIVE AND HEDGING INSTRUMENTS - Summary of Derivative and Financial Instruments Designated as Hedging Instruments (Details) $ in Thousands	Dec. 31, 2018USD ($)instrument	Dec. 31, 2017USD ($)
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	$ 29,344	$ 25,895
Derivative liability, fair value	4,529	0
Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	29,344	25,895
Derivative liability, fair value	$ 96,229	99,588
Designated as Hedging Instrument | Interest rate swap | Cash Flow | Accounts receivable, prepaid expenses and other assets, net
Derivatives, Fair Value [Line Items]
Derivative asset, count | instrument	12
Derivative asset, fair value	$ 25,184	25,221
Designated as Hedging Instrument | Interest rate swap | Cash Flow | Accounts payable and accrued liabilities
Derivatives, Fair Value [Line Items]
Derivative liability, count | instrument	2
Derivative liability, fair value	$ 4,529	0
Designated as Hedging Instrument | Cross currency interest rate swaps | Net Investment | Accounts receivable, prepaid expenses and other assets, net
Derivatives, Fair Value [Line Items]
Derivative asset, count | instrument	2
Derivative asset, fair value	$ 4,160	674
Designated as Hedging Instrument | CAD term loan | Net Investment | Term loans, net
Derivatives, Fair Value [Line Items]
Derivative liability, count | instrument	1
Derivative liability, fair value	$ 91,700	$ 99,588

DERIVATIVE AND HEDGING INSTRU_6

DERIVATIVE AND HEDGING INSTRUMENTS - Effect of Derivatives and Financial Instruments Designated as Hedging Instruments on Income and Equity (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income	[1]	$ 292
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income		3,099	$ (2,174)	$ (1,360)
Interest rate products
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income		3,099
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income			(2,174)	(1,360)
Foreign currency products
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income		0	0	0
CAD term loan
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income		0	0	0
Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Recognized in Other Comprehensive Income		14,149	1,841	44
Designated as Hedging Instrument | Interest rate products | Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Recognized in Other Comprehensive Income		2,707	10,807	5,879
Designated as Hedging Instrument | Foreign currency products
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Recognized in Other Comprehensive Income		3,554	(2,378)	(2,085)
Designated as Hedging Instrument | CAD term loan
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Recognized in Other Comprehensive Income		$ 7,888	$ (6,588)	$ (3,750)
[1]	Amounts are net of income tax benefit of $48,000 and expense of $0.1 million for the years ended December 31, 2018 and 2017, respectively, and none for the year ended December 31, 2016.

DERIVATIVE AND HEDGING INSTRU_7

DERIVATIVE AND HEDGING INSTRUMENTS - Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Offsetting Assets:
Gross Amounts of Recognized Assets / Liabilities	$ 29,344	$ 25,895
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts of Assets / Liabilities presented in the Balance Sheet	29,344	25,895
Financial Instruments	(2,069)	0
Cash Collateral Received	0	0
Net Amount	27,275	25,895
Offsetting Liabilities:
Gross Amounts of Recognized Assets / Liabilities	4,529	0
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts of Assets / Liabilities presented in the Balance Sheet	4,529	0
Financial Instruments	(2,069)	0
Cash Collateral Received	0	0
Net Amount	$ 2,460	$ 0

FAIR VALUE DISCLOSURES - Face V

FAIR VALUE DISCLOSURES - Face Values, Carrying Amounts and Fair Values of Financial Instruments (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable, face value	$ 96,492,000	$ 91,280,000
Preferred equity investments, face value	43,851,000	48,035,000
Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities, face value	1,300,000,000	1,300,000,000
Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities, face value	117,464,000	259,202,000
Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	69,460,000	65,907,000
Preferred equity investments	44,262,000	48,483,000
Carrying Amount | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,307,394,000	1,306,286,000
Carrying Amount | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	115,679,000	256,430,000
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	65,797,000	65,892,000
Preferred equity investments	43,825,000	47,064,000
Fair Value | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,270,877,000	1,329,191,000
Fair Value | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	$ 101,820,000	$ 246,461,000

FAIR VALUE DISCLOSURES - Inputs

FAIR VALUE DISCLOSURES - Inputs Used for Valuation of Financial Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Total
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	$ 65,797	$ 65,892
Preferred equity investments	43,825	47,064
Total | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,270,877	1,329,191
Total | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	101,820	$ 246,461
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	0
Preferred equity investments	0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	0
Preferred equity investments	0
Recurring | Significant Other Observable Inputs (Level 2) | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,270,877
Recurring | Significant Other Observable Inputs (Level 2) | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	65,797
Preferred equity investments	43,825
Recurring | Significant Unobservable Inputs (Level 3) | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Significant Unobservable Inputs (Level 3) | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	101,820
Recurring | Total
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	65,797
Preferred equity investments	43,825
Recurring | Total | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,270,877
Recurring | Total | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	$ 101,820

FAIR VALUE DISCLOSURES - Amount

FAIR VALUE DISCLOSURES - Amounts Measured at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	$ 29,344	$ 25,895
Financial liabilities	4,529	$ 0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Interest Rate Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Financial liabilities	0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Cross Currency Swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Recurring | Significant Other Observable Inputs (Level 2) | Interest Rate Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	25,184
Financial liabilities	4,529
Recurring | Significant Other Observable Inputs (Level 2) | Cross Currency Swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	4,160
Recurring | Significant Unobservable Inputs (Level 3) | Interest Rate Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Financial liabilities	0
Recurring | Significant Unobservable Inputs (Level 3) | Cross Currency Swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Recurring | Total | Interest Rate Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	25,184
Financial liabilities	4,529
Recurring | Total | Cross Currency Swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	$ 4,160

EQUITY - Narrative (Details)

EQUITY - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	Jun. 01, 2018	Oct. 02, 2017	Sep. 28, 2017	Aug. 17, 2017	Mar. 21, 2013	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Class of Stock [Line Items]
Shares of preferred stock issued (in shares)					5,750,000		5,750,000
Preferred stock dividend rate					7.125%
Redemption price per share (in dollars per share)	$ 25				$ 25
Net proceeds from issuance of preferred stock					$ 138,300
Accrued and unpaid dividends (in dollars per share)	0.4453125
Redemption price per share (in dollars per share)	$ 25.4453125
Charge related to original issuance costs						$ 143,750
Vesting of common stock units (in shares)						100,000	300,000
Tax withholding obligations						$ 400	$ 3,100	$ 1,500
Public Stock Offering
Class of Stock [Line Items]
Shares of common stock issued (in shares)		18,400,000	16,000,000
Consideration received		$ 370,900
Common stock share price (in dollars per share)		$ 21
Over-Allotment Option
Class of Stock [Line Items]
Shares of common stock issued (in shares)		2,400,000
Care Capital Properties
Class of Stock [Line Items]
Shares of common stock issued in merger (in shares)				94,000,000
Preferred Stock
Class of Stock [Line Items]
Shares redeemed (in shares)	5,750,000					5,750,000
Charge related to original issuance costs						$ 58
Cumulative Distributions in Excess of Net Income
Class of Stock [Line Items]
Charge related to original issuance costs						$ 5,501

EQUITY - Summary of Accumulated

EQUITY - Summary of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	$ 3,254,747	$ 3,437,249	$ 1,015,609	$ 1,053,876
Total accumulated other comprehensive loss [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	12,301	11,289	$ (1,798)	$ (7,333)
Foreign currency translation loss
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	(2,193)	(2,913)
Unrealized gains on cash flow hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	$ 14,494
Unrealized gains on cash flow hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity		$ 14,202

STOCK-BASED COMPENSATION - Narr

STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding (in shares)			0
Total fair value of units vested	$ 3,600,000	$ 8,400,000	$ 4,700,000
Stock-based compensation expense	7,648,000	8,359,000	7,496,000
Total unrecognized stock-based compensation expense	$ 19,300,000
Weighted average period to recognized stock-based compensation expense	2 years 6 months
Discretionary matching contribution percent	3.00%
Matching contributions	$ 171,000	143,000	73,000
General and Administrative Expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 7,600,000	$ 7,000,000	$ 7,500,000
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average remaining vesting period	2 years 6 months
Weighted average fair value per share (in dollars per share)	$ 16.02	$ 19.38	$ 22.05
FFO Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0.00%
FFO Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	250.00%
TSR Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Historical volatility rate period	3 years
TSR Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0.00%
TSR Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	200.00%
Performance Incentive Plan of 2009 | Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock convertible upon each performance-based restricted stock unit vesting (in shares)	1
Performance Incentive Plan of 2009 | Restricted Stock Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Performance Incentive Plan of 2009 | Restricted Stock Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	5 years
Care Capital Properties
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding (in shares)	1,200,000	1,700,000
Exercise price range, minimum (in dollars per share)	$ 24.24
Exercise price range, maximum (in dollars per share)	34.09
Weighted average exercise price (in dollars per share)	$ 28.04	$ 27.92
Stock options exercised (in shares)	0
Stock options expired (in shares)	500,000
Aggregate intrinsic value	$ 0
Care Capital Properties | General and Administrative Expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 1,400,000

STOCK-BASED COMPENSATION - Summ

STOCK-BASED COMPENSATION - Summary of Additional Information Concerning Restricted Stock Units (Details) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Restricted Stock Units Activity
Vested (in shares)	(100,000)	(300,000)
Restricted Stock Units
Restricted Stock Units Activity
Unvested beginning balance (in shares)	1,125,487
Granted (in shares)	601,696
Vested (in shares)	(170,951)
Dividends reinvested (in shares)	118,797
Cancelled (in shares)	(197,711)
Unvested ending balance (in shares)	1,477,318	1,125,487
Weighted Average Grant Date Fair Value Per Unit
Unvested beginning balance (in dollars per share)	$ 19.71
Granted (in dollars per share)	16.02	$ 19.38	$ 22.05
Vested (in dollars per share)	21.35
Dividends reinvested (in dollars per share)	19.06
Cancelled (in dollars per share)	20.34
Unvested ending balance (in dollars per share)	$ 17.88	$ 19.71

STOCK-BASED COMPENSATION - Su_2

STOCK-BASED COMPENSATION - Summary of Assumptions Used in Total Stockholder Return-Based Stock Units Valuation (Details) - TSR Units	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Assumptions used in fair value valuation
Expected dividend yield (assuming full reinvestment)	0.00%	0.00%	0.00%
Minimum
Assumptions used in fair value valuation
Risk free interest rate	1.42%	1.42%	0.78%
Expected stock price volatility	28.86%	28.86%	27.40%
Expected service period	2 years 6 months	2 years 2 months 12 days	2 years 3 months 18 days
Maximum
Assumptions used in fair value valuation
Risk free interest rate	1.99%	1.99%	1.60%
Expected stock price volatility	30.97%	30.97%	28.42%
Expected service period	3 years	3 years	3 years

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Business Acquisition [Line Items]
Income tax benefit	$ (3,011)	$ (651)	$ (1,049)
Acquisitions in Canada | Foreign Tax Authority | Canada Revenue Agency
Business Acquisition [Line Items]
Income tax benefit	600	1,300	700
Valuation allowance	$ 700	$ 1,200	$ 700

INCOME TAXES - Reconciliation o

INCOME TAXES - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Reconciliation of Unrecognized Tax Benefits
Unrecognized tax benefits, beginning balance	$ 0	$ 0	$ 24,212
Additions (reductions) based on prior years’ tax positions	0	0	(24,212)
Additions (reductions) based on current year tax positions	0	0	0
Unrecognized tax benefits, ending balance	$ 0	$ 0	$ 0

EARNINGS PER COMMON SHARE - Com

EARNINGS PER COMMON SHARE - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Numerator
Net income attributable to common stockholders	$ 269,314	$ 148,141	$ 60,034
Denominator
Basic weighted average common shares and common equivalents (in shares)	178,305,738	105,621,242	65,284,251
Dilutive stock options and restricted stock units (in shares)	416,006	221,192	236,421
Dilutive weighted average common shares (in shares)	178,721,744	105,842,434	65,520,672
Net income attributable to common stockholders, per:
Basic common share (in dollars per share)	$ 1.51	$ 1.40	$ 0.92
Diluted common share (in dollars per share)	$ 1.51	$ 1.40	$ 0.92

EARNINGS PER COMMON SHARE - Nar

EARNINGS PER COMMON SHARE - Narrative (Details) - shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share
Stock options outstanding (in shares)			0
Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share
Anti-dilutive shares excluded from the computation of earnings per share (in shares)	121,000	132,000	128,000
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share
Anti-dilutive shares excluded from the computation of earnings per share (in shares)	0	0

SUMMARIZED CONSOLIDATING INFO_3

SUMMARIZED CONSOLIDATING INFORMATION - Consolidating Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Assets
Real estate investments, net of accumulated depreciation	$ 5,853,545	$ 5,994,432
Loans receivable and other investments, net	113,722	114,390
Investment in unconsolidated joint venture	340,120	0
Cash and cash equivalents	50,230	518,632
Restricted cash	9,428	68,817
Lease intangible assets, net	131,097	167,119
Accounts receivable, prepaid expenses and other assets, net	167,161	168,887
Intercompany	0	0
Investment in subsidiaries	0	0
Total assets	6,665,303	7,032,277
Liabilities
Secured debt, net	115,679	256,430
Revolving credit facility	624,000	641,000
Term loans, net	1,184,930	1,190,774
Senior unsecured notes, net	1,307,394	1,306,286
Accounts payable and accrued liabilities	94,827	102,523
Lease intangible liabilities, net	83,726	98,015
Intercompany	0	0
Total liabilities	3,410,556	3,595,028
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity	3,250,414	3,432,807
Noncontrolling interests	4,333	4,442
Total equity	3,254,747	3,437,249	$ 1,015,609	$ 1,053,876
Total liabilities and equity	6,665,303	7,032,277
Elimination
Assets
Real estate investments, net of accumulated depreciation	0	0
Loans receivable and other investments, net	0	0
Investment in unconsolidated joint venture	0
Cash and cash equivalents	0	0
Restricted cash	0	0
Lease intangible assets, net	0	0
Accounts receivable, prepaid expenses and other assets, net	(11,019)	(5,189)
Intercompany	(4,618,728)	(4,765,381)
Investment in subsidiaries	(2,921,593)	(2,103,428)
Total assets	(7,551,340)	(6,873,998)
Liabilities
Secured debt, net	0	0
Revolving credit facility	0	0
Term loans, net	0	0
Senior unsecured notes, net	0	0
Accounts payable and accrued liabilities	(11,019)	(5,189)
Lease intangible liabilities, net	0	0
Intercompany	(4,618,728)	(4,765,381)
Total liabilities	(4,629,747)	(4,770,570)
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity	(2,921,593)	(2,103,428)
Noncontrolling interests	0	0
Total equity	(2,921,593)	(2,103,428)
Total liabilities and equity	(7,551,340)	(6,873,998)
Parent Company | Reportable Legal Entities
Assets
Real estate investments, net of accumulated depreciation	317	324
Loans receivable and other investments, net	(560)	(97)
Investment in unconsolidated joint venture	0
Cash and cash equivalents	40,835	511,670
Restricted cash	0	0
Lease intangible assets, net	0	0
Accounts receivable, prepaid expenses and other assets, net	798	3,499
Intercompany	1,972,059	2,043,402
Investment in subsidiaries	1,258,715	890,462
Total assets	3,272,164	3,449,260
Liabilities
Secured debt, net	0	0
Revolving credit facility	0	0
Term loans, net	0	0
Senior unsecured notes, net	0	0
Accounts payable and accrued liabilities	21,750	16,453
Lease intangible liabilities, net	0	0
Intercompany	0	0
Total liabilities	21,750	16,453
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity	3,250,414	3,432,807
Noncontrolling interests	0	0
Total equity	3,250,414	3,432,807
Total liabilities and equity	3,272,164	3,449,260
Operating Partnership | Reportable Legal Entities
Assets
Real estate investments, net of accumulated depreciation	0	0
Loans receivable and other investments, net	0	0
Investment in unconsolidated joint venture	0
Cash and cash equivalents	0	0
Restricted cash	0	0
Lease intangible assets, net	0	0
Accounts receivable, prepaid expenses and other assets, net	37,075	36,073
Intercompany	2,646,669	2,721,979
Investment in subsidiaries	1,629,795	1,198,305
Total assets	4,313,539	3,956,357
Liabilities
Secured debt, net	0	0
Revolving credit facility	624,000	641,000
Term loans, net	1,094,177	1,092,397
Senior unsecured notes, net	1,307,394	1,306,286
Accounts payable and accrued liabilities	29,253	26,212
Lease intangible liabilities, net	0	0
Intercompany	0	0
Total liabilities	3,054,824	3,065,895
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity	1,258,715	890,462
Noncontrolling interests	0	0
Total equity	1,258,715	890,462
Total liabilities and equity	4,313,539	3,956,357
Sabra Capital Corporation | Reportable Legal Entities
Assets
Real estate investments, net of accumulated depreciation	0	0
Loans receivable and other investments, net	0	0
Investment in unconsolidated joint venture	0
Cash and cash equivalents	0	0
Restricted cash	0	0
Lease intangible assets, net	0	0
Accounts receivable, prepaid expenses and other assets, net	0	0
Intercompany	0	0
Investment in subsidiaries	0	0
Total assets	0	0
Liabilities
Secured debt, net	0	0
Revolving credit facility	0	0
Term loans, net	0	0
Senior unsecured notes, net	0	0
Accounts payable and accrued liabilities	0	0
Lease intangible liabilities, net	0	0
Intercompany	0	0
Total liabilities	0	0
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity	0	0
Noncontrolling interests	0	0
Total equity	0	0
Total liabilities and equity	0	0
Combined Guarantor Subsidiaries of 2021 Notes and 2023 Notes | Reportable Legal Entities
Assets
Real estate investments, net of accumulated depreciation	1,609,861	1,756,933
Loans receivable and other investments, net	50,534	55,297
Investment in unconsolidated joint venture	0
Cash and cash equivalents	3,508	449
Restricted cash	1,820	36,910
Lease intangible assets, net	15,892	17,577
Accounts receivable, prepaid expenses and other assets, net	58,710	80,739
Intercompany	0	0
Investment in subsidiaries	33,083	14,661
Total assets	1,773,408	1,962,566
Liabilities
Secured debt, net	0	0
Revolving credit facility	0	0
Term loans, net	90,753	98,377
Senior unsecured notes, net	0	0
Accounts payable and accrued liabilities	2,695	3,560
Lease intangible liabilities, net	0	0
Intercompany	399,912	785,120
Total liabilities	493,360	887,057
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity	1,280,048	1,075,509
Noncontrolling interests	0	0
Total equity	1,280,048	1,075,509
Total liabilities and equity	1,773,408	1,962,566
Combined Non-Guarantor Subsidiaries of 2021 Notes and 2023 Notes | Reportable Legal Entities
Assets
Real estate investments, net of accumulated depreciation	4,243,367	4,237,175
Loans receivable and other investments, net	63,748	59,190
Investment in unconsolidated joint venture	340,120
Cash and cash equivalents	5,887	6,513
Restricted cash	7,608	31,907
Lease intangible assets, net	115,205	149,542
Accounts receivable, prepaid expenses and other assets, net	81,597	53,765
Intercompany	0	0
Investment in subsidiaries	0	0
Total assets	4,857,532	4,538,092
Liabilities
Secured debt, net	115,679	256,430
Revolving credit facility	0	0
Term loans, net	0	0
Senior unsecured notes, net	0	0
Accounts payable and accrued liabilities	52,148	61,487
Lease intangible liabilities, net	83,726	98,015
Intercompany	4,218,816	3,980,261
Total liabilities	4,470,369	4,396,193
Equity
Total Sabra Health Care REIT, Inc. stockholders’ equity	382,830	137,457
Noncontrolling interests	4,333	4,442
Total equity	387,163	141,899
Total liabilities and equity	$ 4,857,532	$ 4,538,092

SUMMARIZED CONSOLIDATING INFO_4

SUMMARIZED CONSOLIDATING INFORMATION - Consolidating Statement of Income (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenues:
Rental income	$ 536,605	$ 364,191	$ 225,275
Interest and other income	16,667	15,026	27,463
Resident fees and services	70,137	26,430	7,788
Total revenues	623,409	405,647	260,526
Expenses:
Depreciation and amortization	191,379	113,882	68,472
Interest	147,106	88,440	64,873
Operating expenses	49,546	17,860	5,703
General and administrative	36,458	32,401	17,672
Merger and acquisition costs	636	30,255	1,197
Provision for doubtful accounts, straight-line rental income and loan losses	39,075	17,113	5,543
Impairment of real estate	1,413	1,326	29,811
Total expenses	465,613	301,277	193,271
Other income (expense):
Loss on extinguishment of debt	(2,917)	(553)	(556)
Other income	4,480	3,170	10,677
Net gain (loss) on sales of real estate	128,198	52,029	(6,122)
Total other income	129,761	54,646	3,999
Income in subsidiary	0	0	0
Income before loss from unconsolidated joint venture and income tax expense	287,557	159,016	71,254
Loss from unconsolidated joint venture	(5,431)	0	0
Income tax expense	(3,011)	(651)	(1,049)
Net income	279,115	158,365	70,205
Net income attributable to noncontrolling interests	(33)	18	71
Net income attributable to Sabra Health Care REIT, Inc.	279,082	158,383	70,276
Preferred stock dividends	(9,768)	(10,242)	(10,242)
Net income attributable to common stockholders	$ 269,314	$ 148,141	$ 60,034
Net income attributable to common stockholders, per:
Basic common share (in dollars per share)	$ 1.51	$ 1.40	$ 0.92
Diluted common share (in dollars per share)	$ 1.51	$ 1.40	$ 0.92
Weighted-average number of common shares outstanding, basic (in shares)	178,305,738	105,621,242	65,284,251
Weighted-average number of common shares outstanding, diluted (in shares)	178,721,744	105,842,434	65,520,672
Elimination
Revenues:
Rental income	$ (17,425)	$ (7,513)	$ (2,328)
Interest and other income	(399)	(161)	(253)
Resident fees and services	0	0	0
Total revenues	(17,824)	(7,674)	(2,581)
Expenses:
Depreciation and amortization	0	0	0
Interest	(399)	(143)	0
Operating expenses	(17,425)	(7,531)	(2,363)
General and administrative	0	0	0
Merger and acquisition costs	0	0	0
Provision for doubtful accounts, straight-line rental income and loan losses	0	0	0
Impairment of real estate	0	0	0
Total expenses	(17,824)	(7,674)	(2,363)
Other income (expense):
Loss on extinguishment of debt	0	0	0
Other income	0	0	0
Net gain (loss) on sales of real estate	0	0	0
Total other income	0	0	0
Income in subsidiary	(773,612)	(509,045)	(219,716)
Income before loss from unconsolidated joint venture and income tax expense	(773,612)	(509,045)	(219,934)
Loss from unconsolidated joint venture	0
Income tax expense	0	0	0
Net income	(773,612)	(509,045)	(219,934)
Net income attributable to noncontrolling interests	0	0	0
Net income attributable to Sabra Health Care REIT, Inc.	(773,612)	(509,045)	(219,934)
Preferred stock dividends	0	0	0
Net income attributable to common stockholders	(773,612)	(509,045)	(219,934)
Parent Company | Reportable Legal Entities
Revenues:
Rental income	0	0	0
Interest and other income	110	39	3
Resident fees and services	0	0	0
Total revenues	110	39	3
Expenses:
Depreciation and amortization	887	867	816
Interest	0	0	0
Operating expenses	0	0	0
General and administrative	26,801	24,810	15,798
Merger and acquisition costs	642	30,208	(7)
Provision for doubtful accounts, straight-line rental income and loan losses	822	227	(1,376)
Impairment of real estate	0	0	0
Total expenses	29,152	56,112	15,231
Other income (expense):
Loss on extinguishment of debt	0	0	0
Other income	1,977	2,634	7,366
Net gain (loss) on sales of real estate	0	0	0
Total other income	1,977	2,634	7,366
Income in subsidiary	307,736	212,432	78,783
Income before loss from unconsolidated joint venture and income tax expense	280,671	158,993	70,921
Loss from unconsolidated joint venture	0
Income tax expense	(1,589)	(610)	(427)
Net income	279,082	158,383	70,494
Net income attributable to noncontrolling interests	0	0	0
Net income attributable to Sabra Health Care REIT, Inc.	279,082	158,383	70,494
Preferred stock dividends	(9,768)	(10,242)	(10,242)
Net income attributable to common stockholders	269,314	148,141	60,252
Operating Partnership | Reportable Legal Entities
Revenues:
Rental income	0	0	0
Interest and other income	399	143	0
Resident fees and services	0	0	0
Total revenues	399	143	0
Expenses:
Depreciation and amortization	0	0	0
Interest	134,096	77,767	54,589
Operating expenses	0	0	0
General and administrative	71	65	56
Merger and acquisition costs	0	0	0
Provision for doubtful accounts, straight-line rental income and loan losses	0	0	0
Impairment of real estate	0	0	0
Total expenses	134,167	77,832	54,645
Other income (expense):
Loss on extinguishment of debt	0	(422)	(468)
Other income	(55)	1,130	(196)
Net gain (loss) on sales of real estate	0	0	0
Total other income	(55)	708	(664)
Income in subsidiary	441,560	289,414	134,093
Income before loss from unconsolidated joint venture and income tax expense	307,737	212,433	78,784
Loss from unconsolidated joint venture	0
Income tax expense	(1)	(1)	(1)
Net income	307,736	212,432	78,783
Net income attributable to noncontrolling interests	0	0	0
Net income attributable to Sabra Health Care REIT, Inc.	307,736	212,432	78,783
Preferred stock dividends	0	0	0
Net income attributable to common stockholders	307,736	212,432	78,783
Sabra Capital Corporation | Reportable Legal Entities
Revenues:
Rental income	0	0	0
Interest and other income	0	0	0
Resident fees and services	0	0	0
Total revenues	0	0	0
Expenses:
Depreciation and amortization	0	0	0
Interest	0	0	0
Operating expenses	0	0	0
General and administrative	0	0	0
Merger and acquisition costs	0	0	0
Provision for doubtful accounts, straight-line rental income and loan losses	0	0	0
Impairment of real estate	0	0	0
Total expenses	0	0	0
Other income (expense):
Loss on extinguishment of debt	0	0	0
Other income	0	0	0
Net gain (loss) on sales of real estate	0	0	0
Total other income	0	0	0
Income in subsidiary	0	0	0
Income before loss from unconsolidated joint venture and income tax expense	0	0	0
Loss from unconsolidated joint venture	0
Income tax expense	0	0	0
Net income	0	0	0
Net income attributable to noncontrolling interests	0	0	0
Net income attributable to Sabra Health Care REIT, Inc.	0	0	0
Preferred stock dividends	0	0	0
Net income attributable to common stockholders	0	0	0
Combined Guarantor Subsidiaries of 2021 Notes and 2023 Notes | Reportable Legal Entities
Revenues:
Rental income	170,400	213,162	206,897
Interest and other income	5,632	9,098	27,712
Resident fees and services	0	0	0
Total revenues	176,032	222,260	234,609
Expenses:
Depreciation and amortization	57,143	67,723	61,371
Interest	3,334	2,989	3,497
Operating expenses	0	0	0
General and administrative	2,078	3,854	1,652
Merger and acquisition costs	0	47	1,204
Provision for doubtful accounts, straight-line rental income and loan losses	30,710	16,886	6,498
Impairment of real estate	1,413	1,326	29,811
Total expenses	94,678	92,825	104,033
Other income (expense):
Loss on extinguishment of debt	0	(131)	(88)
Other income	990	(617)	3,507
Net gain (loss) on sales of real estate	108,697	54,627	(6,143)
Total other income	109,687	53,879	(2,724)
Income in subsidiary	24,316	7,199	6,840
Income before loss from unconsolidated joint venture and income tax expense	215,357	190,513	134,692
Loss from unconsolidated joint venture	0
Income tax expense	(1,114)	(139)	(538)
Net income	214,243	190,374	134,154
Net income attributable to noncontrolling interests	0	0	0
Net income attributable to Sabra Health Care REIT, Inc.	214,243	190,374	134,154
Preferred stock dividends	0	0	0
Net income attributable to common stockholders	214,243	190,374	134,154
Combined Non-Guarantor Subsidiaries of 2021 Notes and 2023 Notes | Reportable Legal Entities
Revenues:
Rental income	383,630	158,542	20,706
Interest and other income	10,925	5,907	1
Resident fees and services	70,137	26,430	7,788
Total revenues	464,692	190,879	28,495
Expenses:
Depreciation and amortization	133,349	45,292	6,285
Interest	10,075	7,827	6,787
Operating expenses	66,971	25,391	8,066
General and administrative	7,508	3,672	166
Merger and acquisition costs	(6)	0	0
Provision for doubtful accounts, straight-line rental income and loan losses	7,543	0	421
Impairment of real estate	0	0	0
Total expenses	225,440	82,182	21,725
Other income (expense):
Loss on extinguishment of debt	(2,917)	0	0
Other income	1,568	23	0
Net gain (loss) on sales of real estate	19,501	(2,598)	21
Total other income	18,152	(2,575)	21
Income in subsidiary	0	0	0
Income before loss from unconsolidated joint venture and income tax expense	257,404	106,122	6,791
Loss from unconsolidated joint venture	(5,431)
Income tax expense	(307)	99	(83)
Net income	251,666	106,221	6,708
Net income attributable to noncontrolling interests	(33)	18	71
Net income attributable to Sabra Health Care REIT, Inc.	251,633	106,239	6,779
Preferred stock dividends	0	0	0
Net income attributable to common stockholders	$ 251,633	$ 106,239	$ 6,779

SUMMARIZED CONSOLIDATING INFO_5

SUMMARIZED CONSOLIDATING INFORMATION - Consolidating Statement of Comprehensive Income (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Condensed Financial Statements, Captions [Line Items]
Net income		$ 279,115	$ 158,365	$ 70,205
Other comprehensive income:
Foreign currency translation gain (loss)		720	154	(1,634)
Unrealized gain on cash flow hedges	[1]	292
Unrealized gain on cash flow hedges	[1]		12,933	7,169
Total other comprehensive income		1,012	13,087	5,535
Comprehensive income		280,127	171,452	75,740
Comprehensive (income) loss attributable to noncontrolling interest		(33)	18	71
Comprehensive income attributable to Sabra Health Care REIT, Inc.		280,094	171,470	75,811
Elimination
Condensed Financial Statements, Captions [Line Items]
Net income		(773,612)	(509,045)	(219,934)
Other comprehensive income:
Foreign currency translation gain (loss)		0	0	0
Unrealized gain on cash flow hedges		0
Unrealized gain on cash flow hedges			0	0
Total other comprehensive income		0	0	0
Comprehensive income		(773,612)	(509,045)	(219,934)
Comprehensive (income) loss attributable to noncontrolling interest		0	0	0
Comprehensive income attributable to Sabra Health Care REIT, Inc.		(773,612)	(509,045)	(219,934)
Parent Company | Reportable Legal Entities
Condensed Financial Statements, Captions [Line Items]
Net income		279,082	158,383	70,494
Other comprehensive income:
Foreign currency translation gain (loss)		0	0	0
Unrealized gain on cash flow hedges		0
Unrealized gain on cash flow hedges			0	0
Total other comprehensive income		0	0	0
Comprehensive income		279,082	158,383	70,494
Comprehensive (income) loss attributable to noncontrolling interest		0	0	0
Comprehensive income attributable to Sabra Health Care REIT, Inc.		279,082	158,383	70,494
Operating Partnership | Reportable Legal Entities
Condensed Financial Statements, Captions [Line Items]
Net income		307,736	212,432	78,783
Other comprehensive income:
Foreign currency translation gain (loss)		4,329	(2,821)	(2,080)
Unrealized gain on cash flow hedges		244
Unrealized gain on cash flow hedges			13,078	7,169
Total other comprehensive income		4,573	10,257	5,089
Comprehensive income		312,309	222,689	83,872
Comprehensive (income) loss attributable to noncontrolling interest		0	0	0
Comprehensive income attributable to Sabra Health Care REIT, Inc.		312,309	222,689	83,872
Sabra Capital Corporation | Reportable Legal Entities
Condensed Financial Statements, Captions [Line Items]
Net income		0	0	0
Other comprehensive income:
Foreign currency translation gain (loss)		0	0	0
Unrealized gain on cash flow hedges		0
Unrealized gain on cash flow hedges			0	0
Total other comprehensive income		0	0	0
Comprehensive income		0	0	0
Comprehensive (income) loss attributable to noncontrolling interest		0	0	0
Comprehensive income attributable to Sabra Health Care REIT, Inc.		0	0	0
Combined Guarantor Subsidiaries of 2021 Notes and 2023 Notes | Reportable Legal Entities
Condensed Financial Statements, Captions [Line Items]
Net income		214,243	190,374	134,154
Other comprehensive income:
Foreign currency translation gain (loss)		(2,751)	2,233	364
Unrealized gain on cash flow hedges		48
Unrealized gain on cash flow hedges			(145)	0
Total other comprehensive income		(2,703)	2,088	364
Comprehensive income		211,540	192,462	134,518
Comprehensive (income) loss attributable to noncontrolling interest		0	0	0
Comprehensive income attributable to Sabra Health Care REIT, Inc.		211,540	192,462	134,518
Combined Non-Guarantor Subsidiaries of 2021 Notes and 2023 Notes | Reportable Legal Entities
Condensed Financial Statements, Captions [Line Items]
Net income		251,666	106,221	6,708
Other comprehensive income:
Foreign currency translation gain (loss)		(858)	742	82
Unrealized gain on cash flow hedges		0
Unrealized gain on cash flow hedges			0	0
Total other comprehensive income		(858)	742	82
Comprehensive income		250,808	106,963	6,790
Comprehensive (income) loss attributable to noncontrolling interest		(33)	18	71
Comprehensive income attributable to Sabra Health Care REIT, Inc.		$ 250,775	$ 106,981	$ 6,861
[1]	Amounts are net of income tax benefit of $48,000 and expense of $0.1 million for the years ended December 31, 2018 and 2017, respectively, and none for the year ended December 31, 2016.

SUMMARIZED CONSOLIDATING INFO_6

SUMMARIZED CONSOLIDATING INFORMATION - Consolidating Statement of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	$ 358,543	$ 135,789	$ 175,928
Cash flows from investing activities:
Acquisition of real estate	(261,511)	(419,905)	(153,579)
Cash received in CCP Merger	0	77,859	0
Origination and fundings of loans receivable	(50,731)	(17,239)	(9,675)
Origination and fundings of preferred equity investments	(5,313)	(2,749)	(7,348)
Additions to real estate	(27,697)	(6,954)	(1,003)
Repayments of loans receivable	51,789	32,430	215,962
Repayments of preferred equity investments	6,870	3,755	0
Investment in unconsolidated joint venture	(354,461)	0	0
Net proceeds from sales of real estate	382,560	150,243	98,006
Investment in subsidiary			0
Distribution from subsidiaries	0	0	0
Intercompany financing	0	0	0
Net cash (used in) provided by investing activities	(258,494)	(182,560)	142,363
Cash flows from financing activities:
Net borrowings from revolving credit facility		253,000
Net repayments of revolving credit facility	(17,000)		(229,000)
Proceeds from term loans	0	181,000	69,360
Principal payments on secured debt	(140,338)	(4,145)	(14,768)
Payments of deferred financing costs	(352)	(15,337)	(5,937)
Payment of contingent consideration	0	(382)	0
Distributions to noncontrolling interests	(142)	(30)	0
Issuance of common stock, net	(499)	366,800	(1,289)
Preferred stock redemption	(143,750)	0	0
Dividends paid on common and preferred stock	(325,220)	(182,089)	(119,264)
Contribution from parent			0
Distribution to parent	0	0	0
Intercompany financing	0	0	0
Net cash (used in) provided by financing activities	(627,301)	598,817	(300,898)
Net (decrease) increase in cash, cash equivalents and restricted cash	(527,252)	552,046	17,393
Effect of foreign currency translation on cash, cash equivalents and restricted cash	(539)	738	25
Cash, cash equivalents and restricted cash, beginning of period	587,449	34,665	17,247
Cash, cash equivalents and restricted cash, end of period	59,658	587,449	34,665
Elimination
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	0	0	0
Cash flows from investing activities:
Acquisition of real estate	0	0	0
Cash received in CCP Merger		0
Origination and fundings of loans receivable	0	0	0
Origination and fundings of preferred equity investments	0	0	0
Additions to real estate	0	0	0
Repayments of loans receivable	0	0	0
Repayments of preferred equity investments	0	0
Investment in unconsolidated joint venture	0
Net proceeds from sales of real estate	0	0	0
Investment in subsidiary			400
Distribution from subsidiaries	(10,914)	(4,948)	(12,808)
Intercompany financing	617,098	80,665	(142,358)
Net cash (used in) provided by investing activities	606,184	75,717	(154,766)
Cash flows from financing activities:
Net borrowings from revolving credit facility		0
Net repayments of revolving credit facility	0		0
Proceeds from term loans		0	0
Principal payments on secured debt	0	0	0
Payments of deferred financing costs	0	0	0
Payment of contingent consideration		0
Distributions to noncontrolling interests	0	0
Issuance of common stock, net	0	0	0
Preferred stock redemption	0
Dividends paid on common and preferred stock	0	0	0
Contribution from parent			(400)
Distribution to parent	10,914	4,948	12,808
Intercompany financing	(617,098)	(80,665)	142,358
Net cash (used in) provided by financing activities	(606,184)	(75,717)	154,766
Net (decrease) increase in cash, cash equivalents and restricted cash	0	0	0
Effect of foreign currency translation on cash, cash equivalents and restricted cash	0	0	0
Cash, cash equivalents and restricted cash, beginning of period	0	0	0
Cash, cash equivalents and restricted cash, end of period	0	0	0
Parent Company | Reportable Legal Entities
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	310,442	59,640	153,577
Cash flows from investing activities:
Acquisition of real estate	0	0	0
Cash received in CCP Merger		77,859
Origination and fundings of loans receivable	0	0	0
Origination and fundings of preferred equity investments	0	0	0
Additions to real estate	(40)	(181)	(124)
Repayments of loans receivable	0	0	0
Repayments of preferred equity investments	0	0
Investment in unconsolidated joint venture	0
Net proceeds from sales of real estate	0	0	0
Investment in subsidiary			(200)
Distribution from subsidiaries	5,457	2,474	6,404
Intercompany financing	(317,225)	168,999	(23,484)
Net cash (used in) provided by investing activities	(311,808)	249,151	(17,404)
Cash flows from financing activities:
Net borrowings from revolving credit facility		0
Net repayments of revolving credit facility	0		0
Proceeds from term loans		0	0
Principal payments on secured debt	0	0	0
Payments of deferred financing costs	0	0	0
Payment of contingent consideration		0
Distributions to noncontrolling interests	0	0
Issuance of common stock, net	(499)	366,800	(1,289)
Preferred stock redemption	(143,750)
Dividends paid on common and preferred stock	(325,220)	(182,089)	(119,264)
Contribution from parent			0
Distribution to parent	0	0	0
Intercompany financing	0	0	0
Net cash (used in) provided by financing activities	(469,469)	184,711	(120,553)
Net (decrease) increase in cash, cash equivalents and restricted cash	(470,835)	493,502	15,620
Effect of foreign currency translation on cash, cash equivalents and restricted cash	0	0	0
Cash, cash equivalents and restricted cash, beginning of period	511,670	18,168	2,548
Cash, cash equivalents and restricted cash, end of period	40,835	511,670	18,168
Operating Partnership | Reportable Legal Entities
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	0	0	0
Cash flows from investing activities:
Acquisition of real estate	0	0	0
Cash received in CCP Merger		0
Origination and fundings of loans receivable	0	0	0
Origination and fundings of preferred equity investments	0	0	0
Additions to real estate	0	0	0
Repayments of loans receivable	0	0	0
Repayments of preferred equity investments	0	0
Investment in unconsolidated joint venture	0
Net proceeds from sales of real estate	0	0	0
Investment in subsidiary			(200)
Distribution from subsidiaries	5,457	2,474	6,404
Intercompany financing	(299,873)	(249,664)	165,842
Net cash (used in) provided by investing activities	(294,416)	(247,190)	172,046
Cash flows from financing activities:
Net borrowings from revolving credit facility		253,000
Net repayments of revolving credit facility	(17,000)		(229,000)
Proceeds from term loans		181,000	45,000
Principal payments on secured debt	0	0	0
Payments of deferred financing costs	(352)	(15,337)	(5,326)
Payment of contingent consideration		0
Distributions to noncontrolling interests	0	0
Issuance of common stock, net	0	0	0
Preferred stock redemption	0
Dividends paid on common and preferred stock	0	0	0
Contribution from parent			200
Distribution to parent	(5,457)	(2,474)	(6,404)
Intercompany financing	317,225	(168,999)	23,484
Net cash (used in) provided by financing activities	294,416	247,190	(172,046)
Net (decrease) increase in cash, cash equivalents and restricted cash	0	0	0
Effect of foreign currency translation on cash, cash equivalents and restricted cash	0	0	0
Cash, cash equivalents and restricted cash, beginning of period	0	0	0
Cash, cash equivalents and restricted cash, end of period	0	0	0
Sabra Capital Corporation | Reportable Legal Entities
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	0	0	0
Cash flows from investing activities:
Acquisition of real estate	0	0	0
Cash received in CCP Merger		0
Origination and fundings of loans receivable	0	0	0
Origination and fundings of preferred equity investments	0	0	0
Additions to real estate	0	0	0
Repayments of loans receivable	0	0	0
Repayments of preferred equity investments	0	0
Investment in unconsolidated joint venture	0
Net proceeds from sales of real estate	0	0	0
Investment in subsidiary			0
Distribution from subsidiaries	0	0	0
Intercompany financing	0	0	0
Net cash (used in) provided by investing activities	0	0	0
Cash flows from financing activities:
Net borrowings from revolving credit facility		0
Net repayments of revolving credit facility	0		0
Proceeds from term loans		0	0
Principal payments on secured debt	0	0	0
Payments of deferred financing costs	0	0	0
Payment of contingent consideration		0
Distributions to noncontrolling interests	0	0
Issuance of common stock, net	0	0	0
Preferred stock redemption	0
Dividends paid on common and preferred stock	0	0	0
Contribution from parent			0
Distribution to parent	0	0	0
Intercompany financing	0	0	0
Net cash (used in) provided by financing activities	0	0	0
Net (decrease) increase in cash, cash equivalents and restricted cash	0	0	0
Effect of foreign currency translation on cash, cash equivalents and restricted cash	0	0	0
Cash, cash equivalents and restricted cash, beginning of period	0	0	0
Cash, cash equivalents and restricted cash, end of period	0	0	0
Combined Guarantor Subsidiaries of 2021 Notes and 2023 Notes | Reportable Legal Entities
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	1,639	41,085	10,343
Cash flows from investing activities:
Acquisition of real estate	(77,225)	(419,905)	(153,579)
Cash received in CCP Merger		0
Origination and fundings of loans receivable	(6,317)	(1,799)	(9,675)
Origination and fundings of preferred equity investments	(5,313)	(2,749)	(7,348)
Additions to real estate	(6,862)	(2,339)	(502)
Repayments of loans receivable	8,946	12,441	215,962
Repayments of preferred equity investments	6,870	3,755
Investment in unconsolidated joint venture	0
Net proceeds from sales of real estate	284,958	149,849	97,407
Investment in subsidiary			0
Distribution from subsidiaries	0	0	0
Intercompany financing	0	0	0
Net cash (used in) provided by investing activities	205,057	(260,747)	142,265
Cash flows from financing activities:
Net borrowings from revolving credit facility		0
Net repayments of revolving credit facility	0		0
Proceeds from term loans		0	24,360
Principal payments on secured debt	0	0	(10,766)
Payments of deferred financing costs	0	0	(611)
Payment of contingent consideration		(382)
Distributions to noncontrolling interests	0	0
Issuance of common stock, net	0	0	0
Preferred stock redemption	0
Dividends paid on common and preferred stock	0	0	0
Contribution from parent			0
Distribution to parent	0	0	0
Intercompany financing	(238,392)	254,608	(165,175)
Net cash (used in) provided by financing activities	(238,392)	254,226	(152,192)
Net (decrease) increase in cash, cash equivalents and restricted cash	(31,696)	34,564	416
Effect of foreign currency translation on cash, cash equivalents and restricted cash	(335)	63	72
Cash, cash equivalents and restricted cash, beginning of period	37,359	2,732	2,244
Cash, cash equivalents and restricted cash, end of period	5,328	37,359	2,732
Combined Non-Guarantor Subsidiaries of 2021 Notes and 2023 Notes | Reportable Legal Entities
Condensed Financial Statements, Captions [Line Items]
Net cash provided by operating activities	46,462	35,064	12,008
Cash flows from investing activities:
Acquisition of real estate	(184,286)	0	0
Cash received in CCP Merger		0
Origination and fundings of loans receivable	(44,414)	(15,440)	0
Origination and fundings of preferred equity investments	0	0	0
Additions to real estate	(20,795)	(4,434)	(377)
Repayments of loans receivable	42,843	19,989	0
Repayments of preferred equity investments	0	0
Investment in unconsolidated joint venture	(354,461)
Net proceeds from sales of real estate	97,602	394	599
Investment in subsidiary			0
Distribution from subsidiaries	0	0	0
Intercompany financing	0	0	0
Net cash (used in) provided by investing activities	(463,511)	509	222
Cash flows from financing activities:
Net borrowings from revolving credit facility		0
Net repayments of revolving credit facility	0		0
Proceeds from term loans		0	0
Principal payments on secured debt	(140,338)	(4,145)	(4,002)
Payments of deferred financing costs	0	0	0
Payment of contingent consideration		0
Distributions to noncontrolling interests	(142)	(30)
Issuance of common stock, net	0	0	0
Preferred stock redemption	0
Dividends paid on common and preferred stock	0	0	0
Contribution from parent			200
Distribution to parent	(5,457)	(2,474)	(6,404)
Intercompany financing	538,265	(4,944)	(667)
Net cash (used in) provided by financing activities	392,328	(11,593)	(10,873)
Net (decrease) increase in cash, cash equivalents and restricted cash	(24,721)	23,980	1,357
Effect of foreign currency translation on cash, cash equivalents and restricted cash	(204)	675	(47)
Cash, cash equivalents and restricted cash, beginning of period	38,420	13,765	12,455
Cash, cash equivalents and restricted cash, end of period	$ 13,495	$ 38,420	$ 13,765

PRO FORMA FINANCIAL INFORMATI_3

PRO FORMA FINANCIAL INFORMATION (UNAUDITED) - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Business Acquisition [Line Items]
Merger and acquisition costs	$ 636	$ 30,255	$ 1,197
Care Capital Properties
Business Acquisition [Line Items]
Merger and acquisition costs		$ 30,200

PRO FORMA FINANCIAL INFORMATI_4

PRO FORMA FINANCIAL INFORMATION (UNAUDITED) - Summary of Pro Forma Information (Details) - Care Capital Properties $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)$ / sharesshares
Business Acquisition, Pro Forma Information [Abstract]
Revenues | $	$ 631,041
Net income attributable to common stockholders | $	$ 292,551
Net income attributable to common stockholders, per:
Basic common share (in dollars per share) | $ / shares	$ 1.78
Diluted common share (in dollars per share) | $ / shares	$ 1.78
Weighted-average number of common shares outstanding, basic (in shares) | shares	164,361,139
Weighted-average number of common shares outstanding, diluted (in shares) | shares	164,582,331

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - $ / shares	Feb. 05, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Subsequent Event
Common stock dividends declared (in dollars per share)		$ 1.80	$ 1.73	$ 1.67
Dividend Declared | Subsequent Event
Subsequent Event
Common stock dividends declared (in dollars per share)	$ 0.45

SCHEDULE II - VALUATION AND Q_2

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	$ 17,972	$ 10,111	$ 13,442
Charged to Earnings	41,793	17,498	5,543
Recoveries	(2,718)	(385)	0
Uncollectible Accounts Written-off	(16,305)	(9,252)	(8,862)
Foreign Currency Translation due to Charges	0	0	(12)
Balance at End of Year	40,742	17,972	10,111
Allowance for doubtful accounts
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	5,520	3,693	3,811
Charged to Earnings	986	2,485	235
Recoveries	(2,718)	(385)	0
Uncollectible Accounts Written-off	(82)	(273)	(353)
Foreign Currency Translation due to Charges	0	0	0
Balance at End of Year	3,706	5,520	3,693
Straight-line rent receivable allowance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	12,355	3,668	5,331
Charged to Earnings	39,646	10,487	3,540
Recoveries	0	0	0
Uncollectible Accounts Written-off	(16,223)	(1,800)	(5,191)
Foreign Currency Translation due to Charges	0	0	(12)
Balance at End of Year	35,778	12,355	3,668
Loan loss reserves
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	97	2,750	4,300
Charged to Earnings	1,161	4,526	1,768
Recoveries	0	0	0
Uncollectible Accounts Written-off	0	(7,179)	(3,318)
Foreign Currency Translation due to Charges	0	0	0
Balance at End of Year	$ 1,258	$ 97	$ 2,750

SCHEDULE III - REAL ESTATE AS_2

SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION - Summary of Real Estate Properties (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Real Estate and Accumulated Depreciation
Encumbrances	$ 117,464
Initial Cost to Company
Land	629,582
Buildings and Improvements	5,578,878
Total	6,208,460
Cost Capitalized Subsequent to Acquisition	61,715
Gross Amount at which Carried at Close of Period
Land	629,382
Building and Improvements	5,626,501
Total	6,255,883	$ 6,334,855	$ 2,292,751	$ 2,277,457
Accumulated Depreciation and Amortization	(402,338)	(340,423)	$ (282,812)	$ (237,841)
Deferred financing costs, net	15,661
Aggregate cost of real estate for federal income tax purposes	5,300,000
Secured Debt
Gross Amount at which Carried at Close of Period
Deferred financing costs, net	1,785	$ 2,800
Operating Segments
Real Estate and Accumulated Depreciation
Encumbrances	117,464
Initial Cost to Company
Land	629,582
Buildings and Improvements	5,578,742
Total	6,208,324
Cost Capitalized Subsequent to Acquisition	61,217
Gross Amount at which Carried at Close of Period
Land	629,382
Building and Improvements	5,625,867
Total	6,255,249
Accumulated Depreciation and Amortization	(402,021)
Corporate Assets
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	0
Buildings and Improvements	136
Total	136
Cost Capitalized Subsequent to Acquisition	498
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	634
Total	634
Accumulated Depreciation and Amortization	(317)
Multi-property Indebtedness
Real Estate and Accumulated Depreciation
Encumbrances	11,172
Initial Cost to Company
Land	0
Buildings and Improvements	0
Total	0
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	0
Total	0
Accumulated Depreciation and Amortization	0
Various Skilled Nursing/Transitional Care and Leased Senior Housing Facilities | Multi-property Indebtedness | Real Estate
Gross Amount at which Carried at Close of Period
Collateral amount	11,200
Skilled Nursing/Transitional Care Facilities
Real Estate and Accumulated Depreciation
Encumbrances	60,787
Initial Cost to Company
Land	419,627
Buildings and Improvements	3,645,698
Total	4,065,325
Cost Capitalized Subsequent to Acquisition	39,619
Gross Amount at which Carried at Close of Period
Land	419,197
Building and Improvements	3,675,287
Total	4,094,484
Accumulated Depreciation and Amortization	(224,942)
Skilled Nursing/Transitional Care Facilities | Forest Hills (SNF)
Initial Cost to Company
Land	1,653
Buildings and Improvements	11,259
Total	12,912
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,653
Building and Improvements	10,269
Total	11,922
Accumulated Depreciation and Amortization	$ (4,074)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Seminole Estates
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	655
Buildings and Improvements	3,527
Total	4,182
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	655
Building and Improvements	3,194
Total	3,849
Accumulated Depreciation and Amortization	$ (1,046)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Skilled Nursing/Transitional Care Facilities | Bedford Hills
Real Estate and Accumulated Depreciation
Encumbrances	$ 5,964
Initial Cost to Company
Land	1,911
Buildings and Improvements	12,245
Total	14,156
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,911
Building and Improvements	11,164
Total	13,075
Accumulated Depreciation and Amortization	$ (4,199)
Life on Which Depreciation in Latest Income Statement is Computed	36 years
Skilled Nursing/Transitional Care Facilities | The Elms Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	312
Buildings and Improvements	1,679
Total	1,991
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	312
Building and Improvements	1,419
Total	1,731
Accumulated Depreciation and Amortization	$ (904)
Life on Which Depreciation in Latest Income Statement is Computed	20 years
Skilled Nursing/Transitional Care Facilities | Missouri River
Real Estate and Accumulated Depreciation
Encumbrances	$ 10,609
Initial Cost to Company
Land	2,023
Buildings and Improvements	16,967
Total	18,990
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,023
Building and Improvements	15,816
Total	17,839
Accumulated Depreciation and Amortization	$ (7,347)
Life on Which Depreciation in Latest Income Statement is Computed	30 years
Skilled Nursing/Transitional Care Facilities | Deer Lodge
Real Estate and Accumulated Depreciation
Encumbrances	$ 4,036
Initial Cost to Company
Land	190
Buildings and Improvements	3,032
Total	3,222
Cost Capitalized Subsequent to Acquisition	2
Gross Amount at which Carried at Close of Period
Land	190
Building and Improvements	2,629
Total	2,819
Accumulated Depreciation and Amortization	$ (1,153)
Life on Which Depreciation in Latest Income Statement is Computed	30 years
Skilled Nursing/Transitional Care Facilities | Arden House
Real Estate and Accumulated Depreciation
Encumbrances	$ 18,331
Initial Cost to Company
Land	2,250
Buildings and Improvements	23,816
Total	26,066
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,250
Building and Improvements	22,437
Total	24,687
Accumulated Depreciation and Amortization	$ (9,395)
Life on Which Depreciation in Latest Income Statement is Computed	28 years
Skilled Nursing/Transitional Care Facilities | Lake Drive
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	160
Buildings and Improvements	549
Total	709
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	160
Building and Improvements	64
Total	224
Accumulated Depreciation and Amortization	$ (51)
Life on Which Depreciation in Latest Income Statement is Computed	10 years
Skilled Nursing/Transitional Care Facilities | Mineral Springs
Real Estate and Accumulated Depreciation
Encumbrances	$ 11,858
Initial Cost to Company
Land	417
Buildings and Improvements	5,352
Total	5,769
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	417
Building and Improvements	4,679
Total	5,096
Accumulated Depreciation and Amortization	$ (1,743)
Life on Which Depreciation in Latest Income Statement is Computed	43 years
Skilled Nursing/Transitional Care Facilities | Wolfeboro
Real Estate and Accumulated Depreciation
Encumbrances	$ 9,989
Initial Cost to Company
Land	454
Buildings and Improvements	4,531
Total	4,985
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	454
Building and Improvements	4,074
Total	4,528
Accumulated Depreciation and Amortization	$ (1,515)
Life on Which Depreciation in Latest Income Statement is Computed	41 years
Skilled Nursing/Transitional Care Facilities | Broadmeadow Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,650
Buildings and Improvements	21,730
Total	23,380
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,650
Building and Improvements	21,730
Total	23,380
Accumulated Depreciation and Amortization	$ (4,645)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Capitol Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,940
Buildings and Improvements	15,500
Total	20,440
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,940
Building and Improvements	15,500
Total	20,440
Accumulated Depreciation and Amortization	$ (3,465)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pike Creek Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,460
Buildings and Improvements	25,240
Total	27,700
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,460
Building and Improvements	25,240
Total	27,700
Accumulated Depreciation and Amortization	$ (5,455)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Renaissance Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,640
Buildings and Improvements	22,620
Total	24,260
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,640
Building and Improvements	22,620
Total	24,260
Accumulated Depreciation and Amortization	$ (4,984)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Clara Burke
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,527
Buildings and Improvements	12,453
Total	14,980
Cost Capitalized Subsequent to Acquisition	179
Gross Amount at which Carried at Close of Period
Land	2,527
Building and Improvements	12,631
Total	15,158
Accumulated Depreciation and Amortization	$ (2,661)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Warrington
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,617
Buildings and Improvements	11,662
Total	14,279
Cost Capitalized Subsequent to Acquisition	106
Gross Amount at which Carried at Close of Period
Land	2,617
Building and Improvements	11,768
Total	14,385
Accumulated Depreciation and Amortization	$ (2,269)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Ridgecrest
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	509
Buildings and Improvements	5,018
Total	5,527
Cost Capitalized Subsequent to Acquisition	1,333
Gross Amount at which Carried at Close of Period
Land	509
Building and Improvements	6,351
Total	6,860
Accumulated Depreciation and Amortization	$ (1,399)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Camden Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,235
Buildings and Improvements	5,777
Total	7,012
Cost Capitalized Subsequent to Acquisition	50
Gross Amount at which Carried at Close of Period
Land	790
Building and Improvements	3,090
Total	3,880
Accumulated Depreciation and Amortization	$ (89)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Arbrook Plaza
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,783
Buildings and Improvements	14,219
Total	18,002
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,783
Building and Improvements	14,219
Total	18,002
Accumulated Depreciation and Amortization	$ (2,486)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Northgate Plaza
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,901
Buildings and Improvements	10,299
Total	15,200
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,901
Building and Improvements	10,299
Total	15,200
Accumulated Depreciation and Amortization	$ (1,855)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Gulf Pointe Plaza
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,005
Buildings and Improvements	6,628
Total	7,633
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,005
Building and Improvements	6,628
Total	7,633
Accumulated Depreciation and Amortization	$ (1,254)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Gateway Senior Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	6,368
Buildings and Improvements	29,919
Total	36,287
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	6,368
Building and Improvements	29,919
Total	36,287
Accumulated Depreciation and Amortization	$ (4,140)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Legacy
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	615
Buildings and Improvements	16,176
Total	16,791
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	615
Building and Improvements	16,176
Total	16,791
Accumulated Depreciation and Amortization	$ (2,456)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pointe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	615
Buildings and Improvements	2,943
Total	3,558
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	615
Building and Improvements	2,943
Total	3,558
Accumulated Depreciation and Amortization	$ (530)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Regency
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	246
Buildings and Improvements	6,206
Total	6,452
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	246
Building and Improvements	6,206
Total	6,452
Accumulated Depreciation and Amortization	$ (1,147)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Parkmoor Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	430
Buildings and Improvements	13,703
Total	14,133
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	430
Building and Improvements	13,703
Total	14,133
Accumulated Depreciation and Amortization	$ (2,185)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Onion Creek
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	871
Buildings and Improvements	12,843
Total	13,714
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	871
Building and Improvements	12,843
Total	13,714
Accumulated Depreciation and Amortization	$ (1,769)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Adams PARC
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,332
Buildings and Improvements	6,904
Total	8,236
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,332
Building and Improvements	6,904
Total	8,236
Accumulated Depreciation and Amortization	$ (904)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | PARCway
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,189
Buildings and Improvements	23,567
Total	25,756
Cost Capitalized Subsequent to Acquisition	703
Gross Amount at which Carried at Close of Period
Land	2,189
Building and Improvements	24,271
Total	26,460
Accumulated Depreciation and Amortization	$ (2,759)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brookhaven Extensive Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	869
Buildings and Improvements	5,236
Total	6,105
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	869
Building and Improvements	5,237
Total	6,106
Accumulated Depreciation and Amortization	$ (766)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cadia Healthcare of Hyattsville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	6,343
Buildings and Improvements	65,573
Total	71,916
Cost Capitalized Subsequent to Acquisition	14
Gross Amount at which Carried at Close of Period
Land	6,343
Building and Improvements	65,586
Total	71,929
Accumulated Depreciation and Amortization	$ (6,913)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cadia Healthcare of Annapolis
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,548
Buildings and Improvements	40,773
Total	42,321
Cost Capitalized Subsequent to Acquisition	103
Gross Amount at which Carried at Close of Period
Land	1,548
Building and Improvements	40,876
Total	42,424
Accumulated Depreciation and Amortization	$ (3,996)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cadia Healthcare of Wheaton
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	676
Buildings and Improvements	56,897
Total	57,573
Cost Capitalized Subsequent to Acquisition	22
Gross Amount at which Carried at Close of Period
Land	676
Building and Improvements	56,918
Total	57,594
Accumulated Depreciation and Amortization	$ (5,482)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cadia Healthcare of Hagerstown
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,475
Buildings and Improvements	56,237
Total	57,712
Cost Capitalized Subsequent to Acquisition	500
Gross Amount at which Carried at Close of Period
Land	1,475
Building and Improvements	56,738
Total	58,213
Accumulated Depreciation and Amortization	$ (4,841)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cadia Healthcare of Spring Brook
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	963
Buildings and Improvements	48,085
Total	49,048
Cost Capitalized Subsequent to Acquisition	7
Gross Amount at which Carried at Close of Period
Land	963
Building and Improvements	48,090
Total	49,053
Accumulated Depreciation and Amortization	$ (3,253)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Andrew Residence
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,931
Buildings and Improvements	6,943
Total	9,874
Cost Capitalized Subsequent to Acquisition	192
Gross Amount at which Carried at Close of Period
Land	2,931
Building and Improvements	7,135
Total	10,066
Accumulated Depreciation and Amortization	$ (335)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Atrium Post Acute Care of Chilton
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	230
Buildings and Improvements	3,645
Total	3,875
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	230
Building and Improvements	3,645
Total	3,875
Accumulated Depreciation and Amortization	$ (135)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Fox River Nursing and Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,220
Buildings and Improvements	2,351
Total	3,571
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,220
Building and Improvements	2,351
Total	3,571
Accumulated Depreciation and Amortization	$ (90)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Bridgewood Nursing and Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	890
Buildings and Improvements	2,985
Total	3,875
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	890
Building and Improvements	2,985
Total	3,875
Accumulated Depreciation and Amortization	$ (121)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Kennedy Park Nursing and Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,000
Buildings and Improvements	2,875
Total	3,875
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,000
Building and Improvements	2,875
Total	3,875
Accumulated Depreciation and Amortization	$ (113)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Riverpark of Eugene
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,205
Buildings and Improvements	28,700
Total	30,905
Cost Capitalized Subsequent to Acquisition	2,252
Gross Amount at which Carried at Close of Period
Land	2,205
Building and Improvements	30,952
Total	33,157
Accumulated Depreciation and Amortization	$ (1,238)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Lebanon
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	958
Buildings and Improvements	14,176
Total	15,134
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	958
Building and Improvements	14,176
Total	15,134
Accumulated Depreciation and Amortization	$ (511)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Crestview of Portland
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,791
Buildings and Improvements	12,833
Total	14,624
Cost Capitalized Subsequent to Acquisition	2,761
Gross Amount at which Carried at Close of Period
Land	1,791
Building and Improvements	15,594
Total	17,385
Accumulated Depreciation and Amortization	$ (730)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehabilitation of King City
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,011
Buildings and Improvements	11,667
Total	13,678
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,011
Building and Improvements	11,667
Total	13,678
Accumulated Depreciation and Amortization	$ (435)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehabilitation of Hillsboro
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,387
Buildings and Improvements	14,028
Total	15,415
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,387
Building and Improvements	14,028
Total	15,415
Accumulated Depreciation and Amortization	$ (505)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Junction City
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	584
Buildings and Improvements	7,901
Total	8,485
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	584
Building and Improvements	7,901
Total	8,485
Accumulated Depreciation and Amortization	$ (295)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Eugene
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,380
Buildings and Improvements	14,921
Total	16,301
Cost Capitalized Subsequent to Acquisition	1,791
Gross Amount at which Carried at Close of Period
Land	1,380
Building and Improvements	16,712
Total	18,092
Accumulated Depreciation and Amortization	$ (720)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Coos Bay
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	829
Buildings and Improvements	8,518
Total	9,347
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	829
Building and Improvements	8,518
Total	9,347
Accumulated Depreciation and Amortization	$ (330)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Twin Oaks of Sweet Home
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	238
Buildings and Improvements	3,338
Total	3,576
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	238
Building and Improvements	3,338
Total	3,576
Accumulated Depreciation and Amortization	$ (129)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Clackamas
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	792
Buildings and Improvements	5,000
Total	5,792
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	792
Building and Improvements	5,000
Total	5,792
Accumulated Depreciation and Amortization	$ (191)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Newport
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	406
Buildings and Improvements	5,001
Total	5,407
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	406
Building and Improvements	5,001
Total	5,407
Accumulated Depreciation and Amortization	$ (182)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Oregon City
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,496
Buildings and Improvements	12,142
Total	13,638
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,496
Building and Improvements	12,142
Total	13,638
Accumulated Depreciation and Amortization	$ (437)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Transitional Care of Puget Sound
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,771
Buildings and Improvements	11,595
Total	13,366
Cost Capitalized Subsequent to Acquisition	15
Gross Amount at which Carried at Close of Period
Land	1,771
Building and Improvements	11,610
Total	13,381
Accumulated Depreciation and Amortization	$ (487)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Richmond Beach Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,703
Buildings and Improvements	14,444
Total	19,147
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,703
Building and Improvements	14,444
Total	19,147
Accumulated Depreciation and Amortization	$ (539)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | St. Francis of Bellingham
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	15,330
Total	15,330
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	15,330
Total	15,330
Accumulated Depreciation and Amortization	$ (577)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Olympic Rehabilitation of Sequim
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	427
Buildings and Improvements	4,450
Total	4,877
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	427
Building and Improvements	4,450
Total	4,877
Accumulated Depreciation and Amortization	$ (201)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Heritage Rehabilitation of Tacoma
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,705
Buildings and Improvements	4,952
Total	6,657
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,705
Building and Improvements	4,952
Total	6,657
Accumulated Depreciation and Amortization	$ (195)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere at Pacific Ridge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,195
Buildings and Improvements	1,956
Total	4,151
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,195
Building and Improvements	1,956
Total	4,151
Accumulated Depreciation and Amortization	$ (102)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehabilitation of Cascade Park
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,782
Buildings and Improvements	15,116
Total	16,898
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,782
Building and Improvements	15,116
Total	16,898
Accumulated Depreciation and Amortization	$ (589)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Pearl at Kruse Way
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	5,947
Buildings and Improvements	13,401
Total	19,348
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	5,947
Building and Improvements	13,401
Total	19,348
Accumulated Depreciation and Amortization	$ (504)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere at Medford
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,043
Buildings and Improvements	38,485
Total	40,528
Cost Capitalized Subsequent to Acquisition	2,960
Gross Amount at which Carried at Close of Period
Land	2,043
Building and Improvements	41,445
Total	43,488
Accumulated Depreciation and Amortization	$ (1,636)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Bellingham Healthcare and Rehab Services
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,908
Buildings and Improvements	2,058
Total	4,966
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,908
Building and Improvements	2,058
Total	4,966
Accumulated Depreciation and Amortization	$ (104)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Queen Anne Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,508
Buildings and Improvements	6,401
Total	8,909
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,508
Building and Improvements	6,401
Total	8,909
Accumulated Depreciation and Amortization	$ (244)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Transitional Care and Rehab - Boise
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	681
Buildings and Improvements	9,348
Total	10,029
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	681
Building and Improvements	9,348
Total	10,029
Accumulated Depreciation and Amortization	$ (356)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Transitional Care at Sunnyside
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,114
Buildings and Improvements	15,651
Total	17,765
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,114
Building and Improvements	15,651
Total	17,765
Accumulated Depreciation and Amortization	$ (581)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Health Services of Rogue Valley
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,375
Buildings and Improvements	23,808
Total	25,183
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,375
Building and Improvements	23,808
Total	25,183
Accumulated Depreciation and Amortization	$ (891)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Transitional Care and Rehab - Malley
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,662
Buildings and Improvements	26,014
Total	27,676
Cost Capitalized Subsequent to Acquisition	3,258
Gross Amount at which Carried at Close of Period
Land	1,662
Building and Improvements	29,273
Total	30,935
Accumulated Depreciation and Amortization	$ (1,245)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Transitional Care and Rehab - Brighton
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,933
Buildings and Improvements	11,624
Total	13,557
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,933
Building and Improvements	11,624
Total	13,557
Accumulated Depreciation and Amortization	$ (445)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Phoenix Rehabilitation Services
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,270
Buildings and Improvements	11,502
Total	12,772
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,270
Building and Improvements	11,502
Total	12,772
Accumulated Depreciation and Amortization	$ (415)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Tustin Subacute Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,889
Buildings and Improvements	11,682
Total	13,571
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,889
Building and Improvements	11,682
Total	13,571
Accumulated Depreciation and Amortization	$ (410)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | La Mesa Inpatient Rehabilitation Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,276
Buildings and Improvements	8,177
Total	9,453
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,276
Building and Improvements	8,177
Total	9,453
Accumulated Depreciation and Amortization	$ (298)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Westminster
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,128
Buildings and Improvements	6,614
Total	8,742
Cost Capitalized Subsequent to Acquisition	413
Gross Amount at which Carried at Close of Period
Land	2,128
Building and Improvements	7,028
Total	9,156
Accumulated Depreciation and Amortization	$ (347)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Maple Wood Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,142
Buildings and Improvements	3,226
Total	4,368
Cost Capitalized Subsequent to Acquisition	653
Gross Amount at which Carried at Close of Period
Land	1,142
Building and Improvements	3,878
Total	5,020
Accumulated Depreciation and Amortization	$ (295)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Garden Valley Nursing & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,985
Buildings and Improvements	2,714
Total	4,699
Cost Capitalized Subsequent to Acquisition	303
Gross Amount at which Carried at Close of Period
Land	1,985
Building and Improvements	3,017
Total	5,002
Accumulated Depreciation and Amortization	$ (270)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Worthington Nursing & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	697
Buildings and Improvements	10,688
Total	11,385
Cost Capitalized Subsequent to Acquisition	76
Gross Amount at which Carried at Close of Period
Land	697
Building and Improvements	10,764
Total	11,461
Accumulated Depreciation and Amortization	$ (494)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Burlington House Rehabilitative and Alzheimers Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,686
Buildings and Improvements	10,062
Total	12,748
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,686
Building and Improvements	10,062
Total	12,748
Accumulated Depreciation and Amortization	$ (433)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Charlottesville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,840
Buildings and Improvements	8,450
Total	11,290
Cost Capitalized Subsequent to Acquisition	626
Gross Amount at which Carried at Close of Period
Land	2,840
Building and Improvements	9,076
Total	11,916
Accumulated Depreciation and Amortization	$ (413)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Sleepy Hollow
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	7,241
Buildings and Improvements	17,727
Total	24,968
Cost Capitalized Subsequent to Acquisition	712
Gross Amount at which Carried at Close of Period
Land	7,241
Building and Improvements	18,439
Total	25,680
Accumulated Depreciation and Amortization	$ (768)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Petersburg
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	988
Buildings and Improvements	8,416
Total	9,404
Cost Capitalized Subsequent to Acquisition	141
Gross Amount at which Carried at Close of Period
Land	988
Building and Improvements	8,557
Total	9,545
Accumulated Depreciation and Amortization	$ (359)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Battlefield Park
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,174
Buildings and Improvements	8,858
Total	10,032
Cost Capitalized Subsequent to Acquisition	151
Gross Amount at which Carried at Close of Period
Land	1,174
Building and Improvements	9,009
Total	10,183
Accumulated Depreciation and Amortization	$ (374)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Hagerstown
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,393
Buildings and Improvements	13,438
Total	14,831
Cost Capitalized Subsequent to Acquisition	149
Gross Amount at which Carried at Close of Period
Land	1,393
Building and Improvements	13,587
Total	14,980
Accumulated Depreciation and Amortization	$ (542)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Cumberland
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	800
Buildings and Improvements	16,973
Total	17,773
Cost Capitalized Subsequent to Acquisition	429
Gross Amount at which Carried at Close of Period
Land	800
Building and Improvements	17,403
Total	18,203
Accumulated Depreciation and Amortization	$ (680)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Gilroy Healthcare and Rehabilitiation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	662
Buildings and Improvements	23,775
Total	24,437
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	662
Building and Improvements	23,775
Total	24,437
Accumulated Depreciation and Amortization	$ (847)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | North Cascades Health and Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,437
Buildings and Improvements	14,196
Total	15,633
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,437
Building and Improvements	14,196
Total	15,633
Accumulated Depreciation and Amortization	$ (529)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Granite Rehabilitation & Wellness
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	387
Buildings and Improvements	13,613
Total	14,000
Cost Capitalized Subsequent to Acquisition	1,979
Gross Amount at which Carried at Close of Period
Land	387
Building and Improvements	15,593
Total	15,980
Accumulated Depreciation and Amortization	$ (530)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Rawlins Rehabilitation & Wellness
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	281
Buildings and Improvements	6,007
Total	6,288
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	281
Building and Improvements	6,007
Total	6,288
Accumulated Depreciation and Amortization	$ (222)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wind River Rehabilitation & Wellness
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	199
Buildings and Improvements	11,398
Total	11,597
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	199
Building and Improvements	11,398
Total	11,597
Accumulated Depreciation and Amortization	$ (411)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Sage View Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	420
Buildings and Improvements	8,665
Total	9,085
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	420
Building and Improvements	8,665
Total	9,085
Accumulated Depreciation and Amortization	$ (326)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Shelton Health and Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	415
Buildings and Improvements	8,965
Total	9,380
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	415
Building and Improvements	8,965
Total	9,380
Accumulated Depreciation and Amortization	$ (359)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Dundee Nursing Home
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,437
Buildings and Improvements	4,631
Total	6,068
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,437
Building and Improvements	4,631
Total	6,068
Accumulated Depreciation and Amortization	$ (191)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Mt. Pleasant Nursing Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,689
Buildings and Improvements	3,942
Total	6,631
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,689
Building and Improvements	3,942
Total	6,631
Accumulated Depreciation and Amortization	$ (173)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Tri-State Comp Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,811
Buildings and Improvements	4,963
Total	6,774
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,811
Building and Improvements	4,963
Total	6,774
Accumulated Depreciation and Amortization	$ (222)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Emporia Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,656
Buildings and Improvements	478
Total	2,134
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,656
Building and Improvements	478
Total	2,134
Accumulated Depreciation and Amortization	$ (26)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Epic-Conway
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,408
Buildings and Improvements	10,784
Total	12,192
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,408
Building and Improvements	10,784
Total	12,192
Accumulated Depreciation and Amortization	$ (433)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Epic- Bayview
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,842
Buildings and Improvements	11,389
Total	13,231
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,842
Building and Improvements	11,389
Total	13,231
Accumulated Depreciation and Amortization	$ (444)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Green Acres of Baytown
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	479
Buildings and Improvements	6,351
Total	6,830
Cost Capitalized Subsequent to Acquisition	209
Gross Amount at which Carried at Close of Period
Land	479
Building and Improvements	6,561
Total	7,040
Accumulated Depreciation and Amortization	$ (347)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Allenbrook Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	426
Buildings and Improvements	3,236
Total	3,662
Cost Capitalized Subsequent to Acquisition	173
Gross Amount at which Carried at Close of Period
Land	426
Building and Improvements	3,409
Total	3,835
Accumulated Depreciation and Amortization	$ (199)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Green Acres of Huntsville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	302
Buildings and Improvements	3,153
Total	3,455
Cost Capitalized Subsequent to Acquisition	75
Gross Amount at which Carried at Close of Period
Land	302
Building and Improvements	3,229
Total	3,531
Accumulated Depreciation and Amortization	$ (168)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Green Acres of Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	231
Buildings and Improvements	1,335
Total	1,566
Cost Capitalized Subsequent to Acquisition	312
Gross Amount at which Carried at Close of Period
Land	231
Building and Improvements	1,648
Total	1,879
Accumulated Depreciation and Amortization	$ (180)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Humble Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,114
Buildings and Improvements	1,643
Total	3,757
Cost Capitalized Subsequent to Acquisition	596
Gross Amount at which Carried at Close of Period
Land	2,114
Building and Improvements	2,239
Total	4,353
Accumulated Depreciation and Amortization	$ (273)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Beechnut Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,019
Buildings and Improvements	5,734
Total	6,753
Cost Capitalized Subsequent to Acquisition	318
Gross Amount at which Carried at Close of Period
Land	1,019
Building and Improvements	6,052
Total	7,071
Accumulated Depreciation and Amortization	$ (407)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Linden Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	112
Buildings and Improvements	256
Total	368
Cost Capitalized Subsequent to Acquisition	133
Gross Amount at which Carried at Close of Period
Land	112
Building and Improvements	389
Total	501
Accumulated Depreciation and Amortization	$ (85)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Sherman Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	469
Buildings and Improvements	6,310
Total	6,779
Cost Capitalized Subsequent to Acquisition	255
Gross Amount at which Carried at Close of Period
Land	469
Building and Improvements	6,565
Total	7,034
Accumulated Depreciation and Amortization	$ (411)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Mount Pleasant Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	250
Buildings and Improvements	6,913
Total	7,163
Cost Capitalized Subsequent to Acquisition	345
Gross Amount at which Carried at Close of Period
Land	250
Building and Improvements	7,258
Total	7,508
Accumulated Depreciation and Amortization	$ (305)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Renfro Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	416
Buildings and Improvements	7,259
Total	7,675
Cost Capitalized Subsequent to Acquisition	205
Gross Amount at which Carried at Close of Period
Land	416
Building and Improvements	7,464
Total	7,880
Accumulated Depreciation and Amortization	$ (351)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Upshur Manor Nursing Home
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	707
Buildings and Improvements	4,552
Total	5,259
Cost Capitalized Subsequent to Acquisition	93
Gross Amount at which Carried at Close of Period
Land	707
Building and Improvements	4,647
Total	5,354
Accumulated Depreciation and Amortization	$ (237)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Hearthstone of Northern Nevada
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,986
Buildings and Improvements	9,004
Total	10,990
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,986
Building and Improvements	9,004
Total	10,990
Accumulated Depreciation and Amortization	$ (361)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Sunset Hills Healthcare and Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,595
Buildings and Improvements	5,822
Total	7,417
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,595
Building and Improvements	5,822
Total	7,417
Accumulated Depreciation and Amortization	$ (348)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Mountainview Specialty Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	549
Buildings and Improvements	9,926
Total	10,475
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	549
Building and Improvements	9,926
Total	10,475
Accumulated Depreciation and Amortization	$ (471)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Richmond
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	259
Buildings and Improvements	9,819
Total	10,078
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	259
Building and Improvements	9,819
Total	10,078
Accumulated Depreciation and Amortization	$ (374)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Petersburg
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	581
Buildings and Improvements	5,367
Total	5,948
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	581
Building and Improvements	5,367
Total	5,948
Accumulated Depreciation and Amortization	$ (219)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Beverly Health - Ft. Pierce
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	787
Buildings and Improvements	16,648
Total	17,435
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	787
Building and Improvements	16,648
Total	17,435
Accumulated Depreciation and Amortization	$ (610)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Maryville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	114
Buildings and Improvements	5,955
Total	6,069
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	114
Building and Improvements	5,955
Total	6,069
Accumulated Depreciation and Amortization	$ (250)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Ashland Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	765
Buildings and Improvements	2,669
Total	3,434
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	765
Building and Improvements	2,669
Total	3,434
Accumulated Depreciation and Amortization	$ (120)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Bellefontaine Gardens
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,071
Buildings and Improvements	5,739
Total	7,810
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,071
Building and Improvements	5,739
Total	7,810
Accumulated Depreciation and Amortization	$ (258)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Current River Nursing Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	657
Buildings and Improvements	8,251
Total	8,908
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	657
Building and Improvements	8,251
Total	8,908
Accumulated Depreciation and Amortization	$ (327)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Dixon Nursing & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	521
Buildings and Improvements	3,358
Total	3,879
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	521
Building and Improvements	3,358
Total	3,879
Accumulated Depreciation and Amortization	$ (144)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Forsyth Nursing & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	594
Buildings and Improvements	8,549
Total	9,143
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	594
Building and Improvements	8,549
Total	9,143
Accumulated Depreciation and Amortization	$ (343)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Glenwood Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	658
Buildings and Improvements	901
Total	1,559
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	658
Building and Improvements	901
Total	1,559
Accumulated Depreciation and Amortization	$ (51)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Silex Community Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	807
Buildings and Improvements	4,990
Total	5,797
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	807
Building and Improvements	4,990
Total	5,797
Accumulated Depreciation and Amortization	$ (203)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | South Hampton Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,322
Buildings and Improvements	6,547
Total	8,869
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,322
Building and Improvements	6,547
Total	8,869
Accumulated Depreciation and Amortization	$ (271)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Strafford Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,634
Buildings and Improvements	6,518
Total	8,152
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,634
Building and Improvements	6,518
Total	8,152
Accumulated Depreciation and Amortization	$ (264)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Windsor Healthcare & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	471
Buildings and Improvements	6,819
Total	7,290
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	471
Building and Improvements	6,819
Total	7,290
Accumulated Depreciation and Amortization	$ (250)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of Conroe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,222
Buildings and Improvements	19,099
Total	20,321
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,222
Building and Improvements	19,099
Total	20,321
Accumulated Depreciation and Amortization	$ (684)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of Cypress Station
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,334
Buildings and Improvements	11,615
Total	12,949
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,334
Building and Improvements	11,615
Total	12,949
Accumulated Depreciation and Amortization	$ (434)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of Humble
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,541
Buildings and Improvements	12,332
Total	13,873
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,541
Building and Improvements	12,332
Total	13,873
Accumulated Depreciation and Amortization	$ (459)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of Quail Valley
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,825
Buildings and Improvements	9,681
Total	11,506
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,825
Building and Improvements	9,681
Total	11,506
Accumulated Depreciation and Amortization	$ (376)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of Westchase
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,676
Buildings and Improvements	7,396
Total	10,072
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,676
Building and Improvements	7,396
Total	10,072
Accumulated Depreciation and Amortization	$ (294)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of CyFair
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,732
Buildings and Improvements	12,921
Total	14,653
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,732
Building and Improvements	12,921
Total	14,653
Accumulated Depreciation and Amortization	$ (479)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of McKinney
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,441
Buildings and Improvements	9,017
Total	10,458
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,441
Building and Improvements	9,017
Total	10,458
Accumulated Depreciation and Amortization	$ (364)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Tanglewood Health and Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	176
Buildings and Improvements	2,340
Total	2,516
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	176
Building and Improvements	2,340
Total	2,516
Accumulated Depreciation and Amortization	$ (100)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Smoky Hill Health and Rehbilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	301
Buildings and Improvements	4,201
Total	4,502
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	301
Building and Improvements	4,201
Total	4,502
Accumulated Depreciation and Amortization	$ (171)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Belleville Health Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	600
Buildings and Improvements	1,664
Total	2,264
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	600
Building and Improvements	1,664
Total	2,264
Accumulated Depreciation and Amortization	$ (85)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Westridge Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,067
Buildings and Improvements	7,061
Total	8,128
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,067
Building and Improvements	7,061
Total	8,128
Accumulated Depreciation and Amortization	$ (271)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Willow Bend Living Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,168
Buildings and Improvements	9,562
Total	10,730
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,168
Building and Improvements	9,562
Total	10,730
Accumulated Depreciation and Amortization	$ (350)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Twin City Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	345
Buildings and Improvements	8,852
Total	9,197
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	345
Building and Improvements	8,852
Total	9,197
Accumulated Depreciation and Amortization	$ (323)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pine Knoll Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	711
Buildings and Improvements	5,554
Total	6,265
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	711
Building and Improvements	5,554
Total	6,265
Accumulated Depreciation and Amortization	$ (214)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Willow Crossing Health & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,290
Buildings and Improvements	10,714
Total	12,004
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,290
Building and Improvements	10,714
Total	12,004
Accumulated Depreciation and Amortization	$ (393)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Persimmon Ridge Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	315
Buildings and Improvements	9,848
Total	10,163
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	315
Building and Improvements	9,848
Total	10,163
Accumulated Depreciation and Amortization	$ (367)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Vermillion Convalescent Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	884
Buildings and Improvements	9,839
Total	10,723
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	884
Building and Improvements	9,839
Total	10,723
Accumulated Depreciation and Amortization	$ (385)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Las Vegas Post Acute & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	509
Buildings and Improvements	18,216
Total	18,725
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	509
Building and Improvements	18,216
Total	18,725
Accumulated Depreciation and Amortization	$ (639)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Torey Pines Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,169
Buildings and Improvements	7,863
Total	11,032
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,169
Building and Improvements	7,863
Total	11,032
Accumulated Depreciation and Amortization	$ (311)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Villa Campana Rehabiitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,800
Buildings and Improvements	4,387
Total	6,187
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,800
Building and Improvements	4,387
Total	6,187
Accumulated Depreciation and Amortization	$ (201)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Kachina Point Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,035
Buildings and Improvements	10,981
Total	13,016
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,035
Building and Improvements	10,981
Total	13,016
Accumulated Depreciation and Amortization	$ (440)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Bay View Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,078
Buildings and Improvements	22,328
Total	25,406
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,078
Building and Improvements	22,328
Total	25,406
Accumulated Depreciation and Amortization	$ (801)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Dover Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	522
Buildings and Improvements	5,839
Total	6,361
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	522
Building and Improvements	5,839
Total	6,361
Accumulated Depreciation and Amortization	$ (292)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Augusta Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	135
Buildings and Improvements	6,470
Total	6,605
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	135
Building and Improvements	6,470
Total	6,605
Accumulated Depreciation and Amortization	$ (254)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Eastside Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	302
Buildings and Improvements	1,811
Total	2,113
Cost Capitalized Subsequent to Acquisition	20
Gross Amount at which Carried at Close of Period
Land	302
Building and Improvements	1,832
Total	2,134
Accumulated Depreciation and Amortization	$ (84)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Winship Green Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	250
Buildings and Improvements	1,934
Total	2,184
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	250
Building and Improvements	1,934
Total	2,184
Accumulated Depreciation and Amortization	$ (85)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brewer Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	177
Buildings and Improvements	14,497
Total	14,674
Cost Capitalized Subsequent to Acquisition	3
Gross Amount at which Carried at Close of Period
Land	177
Building and Improvements	14,501
Total	14,678
Accumulated Depreciation and Amortization	$ (552)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Kennebunk Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	198
Buildings and Improvements	6,822
Total	7,020
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	198
Building and Improvements	6,822
Total	7,020
Accumulated Depreciation and Amortization	$ (264)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Norway Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	791
Buildings and Improvements	3,680
Total	4,471
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	791
Building and Improvements	3,680
Total	4,471
Accumulated Depreciation and Amortization	$ (154)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brentwood Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	134
Buildings and Improvements	2,072
Total	2,206
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	134
Building and Improvements	2,072
Total	2,206
Accumulated Depreciation and Amortization	$ (93)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Country Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	269
Buildings and Improvements	4,436
Total	4,705
Cost Capitalized Subsequent to Acquisition	12
Gross Amount at which Carried at Close of Period
Land	269
Building and Improvements	4,448
Total	4,717
Accumulated Depreciation and Amortization	$ (230)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Sachem Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	447
Buildings and Improvements	1,357
Total	1,804
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	447
Building and Improvements	1,357
Total	1,804
Accumulated Depreciation and Amortization	$ (86)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Eliot Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	475
Buildings and Improvements	1,491
Total	1,966
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	475
Building and Improvements	1,491
Total	1,966
Accumulated Depreciation and Amortization	$ (82)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Reservoir Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	942
Buildings and Improvements	1,541
Total	2,483
Cost Capitalized Subsequent to Acquisition	6,013
Gross Amount at which Carried at Close of Period
Land	942
Building and Improvements	7,554
Total	8,496
Accumulated Depreciation and Amortization	$ (92)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Newton Wellesley Center for Alzheimer’s Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,186
Buildings and Improvements	13,917
Total	15,103
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,186
Building and Improvements	13,917
Total	15,103
Accumulated Depreciation and Amortization	$ (511)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Colony Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,727
Buildings and Improvements	2,103
Total	3,830
Cost Capitalized Subsequent to Acquisition	19
Gross Amount at which Carried at Close of Period
Land	1,727
Building and Improvements	2,123
Total	3,850
Accumulated Depreciation and Amortization	$ (107)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Westgate Center for Rehab & Alzheimer’s Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	229
Buildings and Improvements	7,171
Total	7,400
Cost Capitalized Subsequent to Acquisition	10
Gross Amount at which Carried at Close of Period
Land	229
Building and Improvements	7,181
Total	7,410
Accumulated Depreciation and Amortization	$ (286)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | New Orange Hills
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,163
Buildings and Improvements	14,755
Total	18,918
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,163
Building and Improvements	14,755
Total	18,918
Accumulated Depreciation and Amortization	$ (556)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Millbrook Healthcare & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	548
Buildings and Improvements	5,794
Total	6,342
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	548
Building and Improvements	5,794
Total	6,342
Accumulated Depreciation and Amortization	$ (240)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pleasant Valley Health & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,118
Buildings and Improvements	7,490
Total	8,608
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,118
Building and Improvements	7,490
Total	8,608
Accumulated Depreciation and Amortization	$ (295)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Clarksville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	279
Buildings and Improvements	4,269
Total	4,548
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	279
Building and Improvements	4,269
Total	4,548
Accumulated Depreciation and Amortization	$ (190)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | McKinney Healthcare & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,272
Buildings and Improvements	6,047
Total	7,319
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,272
Building and Improvements	6,047
Total	7,319
Accumulated Depreciation and Amortization	$ (256)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Nicholas County Nursing and Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	10
Buildings and Improvements	0
Total	10
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	10
Building and Improvements	0
Total	10
Accumulated Depreciation and Amortization	$ 0
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Hopkins
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	807
Buildings and Improvements	4,668
Total	5,475
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	807
Building and Improvements	4,668
Total	5,475
Accumulated Depreciation and Amortization	$ (222)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Village Gardens
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,299
Buildings and Improvements	1,247
Total	2,546
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,299
Building and Improvements	1,247
Total	2,546
Accumulated Depreciation and Amortization	$ (81)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Florence
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	291
Buildings and Improvements	3,778
Total	4,069
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	291
Building and Improvements	3,778
Total	4,069
Accumulated Depreciation and Amortization	$ (167)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - South Shore
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	166
Buildings and Improvements	1,887
Total	2,053
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	166
Building and Improvements	1,887
Total	2,053
Accumulated Depreciation and Amortization	$ (87)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Rochester East
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	645
Buildings and Improvements	7,067
Total	7,712
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	645
Building and Improvements	7,067
Total	7,712
Accumulated Depreciation and Amortization	$ (273)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Wisconsin Dells
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,640
Buildings and Improvements	1,599
Total	3,239
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,640
Building and Improvements	1,599
Total	3,239
Accumulated Depreciation and Amortization	$ (95)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Sheboygan
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,038
Buildings and Improvements	2,839
Total	3,877
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,038
Building and Improvements	2,839
Total	3,877
Accumulated Depreciation and Amortization	$ (143)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Azalea Gardens of Mobile
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	2,540
Total	2,540
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	2,540
Total	2,540
Accumulated Depreciation and Amortization	$ (125)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Hendersonville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,611
Buildings and Improvements	3,503
Total	5,114
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,611
Building and Improvements	3,503
Total	5,114
Accumulated Depreciation and Amortization	$ (163)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Trisun Care Center Coastal Palms
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	610
Buildings and Improvements	11,296
Total	11,906
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	610
Building and Improvements	11,296
Total	11,906
Accumulated Depreciation and Amortization	$ (414)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Trisun Care Center Westwood
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	366
Buildings and Improvements	6,961
Total	7,327
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	366
Building and Improvements	6,961
Total	7,327
Accumulated Depreciation and Amortization	$ (263)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Trisun Care Center River Ridge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	792
Buildings and Improvements	7,450
Total	8,242
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	792
Building and Improvements	7,450
Total	8,242
Accumulated Depreciation and Amortization	$ (291)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Trisun Care Center - Northeast El Paso
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,331
Buildings and Improvements	10,117
Total	11,448
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,331
Building and Improvements	10,117
Total	11,448
Accumulated Depreciation and Amortization	$ (442)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Lakeside Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,280
Buildings and Improvements	11,705
Total	12,985
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,280
Building and Improvements	11,705
Total	12,985
Accumulated Depreciation and Amortization	$ (487)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Riverside Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,626
Buildings and Improvements	4,659
Total	6,285
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,626
Building and Improvements	4,659
Total	6,285
Accumulated Depreciation and Amortization	$ (191)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Senior Care of West Oaks
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,743
Buildings and Improvements	11,189
Total	13,932
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,743
Building and Improvements	11,189
Total	13,932
Accumulated Depreciation and Amortization	$ (434)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Baytown Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	579
Buildings and Improvements	22,317
Total	22,896
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	579
Building and Improvements	22,317
Total	22,896
Accumulated Depreciation and Amortization	$ (805)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cedar Bayou Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	589
Buildings and Improvements	20,475
Total	21,064
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	589
Building and Improvements	20,475
Total	21,064
Accumulated Depreciation and Amortization	$ (763)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Mystic Park Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	721
Buildings and Improvements	7,979
Total	8,700
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	721
Building and Improvements	7,979
Total	8,700
Accumulated Depreciation and Amortization	$ (314)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Paramount Senior Care Centers at San Antonio
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	914
Buildings and Improvements	12,823
Total	13,737
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	914
Building and Improvements	12,823
Total	13,737
Accumulated Depreciation and Amortization	$ (490)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Senior Care of Westwood
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,300
Buildings and Improvements	13,353
Total	14,653
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,300
Building and Improvements	13,353
Total	14,653
Accumulated Depreciation and Amortization	$ (518)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Paramounty Senior Care Centers at Pasadena
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,148
Buildings and Improvements	23,579
Total	24,727
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,148
Building and Improvements	23,579
Total	24,727
Accumulated Depreciation and Amortization	$ (866)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Pointe Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	904
Buildings and Improvements	10,315
Total	11,219
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	904
Building and Improvements	10,315
Total	11,219
Accumulated Depreciation and Amortization	$ (409)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brodie Ranch Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	610
Buildings and Improvements	8,549
Total	9,159
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	610
Building and Improvements	8,549
Total	9,159
Accumulated Depreciation and Amortization	$ (323)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Bandera Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	691
Buildings and Improvements	4,987
Total	5,678
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	691
Building and Improvements	4,987
Total	5,678
Accumulated Depreciation and Amortization	$ (210)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | West Oaks Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,168
Buildings and Improvements	11,195
Total	12,363
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,168
Building and Improvements	11,195
Total	12,363
Accumulated Depreciation and Amortization	$ (440)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pilgrim Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	772
Buildings and Improvements	23,497
Total	24,269
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	772
Building and Improvements	23,497
Total	24,269
Accumulated Depreciation and Amortization	$ (921)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Spring Lake Campus
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	975
Buildings and Improvements	30,437
Total	31,412
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	975
Building and Improvements	30,437
Total	31,412
Accumulated Depreciation and Amortization	$ (1,188)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Bradford
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,402
Buildings and Improvements	21,494
Total	22,896
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,402
Building and Improvements	21,494
Total	22,896
Accumulated Depreciation and Amortization	$ (862)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Guest House
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,067
Buildings and Improvements	21,983
Total	23,050
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,067
Building and Improvements	21,983
Total	23,050
Accumulated Depreciation and Amortization	$ (896)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Alpine
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	691
Buildings and Improvements	22,205
Total	22,896
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	691
Building and Improvements	22,205
Total	22,896
Accumulated Depreciation and Amortization	$ (878)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Colonial Oaks
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	498
Buildings and Improvements	13,240
Total	13,738
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	498
Building and Improvements	13,240
Total	13,738
Accumulated Depreciation and Amortization	$ (538)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Shreveport Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	457
Buildings and Improvements	14,125
Total	14,582
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	457
Building and Improvements	14,125
Total	14,582
Accumulated Depreciation and Amortization	$ (565)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Booker T. Washington
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	864
Buildings and Improvements	9,286
Total	10,150
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	864
Building and Improvements	9,286
Total	10,150
Accumulated Depreciation and Amortization	$ (380)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Hill Country Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,107
Buildings and Improvements	5,402
Total	6,509
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,107
Building and Improvements	5,402
Total	6,509
Accumulated Depreciation and Amortization	$ (210)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pecan Tree Rehab & Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	315
Buildings and Improvements	9,759
Total	10,074
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	315
Building and Improvements	9,759
Total	10,074
Accumulated Depreciation and Amortization	$ (364)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Senior Care of Jacksonville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	569
Buildings and Improvements	6,300
Total	6,869
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	569
Building and Improvements	6,300
Total	6,869
Accumulated Depreciation and Amortization	$ (251)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Senior Care of San Angelo
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,565
Buildings and Improvements	12,936
Total	14,501
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,565
Building and Improvements	12,936
Total	14,501
Accumulated Depreciation and Amortization	$ (478)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Senior Care of Midland
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	528
Buildings and Improvements	2,311
Total	2,839
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	528
Building and Improvements	2,311
Total	2,839
Accumulated Depreciation and Amortization	$ (105)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Summer Place Nursing and Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	945
Buildings and Improvements	20,424
Total	21,369
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	945
Building and Improvements	20,424
Total	21,369
Accumulated Depreciation and Amortization	$ (740)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Meadows Nursing and Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	711
Buildings and Improvements	10,737
Total	11,448
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	711
Building and Improvements	10,737
Total	11,448
Accumulated Depreciation and Amortization	$ (406)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Heritage Oaks West Retirement Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	823
Buildings and Improvements	4,214
Total	5,037
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	823
Building and Improvements	4,214
Total	5,037
Accumulated Depreciation and Amortization	$ (183)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cypress Glen
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,209
Buildings and Improvements	13,444
Total	14,653
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,209
Building and Improvements	13,444
Total	14,653
Accumulated Depreciation and Amortization	$ (522)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Lake Arthur
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	396
Buildings and Improvements	7,846
Total	8,242
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	396
Building and Improvements	7,846
Total	8,242
Accumulated Depreciation and Amortization	$ (301)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Whitesburg Gardens
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	634
Buildings and Improvements	28,071
Total	28,705
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	634
Building and Improvements	28,071
Total	28,705
Accumulated Depreciation and Amortization	$ (992)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Terre Haute
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	644
Buildings and Improvements	37,451
Total	38,095
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	644
Building and Improvements	37,451
Total	38,095
Accumulated Depreciation and Amortization	$ (1,486)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare at Larkin Springs
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	902
Buildings and Improvements	3,850
Total	4,752
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	902
Building and Improvements	3,850
Total	4,752
Accumulated Depreciation and Amortization	$ (186)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Savannah
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,235
Buildings and Improvements	3,765
Total	5,000
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,235
Building and Improvements	3,765
Total	5,000
Accumulated Depreciation and Amortization	$ (191)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Bluffton
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	254
Buildings and Improvements	5,105
Total	5,359
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	254
Building and Improvements	5,105
Total	5,359
Accumulated Depreciation and Amortization	$ (219)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Bowling Green
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	280
Buildings and Improvements	13,975
Total	14,255
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	280
Building and Improvements	13,975
Total	14,255
Accumulated Depreciation and Amortization	$ (546)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Oakview Nursing and Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,176
Buildings and Improvements	7,012
Total	8,188
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,176
Building and Improvements	7,012
Total	8,188
Accumulated Depreciation and Amortization	$ (291)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Fountain Circle Care and Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	554
Buildings and Improvements	13,207
Total	13,761
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	554
Building and Improvements	13,207
Total	13,761
Accumulated Depreciation and Amortization	$ (526)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Riverside Care & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	613
Buildings and Improvements	7,643
Total	8,256
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	613
Building and Improvements	7,643
Total	8,256
Accumulated Depreciation and Amortization	$ (326)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Bremen
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	173
Buildings and Improvements	7,393
Total	7,566
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	173
Building and Improvements	7,393
Total	7,566
Accumulated Depreciation and Amortization	$ (288)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Muncie
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	374
Buildings and Improvements	27,429
Total	27,803
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	374
Building and Improvements	27,429
Total	27,803
Accumulated Depreciation and Amortization	$ (990)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare at Parkwood
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	612
Buildings and Improvements	11,755
Total	12,367
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	612
Building and Improvements	11,755
Total	12,367
Accumulated Depreciation and Amortization	$ (449)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare at Tower Road
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	364
Buildings and Improvements	16,116
Total	16,480
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	364
Building and Improvements	16,116
Total	16,480
Accumulated Depreciation and Amortization	$ (632)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Danville Centre for Health and Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	790
Buildings and Improvements	9,356
Total	10,146
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	790
Building and Improvements	9,356
Total	10,146
Accumulated Depreciation and Amortization	$ (430)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare at Hillcrest
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,048
Buildings and Improvements	22,587
Total	23,635
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,048
Building and Improvements	22,587
Total	23,635
Accumulated Depreciation and Amortization	$ (847)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Elizabethtown
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	239
Buildings and Improvements	4,853
Total	5,092
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	239
Building and Improvements	4,853
Total	5,092
Accumulated Depreciation and Amortization	$ (204)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Primacy
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,633
Buildings and Improvements	9,371
Total	11,004
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,633
Building and Improvements	9,371
Total	11,004
Accumulated Depreciation and Amortization	$ (385)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Harbour Pointe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	705
Buildings and Improvements	16,451
Total	17,156
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	705
Building and Improvements	16,451
Total	17,156
Accumulated Depreciation and Amortization	$ (698)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Harrodsburg Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,049
Buildings and Improvements	9,851
Total	10,900
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,049
Building and Improvements	9,851
Total	10,900
Accumulated Depreciation and Amortization	$ (431)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Putnam County
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,034
Buildings and Improvements	15,555
Total	16,589
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,034
Building and Improvements	15,555
Total	16,589
Accumulated Depreciation and Amortization	$ (597)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Fayette County
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	405
Buildings and Improvements	4,839
Total	5,244
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	405
Building and Improvements	4,839
Total	5,244
Accumulated Depreciation and Amortization	$ (220)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Warren
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	955
Buildings and Improvements	5,260
Total	6,215
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	955
Building and Improvements	5,260
Total	6,215
Accumulated Depreciation and Amortization	$ (280)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Galion
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	836
Buildings and Improvements	668
Total	1,504
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	836
Building and Improvements	668
Total	1,504
Accumulated Depreciation and Amortization	$ (49)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Roanoke Rapids
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	373
Buildings and Improvements	10,308
Total	10,681
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	373
Building and Improvements	10,308
Total	10,681
Accumulated Depreciation and Amortization	$ (435)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Kinston
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	954
Buildings and Improvements	7,987
Total	8,941
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	954
Building and Improvements	7,987
Total	8,941
Accumulated Depreciation and Amortization	$ (378)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Chapel Hill
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	809
Buildings and Improvements	2,703
Total	3,512
Cost Capitalized Subsequent to Acquisition	302
Gross Amount at which Carried at Close of Period
Land	809
Building and Improvements	3,005
Total	3,814
Accumulated Depreciation and Amortization	$ (181)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Chillicothe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	260
Buildings and Improvements	8,924
Total	9,184
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	260
Building and Improvements	8,924
Total	9,184
Accumulated Depreciation and Amortization	$ (389)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Coshocton
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	374
Buildings and Improvements	2,530
Total	2,904
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	374
Building and Improvements	2,530
Total	2,904
Accumulated Depreciation and Amortization	$ (149)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | McCreary Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	208
Buildings and Improvements	7,665
Total	7,873
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	208
Building and Improvements	7,665
Total	7,873
Accumulated Depreciation and Amortization	$ (304)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Colonial Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	634
Buildings and Improvements	4,094
Total	4,728
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	634
Building and Improvements	4,094
Total	4,728
Accumulated Depreciation and Amortization	$ (190)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Glasgow Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	83
Buildings and Improvements	2,057
Total	2,140
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	83
Building and Improvements	2,057
Total	2,140
Accumulated Depreciation and Amortization	$ (115)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Green Valley Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	124
Buildings and Improvements	1,693
Total	1,817
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	124
Building and Improvements	1,693
Total	1,817
Accumulated Depreciation and Amortization	$ (100)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Hart County Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	208
Buildings and Improvements	7,070
Total	7,278
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	208
Building and Improvements	7,070
Total	7,278
Accumulated Depreciation and Amortization	$ (306)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Heritage Hall Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	635
Buildings and Improvements	9,861
Total	10,496
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	635
Building and Improvements	9,861
Total	10,496
Accumulated Depreciation and Amortization	$ (397)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Jackson Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	479
Buildings and Improvements	6,078
Total	6,557
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	479
Building and Improvements	6,078
Total	6,557
Accumulated Depreciation and Amortization	$ (239)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Jefferson Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,528
Buildings and Improvements	4,653
Total	8,181
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,528
Building and Improvements	4,653
Total	8,181
Accumulated Depreciation and Amortization	$ (230)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Jefferson Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,207
Buildings and Improvements	20,733
Total	22,940
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,207
Building and Improvements	20,733
Total	22,940
Accumulated Depreciation and Amortization	$ (771)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Monroe Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	333
Buildings and Improvements	9,556
Total	9,889
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	333
Building and Improvements	9,556
Total	9,889
Accumulated Depreciation and Amortization	$ (380)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | North Hardin Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,815
Buildings and Improvements	7,470
Total	9,285
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,815
Building and Improvements	7,470
Total	9,285
Accumulated Depreciation and Amortization	$ (376)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Professional Care Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	312
Buildings and Improvements	8,189
Total	8,501
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	312
Building and Improvements	8,189
Total	8,501
Accumulated Depreciation and Amortization	$ (333)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Rockford Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	427
Buildings and Improvements	6,003
Total	6,430
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	427
Building and Improvements	6,003
Total	6,430
Accumulated Depreciation and Amortization	$ (260)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Summerfield Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,134
Buildings and Improvements	9,166
Total	10,300
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,134
Building and Improvements	9,166
Total	10,300
Accumulated Depreciation and Amortization	$ (407)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Tanbark Senior Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,558
Buildings and Improvements	4,311
Total	6,869
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,558
Building and Improvements	4,311
Total	6,869
Accumulated Depreciation and Amortization	$ (209)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Summit Manor Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	114
Buildings and Improvements	11,141
Total	11,255
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	114
Building and Improvements	11,141
Total	11,255
Accumulated Depreciation and Amortization	$ (434)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Meadowview Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	390
Buildings and Improvements	2,410
Total	2,800
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	405
Building and Improvements	2,412
Total	2,817
Accumulated Depreciation and Amortization	$ (83)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Belle View Estates Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	206
Buildings and Improvements	3,179
Total	3,385
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	206
Building and Improvements	3,179
Total	3,385
Accumulated Depreciation and Amortization	$ (148)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | River Chase Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	508
Buildings and Improvements	0
Total	508
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	508
Building and Improvements	0
Total	508
Accumulated Depreciation and Amortization	$ 0
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Heartland Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,336
Buildings and Improvements	7,386
Total	8,722
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,336
Building and Improvements	7,386
Total	8,722
Accumulated Depreciation and Amortization	$ (314)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | River Ridge Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	227
Buildings and Improvements	4,007
Total	4,234
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	227
Building and Improvements	4,007
Total	4,234
Accumulated Depreciation and Amortization	$ (172)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brookridge Cove Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	412
Buildings and Improvements	2,642
Total	3,054
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	412
Building and Improvements	2,642
Total	3,054
Accumulated Depreciation and Amortization	$ (140)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Southern Trace Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	819
Buildings and Improvements	8,938
Total	9,757
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	819
Building and Improvements	8,938
Total	9,757
Accumulated Depreciation and Amortization	$ (339)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Lake Village Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	507
Buildings and Improvements	4,838
Total	5,345
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	507
Building and Improvements	4,838
Total	5,345
Accumulated Depreciation and Amortization	$ (211)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Savannah Specialty Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,194
Buildings and Improvements	11,711
Total	13,905
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,194
Building and Improvements	11,711
Total	13,905
Accumulated Depreciation and Amortization	$ (438)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pettigrew Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	470
Buildings and Improvements	9,633
Total	10,103
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	470
Building and Improvements	9,633
Total	10,103
Accumulated Depreciation and Amortization	$ (357)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Sunnybrook Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,155
Buildings and Improvements	11,749
Total	12,904
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,155
Building and Improvements	11,749
Total	12,904
Accumulated Depreciation and Amortization	$ (446)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Raleigh Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	926
Buildings and Improvements	17,649
Total	18,575
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	926
Building and Improvements	17,649
Total	18,575
Accumulated Depreciation and Amortization	$ (658)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cypress Pointe Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	611
Buildings and Improvements	5,051
Total	5,662
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	611
Building and Improvements	5,051
Total	5,662
Accumulated Depreciation and Amortization	$ (214)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Silas Creek Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	879
Buildings and Improvements	3,283
Total	4,162
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	879
Building and Improvements	3,283
Total	4,162
Accumulated Depreciation and Amortization	$ (159)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Lincolnton Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	9,967
Total	9,967
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	9,967
Total	9,967
Accumulated Depreciation and Amortization	$ (380)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Rehabilitation and Nursing Center of Monroe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	166
Buildings and Improvements	5,906
Total	6,072
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	166
Building and Improvements	5,906
Total	6,072
Accumulated Depreciation and Amortization	$ (250)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Guardian Care of Zebulon
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	594
Buildings and Improvements	8,559
Total	9,153
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	594
Building and Improvements	8,559
Total	9,153
Accumulated Depreciation and Amortization	$ (313)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Guardian Care of Rocky Mount
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	18,314
Total	18,314
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	18,314
Total	18,314
Accumulated Depreciation and Amortization	$ (657)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | San Pedro Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	671
Buildings and Improvements	2,504
Total	3,175
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	671
Building and Improvements	2,504
Total	3,175
Accumulated Depreciation and Amortization	$ (121)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor Health Care & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	942
Buildings and Improvements	6,033
Total	6,975
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	942
Building and Improvements	6,033
Total	6,975
Accumulated Depreciation and Amortization	$ (252)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avalon Place - Trinity
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	363
Buildings and Improvements	3,852
Total	4,215
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	363
Building and Improvements	3,852
Total	4,215
Accumulated Depreciation and Amortization	$ (173)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avalon Place - Kirbyville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	208
Buildings and Improvements	5,809
Total	6,017
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	208
Building and Improvements	5,809
Total	6,017
Accumulated Depreciation and Amortization	$ (250)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Heritage House of Marshall
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	732
Buildings and Improvements	4,288
Total	5,020
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	732
Building and Improvements	4,288
Total	5,020
Accumulated Depreciation and Amortization	$ (190)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Place Health Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	310
Buildings and Improvements	1,190
Total	1,500
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	310
Building and Improvements	1,190
Total	1,500
Accumulated Depreciation and Amortization	$ (57)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Spectrum Healthcare Torrington
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	250
Buildings and Improvements	0
Total	250
Cost Capitalized Subsequent to Acquisition	10
Gross Amount at which Carried at Close of Period
Land	250
Building and Improvements	10
Total	260
Accumulated Depreciation and Amortization	$ 0
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Autumn Woods Residential Health Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,052
Buildings and Improvements	25,539
Total	27,591
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,052
Building and Improvements	25,539
Total	27,591
Accumulated Depreciation and Amortization	$ (1,054)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Autumn View Health Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,026
Buildings and Improvements	54,086
Total	55,112
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,026
Building and Improvements	54,086
Total	55,112
Accumulated Depreciation and Amortization	$ (1,952)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brookhaven Health Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,181
Buildings and Improvements	30,373
Total	32,554
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,181
Building and Improvements	30,373
Total	32,554
Accumulated Depreciation and Amortization	$ (1,153)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Harris Hill Nursing Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,122
Buildings and Improvements	46,413
Total	47,535
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,122
Building and Improvements	46,413
Total	47,535
Accumulated Depreciation and Amortization	$ (1,645)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Garden Gate Health Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,164
Buildings and Improvements	29,905
Total	31,069
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,164
Building and Improvements	29,905
Total	31,069
Accumulated Depreciation and Amortization	$ (1,123)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Northgate Health Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	830
Buildings and Improvements	29,488
Total	30,318
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	830
Building and Improvements	29,488
Total	30,318
Accumulated Depreciation and Amortization	$ (1,107)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Seneca Health Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,325
Buildings and Improvements	26,839
Total	28,164
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,325
Building and Improvements	26,839
Total	28,164
Accumulated Depreciation and Amortization	$ (989)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Blueberry Hill Rehab and Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,410
Buildings and Improvements	13,588
Total	15,998
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,410
Building and Improvements	13,588
Total	15,998
Accumulated Depreciation and Amortization	$ (673)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | River Terrace Rehabilitation and Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	343
Buildings and Improvements	7,733
Total	8,076
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	343
Building and Improvements	7,733
Total	8,076
Accumulated Depreciation and Amortization	$ (296)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Crossings West Campus
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	356
Buildings and Improvements	152
Total	508
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	356
Building and Improvements	152
Total	508
Accumulated Depreciation and Amortization	$ (13)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Crossings East Campus
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	505
Buildings and Improvements	2,248
Total	2,753
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	505
Building and Improvements	2,248
Total	2,753
Accumulated Depreciation and Amortization	$ (147)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Parkway Pavilion Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	437
Buildings and Improvements	16,461
Total	16,898
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	437
Building and Improvements	16,461
Total	16,898
Accumulated Depreciation and Amortization	$ (644)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Quincy Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	894
Buildings and Improvements	904
Total	1,798
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	894
Building and Improvements	904
Total	1,798
Accumulated Depreciation and Amortization	$ (63)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Den-Mar Health & Rebilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	1,765
Total	1,765
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	1,765
Total	1,765
Accumulated Depreciation and Amortization	$ (89)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Firesteel Healthcare Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	621
Buildings and Improvements	14,059
Total	14,680
Cost Capitalized Subsequent to Acquisition	8,636
Gross Amount at which Carried at Close of Period
Land	621
Building and Improvements	22,695
Total	23,316
Accumulated Depreciation and Amortization	$ (1,302)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Fountain Springs Healthcare Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,134
Buildings and Improvements	13,109
Total	14,243
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,134
Building and Improvements	13,109
Total	14,243
Accumulated Depreciation and Amortization	$ (490)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Palisade Healthcare Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	362
Buildings and Improvements	2,548
Total	2,910
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	362
Building and Improvements	2,548
Total	2,910
Accumulated Depreciation and Amortization	$ (123)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Shepherd of the Valley Healthcare Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	803
Buildings and Improvements	19,210
Total	20,013
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	803
Building and Improvements	19,210
Total	20,013
Accumulated Depreciation and Amortization	$ (745)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wheatcrest Hills Healthcare Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	679
Buildings and Improvements	3,216
Total	3,895
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	679
Building and Improvements	3,216
Total	3,895
Accumulated Depreciation and Amortization	$ (149)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Riverview Healthcare Community & Independent Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	240
Buildings and Improvements	6,327
Total	6,567
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	240
Building and Improvements	6,327
Total	6,567
Accumulated Depreciation and Amortization	$ (253)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Prairie View Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	383
Buildings and Improvements	2,041
Total	2,424
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	383
Building and Improvements	2,041
Total	2,424
Accumulated Depreciation and Amortization	$ (95)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Dutchess (Fishkill)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	964
Buildings and Improvements	30,107
Total	31,071
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	964
Building and Improvements	30,107
Total	31,071
Accumulated Depreciation and Amortization	$ (1,131)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Ulster (Highland)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,371
Buildings and Improvements	11,473
Total	15,844
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,371
Building and Improvements	11,473
Total	15,844
Accumulated Depreciation and Amortization	$ (465)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Beacon
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	25,400
Total	25,400
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	25,400
Total	25,400
Accumulated Depreciation and Amortization	$ (1,005)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Springfield
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	817
Buildings and Improvements	11,357
Total	12,174
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	817
Building and Improvements	11,357
Total	12,174
Accumulated Depreciation and Amortization	$ (436)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Andover
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,123
Buildings and Improvements	5,383
Total	7,506
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,123
Building and Improvements	5,383
Total	7,506
Accumulated Depreciation and Amortization	$ (237)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Reading
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,534
Buildings and Improvements	5,221
Total	6,755
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,534
Building and Improvements	5,221
Total	6,755
Accumulated Depreciation and Amortization	$ (235)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Sudbury
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,017
Buildings and Improvements	3,458
Total	5,475
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,017
Building and Improvements	3,458
Total	5,475
Accumulated Depreciation and Amortization	$ (180)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Belvidere (Lowell)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,335
Buildings and Improvements	9,019
Total	10,354
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,335
Building and Improvements	9,019
Total	10,354
Accumulated Depreciation and Amortization	$ (374)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Worcester
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	945
Buildings and Improvements	8,770
Total	9,715
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	945
Building and Improvements	8,770
Total	9,715
Accumulated Depreciation and Amortization	$ (356)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at West Springfield
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,022
Buildings and Improvements	7,345
Total	9,367
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,022
Building and Improvements	7,345
Total	9,367
Accumulated Depreciation and Amortization	$ (328)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at East Longmeadow
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,968
Buildings and Improvements	8,957
Total	11,925
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,968
Building and Improvements	8,957
Total	11,925
Accumulated Depreciation and Amortization	$ (403)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Broadway by the Sea
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,939
Buildings and Improvements	11,782
Total	14,721
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,939
Building and Improvements	11,690
Total	14,629
Accumulated Depreciation and Amortization	$ (449)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Coventry Court Health Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,044
Buildings and Improvements	14,167
Total	16,211
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,044
Building and Improvements	14,167
Total	16,211
Accumulated Depreciation and Amortization	$ (529)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Fairfield Post-Acute Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	586
Buildings and Improvements	23,582
Total	24,168
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	586
Building and Improvements	23,582
Total	24,168
Accumulated Depreciation and Amortization	$ (819)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Garden View Post-Acute Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,270
Buildings and Improvements	17,063
Total	19,333
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,270
Building and Improvements	17,063
Total	19,333
Accumulated Depreciation and Amortization	$ (625)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Grand Terrace Health Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	432
Buildings and Improvements	9,382
Total	9,814
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	432
Building and Improvements	9,382
Total	9,814
Accumulated Depreciation and Amortization	$ (346)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pacifica Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,510
Buildings and Improvements	27,397
Total	28,907
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,510
Building and Improvements	27,397
Total	28,907
Accumulated Depreciation and Amortization	$ (938)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Burien Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	823
Buildings and Improvements	17,431
Total	18,254
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	823
Building and Improvements	17,431
Total	18,254
Accumulated Depreciation and Amortization	$ (629)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park West Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,802
Buildings and Improvements	7,927
Total	12,729
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,802
Building and Improvements	7,927
Total	12,729
Accumulated Depreciation and Amortization	$ (321)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Beachside Nursing Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,312
Buildings and Improvements	9,885
Total	12,197
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,312
Building and Improvements	9,885
Total	12,197
Accumulated Depreciation and Amortization	$ (363)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Chatsworth Park Health Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	7,841
Buildings and Improvements	16,916
Total	24,757
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	7,841
Building and Improvements	16,916
Total	24,757
Accumulated Depreciation and Amortization	$ (648)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cottonwood Post-Acute Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	504
Buildings and Improvements	7,369
Total	7,873
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	504
Building and Improvements	7,369
Total	7,873
Accumulated Depreciation and Amortization	$ (285)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Danville Post-Acute Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,491
Buildings and Improvements	17,157
Total	18,648
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,491
Building and Improvements	17,157
Total	18,648
Accumulated Depreciation and Amortization	$ (615)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Lake Balboa Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,456
Buildings and Improvements	16,462
Total	18,918
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,456
Building and Improvements	16,462
Total	18,918
Accumulated Depreciation and Amortization	$ (568)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Lomita Post-Acute Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,743
Buildings and Improvements	14,734
Total	17,477
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,743
Building and Improvements	14,734
Total	17,477
Accumulated Depreciation and Amortization	$ (553)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | University Post-Acute Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,846
Buildings and Improvements	17,962
Total	20,808
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,846
Building and Improvements	17,962
Total	20,808
Accumulated Depreciation and Amortization	$ (636)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Issaquah Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	10,125
Buildings and Improvements	7,771
Total	17,896
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	10,125
Building and Improvements	7,771
Total	17,896
Accumulated Depreciation and Amortization	$ (331)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Alamitos-Belmont Rehab Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,157
Buildings and Improvements	22,067
Total	25,224
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,157
Building and Improvements	22,067
Total	25,224
Accumulated Depreciation and Amortization	$ (800)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Edgewater Skilled Nursing Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,857
Buildings and Improvements	5,878
Total	8,735
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,857
Building and Improvements	5,878
Total	8,735
Accumulated Depreciation and Amortization	$ (230)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Fairmont Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	812
Buildings and Improvements	21,059
Total	21,871
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	812
Building and Improvements	21,059
Total	21,871
Accumulated Depreciation and Amortization	$ (711)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Palm Terrace Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,717
Buildings and Improvements	13,806
Total	15,523
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,717
Building and Improvements	13,806
Total	15,523
Accumulated Depreciation and Amortization	$ (545)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Woodland Nursing & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	278
Buildings and Improvements	16,729
Total	17,007
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	278
Building and Improvements	16,729
Total	17,007
Accumulated Depreciation and Amortization	$ (598)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor at Bee Cave
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,107
Buildings and Improvements	10,413
Total	12,520
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,107
Building and Improvements	10,415
Total	12,522
Accumulated Depreciation and Amortization	$ (429)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Ramona
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,058
Buildings and Improvements	19,671
Total	21,729
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,058
Building and Improvements	19,671
Total	21,729
Accumulated Depreciation and Amortization	$ (567)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Ridge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	8,861
Buildings and Improvements	11,478
Total	20,339
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	8,861
Building and Improvements	11,478
Total	20,339
Accumulated Depreciation and Amortization	$ (369)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased
Real Estate and Accumulated Depreciation
Encumbrances	$ 29,420
Initial Cost to Company
Land	108,849
Buildings and Improvements	1,119,584
Total	1,228,433
Cost Capitalized Subsequent to Acquisition	10,576
Gross Amount at which Carried at Close of Period
Land	109,835
Building and Improvements	1,127,955
Total	1,237,790
Accumulated Depreciation and Amortization	(125,902)
Senior Housing - Leased | Forest Hills (ALF)
Initial Cost to Company
Land	1,803
Buildings and Improvements	3,927
Total	5,730
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,803
Building and Improvements	3,528
Total	5,331
Accumulated Depreciation and Amortization	$ (1,658)
Life on Which Depreciation in Latest Income Statement is Computed	30 years
Senior Housing - Leased | Langdon Place of Exeter
Real Estate and Accumulated Depreciation
Encumbrances	$ 2,965
Initial Cost to Company
Land	571
Buildings and Improvements	7,183
Total	7,754
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	571
Building and Improvements	6,208
Total	6,779
Accumulated Depreciation and Amortization	$ (2,321)
Life on Which Depreciation in Latest Income Statement is Computed	43 years
Senior Housing - Leased | Langdon Place of Nashua
Real Estate and Accumulated Depreciation
Encumbrances	$ 5,113
Initial Cost to Company
Land	0
Buildings and Improvements	5,654
Total	5,654
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	4,722
Total	4,722
Accumulated Depreciation and Amortization	$ (1,511)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Langdon Place of Keene
Real Estate and Accumulated Depreciation
Encumbrances	$ 4,335
Initial Cost to Company
Land	304
Buildings and Improvements	3,992
Total	4,296
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	304
Building and Improvements	3,533
Total	3,837
Accumulated Depreciation and Amortization	$ (1,516)
Life on Which Depreciation in Latest Income Statement is Computed	46 years
Senior Housing - Leased | Langdon Place of Dover
Real Estate and Accumulated Depreciation
Encumbrances	$ 3,683
Initial Cost to Company
Land	801
Buildings and Improvements	10,036
Total	10,837
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	801
Building and Improvements	9,083
Total	9,884
Accumulated Depreciation and Amortization	$ (3,356)
Life on Which Depreciation in Latest Income Statement is Computed	42 years
Senior Housing - Leased | Age-Well Senior Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	256
Buildings and Improvements	2,262
Total	2,518
Cost Capitalized Subsequent to Acquisition	1,032
Gross Amount at which Carried at Close of Period
Land	256
Building and Improvements	3,294
Total	3,550
Accumulated Depreciation and Amortization	$ (1,368)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | New Dawn Aurora
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,874
Buildings and Improvements	12,829
Total	15,703
Cost Capitalized Subsequent to Acquisition	6
Gross Amount at which Carried at Close of Period
Land	2,874
Building and Improvements	12,835
Total	15,709
Accumulated Depreciation and Amortization	$ (2,173)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Independence Village at Frankenmuth
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	5,027
Buildings and Improvements	20,929
Total	25,956
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	5,027
Building and Improvements	20,929
Total	25,956
Accumulated Depreciation and Amortization	$ (3,830)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Gulf Pointe Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	789
Buildings and Improvements	607
Total	1,396
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	789
Building and Improvements	607
Total	1,396
Accumulated Depreciation and Amortization	$ (180)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Aspen Ridge Retirement Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,024
Buildings and Improvements	5,467
Total	7,491
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,024
Building and Improvements	5,467
Total	7,491
Accumulated Depreciation and Amortization	$ (1,181)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Green Acres of Cadillac
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	217
Buildings and Improvements	3,000
Total	3,217
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	217
Building and Improvements	3,000
Total	3,217
Accumulated Depreciation and Amortization	$ (548)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Green Acres of Greenville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	684
Buildings and Improvements	5,832
Total	6,516
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	684
Building and Improvements	5,832
Total	6,516
Accumulated Depreciation and Amortization	$ (1,061)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Green Acres of Manistee
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	952
Buildings and Improvements	2,578
Total	3,530
Cost Capitalized Subsequent to Acquisition	2,547
Gross Amount at which Carried at Close of Period
Land	952
Building and Improvements	5,125
Total	6,077
Accumulated Depreciation and Amortization	$ (698)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Green Acres of Mason
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	198
Buildings and Improvements	4,131
Total	4,329
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	198
Building and Improvements	4,131
Total	4,329
Accumulated Depreciation and Amortization	$ (786)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Nottingham Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	744
Buildings and Improvements	1,745
Total	2,489
Cost Capitalized Subsequent to Acquisition	400
Gross Amount at which Carried at Close of Period
Land	744
Building and Improvements	2,145
Total	2,889
Accumulated Depreciation and Amortization	$ (408)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Royal View
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	307
Buildings and Improvements	2,477
Total	2,784
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	307
Building and Improvements	2,477
Total	2,784
Accumulated Depreciation and Amortization	$ (516)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Tawas Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	258
Buildings and Improvements	3,713
Total	3,971
Cost Capitalized Subsequent to Acquisition	45
Gross Amount at which Carried at Close of Period
Land	258
Building and Improvements	3,758
Total	4,016
Accumulated Depreciation and Amortization	$ (922)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Turning Brook
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	546
Buildings and Improvements	13,139
Total	13,685
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	546
Building and Improvements	13,139
Total	13,685
Accumulated Depreciation and Amortization	$ (2,150)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Greenfield of Woodstock
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	597
Buildings and Improvements	5,465
Total	6,062
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	597
Building and Improvements	5,465
Total	6,062
Accumulated Depreciation and Amortization	$ (875)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Nye Square
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	504
Buildings and Improvements	17,670
Total	18,174
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	504
Building and Improvements	17,670
Total	18,174
Accumulated Depreciation and Amortization	$ (2,489)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Meadows
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	217
Buildings and Improvements	9,906
Total	10,123
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	217
Building and Improvements	9,906
Total	10,123
Accumulated Depreciation and Amortization	$ (1,453)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Park Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 13,324
Initial Cost to Company
Land	2,300
Buildings and Improvements	21,115
Total	23,415
Cost Capitalized Subsequent to Acquisition	2,747
Gross Amount at which Carried at Close of Period
Land	2,300
Building and Improvements	23,861
Total	26,161
Accumulated Depreciation and Amortization	$ (3,596)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Parkview in Allen
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,190
Buildings and Improvements	45,767
Total	47,957
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,190
Building and Improvements	45,767
Total	47,957
Accumulated Depreciation and Amortization	$ (5,501)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Atrium At Gainesville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,139
Buildings and Improvements	44,789
Total	46,928
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,139
Building and Improvements	44,789
Total	46,928
Accumulated Depreciation and Amortization	$ (5,665)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Chateau
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,760
Buildings and Improvements	44,397
Total	47,157
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,760
Building and Improvements	44,397
Total	47,157
Accumulated Depreciation and Amortization	$ (5,408)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Gardens At Wakefield Plantation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,344
Buildings and Improvements	37,506
Total	39,850
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,344
Building and Improvements	37,506
Total	39,850
Accumulated Depreciation and Amortization	$ (4,430)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Las Brisas
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,992
Buildings and Improvements	30,909
Total	35,901
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,992
Building and Improvements	30,909
Total	35,901
Accumulated Depreciation and Amortization	$ (3,794)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Creekside Terrace
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,995
Buildings and Improvements	24,428
Total	27,423
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,995
Building and Improvements	24,428
Total	27,423
Accumulated Depreciation and Amortization	$ (3,057)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Colonial Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	805
Buildings and Improvements	26,498
Total	27,303
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	805
Building and Improvements	26,498
Total	27,303
Accumulated Depreciation and Amortization	$ (3,270)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Garden Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,325
Buildings and Improvements	20,510
Total	21,835
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,325
Building and Improvements	20,510
Total	21,835
Accumulated Depreciation and Amortization	$ (2,667)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Desert Rose
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	530
Buildings and Improvements	21,775
Total	22,305
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	530
Building and Improvements	21,775
Total	22,305
Accumulated Depreciation and Amortization	$ (2,716)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Windland South
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,996
Buildings and Improvements	19,368
Total	21,364
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,996
Building and Improvements	19,368
Total	21,364
Accumulated Depreciation and Amortization	$ (2,580)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Cedar Woods
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,403
Buildings and Improvements	18,821
Total	21,224
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,403
Building and Improvements	18,821
Total	21,224
Accumulated Depreciation and Amortization	$ (2,347)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Virginian
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,080
Buildings and Improvements	19,545
Total	20,625
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,080
Building and Improvements	19,545
Total	20,625
Accumulated Depreciation and Amortization	$ (2,470)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Monarch Estates
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,209
Buildings and Improvements	17,326
Total	20,535
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,209
Building and Improvements	17,326
Total	20,535
Accumulated Depreciation and Amortization	$ (2,249)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Village At The Falls
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,477
Buildings and Improvements	18,778
Total	20,255
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,477
Building and Improvements	18,778
Total	20,255
Accumulated Depreciation and Amortization	$ (2,434)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Holiday At The Atrium
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	978
Buildings and Improvements	18,257
Total	19,235
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	978
Building and Improvements	18,257
Total	19,235
Accumulated Depreciation and Amortization	$ (2,307)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Lake Ridge Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,152
Buildings and Improvements	17,523
Total	18,675
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,152
Building and Improvements	17,523
Total	18,675
Accumulated Depreciation and Amortization	$ (2,262)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Heritage Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,092
Buildings and Improvements	13,823
Total	17,915
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,092
Building and Improvements	13,823
Total	17,915
Accumulated Depreciation and Amortization	$ (1,850)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Madison Meadows
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,567
Buildings and Improvements	12,029
Total	14,596
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,567
Building and Improvements	12,029
Total	14,596
Accumulated Depreciation and Amortization	$ (1,650)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | South Wind Heights
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,782
Buildings and Improvements	11,244
Total	13,026
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,782
Building and Improvements	11,244
Total	13,026
Accumulated Depreciation and Amortization	$ (1,519)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Harrison Regent
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	794
Buildings and Improvements	10,873
Total	11,667
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	794
Building and Improvements	10,873
Total	11,667
Accumulated Depreciation and Amortization	$ (1,413)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Avalon MC - Boat Club
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	359
Buildings and Improvements	8,126
Total	8,485
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	359
Building and Improvements	8,126
Total	8,485
Accumulated Depreciation and Amortization	$ (991)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Avalon MC - 7200
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	123
Buildings and Improvements	4,914
Total	5,037
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	123
Building and Improvements	4,914
Total	5,037
Accumulated Depreciation and Amortization	$ (601)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Avalon MC - 7204
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	215
Buildings and Improvements	4,821
Total	5,036
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	215
Building and Improvements	4,822
Total	5,037
Accumulated Depreciation and Amortization	$ (593)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Avalon MC - 7140
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	143
Buildings and Improvements	6,653
Total	6,796
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	143
Building and Improvements	6,653
Total	6,796
Accumulated Depreciation and Amortization	$ (794)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Delaney Creek Lodge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,283
Buildings and Improvements	8,424
Total	9,707
Cost Capitalized Subsequent to Acquisition	483
Gross Amount at which Carried at Close of Period
Land	1,283
Building and Improvements	8,907
Total	10,190
Accumulated Depreciation and Amortization	$ (1,141)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Nature Coast Lodge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,031
Buildings and Improvements	5,577
Total	6,608
Cost Capitalized Subsequent to Acquisition	452
Gross Amount at which Carried at Close of Period
Land	1,031
Building and Improvements	6,030
Total	7,061
Accumulated Depreciation and Amortization	$ (874)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | West Winds
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,688
Buildings and Improvements	9,098
Total	10,786
Cost Capitalized Subsequent to Acquisition	360
Gross Amount at which Carried at Close of Period
Land	1,688
Building and Improvements	9,459
Total	11,147
Accumulated Depreciation and Amortization	$ (1,341)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Capital Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,477
Buildings and Improvements	23,767
Total	26,244
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,477
Building and Improvements	23,767
Total	26,244
Accumulated Depreciation and Amortization	$ (2,936)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Tudor Heights
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	561
Buildings and Improvements	4,865
Total	5,426
Cost Capitalized Subsequent to Acquisition	1,139
Gross Amount at which Carried at Close of Period
Land	561
Building and Improvements	6,006
Total	6,567
Accumulated Depreciation and Amortization	$ (933)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Life’s Journey of Mattoon
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	812
Buildings and Improvements	6,796
Total	7,608
Cost Capitalized Subsequent to Acquisition	63
Gross Amount at which Carried at Close of Period
Land	812
Building and Improvements	6,859
Total	7,671
Accumulated Depreciation and Amortization	$ (763)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Life’s Journey of Pana
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	154
Buildings and Improvements	2,098
Total	2,252
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	154
Building and Improvements	2,098
Total	2,252
Accumulated Depreciation and Amortization	$ (264)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Life’s Journey of Taylorville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	267
Buildings and Improvements	5,201
Total	5,468
Cost Capitalized Subsequent to Acquisition	50
Gross Amount at which Carried at Close of Period
Land	267
Building and Improvements	5,252
Total	5,519
Accumulated Depreciation and Amortization	$ (586)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Life’s Journey of Paris
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	132
Buildings and Improvements	3,090
Total	3,222
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	132
Building and Improvements	3,090
Total	3,222
Accumulated Depreciation and Amortization	$ (310)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Ashley Pointe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,559
Buildings and Improvements	9,059
Total	10,618
Cost Capitalized Subsequent to Acquisition	47
Gross Amount at which Carried at Close of Period
Land	1,559
Building and Improvements	9,105
Total	10,664
Accumulated Depreciation and Amortization	$ (905)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Farmington Square Eugene
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,428
Buildings and Improvements	16,138
Total	17,566
Cost Capitalized Subsequent to Acquisition	77
Gross Amount at which Carried at Close of Period
Land	1,428
Building and Improvements	16,214
Total	17,642
Accumulated Depreciation and Amortization	$ (1,428)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Farmington Square Tualatin
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	527
Buildings and Improvements	14,659
Total	15,186
Cost Capitalized Subsequent to Acquisition	12
Gross Amount at which Carried at Close of Period
Land	527
Building and Improvements	14,672
Total	15,199
Accumulated Depreciation and Amortization	$ (1,305)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Farmington Square of Salem
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,074
Buildings and Improvements	19,421
Total	20,495
Cost Capitalized Subsequent to Acquisition	253
Gross Amount at which Carried at Close of Period
Land	1,074
Building and Improvements	19,674
Total	20,748
Accumulated Depreciation and Amortization	$ (1,786)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Colorado Springs
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,210
Buildings and Improvements	9,490
Total	10,700
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,210
Building and Improvements	9,490
Total	10,700
Accumulated Depreciation and Amortization	$ (887)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Sun City West
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	930
Buildings and Improvements	9,170
Total	10,100
Cost Capitalized Subsequent to Acquisition	248
Gross Amount at which Carried at Close of Period
Land	930
Building and Improvements	9,418
Total	10,348
Accumulated Depreciation and Amortization	$ (710)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Poet’s Walk at Fredericksburg
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,379
Buildings and Improvements	21,209
Total	22,588
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,379
Building and Improvements	21,209
Total	22,588
Accumulated Depreciation and Amortization	$ (1,548)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Poet’s Walk at Chandler Oaks
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	679
Buildings and Improvements	13,642
Total	14,321
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	679
Building and Improvements	13,642
Total	14,321
Accumulated Depreciation and Amortization	$ (989)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Montecito Santa Fe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,536
Buildings and Improvements	19,441
Total	21,977
Cost Capitalized Subsequent to Acquisition	518
Gross Amount at which Carried at Close of Period
Land	2,729
Building and Improvements	21,483
Total	24,212
Accumulated Depreciation and Amortization	$ (1,358)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Golden Crest
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	292
Buildings and Improvements	6,889
Total	7,181
Cost Capitalized Subsequent to Acquisition	97
Gross Amount at which Carried at Close of Period
Land	292
Building and Improvements	6,996
Total	7,288
Accumulated Depreciation and Amortization	$ (495)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Poet’s Walk at Henderson
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,430
Buildings and Improvements	21,850
Total	23,280
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,430
Building and Improvements	21,862
Total	23,292
Accumulated Depreciation and Amortization	$ (1,297)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Kruse Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	476
Buildings and Improvements	11,912
Total	12,388
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	476
Building and Improvements	11,922
Total	12,398
Accumulated Depreciation and Amortization	$ (810)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Poet’s Walk of Cedar Parks
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,035
Buildings and Improvements	13,127
Total	14,162
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,035
Building and Improvements	13,127
Total	14,162
Accumulated Depreciation and Amortization	$ (612)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Avamere Court at Keizer
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,220
Buildings and Improvements	31,783
Total	33,003
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,220
Building and Improvements	31,783
Total	33,003
Accumulated Depreciation and Amortization	$ (1,144)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Arbor Court Retirement Community at Alvamar
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	584
Buildings and Improvements	4,431
Total	5,015
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	584
Building and Improvements	4,431
Total	5,015
Accumulated Depreciation and Amortization	$ (179)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Arbor Court Retirement Community at Salina
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	584
Buildings and Improvements	3,020
Total	3,604
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	584
Building and Improvements	3,020
Total	3,604
Accumulated Depreciation and Amortization	$ (121)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Arbor Court Retirement Community at Topeka
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	313
Buildings and Improvements	5,492
Total	5,805
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	313
Building and Improvements	5,492
Total	5,805
Accumulated Depreciation and Amortization	$ (204)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Summit West
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	996
Buildings and Improvements	4,401
Total	5,397
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	996
Building and Improvements	4,401
Total	5,397
Accumulated Depreciation and Amortization	$ (184)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Crownpointe of Carmel
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,107
Buildings and Improvements	1,532
Total	2,639
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,107
Building and Improvements	1,532
Total	2,639
Accumulated Depreciation and Amortization	$ (62)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Crown Pointe Senior Living Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	396
Buildings and Improvements	7,425
Total	7,821
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	396
Building and Improvements	7,425
Total	7,821
Accumulated Depreciation and Amortization	$ (270)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Lakeview Commons Assisted Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	213
Buildings and Improvements	1,282
Total	1,495
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	213
Building and Improvements	1,282
Total	1,495
Accumulated Depreciation and Amortization	$ (45)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Azalea Hills
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,256
Buildings and Improvements	14,118
Total	16,374
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,256
Building and Improvements	14,118
Total	16,374
Accumulated Depreciation and Amortization	$ (511)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Lakeside ALF
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,158
Buildings and Improvements	2,536
Total	3,694
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,158
Building and Improvements	2,536
Total	3,694
Accumulated Depreciation and Amortization	$ (131)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Heritage Oaks Retirement Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,300
Buildings and Improvements	14,406
Total	15,706
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,300
Building and Improvements	14,406
Total	15,706
Accumulated Depreciation and Amortization	$ (554)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Aspen Grove Assisted Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	555
Buildings and Improvements	6,487
Total	7,042
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	555
Building and Improvements	6,487
Total	7,042
Accumulated Depreciation and Amortization	$ (265)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Maurice Griffith Manor Living Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	294
Buildings and Improvements	72
Total	366
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	294
Building and Improvements	72
Total	366
Accumulated Depreciation and Amortization	$ (5)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Peaks at Old Laramie Trail (Lafayette)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,085
Buildings and Improvements	19,243
Total	20,328
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,878
Building and Improvements	19,196
Total	21,074
Accumulated Depreciation and Amortization	$ (676)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Prairie View
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	263
Buildings and Improvements	3,743
Total	4,006
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	263
Building and Improvements	3,743
Total	4,006
Accumulated Depreciation and Amortization	$ (109)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Arbor View Assisted Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,019
Buildings and Improvements	3,606
Total	4,625
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,019
Building and Improvements	3,606
Total	4,625
Accumulated Depreciation and Amortization	$ (75)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Legacy Assisted Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	661
Buildings and Improvements	5,680
Total	6,341
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	661
Building and Improvements	5,680
Total	6,341
Accumulated Depreciation and Amortization	$ (109)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Greenfield of Strasburg
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	666
Buildings and Improvements	5,551
Total	6,217
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	666
Building and Improvements	5,551
Total	6,217
Accumulated Depreciation and Amortization	$ (109)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Poets Walk of Sarasota
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,440
Buildings and Improvements	22,541
Total	23,981
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,440
Building and Improvements	22,541
Total	23,981
Accumulated Depreciation and Amortization	$ (365)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Pointe at Lifespring
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,603
Buildings and Improvements	9,219
Total	10,822
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,603
Building and Improvements	9,219
Total	10,822
Accumulated Depreciation and Amortization	$ (103)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Shavano Park Senior Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,131
Buildings and Improvements	11,541
Total	13,672
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,131
Building and Improvements	11,541
Total	13,672
Accumulated Depreciation and Amortization	$ (118)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Traditions of Beavercreek
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,622
Buildings and Improvements	24,215
Total	25,837
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,622
Building and Improvements	24,215
Total	25,837
Accumulated Depreciation and Amortization	$ (121)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed
Real Estate and Accumulated Depreciation
Encumbrances	$ 16,085
Initial Cost to Company
Land	25,487
Buildings and Improvements	275,009
Total	300,496
Cost Capitalized Subsequent to Acquisition	3,854
Gross Amount at which Carried at Close of Period
Land	24,731
Building and Improvements	277,008
Total	301,739
Accumulated Depreciation and Amortization	(19,537)
Senior Housing - Managed | Stoney River Marshfield
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	574
Buildings and Improvements	8,733
Total	9,307
Cost Capitalized Subsequent to Acquisition	92
Gross Amount at which Carried at Close of Period
Land	574
Building and Improvements	8,825
Total	9,399
Accumulated Depreciation and Amortization	$ (1,541)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Kensington Court
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,360
Buildings and Improvements	16,855
Total	18,215
Cost Capitalized Subsequent to Acquisition	383
Gross Amount at which Carried at Close of Period
Land	1,341
Building and Improvements	17,002
Total	18,343
Accumulated Depreciation and Amortization	$ (1,783)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Masonville Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	960
Buildings and Improvements	19,056
Total	20,016
Cost Capitalized Subsequent to Acquisition	231
Gross Amount at which Carried at Close of Period
Land	947
Building and Improvements	19,020
Total	19,967
Accumulated Depreciation and Amortization	$ (1,959)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Okanagan Chateau
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,321
Buildings and Improvements	8,308
Total	10,629
Cost Capitalized Subsequent to Acquisition	449
Gross Amount at which Carried at Close of Period
Land	2,288
Building and Improvements	8,641
Total	10,929
Accumulated Depreciation and Amortization	$ (996)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Court at Laurelwood
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,823
Buildings and Improvements	22,135
Total	23,958
Cost Capitalized Subsequent to Acquisition	146
Gross Amount at which Carried at Close of Period
Land	1,797
Building and Improvements	21,972
Total	23,769
Accumulated Depreciation and Amortization	$ (2,234)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Fairwinds Lodge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,187
Buildings and Improvements	20,346
Total	21,533
Cost Capitalized Subsequent to Acquisition	179
Gross Amount at which Carried at Close of Period
Land	1,170
Building and Improvements	20,241
Total	21,411
Accumulated Depreciation and Amortization	$ (2,072)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | The Shores
Real Estate and Accumulated Depreciation
Encumbrances	$ 4,889
Initial Cost to Company
Land	679
Buildings and Improvements	8,024
Total	8,703
Cost Capitalized Subsequent to Acquisition	97
Gross Amount at which Carried at Close of Period
Land	669
Building and Improvements	8,009
Total	8,678
Accumulated Depreciation and Amortization	$ (862)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Orchard Valley
Real Estate and Accumulated Depreciation
Encumbrances	$ 6,509
Initial Cost to Company
Land	843
Buildings and Improvements	10,724
Total	11,567
Cost Capitalized Subsequent to Acquisition	118
Gross Amount at which Carried at Close of Period
Land	266
Building and Improvements	10,692
Total	10,958
Accumulated Depreciation and Amortization	$ (1,083)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Cherry Park
Real Estate and Accumulated Depreciation
Encumbrances	$ 4,687
Initial Cost to Company
Land	763
Buildings and Improvements	6,771
Total	7,534
Cost Capitalized Subsequent to Acquisition	412
Gross Amount at which Carried at Close of Period
Land	753
Building and Improvements	7,089
Total	7,842
Accumulated Depreciation and Amortization	$ (730)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Maison Senior Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,908
Buildings and Improvements	20,996
Total	24,904
Cost Capitalized Subsequent to Acquisition	219
Gross Amount at which Carried at Close of Period
Land	3,857
Building and Improvements	20,918
Total	24,775
Accumulated Depreciation and Amortization	$ (1,874)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Ramsey
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,182
Buildings and Improvements	13,280
Total	14,462
Cost Capitalized Subsequent to Acquisition	30
Gross Amount at which Carried at Close of Period
Land	1,182
Building and Improvements	13,315
Total	14,497
Accumulated Depreciation and Amortization	$ (504)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Marshfield II
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	500
Buildings and Improvements	4,134
Total	4,634
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	500
Building and Improvements	4,139
Total	4,639
Accumulated Depreciation and Amortization	$ (176)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Dover Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,797
Buildings and Improvements	23,054
Total	25,851
Cost Capitalized Subsequent to Acquisition	49
Gross Amount at which Carried at Close of Period
Land	2,797
Building and Improvements	23,103
Total	25,900
Accumulated Depreciation and Amortization	$ (685)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Kanawha Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	419
Buildings and Improvements	4,239
Total	4,658
Cost Capitalized Subsequent to Acquisition	249
Gross Amount at which Carried at Close of Period
Land	419
Building and Improvements	4,488
Total	4,907
Accumulated Depreciation and Amortization	$ (171)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Leighton Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	296
Buildings and Improvements	9,191
Total	9,487
Cost Capitalized Subsequent to Acquisition	122
Gross Amount at which Carried at Close of Period
Land	296
Building and Improvements	9,313
Total	9,609
Accumulated Depreciation and Amortization	$ (287)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Maidencreek Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	684
Buildings and Improvements	12,950
Total	13,634
Cost Capitalized Subsequent to Acquisition	13
Gross Amount at which Carried at Close of Period
Land	684
Building and Improvements	12,963
Total	13,647
Accumulated Depreciation and Amortization	$ (397)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Rolling Meadows Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	230
Buildings and Improvements	6,271
Total	6,501
Cost Capitalized Subsequent to Acquisition	193
Gross Amount at which Carried at Close of Period
Land	230
Building and Improvements	6,464
Total	6,694
Accumulated Depreciation and Amortization	$ (232)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Willowbrook Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	406
Buildings and Improvements	9,471
Total	9,877
Cost Capitalized Subsequent to Acquisition	219
Gross Amount at which Carried at Close of Period
Land	406
Building and Improvements	9,690
Total	10,096
Accumulated Depreciation and Amortization	$ (320)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Wyncote Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,781
Buildings and Improvements	4,911
Total	6,692
Cost Capitalized Subsequent to Acquisition	137
Gross Amount at which Carried at Close of Period
Land	1,781
Building and Improvements	5,048
Total	6,829
Accumulated Depreciation and Amortization	$ (196)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Amity Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	611
Buildings and Improvements	19,083
Total	19,694
Cost Capitalized Subsequent to Acquisition	25
Gross Amount at which Carried at Close of Period
Land	611
Building and Improvements	19,108
Total	19,719
Accumulated Depreciation and Amortization	$ (551)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Milford Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,199
Buildings and Improvements	18,786
Total	19,985
Cost Capitalized Subsequent to Acquisition	100
Gross Amount at which Carried at Close of Period
Land	1,199
Building and Improvements	18,886
Total	20,085
Accumulated Depreciation and Amortization	$ (557)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Oak Hill Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	609
Buildings and Improvements	2,636
Total	3,245
Cost Capitalized Subsequent to Acquisition	95
Gross Amount at which Carried at Close of Period
Land	609
Building and Improvements	2,731
Total	3,340
Accumulated Depreciation and Amortization	$ (126)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Seasons Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	355
Buildings and Improvements	5,055
Total	5,410
Cost Capitalized Subsequent to Acquisition	296
Gross Amount at which Carried at Close of Period
Land	355
Building and Improvements	5,351
Total	5,706
Accumulated Depreciation and Amortization	$ (201)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	75,619
Buildings and Improvements	538,451
Total	614,070
Cost Capitalized Subsequent to Acquisition	7,168
Gross Amount at which Carried at Close of Period
Land	75,619
Building and Improvements	545,617
Total	621,236
Accumulated Depreciation and Amortization	(31,640)
Specialty Hospitals and Other | Texas Regional Medical Center
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,020
Buildings and Improvements	57,620
Total	61,640
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,020
Building and Improvements	57,620
Total	61,640
Accumulated Depreciation and Amortization	$ (14,081)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Baylor Orthopedic Spine Hospital at Arlington
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	44,217
Total	44,217
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	44,217
Total	44,217
Accumulated Depreciation and Amortization	$ (1,515)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Touchstone Neurorecovery Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,935
Buildings and Improvements	25,003
Total	27,938
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,935
Building and Improvements	25,003
Total	27,938
Accumulated Depreciation and Amortization	$ (968)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | HealthBridge Children’s Hospital (Houston)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,001
Buildings and Improvements	14,581
Total	17,582
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,001
Building and Improvements	14,581
Total	17,582
Accumulated Depreciation and Amortization	$ (509)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Nexus Speciality Hospital - Woodlands Campus
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,319
Buildings and Improvements	15,153
Total	16,472
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,319
Building and Improvements	15,153
Total	16,472
Accumulated Depreciation and Amortization	$ (530)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | HealthBridge Children’s Hospital (Orange)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,060
Buildings and Improvements	5,538
Total	7,598
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,060
Building and Improvements	5,538
Total	7,598
Accumulated Depreciation and Amortization	$ (202)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Texas Hill Country School
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	902
Buildings and Improvements	2,384
Total	3,286
Cost Capitalized Subsequent to Acquisition	1
Gross Amount at which Carried at Close of Period
Land	902
Building and Improvements	2,385
Total	3,287
Accumulated Depreciation and Amortization	$ (97)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Chaparral
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	901
Buildings and Improvements	1,198
Total	2,099
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	901
Building and Improvements	1,198
Total	2,099
Accumulated Depreciation and Amortization	$ (59)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Sierra Verde & Roca Vista
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	456
Buildings and Improvements	2,632
Total	3,088
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	456
Building and Improvements	2,632
Total	3,088
Accumulated Depreciation and Amortization	$ (100)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - 618 W. Hutchinson
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	51
Buildings and Improvements	359
Total	410
Cost Capitalized Subsequent to Acquisition	62
Gross Amount at which Carried at Close of Period
Land	51
Building and Improvements	421
Total	472
Accumulated Depreciation and Amortization	$ (40)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Ranch
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	539
Buildings and Improvements	2,627
Total	3,166
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	539
Building and Improvements	2,627
Total	3,166
Accumulated Depreciation and Amortization	$ (127)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Mesquite
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	228
Buildings and Improvements	3,407
Total	3,635
Cost Capitalized Subsequent to Acquisition	79
Gross Amount at which Carried at Close of Period
Land	228
Building and Improvements	3,486
Total	3,714
Accumulated Depreciation and Amortization	$ (141)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Hacienda
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	104
Buildings and Improvements	2,788
Total	2,892
Cost Capitalized Subsequent to Acquisition	27
Gross Amount at which Carried at Close of Period
Land	104
Building and Improvements	2,813
Total	2,917
Accumulated Depreciation and Amortization	$ (104)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Loma Linda
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	52
Buildings and Improvements	805
Total	857
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	52
Building and Improvements	805
Total	857
Accumulated Depreciation and Amortization	$ (33)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora Chicago Lakeshore Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	8,574
Buildings and Improvements	39,732
Total	48,306
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	8,574
Building and Improvements	39,732
Total	48,306
Accumulated Depreciation and Amortization	$ (1,472)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora Arizona West
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,501
Buildings and Improvements	67,046
Total	68,547
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,501
Building and Improvements	67,046
Total	68,547
Accumulated Depreciation and Amortization	$ (2,345)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora Arizona East
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,137
Buildings and Improvements	50,073
Total	53,210
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,137
Building and Improvements	50,073
Total	53,210
Accumulated Depreciation and Amortization	$ (1,791)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora Charter Oak Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	23,472
Buildings and Improvements	71,542
Total	95,014
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	23,472
Building and Improvements	71,542
Total	95,014
Accumulated Depreciation and Amortization	$ (2,600)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora Vista del Mar Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	8,089
Buildings and Improvements	43,645
Total	51,734
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	8,089
Building and Improvements	43,645
Total	51,734
Accumulated Depreciation and Amortization	$ (1,724)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora San Diego Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	8,403
Buildings and Improvements	55,015
Total	63,418
Cost Capitalized Subsequent to Acquisition	6,999
Gross Amount at which Carried at Close of Period
Land	8,403
Building and Improvements	62,014
Total	70,417
Accumulated Depreciation and Amortization	$ (2,022)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Gateway Rehabilitation Hospital at Florence
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,866
Buildings and Improvements	26,447
Total	30,313
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,866
Building and Improvements	26,447
Total	30,313
Accumulated Depreciation and Amortization	$ (923)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Highlands Regional Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,009
Buildings and Improvements	6,639
Total	8,648
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,009
Building and Improvements	6,639
Total	8,648
Accumulated Depreciation and Amortization	$ (257)
Life on Which Depreciation in Latest Income Statement is Computed	40 years

SCHEDULE III - REAL ESTATE AS_3

SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION - Rollforward of Real Estate and Accumulated Depreciation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Real estate:
Balance at the beginning of the year	$ 6,334,855	$ 2,292,751	$ 2,277,457
Acquisitions	262,605	4,145,977	150,782
Real estate acquired through loan receivable foreclosure	0	19,096	10,100
Improvements	27,697	6,954	1,003
Impairment	(1,576)	(2,211)	(39,058)
Sale of real estate	(351,922)	(133,897)	(107,930)
Foreign currency translation	(12,639)	10,556	4,623
Write-off of fully depreciated assets	(3,137)	(4,371)	(4,226)
Balance at the end of the year	6,255,883	6,334,855	2,292,751
Accumulated depreciation:
Balance at the beginning of the year	(340,423)	(282,812)	(237,841)
Depreciation expense	(174,398)	(101,198)	(64,463)
Impairment	163	885	9,247
Sale of real estate	108,122	38,914	6,023
Foreign currency translation	1,061	(583)	(4)
Write-off of fully depreciated assets	3,137	4,371	4,226
Balance at the end of the year	$ (402,338)	$ (340,423)	$ (282,812)

SCHEDULE IV - MORTGAGE LOANS _2

SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Prior Liens				$ 0
Principal Balance	$ 16,033	$ 39,026	$ 241,038	23,146
Book Value				23,206
Aggregate cost for federal income tax purposes				23,300
SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward]
Balance at the beginning of the year	16,033	39,026	241,038
Additions during period:
Draws	10,943	1,738	0
New mortgage loans	0	12,987	3,767
Interest income added to principal	1,528	539	690
Deductions during period:
Paydowns/repayments	(5,358)	(14,570)	(193,075)
Conversion to real property	0	(19,085)	(10,100)
Write-offs	0	(4,602)	(3,294)
Balance at the end of the year	$ 23,146	$ 16,033	$ 39,026
Mortgages | River Vista
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Contractual Interest Rate	10.00%
Prior Liens				0
Principal Balance	$ 18,577			18,577
Book Value				18,577
Deductions during period:
Balance at the end of the year	$ 18,577
Construction Mortgages | McKinney
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Contractual Interest Rate	8.00%
Prior Liens				0
Principal Balance	$ 3,513			3,513
Book Value				3,551
Deductions during period:
Balance at the end of the year	$ 3,513
Construction Mortgages | Arlington
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Contractual Interest Rate	8.00%
Prior Liens				0
Principal Balance	$ 1,056			1,056
Book Value				$ 1,078
Deductions during period:
Balance at the end of the year	$ 1,056